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Abstract
Lymph nodes contain complex vascular networks composed of lymphatic and blood
vessels. The blood vasculature contains specialised high endothelial venules func-
tioning to permit the eﬃcient entry of blood-borne lymphocytes into the node, while
the lymphatics contain antigen-presenting cells draining from tissues. In contrast
to the well understood cellular interactions and signalling mechanisms driving de-
velopment of the stromal networks upon which immune cell interactions occur, the
processes bywhich the complex vascular networks develop are poorly characterised.
This study aimed to determine the mechanisms by which vascularisation of lymph
node anlagen occurs during development.
The structure of developing lymph nodes was studied using confocal microscopy
to observe the organisation of basement membranes and the diﬀerent cell types in-
volved in the process. Expression of angiogenesis-related genes was studied using
quantitative real-time PCR and microarrays. No evidence for vascularisation of the
anlagen was found, though the markers used may not have stained nascent vessels.
The lymph sac surrounding the anlagen was shown to exist as a two-layered struc-
ture composed of anastomosing blood and lymphatic endothelium.
In vitromodels of vasculogenesis and angiogenesis were developed utilising hu-
man umbilical vein endothelial cells in three dimensional collagen gels, with and
without smooth muscle coverage. A spheroid-based model of angiogenesis was
used to study the net angiogenic environment in developing E14.5–E17.5 anlagen,
which determined that a net anti-angiogenic environment existed at all timepoints
in the lymph nodes and thymus, but not skin. Additionally, tensional forces were
observed to aﬀect angiogenic sprouting in addition to soluble growth factors.
As a consequence of the double-layered lymph sac observed in vitro, and the in-
ﬂuence of anti-angiogenic factors and tensional forces observed ex vivo, a model of
lymph node development involving anlagen patterning and vascularisation as a res-
ult of condensation-induced tensional forces was proposed, complementary to sol-
uble growth factor-driven angiogenesis.
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Chapter 1
Introduction
1.1 Background to project
During embryonic development, the embryo undergoes many changes as it grows,
from the general patterning of body axes to the diﬀerentiation of cells into the spe-
cialised types which will fulﬁl a unique role in the diﬀerent organs of the developed
adult. In addition to tissues and organs located at speciﬁc sites in the body, the
nervous and vascular systems initially develop in a limited number of locations, but
then proceed to migrate and ramify thoughout the body to give rise to the fully-
developednervous, blood and lymphatic vascular systems found in the adult (Adams
and Alitalo, 2007). The process of vascular development has been studied in great
detail, and today many of the key signalling molecules, receptors and cell types in-
volved are well known. However, the majority of this work has used model systems
such as the murine eye, chick chorioallantoic membrane, and zebraﬁsh, as well as
various simple in vitromodels (Bishop, Bell et al., 1999; Eichmann, Yuan et al., 2005b;
Gerhardt, Golding et al., 2003; Vailhé, Vittet et al., 2001). While these systems have
been useful in the dissection of the signalling pathways, and the identiﬁcation of the
various molecules involved, the processes and mechanisms by which organs of the
mammalian body become vascularised during development have been subjected to
comparatively little investigation.
Lymph nodes (LNs) are secondary lymphoid organs, whose purpose is under-
stood to be the enabling of eﬃcient interaction between cells of the immune sys-
tem, including antigen presenting cells (APCs) such as dendritic cells and macro-
phages (MØs), and T and B lymphocytes, in order to eﬀectively initiate an immune
response (Creusot, Mitchison et al., 2002). Without the existence of such organs, the
chance of an encounter of a T cell with an APC or B cell bearing an antigen speciﬁc
for its T cell receptor is relatively small. The structure and organisation of a lymph
node is related to its highly specialised function (Willard-Mack, 2006), and the cellu-
lar interactions andmolecularmechanisms governing the development of secondary
lymphoid organs are now well established (van de Pavert and Mebius, 2010). How-
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ever, two major gaps remain. Firstly, the events which establish the speciﬁc sites of
development are yet to be determined, though the subsequent steps involving de-
velopment of the stroma and recruitment are well understood. The second gap is
in our understanding of how the resulting structure is vascularised. The developed
node is highly vascularised, containing an elaborate network of specialised high en-
dothelial venules critical for its function, yet how this vascular network is established
is not clear. Likewise, the node is also connected to aﬀerent and eﬀerent vessels of
the lymphatic system, and while the node develops in the context of a lymph sac,
how this is connected to the lymphatic system is also poorly understood.
LN development in vivo provides much information regarding changes in cellu-
lar organisation and structure over time (Mebius, 2003; van de Pavert and Mebius,
2010). However, dissecting the speciﬁc cellular interactions and signalling pathways
involved is rather diﬃcult, if not intractable, due to diﬃculties in manipulating a
very complex system. While much work identifying the molecular players involved
in vascular development has used animal models and selective knockout of genes
to elucidate their function, in many cases the signalling pathways and mechanisms
involved are not tractable in vivo, the principal problem being that a nonfunctional
vascular system is simply incompatible with life past a certain developmental point,
and hence many knockouts are embryonic lethal, resulting for example in œdema
and hæmorrhage (Aszódi, Legate et al., 2006). Of the genes discussed in the con-
text of angiogenesis and LN development, only the Vegfa and Dll4 genes are het-
erozygous lethal, in the case of Vegfa due to haploinsuﬃciency, and in the case
of Dll4 with incomplete penetrance, having complete lethality only on an inbred
background(Carmeliet, Ferreira et al., 1996; Ferrara, Carver-Moore et al., 1996; Gale,
Dominguez et al., 2004). Nevertheless, in vivo models have been essential for the
identication of the key components of signalling pathways aﬀecting angiogenesis
and LN development, and will continue to play an important role, particularly with
the generation of mice with mutated or knocked-out genes as new genes are identi-
ﬁed which may aﬀect these processes. While useful, no in vitromodel can replace in
vivo models for the study of the functional role of particular genes and proteins in
the context of a complete, living organism. However, an in vitromodel of angiogen-
esis would allow the dissection of speciﬁc signalling pathways with an absent or
reduced requirement for a functional vascular system, and hence permit the iden-
tiﬁcation and study of mechanisms which are not feasible using in vivo models. In
order to understand the developmental processes which drive the vascularisation of
LNs, in vitromodellingmay provide new insights into themechanisms involved, due
to such systems being readily amenable to manipulation, and additionally allowing
single aspects to be studied in relative isolation.
In order for the process of LN vascularisation to be understood in context, the
structure and organisation of the vascular systemwill be discussed in brief, followed
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by the processes of vasculogenesis and angiogenesis which underlie its development
and maintenance. The structure and function of the lymph node and our current
understanding of the mechanisms underlying its development will then be covered.
The genes and proteins relating to vascular and lymphoid development and function
referred to in this and later chapters are summarised in Table 1.1.
1.2 The vascular system
The primary purpose of the vascular system is to deliver oxygen and nutrients to
tissues, without which a tissue could be no larger than approximately 1 µm3 due
to oxygen diﬀusion being a limiting factor, resulting in hypoxia and necrosis in the
centre of larger tissues (Chan and Giaccia, 2007). Inter-tissue signals are additionally
communicated via the vascular system, through the delivery of endocrine signals
such as hormones and growth factors, and the delivery of cells from one tissue to
another.
1.2.1 Organisation, structure and function
The mammalian vascular system is responsible for the transport of ﬂuid in the body,
and is divided into two major compartments, the blood and lymphatic vasculature.
The blood vascular system circulates blood, which actively pumped by the heart
muscle, while the lymphatic vascular systempassively drains lymph from tissues, ul-
timately returning the drained ﬂuid to the blood circulation as the lymphatics empty
into the subclavian vein (Lewis, 1905; Oliver, 2004).
The blood transports water, ions, oxygen, metabolites and cells to almost every
part of the body, and removes the waste products of metabolism, carbon dioxide
and cells. The blood vasculature is intimately associated with the basic functioning
of every tissue, and is hence highly specialised for the tissue-speciﬁc functionality
required of it, be it for example transport of absorbed nutrients (small intestine), stor-
age andmobilisation of lipid deposits (adipose tissue), satisfying glucose and oxygen
demand (brain), ﬁltration and processing of waste products (kidney and liver), de-
livery of lymphocytes (thymus, lymph nodes and spleen), or delivery of immature
macrophages and dendritic cells (all tissues). The lymphatic vasculature is respons-
ible for return of interstitial ﬂuid to general circulation and transport of dendritic
cells and macrophages from tissues, particularly following their activation after im-
munological insult, which results in their leaving the tissue and entering the lymph
in order to be transported to draining lymph nodes in order to engage in the initi-
ation of an immune responsewith lymphocytes, which enter the node from the blood
(Willard-Mack, 2006). The lymphatics are also required for the return of lymphocytes
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Table 1.1: Genes relating to vascular function and remodelling.
Category Gene Name
Lymph node
development
and
maintenance
Ccl19 Chemokine (C-C motif) ligand 19
Ccl21 Chemokine (C-C motif) ligand 21
Cxcl13 Chemokine (C-X-C motif) ligand 13
Il7 Interleukin 7
Lta Lymphotoxin α
Ltb Lymphotoxin β
Ltbr Lymphotoxin β receptor
Tnfrsf11a Tumour necrosis factor receptor superfamily,
member 11a; TRANCER; RANK
Tnfrsf11b Tumour necrosis factor receptor superfamily,
member 11b (osteoprotegerin)
Tnfsf11 Tumour necrosis factor (ligand) superfamily,
member 11; TRANCE; RANKL
Icam1 Intercellular adhesion molecule 1
Madcam1 Mucosal vascular addressin cell adhesion mo-
lecule 1
Vcam1 Vascular cell adhesion molecule 1
Angiogenesis
related
Angpt1 Angiopoietin 1
Angpt2 Angiopoietin 2
Flt1 FMS-like tyrosine kinase 1; VEGFR1
Kdr Kinase insert domain protein receptor; VEGFR2;
FLK1
Pdgfa Platelet derived growth factor, A polypeptide
Pdgfb Platelet derived growth factor, B polypeptide
Pdgfc Platelet-derived growth factor, C polypeptide
Pgf Placental growth factor
Vegfa Vascular endothelial growth factor A
Vegfb Vascular endothelial growth factor B
Vegfc Vascular endothelial growth factor C
Angiogenesis
inhibitors
Serpinf1 Serine (or cysteine) peptidase inhibitor, clade F,
member 1; pigment epithelium derived factor
(PEDF)
Thbs1 Thrombospondin 1
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Table 1.1: Genes relating to vascular function and remodelling (continued).
Category Gene Name
Proteases Mmpn Matrix metallopeptidase n
Adamn A disintegrin and metallopeptidase domain n
Adamtsn ADAM metallopeptidase with thrombospondin
type 1 motif n
Ctsa Cathepsin a
MMP
inhibitors
Timp2 Tissue inhibitor of metalloproteinase 2
Timp3 Tissue inhibitor of metalloproteinase 3
Hypoxia
related
Hif1a Hypoxia inducible factor 1, α subunit
Arnt Aryl hydrocarbon receptor nuclear translocator;
HIF-1β
Ccl2 Chemokine (C-C motif) ligand 2; monocyte
chemoattractant protein 1 (MCP-1)
Csf1 Colony stimulating factor 1 (macrophage)
Cxcl12 Chemokine (C-X-C motif) ligand 12
Epas1 Endothelial PAS domain protein 1
Ldha Lactate dehydrogenase A
Ldhb Lactate dehydrogenase B
Slc2a1 Solute carrier family 2 (facilitated glucose trans-
porter), member 1; GLUT-1
Angpt1 Angiopoietin 1
Angpt2 Angiopoietin 2
Flt1 FMS-like tyrosine kinase 1; VEGFR1
Endogenous
controls
B2m β-2 microglobulin
Gapdh Glyceraldehyde-3-phosphate dehydrogenase
Hprt1 Hypoxanthine guanine phosphoribosyl trans-
ferase
Leng8 Leukocyte receptor cluster (LRC) member 8
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to the blood after exiting a lymph node. This process is further elaborated in Section
1.3.
The blood circulation is eﬀectively a closed loop. Blood pumped by the heart
muscle ﬂows through a branching network of arteries. Upon entering a tissue or
organ, an artery branches into smaller arterioles which then repeatedly branch into
a capillary bed of very small vessels (Eichmann et al., 2005b). The vessels of the ca-
pillary bed subsequently merge to form larger venules which again merge together
to form even larger veins. Blood is returned to the heart via the venous circulation
to complete the loop.
The capillary bed is the primary site for exchange of gases, nutrients and meta-
bolites, as well as cells. The arterial vessels are subject to a high pressure, pulsatile
ﬂuid ﬂow as a consequence of the pumping action of the heart, while veins experi-
ence a smooth low pressure ﬂow (Eichmann et al., 2005b; Jones, le Noble et al., 2006).
The capillary bed separates these two systems, and is responsible for smoothing the
pulsatile ﬂow, and having a pressure diﬀerential imposed upon it. Restricted ﬂow
in the capillaries, due to the limited capillary diameter, and the fact that the capil-
laries are somewhat leaky, causes ﬂuid entering the capillary bed to be forced both
through the capillaries and out into the surrounding tissue. The negative pressure at
the venous side consequently causes some interstitial ﬂuid to re-enter the capillaries
and ﬂow into the veins, but not all. The remaining interstitial ﬂuid in the tissue, if not
removed, would result in œdema (swelling due to ﬂuid accumulation), reviewed by
Alitalo, Tammela et al. (2005). The lymphatic system is responsible for the draining of
this excess interstitial ﬂuid and its return to the main circulation. While the lymph-
atic system is also closed, it is not a loop but a branched network of blind-ending
tubules. Fluid and cells may enter the blind endpoints of the network from within
a tissue, and travel along it as the tubules merge to form increasingly larger vessels
(Alitalo et al., 2005). Fluid ﬂow in lymphatic vessels, and to an extent in veins, is
passive and hence both of these vessels contain valves which prevent the ﬂuid from
ﬂowing backwards. Flow is assisted where the vessels pass through skeletal muscle,
whose contraction squeezes the vessel, forcing the ﬂuid to ﬂow in a forward direc-
tion, reverse ﬂow being prevented by the valves.
Arteries, veins, capillaries and lymphvessels have common features in their struc-
ture and cellular organisation, as well as diﬀerences owing to the requirements of
their diﬀering function. All of the vessels contain an inner lining with endothelial
cells (ECs), ﬂattened cells which make contact with the ﬂuid the vessel carries on
their apical (lumenal) side, and the underlying extracellular basement membrane
on their basal side. Adherens junctions contact adjacent neighbouring cells on all
sides, providing a mostly watertight barrier to prevent unwanted egress of the ves-
sel contents. These cell–cell contacts are reduced in the capillary bed, where the
vessels become leakier (Dejana, Valiron et al., 1997).
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Vascular smooth muscle
Vascular smooth muscle cells (VSMCs, also known as mural cells) surround the
blood endothelial cells (BECs) to provide structural integrity, as well as to regu-
late vessel diameter (vasodilation and constriction) and permeability (Bergers and
Song, 2005). Smooth muscle is also responsible, along with ECs, for the secretion
andmaintenance of the vascular basementmembrane separating them, and also crit-
ical in maintaining the stability of the vessel. Vascular smooth muscle may be iden-
tiﬁed by expression of a number of markers, including desmin, α-smooth muscle
actin (α-SMA), neuron-glial 2 (NG2) and platelet-derived growth factor receptor
β (PDGFRβ) (Bergers and Song, 2005; Ozerdem, Grako et al., 2001). Pericytes are also
believed to play a role in sprouting angiogenesis, where theymay guide the tip of the
endothelial sprout (Bergers and Song, 2005). While platelet-derived growth factor
(PDGF) is believed to be the main molecular regulator of VSMCs, being attracted
to PDGF-secreting ECs, vascular endothelial growth factor (VEGF) has been found
to play the role of a negative regulator in PDGF-mediated angiogenesis involving
vascular endothelial growth factor receptor positive (VEGFR+) VSMCs (Greenberg,
Shields et al., 2008). Pericyte abnormalities can result in poor coverage of vessels,
leading to loss of vessel integrity and ﬂuid leakage. This is one reason for the tortu-
ous and leaky vasculature observed in some tumours (Morikawa, Baluk et al., 2002).
In arteries andveins, smoothmuscle and elastic ﬁbres surround the vessel, provid-
ingmechanical support to prevent the vessel from rupturing under the high pressure
pulsatile ﬂow in arteries, or collapsing under negative pressure in veins. The smooth
muscle may additionally constrict to regulate blood pressure and ﬂow. Capillaries
have a much sparser distribution of smooth muscle cells, with coverage being lim-
ited to around one smooth muscle cell to ten endothelial cells. In capillaries, these
cells are referred to as pericytes, and are also involved in maintaining vascular integ-
rity and regulating ﬂow by constricting and opening the vessels they surround as
they contract and relax (Bergers and Song, 2005).
Extracellular matrix
The basement membrane separating the inner endothelial and outer smooth muscle
layers is composed of several proteins, the primary components being collagen IV,
the proteoglycan perlecan, laminin, ﬁbronectin and additional linker proteins such
as the non-collagenous glycoprotein nidogen, other components including collagen
I and the proteoglycan decorin (Davis and Senger, 2005). Elastins are also found,
but are found primarily in larger vessels. The basement membrane is secreted by
both ECs and VSMCs and exists as a sheet sandwiched between the two cell layers,
providing a strong surface for the basal surface of the endothelial layer to adhere.
The smooth muscle layer is also able to adhere to the basement, and in capillaries
the two cell types are additionally also able to make direct contacts with one another
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through holes in the membrane (Armulik, Genové et al., 2011). Integrin α2β1 is ex-
pressed by both ECs and VSMCs, enabling both of the cellular components of blood
vessels to interact with collagen I, IV and laminin (Languino, Gehlsen et al., 1989).
ECs also express α5β1, which binds ﬁbronectin. Integrin signalling is required for
establishment of EC polarity (Languino et al., 1989).
Laminin, collagen and ﬁbronectin are all capable of polymerising to form inde-
pendent networks, which may be in close proximity and yet not physically inter-
connected. A variety of adapter and linker proteins exist to bridge the diﬀerent
networks, including perlecan (connecting collagen IV and laminin), nidogen (also
knownas entactin; it binds collagen IV, laminin, ﬁbronectin, andmore), andﬁbronectin
can bind collagen IV directly (Aszódi et al., 2006; Davis and Senger, 2005). The res-
ult is a complex arrangement of diﬀerent matrix molecules capable of participating
in many diﬀerent interactions. An overview of how collagen I polymerisation pro-
ceeds to form increasingly larger, higher-order structures is shown in Figure 1.1(A).
The composition and structure of some of the most common basement membrane
components are shown in Figure 1.1(B), and their properties are discussed in more
detail, below. Collagen, laminin and ﬁbronectin all promote EC survival, growth,
migration and tube formation (Kim, Bakre et al., 2002).
Collagen IV
Collagen IV is amajor component of the basementmembrane, existing as a heterotri-
mer composed of a combination of six diﬀerent α chains. The process ofmatrix form-
ation has been reviewed by Hudson, Tryggvason et al. (2003); the non-collagenous
C-terminal domains of three α chains associate to form a trimer, the collagenous do-
mains zipping up to form a triple helix. The non-collagenous domains of two trimers
can dimerise to form a hexamer, and theN terminal end of the triple helix can associ-
ate with three other ends to form a tetramer. Additionally, the triple helix is capable
of supercoiling, winding tightly around other triple helices. Through these three
mechanisms of self-association, assembly of large networks is possible, the structure
of which may be altered by the use of diﬀerent α chains.
While not strictly required for basement membrane assembly, collagen IV has
been found to be required for maintenance of vascular integrity under conditions
such as mechanical stress and ﬂuid pressure. Vessels in heterozygotes are weaker,
leading to hæmorrhage and death by E11.5 (Aszódi et al., 2006).
Fibronectin
Fibronectin plays an important role in matrix turnover, as well as in regulating EC
behaviour as discussed above. Its multiple eﬀects include inﬂuencing the cell cycle
(Sechler and Schwarzbauer, 1998) andmodulating the activity of sequestered growth
factors, e.g. VEGF complexed with ﬁbronectin has greater activity than unbound
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Figure 1.1: Matrix polymerisation and organisation. The formation of complete colla-
gen type I ﬁbrils is shown in (A). Secreted in precursor form, the enzymatic cleavage of
the C- and N-terminal ends of both procollagen I and procollagen III or V produce tro-
pocollagens capable of ﬁbrillogenesis. Collagen III or V trimers are required to organise
collagen I ﬁbrils correctly during nucleation. Following the formation of ﬁbril interme-
diates, linear and lateral fusions increase the length and width of ﬁbrils to produce a
complete heterotypic ﬁbril. The structural organisation of the vascular basement mem-
brane is shown in (B). Collagen IV and laminin are shown to assemble into separate
networks, linked together through both nidogen and perlecan. A is after Aszódi et al.
(2006); B is from Sorokin (2010).
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VEGF (Wijelath, 2002), enhancing ECmigration. Inhibition of ﬁbronectin deposition
or disruption of the matrix inhibits EC growth. Additionally, ﬁbronectin polymer-
isation also regulates matrix turnover and retention of other components such as
thrombospondin. Inhibition results in loss of thrombospondin and inhibition of col-
lagen I and III deposition, which also causes loss of existing collagen I ﬁbrils, thus
regulating extracellular matrix (ECM) turnover and stability (Sottile and Hocking,
2002). As for collagen IV, ﬁbronectin knockout is embryonic lethal as a result of
vascular defects (Aszódi et al., 2006)..
Fibronectin also has the interesting property of being sensitive to stress forces
within the ECM, having cryptic integrin binding siteswhich are exposeduponmech-
anical deformation (i.e. extension), a mechanotransduction mechanism to transduce
ECM stress into altered integrin binding, and consequent cellular response (Jean,
Gravelle et al., 2011).
Laminin
Like collagen IV, laminin is one of the principal components of the basement mem-
brane. Laminin exists in the basement membrane as a heterotrimer, having a cross
shape, and composed of α, β and γ chains, multiple types of each chain giving rise to
15 diﬀerent isoforms, reviewed by Hallmann, Horn et al. (2005). The α subunit iso-
forms are expressed in both developmentally- and tissue-speciﬁc patterns, with the
regulation of isoform expression believed to confer tissue-speciﬁc functionality to the
matrix. Basement membrane expresses laminin 8 (α4β1γ1) and laminin 10 (α5β1γ1)
(Hallmann et al., 2005). Laminin 8 is expressed in all basement membranes, while
laminin 10 is expressed during development and under inﬂammatory conditions.
Laminins self-associate to form supra-molecular assemblies, as a result of dimerisa-
tion or trimerisation between the C- and N- termini of its component α, β and γ
chains. Laminin in the vascular basement membrane is secreted by ECs, and poten-
tially also by pericytes and VSMCs (Hallmann et al., 2005). Knockout of α4 results
in defects in basement membrane, including in the deposition of other membrane
components (Thyboll, Kortesmaa et al., 2002).
Laminin contains sites which are known to interact with a variety of other ECM
molecules, including perlecan and nidogen to cross link the collagen IV and laminin
networks (Aszódi et al., 2006). It also allows cell–matrix interactions via cell surface
molecules, including integrins and α-dystroglycan. Integrins and α-dystroglycan
both connect intracellularly to the actin cytoskeleton, and binding of laminin res-
ults in the activation of multiple signalling pathways (Aszódi et al., 2006; Sorokin,
2010). In consequence, laminin binding can result in changes to cellular behaviour
and function.
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Proteoglycans
Proteoglycans consist of a core protein with glycosaminoglycan side chains, which
regulate the hydration andosmotic properties of ECM (Rozario andDeSimone, 2010).
They additionally interact with matrix components, growth factors and cell surface
receptors.
Perlecan Themost abundant heparan sulphate proteoglycan, cross-linking themat-
rix through binding of multiple components, including laminin, collagen IV, en-
tactin/nidogen, ﬁbulin, collagen XVIII/endostatin (Aszódi et al., 2006). It addition-
ally binds integrins, alpha-dystroglycan and growth factors which include ﬁbroblast
growth factors (FGFs), VEGFs, and PDGF. While not required for development, it
is required to preserve the integrity of the basement membrane under mechanical
stress (as for collagen IV) (Aszódi et al., 2006). It acts to stabilisemural cells by seques-
tering basic ﬁbroblast growth factor (bFGF), promoting proliferation and angiogen-
esis, while also inhibiting proliferation via the tumour suppressor PTEN (Aszódi
et al., 2006; Garl, Wenzlau et al., 2004).
Nidogen Expressed by the mesenchyme and ECs in all embryonic basement mem-
branes, havingmultiple binding partners including collagen IV, laminin, ﬁbronectin,
elastin (larger arteries) and perlecan (Aszódi et al., 2006). Its most signiﬁcant role is
probably the cross-linking and stabilisation of laminin and collagen IV networks,
which is stabilised by the formation of covalent bonds by transglutaminase 2 (Ho,
Böse et al., 2008). Additionally, it contains an RGD motif for integrin engagement.
1.2.2 Vascular development
The early stages of vascular development have been studied extensively, with the
stages having been reviewed by Eichmann et al. (2005b) and Adams and Alitalo
(2007), and illustrated in Figure 1.2. The vascular system arises as the result of the
diﬀerentiation of hæmangioblasts from the mesoderm, multipotent progenitors of
both hæmatopoietic and angioblast lineages, which subsequently aggregate and dif-
ferentiate to form blood islands, small pockets of hæmatopoietic cells lined with en-
dothelium. Fusion of the blood islands leads to the formation of the primary capillary
plexus, an interconnected endothelial network (vasculogenesis). Subsequent elab-
oration and remodelling of this network (angiogenesis) results in the formation of
a hierarchical network. The major vessels consist of the dorsal aorta and cardinal
veins, which are largely assembled from angioblasts (Adams and Alitalo, 2007). The
complete blood vascular system is subsequently formed as a result of further out-
growth from this initial network.
The cardinal veins are of particular importance due to being the origin of the
cells forming the jugular lymph sacs, which is the origin of the interconnected (but
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Figure 1.2: Vascular development. Blood islands formed from the mesenchyme fuse to
give rise to the primary capillary plexus. Angiogenic remodelling of the plexus results
in the formation of the hierarchical vasculature, containing arteries, veins, arterioles,
venules and capillary beds. Larger arteries and veins are assembled directly from angio-
blasts rather than through remodelling. Arteries and veins gain coverage from smooth
muscle layers, while capillaries recruit pericytes to stabilise the networks. Later, the
lymphatic system of blind-ended collecting ducts and capillaries develops alongside
the vascular system, but does not have smooth muscle coverage. From Adams and Al-
italo (2007).
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separate) lymphatic system, and also a site for subsequent lymph node development
(Sabin, 1913; Srinivasan, Dillard et al., 2007), discussed in more detail in Section 1.3.
1.2.3 Vasculogenesis
Vasculogenesis, the de novo formation of a capillary plexus from angioblasts, occurs
in the developing embryo. Subsequently angiogenesis, branching and outgrowth of
the existing network, is responsible for the extension and modiﬁcation of this net-
work. Both processes have been reviewed previously (Bohnsack and Hirschi, 2004;
Davis, Bayless et al., 2002; Eichmann et al., 2005b). Capillaries are formed as en-
dothelial cells (ECs) elongate and join end-to-end. The formation of open lumens
occurs inside ECs, which endocytose their own plasma membrane and construct an
intracellular vacuole through vesicle fusion to create a tube running through the in-
terior of the cell (Davis and Camarillo, 1996; Kamei, Saunders et al., 2006). Patterning
of blood vessels involve many of the same signalling and positive and negative guid-
ance cues used for patterning neurons, such as netrins and semaphorins (Adams and
Alitalo, 2007; Freitas, Larrivée et al., 2008; Suchting, Freitas et al., 2007), leading to the
general hypothesis that the nervous and vascular systems are developmentally re-
lated, and that their gross structure may be deﬁned using the same signals.
Over the last two decades, many of the extracellular signalling molecules, trans-
membrane receptors, and components of the intracellular signalling pathways con-
trolling EC proliferation, migration, diﬀerentiation, and survival have been elucid-
ated, though our understanding is still incomplete. Reviews by George Davis out-
line the mechanisms governing endothelial cell lumen formation and tube assembly,
from integrin–matrix interactions to activation of Rho GTPases, Cdc42 and Rac1
(Davis, Koh et al., 2007; Davis and Senger, 2005). The process is additionally de-
pendent upon VEGFR2 and VEGF signalling (Shalaby, Rossant et al., 1995).
Subsequently, pericytes are recruited to the nascent vascular network via PDGF
signalling, and the association of ECs and pericytes results in the production and
deposition of basement membrane proteins, as well as upregulation of integrins,
resulting in stabilisation of the network (Stratman, Malotte et al., 2009a; Stratman,
Schwindt et al., 2010). Later, arterial and venous diﬀerentiation occurs, and this was
previously shown to be a result of blood ﬂow (le Noble, Moyon et al., 2004), however
later work has shown that it is also a result of Notch and Eph/Ephrin signalling, the
principal eﬀect of which is to downregulate the expression of VEGFR2 in order to
limit cellular responsiveness to VEGF (Gridley, 2007; Harrington, Sainson et al., 2008;
Siekmann, Covassin et al., 2008).
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1.2.4 Angiogenesis
Angiogenesis is the outgrowth of an established vascular network, typically by the
sprouting of new outgrowths. However, other forms of angiogenesis also occur, in-
cluding intussception, the splitting of a vessel by insertion of tissue pillars (Adams
and Alitalo, 2007), and more recently a third form, “looping angiogenesis”, was de-
scribed, acting through the generation of tensional forces in granulation tissue (Kil-
arski, Samolov et al., 2009).
Pro-angiogenic factors
Basic ﬁbroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF)
are the two main inducers of EC proliferation and diﬀerentiation (Bohnsack and
Hirschi, 2004; Eichmann et al., 2005b). Both VEGF and bFGF act synergistically to
stimulate angiogenesis, aﬀecting EC migration along growth factor gradients, pro-
liferation and survival. bFGF also induces EC expression of VEGF. VEGF is required
for tube formation (Seghezzi, Patel et al., 1998), existing in several variants (VEGF-
A–D and placental growth factor (PlGF), as well as splice variants), which bind to
the VEGF receptors, VEGFR1 (FLT1), VEGFR2 (KDR or FLK1) and VEGFR3 (FLT-4)
as well as neuropilins 1 and 2 (Dormer and Beck, 2005; Neufeld, Cohen et al., 1999).
VEGF-A has six splice variants in the mouse, of which ﬁve have been observed in
vivo, and several of which are, along with bFGF, heparin binding and hence may
be sequestered by the ECM with diﬀering matrix aﬃnities and biological activities,
and released by matrix proteolysis (Lohela, Bry et al., 2009; Park, Keller et al., 1993).
The VEGF-A splice variants and their properties are listed in Table 1.2. The rela-
tionship between the diﬀerent ligands and receptors is complex, due to the diﬀering
aﬃnities of the receptors for their ligands, as well as their diﬀering intracellular tyr-
osine kinase activities. VEGFR1 has a higher aﬃnity for VEGF-B, while VEGFR2
has a higher aﬃnity for VEGF-A (Fischer, Mazzone et al., 2008). VEGF-A plays
an important role in the diﬀerentiation and chemotaxis of ECs through VEGFR2,
though its activity may be modulated by upregulated expression of VEGFR1, which
has a weaker tyrosine kinase activity (Adams and Alitalo, 2007; Huang, Andersson
et al., 2001; Waltenberger, Claesson-Welsh et al., 1994), and it may also signal via
FGF pathways (Jonca, Ortéga et al., 1997). VEGF-A expression is regulated by hyp-
oxia through hypoxia inducible factor-1α (HIF-1α), which binds hypoxic response
elements (HREs) in its promoter (Ho and Kuo, 2007). Intracellular signalling from
VEGFR1 is believed to bemediated by nitric oxide (NO), which drives reorganisation
and negatively regulates signalling from VEGFR2, which acts via a traditional MAP
kinase kinase (MEK)/mitogen-activated protein kinase (MAPK) pathway, driving
proliferation (Bussolati, Dunk et al., 2001). VEGF is also sequestered by the ECM,
and is released uponmatrix degradation by matrix metallopeptidases (MMPs) (Ahn
and Brown, 2008), and hence angiogenesismay be triggered due to changes in the ex-
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tracellular matrix, for example upon injury, during an inﬂammatory response, and
by tumour secretion of MMPs (Sorokin, 2010; Stetler-Stevenson, 2008).
The platelet-derived lipid sphingosine-1-phosphate (S1P) is also known to have
a pro-angiogenic and pro-migratory role, as well as playing a role in adherens junc-
tion formation, acting via extracellular-regulated kinases (ERKs), MAPK and the
Gi protein-coupled receptors Edg-1 and Edg-3 (Bayless, 2003; Lee, Thangada et al.,
1999a; Lee, Lee et al., 1999b; Wang, van Brocklyn et al., 1999), and is inducible by the
agonist FTY720 via S1P receptors (Butler, Lana et al., 2004).
CD31, also known as platelet/endothelial cell adhesion molecule 1 (PECAM-1),
is expressed on ECs and platelets, and has been implicated in both angiogenesis and
EC migration (though evidence is conﬂicting), as well as cell survival (Bird, Taylor
et al., 1999; Cao, O’Brien et al., 2002). CD31, in cooperationwithCD144, also knownas
vascular endothelial cadherin (VE-cadherin), is associated with endothelial cell–cell
adherens junctions. These play a role in junction formation, rearrangement, and
permeability, for example in response to bFGF, as well as contact-inhibition of cell
growth, signalling via intracellular pathways through binding partners such as β-
catenin (Bazzoni and Dejana, 2004; Halama, Èger et al., 2001; Yang, Graham et al.,
1999). Blockade of CD31 and CD144 with monoclonal antibodies demonstrated that
both molecules play a critical role in formation of a vascular tube, including forma-
tion and fusing of intracellular vacuoles to create the vessel lumen (Yang et al., 1999).
ECs can also form tight junctions, important in the regulation of vascular permeab-
ility (Bazzoni and Dejana, 2004).
ECs are classiﬁed according to their role, being termed phalanx, tip or stalk cells
depending upon whether they are quiescent (normal stationary state), invasive and
migratory (leading) ormigratory (following), respectively (Augustin, Koh et al., 2009;
Gerhardt et al., 2003). During angiogenesis, the basement membrane must be de-
graded in order to allow ECs to exit the vessel. New basement membrane, consist-
ing primarily of collagen IV and laminin, is laid down as new vessels form (Sephel,
Kennedy et al., 1996). Control of which cells become tip and stalk cells is controlled
by Notch, Delta and Jagged signalling, causing tip cells secreting delta-like 4 (Dll4)
to inhibit surrounding stalk and phalanx cells also becoming tip cells (Suchting et al.,
2007). Jagged signalling results in an opposing pro-angiogenic eﬀect, antagonising
Dll4–Notch signalling (Benedito, Roca et al., 2009). As a result of these opposing
signals, branching and sprouting in response to pro-angiogenic stimuli are tightly
controlled.
Tumour vascularisation is driven by VEGF secretion from tumour cells as well
as inﬁltrating macrophages and ﬁbroblasts (Ho and Kuo, 2007), and this may also
play a role in organ vascularisation during development. VEGF signalling has been a
widely studied as a potential target for pro- and anti-angiogenic cancer therapeutics,
with inhibitors being developed targeting both extracellular receptor domains and
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Table 1.2: VEGF-A isoforms. This
table shows the association between
splice variant number and name of
all known and predicted VEGF-A
splice variants, based upon their
human counterparts and multiple
alignment of the splice variants
(Krüssel et al., 2001; Robinson and
Stringer, 2001).
Isoform Length (aa) Name
1 392 VEGF188a,c,d,e
2 368 VEGF164a,c,e,f,g
3 324 VEGF120a,c,e,f
4 137 VEGF115b,c,e
5 113 VEGF102b,e
6 69 Noneb
a Secreted
b Predicted only
c Binds heparin
d Cell membrane-bound due to strong
heparin binding aﬃnity
e Binds VEGFR1
f Binds VEGFR2
g Binds neuropilins
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the intracellular tyrosine kinase domain (Bozec, Gros et al., 2008; Lacal, Morea et al.,
2008). To date, several potent endogenous inhibitors have been found, discussed
in detail below, and reviewed several times (Cao, 2001; Folkman, 2004; Nyberg, Xie
et al., 2005; Zhang and Ma, 2007).
PEDF
One such example of an endogenous inhibitor is pigment epithelium-derived factor
(PEDF), a secreted protein which has been found to strongly suppress angiogenesis
through direct signalling upon contact with ECs, originally identiﬁed by Dawson
(1999) as an inhibitor in the eye secreted by retinal cells, later reviewed by Bouck
(2002); Ek, Dass et al. (2006). Intriguingly, PEDF was originally identiﬁed as a neur-
otrophic factor, again highlighting the similarities between neural and endothelial
signalling and regulation (Becerra, 1997). The putative receptor for PEDF is a trans-
membrane receptor having intracellular phospholipase A(2) activity (Subramanian,
Notario et al., 2010). This matches previous work describing PEDF acting via cytoso-
lic phospholipase A(2), triggering apoptosis by sequential activation of proliferator-
activated receptor γ (PPAR-γ), MAPK and p53 (Ho, Chen et al., 2009). Like VEGF,
PEDFassociateswith collagenECMvia heparin binding (Sekiya, Okano-Kosugi et al.,
2011). Recently, PEDF has also been shown to also play a protective role in blocking
tumour metastasis (Ladhani, Sánchez-Martinez et al., 2011).
Thrombospondin
Thrombospondin is the major component of platelet alpha granules, released on
platelet activation during blood clotting, but also secreted by many cell types, in-
cluding ECs, VSMCs and ﬁbroblasts (Jaﬀe, Ruggiero et al., 1983; Mosher, Doyle et al.,
1982; Raugi, Mumby et al., 1982) and incorporated into the surrounding extracellular
matrix. It has been implicated in several diseases, reviewed in Esemuede, Lee et al.
(2004), giving some insight into its normal function.
Thrombospondin localises to the ECMboth in vivo and in vitro, associating via col-
lagen IV binding, but plays a regulatory, rather than structural, role and is termed
a matricellular protein (Aszódi et al., 2006). It also associates with ﬁbronectin, ﬁb-
rinogen and heparin sulphate proteoglycans. It is a multifunctional protein, hav-
ing several diﬀerent domains dedicated to diﬀerent roles. It is responsible, for the
binding and activation of latent TGF-β, but is also capable of binding other growth
factors containing heparin-binding domains, cytokines and proteases (Armstrong
and Bornstein, 2003; Aszódi et al., 2006). It is also capable of binding to cells via trans-
membrane receptors, since it possesses the integrin-binding RGD peptide sequence
also found in collagens (Armstrong and Bornstein, 2003). Such integrin interactions
can inﬂuence cell behaviour and migration. Thrombospondin expression is highest
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during embryogenesis, then declines postnatally (Morwood and Nicholson, 2006;
Sun, Hopkins et al., 2009).
Both variants of thrombospondin (Thbs1 and Thbs2) are potent inhibitors of an-
giogenesis (Good, Polverini et al., 1990), thought to act via endocytosis mediated
via the low density lipoprotein receptor-related protein (Godyna, Liau et al., 1995).
Knockout models exhibit increased neovascularisation, with deﬁciency leading to
an increased vascular density in several tissues and increased incidence of tumours
(Aszódi et al., 2006), indicating that thrombospondin plays a role in the regulation
of angiogenesis. Additionally, Thbs1 or Thbs2 knockouts show impaired wound
healing responses (Esemuede et al., 2004); normally thrombospondin is present at
wound sites as a result of release from platelet alpha granules, and impaired healing
due to loss of thrombospondin may be due to changes in the neovascularisation or
ﬁbroblast inﬁltration of granulation tissue, or due to loss of growth factor sequest-
ration which results in impaired signalling and/or reduced inmigration of cells, for
example ECs in response to damping of pro-angiogenic signals, or ﬁbroblasts and
VSMCs in response to reduction of latent TGF-β activation (Esemuede et al., 2004).
Thrombospondin has been shown to inhibit metastatic tumour growth (Volpert,
Lawler et al., 1998), and additionally thrombospondin expression levels in platelets
are also related to the pro-angiogenic environment created by tumours, illustrated by
Zaslavsky, Baek et al. (2010), who demonstrated that levels rise in the presence of a tu-
mour, and fall upon tumour resection. This again demonstrates the anti-angiogenic
role of thrombospondin, but also shows that its anti-angiogenic eﬀects are, in the
case of platelet-derived thrombospondin, both systemic in nature and responsive to
the systemic “angiogenic environment” of the entire organism, playing an import-
ant role in the suppression of unwanted angiogenesis. In contrast, thrombospondins
secreted directly in the basementmembranemay have their actions and eﬀects much
more spatially restricted.
The anti-angiogenic activity of thrombospondin is due to several factors. Firstly,
Thbs1 reducesMMP-9 activity by suppressing the conversion of pro-MMP-9 toMMP-
9 by MMP-3, while Thbs2 suppresses MMP-2 (Aszódi et al., 2006), hence reducing
degradation of the basement membrane and thereby invasive angiogenesis. Throm-
bospondin can also exert its anti-angiogenic eﬀects directly, with blocking antibodies
shown to increase EC cord formation in vitro by Iruela-Arispe, Bornstein et al. (1991).
While this paper does not demonstrate the mode of action, the implication is that
it was by direct contact, though the possibility exists that the antibodies may have
blocked something else other than integrin binding. However, the observation was
made that thrombospondin expression and secretionwas related to cell shape, which
may mean that phalanx cells, which are by their nature the most sessile and stable,
may secrete more and promote their ongoing stabilisation, while tip and stalk cells
do not. Thrombospondin can also inhibit bFGF-stimulated angiogenesis (Tolsma,
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Volpert et al., 1993). However, later work by Jiménez, Volpert et al. (2000) demon-
strated that thrombospondin is also capable of inducing apoptosis in ECs; given the
ubiquitous nature of thrombospondin and its production and secretion by ECs, this
would lead to the hypothesis that if thrombospondin is capable of inducing EC ap-
optosis, it must be counterbalanced by opposing pro-survival signals which would
normally prevent this course of action. It is most likely that this direct action is due
to VEGF signalling inhibition via protein kinase B (PKB)/Akt, resulting in decreased
survival (Sun et al., 2009).
Collagen and ﬁbrin
Other factors are also known to induce EC proliferation, growth and tube formation,
including basement membrane components such as collagen (Madri and Williams,
1983), and wound-triggered clotting products such as ﬁbrin (Olander, Bremer et al.,
1985), which may play a critical role in wound repair by driving revascularisation of
damaged tissue and repair of damaged vessels.
Matrikines
“Matrikine subdomains” are domains in ECM proteins which can signal through
cell surface receptors and regulate biological functions. Matrikines may act directly
(natural matrikines) or may require exposure of via conformational change or pro-
teolysis (crypticmatrikines). Arresten, canstatin and tumstatin are derived frompro-
teolysis of collagen IV non-collagenous domains, and endostatin from collagen XVIII
(Kamphaus, Colorado et al., 2000; Petitclerc, Boutaud et al., 2000). These are all potent
angiogenesis inhibitors in vivo and in vitro. These factors are released from collagen
by the action of MMPswhich degrade basement membrane, MMP9 /  mice having
reduced levels (Aszódi et al., 2006). Fragments of Thbs1, ﬁbronectin, perlecan (en-
dorepellin) and ﬁbrinogen additionally inhibit EC functions needed for angiogenesis
or inhibit angiogenesis (Mongiat, Sweeney et al., 2003).
However, there is also evidence that pro-angiogenic matrikines also exist, such as
collagen IV sites exposed by MMP activity in the retina (Hangai, Kitaya et al., 2002).
Soluble VEGFR1
The VEGF receptor VEGFR1 also exists in a secreted, soluble form, sVEGFR1 (Chap-
pell, Taylor et al., 2009; Kappas, Zeng et al., 2008). Being catalytically inactive due to
the lack of an intracellular tyrosine kinase domain, sVEGFR1 serves to sequester free
VEGF and thus modulates pro-angiogenic signalling.
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Apoptosis
EC are susceptible to apoptosis under certain circumstances, which may play an es-
sential role in the natural balance of pro- and anti-angiogenic factors which inﬂuence
the expansion or regression of the vascular network. Serum albumin is known to in-
hibit EC apoptosis and promote adherence to the basement membrane (Zoellner,
Höﬂer et al., 1996), and conversely serum starvation has long been known to result
in EC apoptosis, and as such may play a role in the “pruning” of the vasculature
when blood ﬂow is restricted, which may result in decrease in exposure to albumin,
promoting apoptosis (Zoellner et al., 1996). Additionally, ECs are also susceptible to
apoptosis on loss of adhesion with the basement membrane, and this is not rescued
by the presence of serum (Zoellner et al., 1996). The consequences of ECs detaching
and entering the circulation to survive and lodge elsewhere are potentially rather
serious (e.g. blockage of microvessels, and even stroke), so it is logical that detach-
ment is a fatal condition for an EC.
Angiostatin is a degradation product of plasmin or its precursor, plasminogen
(O’ Reilly, Holmgren et al., 1994), having anti-angiogenic properties. Upon inter-
nalisation, it promotes mitochondrial apoptosis and also upregulates Thbs1 (Lee,
Muschal et al., 2009b).
1.2.5 Basement membrane degradation
Degradation of the basement membrane by proteolysis can be both pro- and anti-
angiogenic, depending upon the context. Activation of MMPs 1 and 9 results in
endothelial tube regression (Davis, Pintar Allen et al., 2000b; Saunders, Bayless et al.,
2005), and addition of exogenous RGD peptide can result in disruption of sprouts
and apoptosis (Korﬀ and Augustin, 1999), presumably a result of loss of matrix at-
tachment via integrins. However, some proteolysis is required for tube outgrowth
and lumen formation, such as MT1-MMP which degrades collagens I and III (Roy,
Zhang et al., 2006; Sacharidou, Koh et al., 2010; Stratman, Saunders et al., 2009b).
As discussed above, proteolysis can also expose cryptic binding sites, and release
matrix-bound factors such as VEGF, bFGF and matrix fragments such as arresten,
endostatin and angiostatin which may result in a variety of pro- and angiogenic ef-
fects (Mundel and Kalluri, 2007; Roy et al., 2006). Degradation additionally reduces
the density of the ECM, potentially allowing EC migration through the basement
membrane.
The major proteases inﬂuencing angiogenesis have been previously reviewed by
Roy et al. (2006). TheMMP, a disintegrin andmetallopeptidase domain (ADAM) and
adisintegrin andmetallopeptidase domainwith thrombospondinmotifs (ADAMTS)
families can collectively degrade all matrix components. MMPs and ADAMTS are
soluble, secreted enzymes while the related membrane-type matrix metallopepti-
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dases (MT-MMPs) and ADAMs are membrane-bound, acting upon their immedi-
ate environment. Some have additional activities, such as direct sequestration of
VEGF byADAMTS1 (Luque, Carpizo et al., 2003) in addition to its generation of anti-
angiogenic Thbs1 and Thbs2 (Lee, Sato et al., 2006b). Of relevance to basement mem-
brane remodelling are MMPs 1 and 8 which degrade collagens I and III, and MMPs
2, 3, 9 and 10 which degrade collagen IV (Roy et al., 2006), though all have aﬃnities
for multiple substrates. The substrates of the ADAM and ADAMTS families are less
well characterised, ADAMs 10, 12 and 15 cleaving collagen IV andADAMTS 2, 3 and
14 cleaving procollagen I (i.e. are involved in collagen ﬁbrillogenesis), and ADAMTS
4, 5 and 9 cleave chondroitin sulphate proteoglycans such as versican, which are also
found in the basement membrane (Roy et al., 2006).
1.2.6 Summary
The process of the development of the mammalian vasculature is well understood,
with many of the signalling processes involved having been identiﬁed using in vivo
knockout models and several diﬀerent in vitro systems. The main feature of vascu-
logenesis and angiogenesis is the requirement for the growth factor VEGF, whose
eﬀects are modulated via the diﬀerent isoforms of VEGF, including diﬀerent genes
and splice variants, and their diﬀering aﬃnities for the several VEGFRs, which have
diﬀerent tyrosine kinase activities, resulting in the diﬀerential activation of intra-
cellular signalling pathways. The activity of VEGF is also modiﬁed by inhibitors,
including sequestration by sVEGFR1 and ADAMTS1, and additionally by direct in-
hibition by factors such as PEDF and thrombospondin. After establishment of the
blood vasculature, many of the same molecules are involved in continual mainten-
ance and repair of the vasculature. However, organ vascularisation is relatively poorly
studied. Every organ is vascularised, and contains vasculature specialised for its spe-
ciﬁc function. While the structure and function of these specialised vascular systems
have been widely studied in the context of the developed, functional tissues, the lit-
erature contains very little information regarding the mechanisms and processes of
initial organ vascularisation.
1.3 Secondary lymphoid organs
This section discusses the development, structure and function of peripheral lymph
nodes, which are intimately associated with the blood and lymphatic vascular sys-
tems. However, our current understanding of the role of of the vasculature in LN
development is poor, and in common with other organs the mechanisms driving
vascularisation are poorly understood.
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The lymphatic system consists of blind ending vessels which drain lymph, the
ﬂuid arising in the interstitial spaces in the tissues of the body, ultimately return-
ing the lymph to the main blood circulation via the thoracic duct. Lymph nodes
(LNs) are found at the major points of convergence of lymphatic vessels, the human
body containing around 450 individual lymph nodes, whilst the mouse contains 22
(Willard-Mack, 2006).
1.3.1 Origin of the lymphatic system
The origins of the lymphatic system and lymph nodes have been a question studied
by researchers for several hundred years. Many of the prevailing hypotheses at the
time were disproved by Sabin and her peers, covered in detail in her book (Sabin,
1913) and in Sabin (1916). Sabin carefully mapped the structure of the lymphatic
vasculature using the technique of ink injection and light microscopy of cleared tis-
sues, and by studying embryos throughout their developmentwas able to determine
how the lymphatic systemdeveloped, but lacking the availability ofmodernmolecu-
lar biology was unable to examine the mechanisms involved. Sabin concluded from
her observations that the lymphatics originated from lymph sacs, most importantly
the jugular lymph sac, that lymph sacs were derived from veins at junctions, and
that lymph sacs were the site of lymph node development (Sabin, 1909). It is only in
recent years that these observations have been conﬁrmed deﬁnitively using mouse
mutants, demonstrating that all lymphatic endothelium is derived from venous ori-
gin (Srinivasan et al., 2007). More recently, it has been shown that the lymph sacs
are not strictly required to initiate LN formation, though the process is less eﬃcient
(Vondenhoﬀ, van de Pavert et al., 2009b).
The steps involved in the formation of the lymphatic vasculature have been previ-
ously been reviewed byOliver (2004). Some of themolecular regulators of lymphatic
endothelial cell (LEC) speciﬁcation are known, such as the activation of the tran-
scription factor Prox1, whose expression is induced by the co-expression of both the
venous transcription factor COUP-TFII and the Sox18 transcription factor to result
in lymphatic diﬀerentiation (François, Caprini et al., 2008; Lee, Kang et al., 2009a;
Srinivasan, Geng et al., 2010; Wigle and Oliver, 1999). Prox1 expression is preceded
by expression of the lymphatic marker LYVE-1. However, LYVE-1 is a marker of
lymphatic competence only. LECs also express VEGFR3 and ﬁbroblast growth factor
receptor (FGFR)-3 (Shin,Min et al., 2006), resulting in sensitivity toVEGF-C andFGFs
which is not shared with BECs. VEGF-C is capable of activating BECs via VEGFR2,
but only following proteolytic processing (Joukov, Sorsa et al., 1997), again resulting
in diﬀerent eﬀects upon LECs and BECs.
Given the fact that lymph sacs are always located at branchpoints in veins, it is
possible that this is a result of physical forces acting at the conﬂuence, for example a
pressure diﬀerential and/or shear stress. On a two dimensional surface, increased
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shear stress reduced ECmigration (Hsu, Thakar et al., 2005), but the eﬀects of deﬁned
physical forces on cells within a vessel remain to be investigated. However, what is
known is that the putative signal results in vascular endothelium biased towards a
lymphatic lineage being induced to migrate out from the vessel wall into the tissue
as a series of vessels which anastomose to form the lymph sac, the site of the origin
of the lymphatic system and also of a site of lymph node development (Sabin, 1909).
This process will be discussed in more detail, below.
1.3.2 Lymph node structure and function
The major purpose of the lymph node is to act as a focal point for the immune sys-
tem’s surveillance of the body,where an adaptive immune responsemaybe triggered
in response to foreign antigen. The activation of a T cell on encounter with an APC
presenting its cognate antigen is a very low probability event, and it appears that
the structure of the LN increases the probability of such an encounter in order to
eﬃciently initiate an immune response (Bajénoﬀ, Egen et al., 2006).
An overview of the various aspects of the structure, cellular composition, com-
partmentalisation and vascularisation of an idealised lymph node is illustrated in
Figure 1.3 and reviewed by Blum and Pabst (2006); Willard-Mack (2006). The ex-
ternal surface of the lymph node is bounded by a tough capsule composed primarily
of connective tissue containing type I collagen, providing structural support to the
organ. Larger lymph nodes, as illustrated, are divided into several lobules separated
by trabeculæ, extensions of the capsule which extend radially toward the centre of
the node. In the mouse, lymph nodes are typically smaller and are composed of a
single lobule with no subdividing trabeculæ. The number of lobes is likely to be a
function of the size of the organism, given that therewill be a larger number of drain-
ing lymphatic vessels at points of conﬂuence. Each lobule is segmented into three
major compartments. Moving from the cortex in to the hilum, these are the cortex,
mainly composed of B cell follicles, the paracortex (or deep cortex) composedmainly
of T cells, with a lesser frequency of B cells and interdigiating dendritic cells (IDCs),
and themedulla, containing B cells and plasma cells, as theirmajor components. The
most distinctive division is the segregation of the lobule parenchyma into distinct B
cell areas (follicles) surrounded by the T cell area.
Draining lymph containing interstitial ﬂuid, cells, soluble antigen and inﬂammat-
ory chemokines etc. enters the lymph node via the aﬀerent lymphatics. Upon enter-
ing the cortical (subcapsular or marginal) sinus, the lymph may either drain around
the lobule via the intermediate (trabecular) sinus, and then the medullary sinus, to
exit in the draining lymph node at the hilum, or it may enter the lobule via the leaky
subcapsular sinus ﬂoor or the conduit system (Roozendaal, Mempel et al., 2009; Sixt,
Kanazawa et al., 2005). Macrophages and dendritic cells (DCs) in the lymph may
enter the lobule through the subcapsular sinus ﬂoor and/or the other lymphatic si-
28 CHAPTER 1. INTRODUCTION
Dendritic cells
Lymph flow
Blood flow
Conduits
Lymphoid cells
Compartments
T lymphocytes
B lymphocytes
Plasma cells
Medulla
Paracortex
Cortex Conduit
HEV
HEV
FDC
IDC
Afferent lymphatic vessel
Efferent lymphatic vessel
Artery
Vein
Reticular cells
FRC
MRC
Corona
Germinal
centre
Trabecula CapsuleFollicle
Intermediate sinus
Cortical sinus
Medullary sinus
Lymphatic cord
Lymph sinus
Basic structure
Figure 1.3: Structure and composition of the lymph node. The basic organisational unit
of the lymph node is the lobule, bounded by trabeculæ, which are continuous with
the surrounding capsule. Each lobe may be separated into cortical, paracortical and
medullary regions, which possess diﬀerent cellular composition and organisation. The
cortex primarily contains follicles comprised of B cells, supported by an FDC stromal
network. The paracortex is primarily comprised of T cells, supported by an FDC stromal
network. B cells (including plasma cells) and T cells exit the node via the medulla and
draining eﬀerent lymphatic vessel. B and T cells enter the node from the blood via the
HEVs to enter the cortex and paracortex, while IDCs enter via the aﬀerent lymphatics.
Soluble antigen and cytokines in the aﬀerent lymph may enter the node via the conduit
system, which terminates at HEVs. The lymph entering via the cortical (subcapsular)
sinus drains through intermediate (trabecular and paracortical) and medullary sinuses
to form the eﬀerent lymph. After Blum and Pabst (2006).
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nuses passing through the cortex and paracortex (Randolph, 2001). T and B cells do
not typically enter the node via this route, and will instead ﬂow around the lobule to
enter the eﬀerent lymphatic vessel without interaction with other cells in the node.
The main route of entry for these cells is from the blood, extravasating via high en-
dothelial venules (HEVs) to enter predominantly the paracortex, and also the cortex
(Willard-Mack, 2006).
Lymphocytes ultimately exit the node via via the paracortical and medullary si-
nuses, entering the lymph draining into themedulla, and ﬂowing out of the node via
its aﬀerent lymphatic vessel. The process of crossing the lymphatic endothelium to
enter the sinus is a S1P-dependent process (Matloubian, Lo et al., 2004); S1P is found
at a relatively high concentration in the blood and lymph, but at low concentration
inside the lymphoid tissue, and is produced in the LN by the lymphatic endothelium
lining the sinus signals via the S1P1 receptor found on lymphocytes. Blocking this
signal results in retention of lymphocytes within the node (Pham, Baluk et al., 2010).
The relationship between ﬂuid ﬂow and cellular migration in the rat lymph node
has been shown using confocal and scanning electron microscopy (SEM) by Ohtani
and Ohtani (2008), clearly showing entry of cells in the subcapsular sinus, exit of
lymphocytes in the paracortical sinus, and the structure of themedullary cords (con-
taining HEVs) and medullary sinus. Ohtani also shows the structure of the reticular
networks in the cortex and paracortex, their loose association with packed lymph-
ocytes, and intriguingly, continuity between the conduits and reticular networks of
the cortex with pillars spanning the roof and ﬂoor of the subcapsular sinus. These
pillars may play a role in loading the conduit system with small molecular weight
antigen and signalling molecules, as well as keeping the subcapsular sinus from
blocking aﬀerent lymph ﬂow when the node expands in size. All sinuses, which
are continuous with the aﬀerent and eﬀerent lymphatics, stain positively for LYVE-
1, indicating that they are all lined with lymphatic endothelium (Ohtani and Ohtani,
2008).
The lymph node is composed of several diﬀerent types of cell, which can be di-
vided broadly into diﬀerent categories (Link, Vogt et al., 2007). Cells may be classed
as hæmatopoietic or non-hæmatopoietic, based upon CD45 expression). The CD45+
population includes T lymphocytes, B lymphocytes, IDCs and MØs, and hence may
be further characterised using the lineage-speciﬁc markers for these cell types. The
CD45  fraction may be subdivided based upon CD31 and glycoprotein 38; podo-
planin (Gp38) expression. CD31 distinguishes between CD31+ endothelial cells and
CD31  stromal cells. The endothelial population may be divided into CD31+Gp38 
BECs and CD31+Gp38+ LECs. Stromal cells including ﬁbroblastic reticular cells
(FRCs) are CD31 Gp38+, while CD31 Gp38  comprises multiple cell types, not all
of which have been characterised.
The reticular networks in the cortex and paracortex are partitioned into two dis-
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tinct areas: follicles containing predominantly B cells, with the surrounding area
occupied mainly by T cells (Willard-Mack, 2006). Based upon the expression of dif-
ferentmarkers, the reticular cells may be classiﬁed as follicular dendritic cells (FDCs)
(within B cell follicles) or FRCs. FRCs are identiﬁed using the ﬁbroblast marker
ERTR-7 or gp38 or vascular cell adhesion molecule (VCAM)-1, all absent from FDCs
whichmay be identiﬁed by complement receptor 1 (CD35) expression (Katakai, Hara
et al., 2004; Ma, Jablonska et al., 2007). The follicles are also marked by their lack of
HEVs, and also contain less blood vessels than the surrounding FRC network. Re-
cently, a third stromal subset, marginal reticular cells (MRCs) has been identiﬁed
(Katakai, Suto et al., 2008). Found immediately underneath the subcapsular sinus,
these cells express intercellular adhesion molecule (ICAM), VCAM andmucosal ad-
dressin cellular adhesionmolecule (MAdCAM) and share similaritieswith lymphoid
tissue organisers (LTos) seen during LN development, discussed below.
A network of collagen I ﬁbrils enclosed by FRCs forms the conduit system link-
ing the subcapsular sinus and transporting low molecular weight antigen and sol-
uble factors from the lymph to the HEVs. The conduits consist of a core of collagen
ﬁbres surrounded by a microﬁbrillar zone consisting of ﬁbrillin and ERTR7. This
is enclosed by a basement membrane consisting of perlecan, collagen IV, nidogen,
laminin and ﬁbronectin, which is ensheathed by (and presumably synthesised by)
FRCs. The contents of the conduits are sampled by ﬁbre-associated DCs (Sixt et al.,
2005). Recent evidence also indicates that conduits also exist to transport antigen to
B cells in the follicles (Roozendaal et al., 2009).
In summary, the developed lymph node is dependent upon an intricate associ-
ation of blood and lymphatic vessels, required for it to perform its unique function
of bringing together antigen presenting cells from peripheral tissues with T and B
lymphocytes recruited from the blood. The diﬀerent reticular networks within the
node serve to support and segregate the lymphocytes, as well as providing a plat-
form for their interaction with other cell types. The question arising from these ob-
servations is how these unique and intricate vascular structures develop, and how
their formation is initiated. This is a process which begins, at least partially, with the
formation of the LN stromal networks, discussed next.
1.3.3 Development of lymph nodes
Peripheral draining lymph nodes are generally formed by the same set of basic cellu-
lar interactions between lymphoid tissue inducer (LTi) and LTo cells. Our current un-
derstanding of the process has been reviewed by Blum and Pabst (2006); Nishikawa,
Honda et al. (2003) and most recently by van de Pavert and Mebius (2010). An over-
view illustrating the process is shown in Figure 1.4. The ﬁrst secondary LNs begin
to form at day E12.5, when LTis are seen to begin to cluster at the sites of LN forma-
tion. Pre-LTi cells are derived from hæmatopoietic precusors, and are characterised
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by their expression of CD45 and CD4 but are not from a T cell lineage (lacking CD3),
nor are from a B cell lineage (CD3 CD4+CD35 ) (Mebius, Rennert et al., 1997). They
are additionally characterised by the expression of interleukin (IL)-7Rα, retinoic acid
receptor-related orphan receptor-γt (RORγt), inhibitor of DNAbinding 2 (ID2), TNF-
related activation-induced cytokine (TRANCE) and TNF-related activation-induced
cytokine receptor (TRANCER). (TRANCE was previously known as receptor activ-
ator of NF-κB ligand (RANKL) and TRANCER as RANK.) Human LTis express the
equivalent humanmarkers, but lack CD4 expression. LTi derive from CD35+cKitint-
IL7Rα+CD3 CD4  precursors found in fœtal mouse liver (Coles, Kioussis et al.,
2010). The IL-7Rα-expressing precursors only diﬀerentiate into pre-LTi cells follow-
ing expression of the protein ID2 which suppresses the transcription factor E2A. In
the absence of ID2, the precursors diﬀerentiate down a B cell lineage, whereas in the
presence of ID2 form pre-LTi cells; the pre-LTi cells are also characterised by their
expression of RORγt (Coles et al., 2010).
Circulating pre-LTi cells are recruited to the sites of LN development via the ac-
tion of several chemokines secreted by the local stromal environment such asCXCL13
and CCL21. Pre-LTis possess the chemokine receptors CXC chemokine receptor
(CXCR)5 and CC chemokine receptor (CCR)7 and can hence respond to the CXCL13
and CCL21 paracrine signals, respectively. This results in a local clustering of re-
cruited LTi cells. The source of the CXCL13 signal is the local stroma, but the trigger
for the induction of CXCL13 expression has not yet been ﬁrmly established. CXCL13
expression is induced by retinoic acid (RA)-driven expression driven via retinoic
acid response elements (RAREs) in its promoter, which has been demonstrated us-
ingDR5/RARE reportermice, which express luciferasewhere RA is expressed; these
show that all CXCL13+ cells express luciferase and hence have also expressed RA
(van de Pavert, Olivier et al., 2009). While the mechanism of RA paracrine signalling
is not yet ﬁrmly established, CXCL13-expressing LTo cells were shown by van de
Pavert et al. (2009) to exist adjacent to neurons expressing retinaldehyde dehydro-
genase 2 (RALDH2), the major enzyme responsible for production of RA from ret-
inal, and CXCL13 was shown to result in the ileum from stimulation of the vagal
nerve.
LTis express both TRANCE and TRANCER, and in consequence signalling is in-
duced via juxtacrine and paracrine signalling as the cells cluster and come into in-
timate contact with one another. The expression of LT is induced by signalling via
TRANCER, leading to LTαβ expression on mature LTis, which binds LTβR on LTos,
activating them. The lymphokine cytokine LT, a member of the tumour necrosis
factor (TNF) family formerly known as TNF-β, has been shown to be required for
LN development. LT-α /  knockout mice have no draining LNs, but the lymph-
atic vessels are present, demonstrating that LT is critically required in order to drive
formation of LNs, but is not important in the development of lymph vessels (Nishi-
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Figure 1.4: LN development from lymphoid tissue inducers and stromal organisers.
CXCL13 arising from the mesenchyme results in the recruitment of pre-LTi cells from
the circulation. CXCL13 production may be initiated through retinoic acid production
from neurons, but this is not yet conﬁrmed. Clustering LTis are mutually activated by
TRANCE–TRANCER signalling, becoming mature LTis expressing LT. LT signalling
through LTβR present on mesenchymal cells activates them to become stromal organ-
isers, resulting in increased production of chemokines (CXCL13, CCL19 and CCL21),
adhesion molecules (ICAM, VCAM andMAdCAM), IL-7 and TRANCE, leading to fur-
ther LTi recruitment, clustering and activation. From van de Pavert and Mebius (2010).
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kawa et al., 2003; White, Carragher et al., 2007).
LTo cells are derived from the local mesenchyme at the site of LN development,
and are characterised by the expression of MAdCAM, ICAM and VCAM and a lack
of CD45 expression. Activation of the stroma by LT signalling leads to upregulation
of MAdCAM, ICAM and VCAM, and the chemokines CCL19, CCL21, CXCL13 and
TRANCE, leading to further LTi recruitment and hence more LTo activation, i.e. a
cycle of positive feedback resulting in increased LTi clustering and LTo activation
(van de Pavert and Mebius, 2010). VEGF-C expression by LTos is also upregulated,
which may a role in the establishment of lymphatic structures. Upregulation of IL-
7 by the stroma may further stimulate the LTis, as well as serving to support the
homeostasis of T lymphocytes, which are required to maintain the node after initial
development (Coles, Veiga-Fernandes et al., 2006; Vivien, Benoist et al., 2001).
Following these steps, it is currently accepted that the microvasculature diﬀer-
entiates into a functional HEV network to allow recruitment and ingress of T and
B cells, attracted to the node by HEV expression of CCL21 which can recruit DCs
expressing CCR7; DCs in turn express CCL18, 19 and 21 which can recruit T cells
expressing CCR7, and B cells are recruited by CXCL13 (Blum and Pabst, 2006). Se-
gregation of the stroma into T and B zones follows, CXCR5-expressing B cells being
attracted by FDC secretion of CXCL13, while T cells are attracted to the CCL19 and
21-expressing FRCs.
While these steps are of critical importance in the establishment of the lymph
node, and the concepts of LTi and LTo interaction are nowwell understood, there is a
large gap in our understanding. These processes describe in detail how the formation
of LN stroma is induced, but they do not relate these changes to the concomitant
changes in the vasculature. These cellular interactions and signalling processes take
place in close proximity to the lymph sac, and additionally the blood vasculature
from which the sac originates, but the process by which the lymphatics and blood
vessels within the node form the complex interrelated networks found within the
developed, functional node is unclear.
If the process of CXCL13 production is initiated by RA production by neurons,
this leads to the question of whether the budding of the lymph sac is driven by the
same process, or if both events are a result of an earlier, as yet unidentiﬁed signal.
Given the close spatio-temporal association of lymph sac formation and stromal spe-
ciﬁcation, it is unlikely that these events are not closely coordinated. Angiogenesis
and neural development both involve the migration of adventitious cells, and en-
dothelial and neural cell types have been observed tomake use of the same guidance
molecules to direct their movement (Eichmann, Makinen et al., 2005a), and evidence
exists that neural cells can use an existing vascular network for guidance during mi-
gration (Nagy, Mwizerwa et al., 2009). It is therefore possible that the patterning of
both networks results in the formation of lymph nodes at discrete points where cer-
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tain conditions are met. Particular interactions between the endothelium and mes-
enchyme may also play a role.
Due to the small size of early LN anlagen, and diﬃculty in identifying and obtain-
ing them, it would be desirable to be able to model the speciﬁc cellular interactions
and signalling processes using an in vitromodel to study factors which may control
angiogenesis, and hence vascular development, in the developing LN anlagen.
1.4 Overall Aims
This PhD research project aims to investigate the processes involved in lymphoid
tissue organogenesis required to form a functional LN. The eﬀects of vascularisation
upon cell and matrix organisation, and the mechanisms driving vascularisation will
be determined, using both in vivo and in vitromodels. Thus the aims of the PhD are:
1. Analysis of vascularisation of lymph node anlagen in vivo.
2. Development of an in vitromodel of angiogenesis.
3. Modelling the role of vascularisation in lymph node development.
1.4.1 Aim 1: Analysis of vascularisation of lymph node anlagen in
vivo
During the process of organogenesis, hypoxia is thought to induce the vascularisa-
tion of organs. The process of vascularisation may be important not only to meet
the metabolic oxygen and nutrient demands of the tissue, but may also drive the
structural organisation of organs through both deposition and organisation of the
extracellular matrix. The pattern and kinetics of the formation and development of
vascular networks in LNs is currently unknown, thus confocal microscopy will be
used to determine and quantify the formation of vascular networks in LN anlagen,
and use microarrays and quantitative real-time reverse transcriptase PCR (RTPCR)
to determine if hypoxia plays a role in this process, and also examine the role of pro-
and anti-angiogenic genes to determine if a switch in their balance occurs during
development.
1.4.2 Aim 2: Development of in vitromodel of angiogenesis
In order to study the role andmechanismof angiogenesis during lymphoid tissue de-
velopment, an in vitromodel will be requiredwhich phenotypically resembles in vivo
angiogenesis, and which is both reproducible and quantiﬁable. Three-dimensional
(3-D)models of both vasculogenesis and angiogenesis will be established and tested.
It would be desirable to have a model which closely resembled the vasculature in
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vivo, thus a microﬂuidic network will be integrated within the 3-D model to simu-
late a perfused capillary network, modelling the physical forces and bulk ﬂow of tis-
sue perfusion, in addition to incorporating vascular endothelial and smooth muscle
cells into the vascular model. Imaging changes in the model in real-time using mul-
tiphoton (MP) imaging to visualise changes in the organisation of cells and the extra-
cellular matrix would also be desirable. Changes in the model must be quantiﬁable
by image analysis, and the model must be responsive to pro- and anti-angiogenic
factors to allow it to be used to answer important biological questions.
1.4.3 Aim 3: Modelling the role of vascularisation in lymph node
development
Using the developed in vitro model of angiogenesis, the process of LN vascularisa-
tion will be studied using LN explants from timepoints throughout LN develop-
ment. The model will be used to study the eﬀects of the explants upon angiogenesis
in detail, and dissect the signalling pathways involved in the process of tissue vas-
cularisation.
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Chapter 2
Materials and Methods
2.1 Cell culture
2.1.1 Culture conditions
Human Umbilical Vein Endothelial Cells Primary human umbilical vein endo-
thelial cells (HUVECs; HUVEC-c, PromoCell, Heidelberg, Germany) were grown
from passages 1–7 in endothelial cell growth medium (ECGM, PromoCell), supple-
mented with 10% fœtal bovine serum (FBS), at 37 °C with 5% CO2. Note that the ad-
dition of 10% FBS is atypical and may have undesirable eﬀects, so is not recommen-
dedwithout good reason. HUVECswere seeded at a density of 5–10 103 cells/cm2.
Human Dermal Lymphatic Endothelial Cells Primary human dermal lymphatic
endothelial cells (HDLECs; HDLEC-c, PromoCell) were grown from passages 1–7 in
endothelial cell growth medium (microvascular) 2 (ECGMMV2, PromoCell), sup-
plemented with 10% FBS, at 37 °C with 5% CO2. Note that the addition of 10% FBS
is atypical and may have undesirable eﬀects, so is not recommended without good
reason. HDLECs were seeded at a density of 10–20 103 cells/cm2.
Vascular Smooth Muscle Cells Vascular smooth muscle cells (VSMCs) isolated
from the aorta of the Immorto mouse (Foo, Turner et al., 2006; Jat, Noble et al., 1991),
a gift from Prof. Ralf Adams, Max Planck Institute for Molecular Biomedicine, Mün-
ster, Germany, were cultured from passages 1–12 in Dulbecco’s modiﬁed Eagle’s me-
dium (DMEM, Sigma-Aldrich, Gillingham, UK), supplementedwith 10% FBS, 2mM
-glutamine (Invitrogen, Paisley, UK), and 5ng/mL interferon γ (IFN-γ, Peprotech,
Rocky Hill, NJ, USA), at 33 °C with 5% CO2. This cell line expresses the simian virus
40 (SV40) large tumour antigen (TAg) under the control of an IFN-γ-inducible pro-
moter (Jat and Sharp, 1989), used to induce proliferation. The TAg is temperature
sensitive, only allowing proliferation at the permissive temperature (33 °C). Upon
removal of IFN-γ from the medium and raising of the temperature to 37 °C, the cells
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growth arrest in stages G1 or G2 of the cell cycle (Jat et al., 1991). VSMCs required
seeding at high density and were split 1:3.
C3H/10T½, clone 8 cells obtained from the American Type Culture Collection
(ATCC) were cultured from passages 9–20 in DMEM, supplemented with 10% FBS,
and 2mM -glutamine at 37 °C with 5% CO2. C3H/10T½ were seeded at a density
of 3 103 cells/cm2.
2.1.2 Recovery and subculture of cell lines
Subconﬂuent cells were subcultured by aspiration of the culture medium followed
by two washes in Ca2+ and Mg2+ free Dulbecco’s phosphate buﬀered saline (DPBS,
PAA) and addition of Trypsin-ethylenediaminetetraacetic acid (EDTA) (6 µL/cm2,
0.05% trypsin, 0.2 g/L EDTA.4Na, Invitrogen). Primary cells requiring more del-
icate handling, such as HUVECs and HDLECs, were incubated in Trypsin-EDTA
at room temperature (RT), while established lines such as C3H/10T½ were incub-
ated at 37 °C, until over half the cells were rounded, then cells were detached with
gentle tapping. An alternative form of trypsin was used for HDLECs (DetachKit,
PromoCell), using 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buﬀered sa-
line solution (HEPES-BSS) in place of DPBS, and trypsin neutralising solution in
place of FBS-containing media to inhibit trypsin activity).
Cells were split in order to seed at the appropriate seeding density; HUVECs and
HDLEC were a counted in order to seed at the recommended densities, while split
factors were used for other cells. Depending upon the required number of cells for
experiments or maintenance of stocks, T25, T75 or T175 ﬂasks were used (Corning,
Corning, NY, USA).
When speciﬁc numbers of cells were required for experiments, HUVECs and
HDLECs were spun down at 220 g and all other cell types at 300 g prior to resuspen-
sion in growthmedium, freezingmediumor collagen using the appropriate quantity
of cells.
2.1.3 Cryopreservation
Cells were frozen in a 1:1 mixture of their speciﬁc medium and freezing medium
(20% dimethyl sulphoxide (DMSO) (Sigma) and 80% FBS) to give a ﬁnal concentra-
tion of 10%DMSO and at least 40% FBS. A deﬁned number of cells were spun down
prior to resuspension in growthmedium, then an equal amount of freezingmedium
was added dropwise. The cell suspension was then aliquoted into cryovials (Corn-
ing andNunc) and transferred to a -80 °C freezer to freeze in a “Mr Frosty” 1 °C/min
freezing container (Nalgene, Fisher Scientiﬁc, Loughbrough, UK), or a polystyrene
tube tray wrapped in foil, prior to long-term storage in liquid and vapour phase ni-
trogen (-196 °C and -190– -135 °C, respectively).
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Cells were recovered from cryopreservation by rapid thawing in a 37 °C water
bath until a small amount of frozen material remained. The cryovial was washed
with copious 70% ethanol and allowed to dry prior to aspiration of the contents
along with 1mL normal culture medium and transferred to a 15mL centrifuge tube
containing 4mL culture medium and spun down. The supernatant was aspirated
and the cell pellet resuspended in 5mL pre-warmed culture medium, then trans-
ferred to an appropriate number of culture ﬂasks also containing pre-warmed me-
dium. The ﬂasks were checked under a phase contrast microscope to ensure the
presence of cells at the appropriate density and transferred to an incubator at the
appropriate temperature to allow cells to attach.
2.1.4 Growth factors and media supplements
A summary of the growth factors used is shown in Table 2.1. In order to induce
vasculogenesis and capillary outgrowth in 3-D, a cocktail of growth factors was
used. Tube forming medium, derived from Yang et al. (1999) and Davis, Black et al.
(2000a), contained 40 ng/mL human VEGF (hVEGF165, Peprotech, Rocky Hill, NJ,
USA), 40 ng/mL basic ﬁbroblast growth factor (bFGF, Peprotech), 50 ng/mL phor-
bol 12-myristate 13-acetate (PMA, Sigma) and 50µg/ml -ascorbic acid 2-phosphate
sesquimagnesium salt hydrate (ascorbate, Sigma) in ECGM. VEGF and bFGF were
reconstituted in phosphate buﬀered saline (PBS) with 0.1% bovine serum albumin
(BSA) carrier, PMA in ethanol and ascorbate in PBS.
Lyophilised human transforming growth factor β1 (TGF-β1, Peprotech) was re-
constituted in 10mM citrate buﬀer, pH 3 with 0.2% BSA carrier at a concentration
of 4.5 µg/mL. TGF-β1 was used to diﬀerentiate C3H/10T½ toward a smooth muscle
lineage.
2.1.5 Labelling cells
CFSE and CMTMR Cells were labelled by resuspending in 1mL labelling buﬀer,
and mixing with 1mL labelling buﬀer containing 5 µM carboxyﬂuorescein succin-
imidyl ester (CFSE) or chloromethyl tetramethylrhodamine (CMTMR) (Invitrogen),
and incubated at room temperature for 8min. Excess probe was removed by the
addition of 1mL FBS, followed by three washes in labelling buﬀer containing 20%
FBS. Labelling buﬀers used included serum-free medium (DMEM, RPMI, M199)
and PBS.
Transfection HUVECs and VSMCs were transfected using Amaxa nucleofection
(Lonza, Cologne, Germany) with the appropriate cell-speciﬁc solution. 5 105 cells
were resuspended in 100 µL nucleofection solution, and 1–2 µg plasmid DNA was
added. Following transfer to an Amaxa cuvette, the cells were transfected using the
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Table 2.1: Growth factors used for in-
ducing vasculogenesis, capillary outgrowth
and smooth muscle diﬀerentiation.
Name Targets Supplier
PMA PKC Sigma
bFGF FGFR Peprotech
hVEGF165 VEGFR1, VEGFR2 Peprotech
TGF-β1 TGF-βR Peprotech
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appropriate programme, then transferred into plates or ﬂasks to allow recovery for
24 hours prior to further use.
The newer Neon system (Invitrogen) as also used for transfection. Cells were
resuspended in the provided transfection buﬀer, plus the plasmid being transfected,
and then drawn into the pipette tip cuvette with integrated electrode used by the
system. The appropriate settings (voltage, pulse width and pulse count) were set for
the cell type being transfected. Transfected cells were then transferred into plates
prior to use.
2.2 Mice
C57BL/6 human-CD2-GFP (hCD2-GFP) transgenic mice (de Boer, Williams et al.,
2003) express green ﬂuorescent protein (GFP) in LTi cells, as well as other cell lines
deriving from the same lineage (thymocytes, T cells and natural killer (NK) cells). In
the developing embryo, GFP-expressing LTi cells present in LN anlagen primordia
and thymi allowed visualisation of the developing organs using a stereo ﬂuores-
cence microscope (Zeiss). During development, mature T cells are yet to complete
their development and exit the thymus, so clusters of GFP+ cells in the periphery
can be assumed to be LTi cells. LN anlagen, thymi, fœtal liver and skin samples
were ﬁnely dissected with Dumont № 5 forceps (Fine Science Tools, Heidelberg,
Germany), using GFP expression to identify the developing axillary, brachial, cer-
vical and inguinal nodes below the skin, and the thymus in the thoracic cavity, and
placed on ice in Iscove’s modiﬁed Dulbecco’s medium (IMDM) prior to use in exper-
iments, or ﬁxed with 4% paraformaldehyde (PFA, Sigma) for immunohistochemical
staining. All mice were bred at the the National Institute forMedical Research under
Home Oﬃce licence and guidance.
2.3 Glass and metal surface preparation
2.3.1 Cleaning
A saturated solution of KOH in isopropanol was used to clean glass slides and stain-
less steel metalwork prior to use, removing all traces of grease and dirt. Glass was
further cleaned in 0.1MHCl overnight. Both glass andmetal were rinsedwith water
before oven drying, or autoclaving for use in cell culture.
2.3.2 Non-stick non-wetting coating
To render glass surfaces non-stick and non-wettable, glass slides were washed with
chloroform, 5% (v/v) dimethyldichlorosilane (DMDCS, Sigma) in chloroform, and
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again with chloroform (10min for each wash), before baking at 65 °C for 3 hours.
2.3.3 Collagen binding coating
Glass slides and metal collagen supports may be coated with poly(ethylenimine)
(PEI, Sigma) and functionalised with glutaraldehyde in order that they react and
covalently bond with a collagen extracellular matrix, stabilising and supporting the
matrix along all contacting surfaces.
Under sterile conditions, glass or metal supports were cleaned with ethanol and
air dried prior to coating with PEI 1% (v/v) in H2O for 30min. Excess unbound PEI
was washed away using 95% (v/v) ethanol and the support air dried. The support
was then functionalised with glutaraldehyde 1% (v/v) for 30min and the glutaral-
dehyde removed by at least six washes with H2O, then air dried prior to use.
2.4 Collagen matrix
2.4.1 Preparation of collagen type I from rat tail
All solutions were 0.02 µm ﬁlter sterilised and kept on ice. All equipment was auto-
claved or sterilised with ethanol prior to use, and all steps were performed under
sterile conditions since collagen cannot be sterilised after preparation.
Tendon isolation Frozen tails collected from adolescent rats were thawed, then
rinsed in 95% ethanol. Using a scalpel, the distal end of the tail was removed, and
the epidermis removed by cutting down the length of the tail and separating with
hæmostats. This exposed the tail tendons, seen running in four bundles down the
length of the tail. The proximal end of the tail was clamped with a hæmostat and
the collagen bundles severed immediately distal to it. The tendons were removed
by clamping the tail at the proximal end using a second hæmostat, then fracturing
this end by bending and gentle pulling until the tail tendons slid out along the entire
length. The exposed tendons were cut oﬀ into sterile water and the process repeated
for each joint, working towards the proximal end. The tendonswerewashed in sterile
water three times and teased apart with forceps to form a ﬁne mesh, then quickly
washed in 95% ethanol and air dried before weighing.
Monomeric collagen extraction The tendons were dissolved in 50mL 0.5M acetic
acid per 1 g of tendon at 4 °C in a 200mL ﬂask, stirring as slowly as possible for
26–36 hours, 30 hours being optimal, then spun down at 20000 g, 4 °C for 60min to
pellet the remainder, using 250mL polypropylene centrifuge tubes (Nalgene). The
supernatant was retained and stored at 4 °C. The acidity was subsequently reduced
by either dialysis or by lyophilisation and reconstitution.
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Dialysis Dialysis was performed to remove excess acid while retaining a low pH
(collagen gels under alkaline conditions). Monomeric collagen in 0.5M acetic acid
was dialysed against 2 L of 0.1× DMEM in 0.02M acetic acid using high retention
seamless cellulose tubing (Sigma), replacing the dialysis buﬀer twice over three days.
Dialysed aliquots were stored at 4 °C. Following dialysis, the concentration of the
collagen solutions was determined using Coomassie Plus staining (BioRad, Hemel
Hempstead, UK), comparing with a standard curve determined using a type I rat
tail collagen standard (Becton Dickinson, Oxford, UK). This step was unnecessary
for redissolved lyophilised collagen whose concentration was already known.
Lyophilisation Lyophilisation was used as an alternative to dialysis in order to
more accurately determine the collagen concentration. Monomeric collagen in 0.5M
acetic acid was lyophilised for at least three days using a Lyotrap lyophiliser (LTE,
Oldham, UK), giving a dry white solid, stored at room temperature. Collagen stock
solutions were prepared by dissolving speciﬁc mass fractions of collagen solid in
0.02M or 0.04M acetic acid for further dilution.
Support An artiﬁcial collagen gel does not possess great mechanical strength, be-
ing easy to compress and stretch, and so can not hold its shape without external
support. In order to create collagen gels of deﬁned size and shape, several sup-
port structures were designed and fabricated for this purpose. Figure 2.1 shows the
designs for several diﬀerent supports for use in diﬀerent situations. Plateswith holes
of deﬁned diameter and height were used to create larger gels, including wells to
contain media for live imaging of cell-seeded gels, while rings were used to allow
the culture of cells-seeded gels of deﬁned size in multi-well plates. 24 well glass-
bottomed imaging plates were used for imaging collagen gels in metal rings (PAA
and Iwaki, Tokyo, Japan), and also glass-bottomed dishes with a 14mm window
(Iwaki). Supports in 2.1(A) and (B) were machined from aluminium sheet and steel
washers, respectively, by the Biology department workshop, while (C) and (D) were
machined from stainless steel by computer aided design / computer aided manu-
facturing (CAD/CAM) , contracted to Aztech Precision Engineering, Riccall, York,
UK using CAD drawings drafted by myself.
Gelation Existing collagen stock was diluted as required with 0.02M acetic acid,
then further diluted with 1 part 10× DMEM containing phenol red to 9 parts colla-
gen to create a working solution (containing 1× DMEM for buﬀering). For all the
experiments shown in this thesis, all working solutions contained collagen at a con-
centration of 3mg/mL. An appropriate amount of the working solution was then
neutralised with 0.8MNaHCO3 or 1MNaOH on ice to pH 7.5, using the phenol red
indicator colour change to monitor neutralisation, and pH indicator strips (Neutralit
pH test strips pH 4.5-10.0, VWR, Batavia, IL, USA) to check the resulting pH.
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A
B
Figure 2.1: Collagen matrix supports. (A) Support slide for 30× 3mm diameter, 3mm
thick collagen gels. (B) Support ring for 6mm diameter, 1mm thick collagen gels.
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D
C
Figure 2.1: Collagen matrix supports (continued). (C) Support with 3 wells and (D)
support with 30 wells for 3mm diameter, 3mm thick collagen gels. The ﬂat base allows
coverslip attachment to permit imaging. Side ports permit gas entry and exit for live
imaging, with a recess to allow attachment of top slide to maintain sterility.
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The required number of cells or spheroidswere spundown, and seeded in the col-
lagen gel by resuspending in a suitable volume of neutralised collagen. The seeded
collagen solutionwas then transferred into a suitable container for gelling (see Figure
2.1). The solution was gelled for 2 hours at 15 °C before covering with the appropri-
ate medium and culturing at 37 °C with 5% CO2. Faster gelation times were used
for spheroid cultures, gelling at 37 °C for 10min. Gelation may be performed at any
temperature from 15 °C to 37 °C. Gelling was faster at higher temperatures, but the
gel would contain a large number of very short ﬁbres. Gelling would take longer
(1–2 hours) at lower temperatures, but the gel would contain a smaller number of
long ﬁbres. Cell viability during the gelling period was also taken into considera-
tion.
Culture medium was added on top of the gel following gelation, taking care to
pre-wet the gel surface to prevent surface tension from disrupting the gel. In or-
der to minimise risk of infection when using dishes containing metal plates, penicil-
lin/streptomycin (Invitrogen) or gentamycin (Sigma) was added to a ﬁnal concentra-
tion of 100U penicillin, 100 µg/mL streptomycin (1% (v/v)) or 50 µg/mL, respect-
ively, to the medium.
2.5 Formation of methylcellulose spheroids
This protocol is derived from previously published work (Korﬀ and Augustin, 1998;
Laib, Bartol et al., 2009), which describe the production of HUVEC spheroids using
a methylcellulose hanging drop culture method.
2.4% (w/v) methylcellulose stock was made using 6 g methylcellulose (Sigma
M-0512, 4000 centipoises), autoclaved in a 500mL Schott bottle containing a mag-
netic stirrer, and dissolved in 150mL unsupplemented basal growth medium pre-
warmed to 60 °C, stirring at RT for 20min. A further 100mL unsupplemented basal
medium was added (RT) to make a ﬁnal volume of 250mL, and the solution mixed
for 2–3 hours at 4 °C to give a clear, viscous solution. The solution was cleared by
centrifugation at 3600 g for 2 hours at RT, retaining the clear viscous supernatant.
2.4% (w/v)methylcellulose stock in unsupplemented basal growthmediumwas
diluted to aworking concentration of 0.3% (w/v) in supplemented growthmedium.
HUVECs were, for example, resuspended at a concentration of 0.3 106 cells/mL
and 25µL drops of the cell suspension were hung from the lids of 10×10 cm2 Petri
dishes (Sterilin, Caerphilly, UK) and cultured for 24 hours. Each spheroid contained
750 cells.
Spheroids were recovered by gentle washing in 10% (v/v) FBS in PBS, the FBS
being used to reduce adherence of spheroids to the plastic. The spheroid suspension
was spun down at 100 g with no brake prior to aspiration of the supernatant and
resuspension of the spheroid pellet in neutralised collagen.
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2.6 Imaging
2.6.1 Immunohistochemistry using frozen sections
Fixation Samples were prepared by ﬁxation in 4% PFA for 20mins, and washed
twice in PBS prior to putting through a sucrose gradient: 15% sucrose for at least
4 hours followed by 30% sucrose overnight. A sucrose gradient was required to pre-
serve GFP ﬂuorescence and permit staining with anti-GFP antibodies. The samples
were then embedded in Tissue-Tek optimal cutting temperature embeddingmedium
(OCT, Baxter Diagnostics, McGaw Park, IL, USA). The OCTwas set on dry ice mixed
with isopropanol, or snap frozen in liquid nitrogen, and then transferred to a -80 °C
freezer prior to sectioning.
Sectioning 6–10 µm sections were cut from samples embedded in OCT using a
cryostat (Leica Microsystems, Wetzlar, Germany) and placed on poly--lysine- or
SuperFrost-coated glass slides (VWR). Sections were air dried at RT for at least one
hour and stored at -80 °C in slide boxes containing silica gel beads (Sigma) to absorb
moisture.
Staining A complete list of all primary and secondary antibodies used is shown in
Tables 2.2 and 2.3. Additional non-antibody stains are also shown in Table 2.2.
Slides were defrosted at RT in covered boxes and ﬁxed in ice cold acetone (-20 °C)
or 4% PFA for 5min. A wax circle was drawn around each section using a hydro-
phobic pen (PAP pen, Fisher Scientiﬁc, Loughbrough, UK) and allowed to dry. Sec-
tions were then rehydrated using washing buﬀer (PBS containing 0.05% (w/v) BSA)
for 10–15min in a slide bath, and then blocked using blocking buﬀer (PBS containing
5% (v/v) serum from the same species as the secondary was raised in) for 30min at
RT, then washed again for 5min in washing buﬀer. The primary antibody cocktail
was made up in blocking buﬀer and one drop added to each section, then incubated
at RT for 45min. The slides were covered with a lid to prevent dehydration, and
foil to prevent photobleaching of any ﬂuorochromes. The slides were then washed
quickly with wash buﬀer, and then again three times, incubating for 10mins each
time. The secondary antibody cocktail was made up in blocking buﬀer and added
as for the primary antibody, incubating for 30mins at RT, then washed again as for
after the primary antibody. A ﬁnal wash was performed using PBS only, thenmoun-
ted using ProLong Gold antifade reagent (Invitrogen), coveringwith№ 1½ coverslip
glass (Agar Scientiﬁc, Stansted, UK) and stored overnight at 4 °C before sealing with
nail varnish. Sealed slides were stored at 4 °C in aluminium foil prior to imaging.
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Table 2.2: Primary antibodies and other reagents.
Speciﬁcity Species Clone Supplier Fluor
Mouse CD31 Rat IgG2a,κ 390 eBioscience 14-0311-85 None
Mouse CD31 Rat IgG2a,κ 390 eBioscience E93-0311-41 EF 605
Human CD31 Mouse IgG1 10G9 Santa Cruz sc-13537 None
Human CD31 Mouse IgG2a,κ M89D3 BD Pharmingen 558068 AF488
Mouse CD54 Rat IgG2b,κ YN1/1.7.4 BioLegend 116113 AF647
Mouse CD54 Rat IgG2b,κ YN1/1.7.4 eBioscience 12-0541-82 PE
Human CD54 Mouse IgG1,κ HA58 eBioscience 12-0549-71 PE
Mouse CD106 Rat IgG2a,κ 429 eBioscience 51-1061-80 AF647
Mouse CD144 Rat IgG1 BV13 eBioscience 51-1441-80 AF647
Mouse CD144 Rat IgG2a,κ 11D4.1 BD Pharmingen 555289 None
Endomucin Rat IgG2a V.7 C7 eBioscience 51-5851-82 AF647
Pan-
endothelial
Rat IgG2a,κ MECA-32 BioLegend 120504 None
LYVE1 Rabbit poly Millipore 07-538 None
HumanLYVE-
1
Rabbit IgG poly AngioBio 11-032 None
Mouse LYVE-
1
Rabbit IgG poly AngioBio 11-034 None
NG2 Rabbit poly Chemicon ab5320 None
α-SMA Mouse IgG2a 1A4 Sigma C6198 Cy3
Collagen I Rabbit poly Abcam ab34710 None
Collagen IV Rabbit poly Abcam ab6586 None
Desmin Rabbit poly Abcam ab8592 None
Fibronectin Rabbit poly Abcam ab23750 None
Laminin Rabbit poly Sigma L9393 None
Perlecan Rat IgG2a A7L6 Millipore MAB1948 None
GFP Rabbit IgG poly Invitrogen A21311 AF488
GFP Rabbit IgG poly Invitrogen A21312 AF594
GFP Rabbit IgG poly Invitrogen A31852 AF647
Pimonidazole Rabbit poly Hypoxyprobe 2627 None
Phalloidin N/A N/A Sigma 65906 Atto647
Genomic
DNA
N/A N/A Invitrogen D1306 DAPI
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Table 2.3: Secondary antibodies.
Speciﬁcity Species Supplier Conjugation
Mouse IgG H+L Goat polyclonal Invitrogen A11001 AF488
Mouse IgG H+L Goat polyclonal Invitrogen A11005 AF594
Mouse IgG H+L Goat polyclonal Invitrogen A21235 AF647
Rabbit IgG H+L Goat polyclonal Invitrogen A11008 AF488
Rabbit IgG H+L Goat polyclonal Invitrogen A11037 AF594
Rabbit IgG H+L Goat polyclonal Invitrogen A21245 AF647
Rat IgG H+L Goat polyclonal Invitrogen A11006 AF488
Rat IgG H+L Goat polyclonal Invitrogen A11081 AF561
Rat IgG H+L Goat polyclonal Invitrogen A11007 AF594
Rat IgG H+L Goat polyclonal Invitrogen A21247 AF647
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2.6.2 3-D immunohistochemistry using wholemount specimens
Dissected tissue samples were ﬁxed in 4% PFA for 1 hour, and whole embryos ﬁxed
overnight at 4 °C, then washed three times in PBS and stored at 4 °C prior to stain-
ing. Embroyos from timepoints E15.5 and later were slit longitudinally along the ab-
dominal cavity and thorax to permit more eﬃcient ﬁxation of internal visceral and
thoracic tissues and organs. Embryos and organs were embedded in 8% low melt-
ing point agarose (Invitrogen) and sectioned on a vibratome (Leica) to a thickness
of 250–300 µm. To stain, ﬁxed sections and smaller unsectioned ﬁxed pieces were
washed three times in PBS containing 0.15% (v/v) Triton X-100 (Sigma) (PBS-Triton)
over 30mins. The samples were then blocked in PBS-Triton containing 3% (v/v)
serum from the same species as the secondary antibody was raised in) for 30min
at RT (blocking solution). A primary antibody cocktail was prepared in blocking
solution, and each sample incubated in the cocktail overnight at 4 °C on a rocker.
The samples were then washed at least three times over the day with PBS-Triton. A
secondary antibody cocktail was prepared in blocking solution as for the primary
antibody and again incubated overnight in the dark. If necessary, further block-
ing, staining and washing steps were performed for additional antibodies, then the
samples were ﬁxed for 15mins with 4% PFA and washed three times in PBS-Triton
over 30mins. Note that the staining times are minimum times, and were routinely
extended up to several days in order to improve the staining of thick sections.
The samples were dehydrated in a methanol series (25%, 50%, and 75% (v/v)
methanol in PBS-Triton for 15mins, then 100% for 5mins and again for 1 hour, and
then cleared using benzyl alcohol benzyl benzoate (BABB). BABB is a 1:2 mixture
of benzyl alcohol:benzyl benzoate (Sigma). Samples were transferred to a glass con-
tainer of BABB:MeOH for 15mins, then to BABB for 15mins. Cleared samples were
mounted in BABB using metal slides with holes for samples as shown in Figure
2.2(A). № 1½ coverslip glass was sealed to one side of the slide using nail varnish,
then the wells were ﬁlled with BABB and the samples placed in the wells, then a
second coverslip was sealed to the upper side and the slides stored at 4 °C in the
dark. The parts shown in Figure 2.2 were machined from aluminium sheet by the
Biology department workshop using CAD drawings drafted by myself.
2.6.3 3-D immunohistochemistry using collagen gels
Collagen gels were ﬁxed 4% PFA for 1 hour, then stained using the wholemount
staining protocol in Section 2.6.2. Note that due to the less dense nature of collagen
gels in comparison to tissue, the minimum staining times could be reduced to hours
rather than days. Less dense samples such as collagen gels were not dehydrated or
cleared and were imaged in slides such as shown in Figure 2.2(B).
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Figure 2.2: Imaging slides, fabricated from aluminium sheet. (A)Wholemount imaging
slide with 10mm diameter, 2mm thick holes to accommodate vibratome-sectioned,
BABB-cleared samples in BABB. (B) Gel imaging slide with 4mm diameter, 3mm thick
holes to accommodate 3mm diameter, 3mm thick collagen gels after ﬁxation and clear-
ing.
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2.6.4 Confocal and multiphoton imaging
Fixed, stained samples were imaged using single photon confocal microscopy using
LSM 510META and LSM 510METANLO systems on Axiovert 200M inverted bases,
and an LSM 710 system on an Observer.Z1 inverted base (all Zeiss) using 0.3, 0.5
and 1.4 numerical aperture (NA) 10×, 20× and 40× objectives, respectively. The laser
power (where applicable) and photomultiplier gain voltage and oﬀset were set to use
the full 8- or 12-bit sampling range with a minimum of under- and over-saturation.
When imaging diﬀerent treatments and controls, the laser and photomultiplier set-
tings were kept constant to permit direct comparisons between samples. Multi-track
imaging ensured that bleedthrough was minimised through the excitation of only
one ﬂuorochrome at once by only exciting with one laser line in each pass. Addi-
tionally, when imaging z-stacks, depth correction was employed to ramp the laser
power and/or gain in order to attain consistent signal at all z depths. Line averaging
was used to improve the signal:noise ratio.
Live samples, including collagen gels, were imaged using the the LSM 510META
NLO with non-descanned detectors (NDDs) and a Chameleon Ti:Sapphire femto-
second pulsed, tunable laser (Coherent, Santa Clara, CA) for MP imaging, later re-
placed with an LSM 780 system with GaAsP and binary GaAsP (BiG) NDDs and
the same MP laser. The same considerations as for single photon confocal imaging
applied for multiphoton imaging, with the addition of controlling for photobleach-
ing, phototoxicity and ablation of cells by the MP laser. This required reducing the
laser power and increasing the NDD photomultiplier gain at the expense of noise.
Additionally, line averaging was replaced with with frame averaging and the num-
ber of averaging passes were reduced in order to decrease the energy being put into
the sample by avoiding rapid, repeated excitation of the same volume. Collagen was
imaged label-free using second harmonic generation (SHG). Due to the constraints
of the available ﬁlters and the tunable range of the MP laser, SHG was visualised
between 415–435 nm as a result of excitation at  840nm, or 435-485 nm from 870-
890 nm excitation.
2.6.5 Stereo imaging
A SteReo Lumar stereo ﬂuorescence microscope (Zeiss) with HBO100mercury lamp
and EBQ100 isolated power supply were used to dissect hCD2-GFP embryos and
to image microﬂuidic network parts (see below) using both transmitted and reﬂec-
ted white light and darkﬁeld illumination, and ﬂuorescent excitation with an Ax-
ioCam digital CCD camera (Zeiss). Microﬂuidic network parts were also separated
and cleaned up using an MZ8 stereo microscope (Leica) with both transmitted and
reﬂected white light, using Dumont № 5 forceps and 0.10 and 0.15mm insect pins
(Austerlitz, Interfocus, Cambridge, UK) for delicate manipulation.
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2.6.6 Whole gel imaging
Large (6mm diameter) gels were imaged by hand using an Axiovert 40 CFL inverted
epiﬂuorescence microscope (Carl Zeiss) with a Lumen 200 metal arc lamp (Prior Sci-
entiﬁc Inc., Rockland, MA, USA) a 5× objective and exiBlue CCD camera (QImaging,
Surrey, BC, Canada). Due to the large scale of the gels, gels was imaged as a set of
1/3 overlapping tiles which were stitched together using ImageJ and a globally op-
timal stitching algorithm to automatically align and blend all tiles to form a single
image (Preibisch, Saalfeld et al., 2009). Due to the use of a monochrome camera, the
process was repeated for each colour required. Single images of gels without tiling
were also taken using a DM IRB inverted epiﬂuorescence microscope (Leica) with a
DC500 colour CCD camera (Leica).
6mm diameter gels were also imaged using a high-throughput ImageXpress epi-
ﬂuorescence system (Molecular Devices). Gels were imaged as a series of 3×3 tiles
using a 4x objective at a resolution of 2.48 µm/pixel. In addition to tiling, the gels
were imaged inmultiple (15–40) z planes as a z-stack, and inmultiple colours. ImageJ
macros were used to assemble a composite stack from the separate images. Images
were ﬁrst combined into 3×3 tiles; no specialised alignment and blending was pos-
sible due to there being no overlap between tiles. The colour channels were then
merged to give a single image per plane, and then each plane was combined to pro-
duce a ﬁnal colour z-stack.
2.6.7 Cell imaging
Adherent cells on glass or plastic were imaged using the Axiovert 40 CFL and DM
IRB inverted epiﬂuorescence microscopes described above.
2.6.8 Transmission electron microscopy
Whole collagen gels and tissue samples were prepared for transmission electron
microscopy (TEM) by ﬁxation in TEM ﬁxative, composed of 5mM 200mM phos-
phate buﬀer, pH 7.2, 2.5mL 16% PFA (Sigma), 1mL 25% glutaraldehyde (Sigma)
and 1.5mL distilled water to give a ﬁnal concentration of 4% PFA and 2.5% glut-
araldehyde in 100mM phosphate buﬀer. Phosphate buﬀer, pH 7.2, was made from
77mL 200mM Na2HPO4 and 23mL NaH2PO4 adjusted to pH 7.2 using a pH probe
and dropwise addition of the needed buﬀer component.
Samples were ﬁxed in TEM ﬁxative overnight at 4 C, then washed three times in
phosphate buﬀer and stored at 4 C in phosphate buﬀer. Fixed samples were stained
with 1% (w/v) osmium tetroxide followed by dehydration using an acetone series
and embedding in Spurr’s resin. Thick sections were stainedwith toluidine blue and
used to identify features of interest prior tomaking ultrathin sections (approximately
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80 nm). Ultrathin sections transferred to grids were stained with uranyl acetate and
Reynold’s lead citrate prior to imaging.
Samples were imaged using an TECNAI G2 TEM (FEI, Hillsboro, Oregon, USA)
with a MegaView III CCD (Olympus Soft Imaging Solutions, Münster, Germany).
2.7 Image analysis
2.7.1 Manual analysis
Example spheroid measurements using ImageJ are shown in Figure 2.3. For each
image to be analysed, every spheroid was assigned a unique identiﬁer to allow the
generated numerical data to be uniquely associated with each spheroid. Spheroids
which were either out of focus or inseparable from neighbouring spheroids were
excluded. For each spheroid:
• The total number of sprouts tips (endpoints) were counted, classiﬁed as pro-
trusions outside the inner cell mass circumference, plus any further branching
(i.e. total number of endpoints from initial protrusions).
• Circles were drawn around the inner mass (initial size) and the entire spheroid
(to the extent of the largest outgrowth) centred on the inner mass, using the
previously drawn border as a guide. The minimum width of the inner mass
was used in the case that it was not perfectly spherical. From this, the ratio
of the outer:inner radius was calculated, which gave an approximation of the
change in size from the initial radius.
• A border was drawn around the spheroid and any outgrowing tubes, allowing
measurement of the surface area and perimeter length. Tubes touching from
neighbouring spheroids were split equidistantly between the two. From this, a
perimeter:surface area ratio was calculated (akin to surface area:volume ratio,
but in 2D). This additionally allowed the calculation of Feret’s diameter (or
maximum caliper), the longest distance between any two points.
• The total outgrowth length was calculated, deﬁned as the summed outgrowth
length of all sprouts, including all branches.
• The straight-line distance between the circumferences of the inner cell mass of
the spheroid and its nearest neighbour, and between the circumference of the
inner cell mass and the edge of tissue explant (if present) were measured.
2.7.2 Automated analysis
Example spheroid measurements performed using ImageJ for whole-well tiled im-
ages from the ImageXpress imaging platform are shown in Figure 2.4.
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Figure 2.3: Image analysis strategies. An example of the outgrowth of two HUVEC
spheroids labelledwith anti-CD31 (white) following 24 hours of culture in a collagen gel
is illustrated in (A). Angiogenic outgrowth via sprouting into the gel is clearly visible;
arrows indicate additional 2D outgrowth where a sprout has made contact with the gel
surface, which will not be included in the analysis. The angiogenic outgrowth may be
quantiﬁed by (B) computing the total integrated density by summing the pixel values of
all pixels in the image, the pixel intensities are shown here as a colour ramp from black
to red, (C) counting the total number of sprout tips or endpoints, (D) measurement of
the initial minimum spheroid diameter and maximum outgrowth length as a radius
from the centre of the spheroid, (E) computing the perimeter length, surface area (red
outline) and Feret’s diameter (yellow line), and (F) measurement of the total amount of
outgrowth by summing the outgrowth length of each sprout from the spheroid edge.
Scale bar is 200 µm.
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Figure 2.4: Analysis of images with ImageJ. A single ﬁeld of view for a larger well
is illustrated here to allow individual spheroids to be seen. The original image (A) is
has the region of interested selected by hand with a polyline (B), shown as a yellow
line which is then converted to a bitmask (C) which is subsequently inverted (D). The
bitmask was subtracted from the original image to form a new image containing only
the region of interest (E). This imagemay then be processed to detect edges (F) and then
thresholded to select the edges (G) and inverted (H). All objects larger than a speciﬁed
minimum size may then be quantiﬁed (I).
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• Using the original image (A), a region was drawn around the features of in-
terest using a polyline, excluding the well edge and any spheroids touching
the edge (B) From this region, a mask was created (C) and then inverted (D).
The inverted mask was then subtracted from the original image to give an im-
age containing only the features of interest (E).
• The edges of the spheroids were found using an edge-detection algorithm (F).
A threshold was then set to select pixels less than or equal to the threshold
intensity (G). The image was then inverted and converted to a binary image
(H).
• To quantify the spheroids, the “analyse particles” algorithm was used to de-
termine the surface area and perimeter length of each object, as well as the x
and y coordinates of the centres, used for measuring the distance to the tissue
explants. The Feret diameter may also be calculated at this point.
• The same process was used for both the CD31 (HUVEC) and GFP (LN anla-
gen) channels. The distances between spheroids and explants may then be
computed based upon their object centres or nearest points using simple tri-
gonometry.
2.8 Quantitative Real-Time Reverse Transcriptase PCR
2.8.1 Tissue isolation
Lymph node anlagen from hCD2-GFP embryos were ﬁnely dissected and kept on
ice in IMDMprior to transfer to RNAlater (Ambion) and stored at 4 °C and -80 °C for
short- and long- term storage, respectively.
2.8.2 RNA extraction
The tissue was macerated on ice and RNA isolated using a Nucleospin RNA II kit
(Macherey-Nagel). Brieﬂy, 350 µL of extraction buﬀer was added to the homogen-
ised sample, and the sample vortexed vigorously. The lysate was further homogen-
ised and cleared by repeated passage through a 23 gauge needle followed by pas-
sage through aNucleoSpin column (all columnswere centrifuged at 11000 g). 350 µL
ethanol was mixed with the homogenised lysate and the entire mixture, including
precipitate, passed through a NucleoSpin RNA II column (RNA binding). The spin
columnmembrane was washed with 350 µLmembrane desalting buﬀer, then incub-
ated at RT for 10minwith 95 µLDNase reactionmixture. TheDNasewas inactivated
by passage of 200 µL buﬀer RA2, followed by two washes with buﬀer RA3. Finally,
pure RNA was eluted using 60 µL RNase-free H2O.
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The RNA concentration and quality were determined using a NanoDrop spec-
trophotometer (ThermoFisher). RNA was stored at -20 °C.
2.8.3 cDNA synthesis
Previously extracted total RNA was used for ﬁrst strand cDNA synthesis using an
EZ-ﬁrst strand cDNA synthesis kit (Biological Industries, Geneﬂow, Fradley, UK)
using the provided protocol. Brieﬂy, 1 µg total RNA was mixed with 1µL 40µM
oligo(dT) primer and made up to a total volume of 10 µL with DEPC-treated water,
then incubated for 10min at 70 °C in a thin-walled PCR tube. Following rapid cooling
on ice, 2 µL dithiothreitol (DTT) and 8µL 2.5× RT reaction mix were added to give a
ﬁnal volume of 20 µL. The tube contentsweremixed by gentle pipetting, and then the
following incubation was performed using a thermal cycler (Labcycler, SensoQuest,
Göttingen, Germany): 42 °C for 60min, then held at 4 °C. Finally, 80 µLDEPC-treated
water was added to give a ﬁnal volume of 100 µL, and the synthesised cDNA was
stored at -20 °C.
2.8.4 Primer design
Primers were designed using Primer-BLAST (NCBI, 2009) to both span an exon-exon
boundary and create a product ideally between 90–200 base pairs in length, shown
in Table 2.4. Primers were additionally checked against themouse genome+transcript,
refseq_rna and nr databases (Mus musculus only, where the mouse genome+transcript
database lacked more recent entries) to ensure their speciﬁcity. Primer eﬃciencies
were determined using serial dilution of cDNA from E14.5 whole embryo lysate,
shown in Figure 2.5.
2.8.5 Polymerase chain reaction
The annealing temperatures of the primers were tested using gradient polymerase
chain reaction (PCR) using each of the primers at a concentration of 10 mM and 5ng
template per reaction with SYBR green (Applied Biosystems, Carlsbad, CA, USA).
The PCR protocol used a 5 minute 95 C initialisation followed by a 40 cycle of de-
naturation at 57 C (15 s), annealing at the speciﬁed temperature (30 s) and extension
at 72 C (30 s). A ﬁnal elongation was performed at 72 C (7min) and then held at
4 C (¥).
Conventional PCR to test primers and perform non-real-time analysis utilised
GoTaq polymerase and GoTaq Green master mix containing loading dye (Promega,
Madison, WI, USA), performed using a LabCycler thermal cycler (SensoQuest). PCR
products were run out on a 1% (w/v) agarose gel in TAE buﬀer (UltraPure, Invitro-
gen) using an iMyRun gel electrophoresis system (Cosmo Bio, Carlsbad, CA, USA)
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Figure 2.5: Primer eﬃciencies. For each primer pair being tested, control cDNA (E14.5
whole embryo lysate) was diluted 1:10 three times to give four dilutions, and tested
in triplicate for each dilution. Some genes were not present in great abundance, and
so did not cross the threshold for the greatest dilution and hence have been excluded.
Reactions which failed have also been excluded. The eﬃciency was calculated using
least squares linear regression using the formula E = (10(  1coef )   1), where coef is the
slope of the ﬁtted line, and then converted to a percentage.
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Table 2.4: Primers for RTPCR. Underlined pairs of bases indicate the position of
exon–exon boundaries crossed by one of the primer pairs.
Gene Refseq Direction Sequence
Hprt NM_021704.3
Forward CCTCACTGCTTTCCGGAGCGG
Reverse TCGCTAATCACGACGCTGGGACT
B2m NM_009735.3
Forward GGCCTGTATGCTATCCAGAAAACCCCT
Reverse TTGGATTTCAATGTGAGGCGGGTGG
Eef2 NM_021704.3
Forward TCCCTTGTGTGCAAGGCTGGC
Reverse GTAGAAGAGGGAGATGGCGGTGGATT
Leng8 NM_021704.3
Forward CGGGAGCGAGCGGTCCTAAC
Reverse TGTACTGAGAAGACCAGTCTGCAGCA
Hif1a NM_010431.2
Forward TGCTTACACACAGAAATGGCCCAGTG
Reverse TCGTCCTCCCCCGGCTTGTT
Arnta NM_009709.4
Forward CGCTGGGTCCCACCATTGCTT
Reverse AAAATCCAGCCCTGACCGTCGC
Vegfa 1,4b NM_001110268.1
Forward GCACAGCAGATGTGAATGCAGACCA
Reverse ACCGGGATTTCTTGCGCTTTCGT
Vegfa 2,5b NM_001110268.1
Forward AGCCAGAAAATCACTGTGAGCCTTGTT
Reverse TCAAGCTGCCTCGCCTTGCAA
Vegfa 3,6b NM_001110268.1
Forward TGCGGATCAAACCTCACCAAAGCC
Reverse CACCGCCTTGGCTTGTCACATTTTTC
Vegfac NM_001110268.1
Forward GCACAGCAGATGTGAATGCAGACCA
Reverse TCCCGAAACCCTGAGGGAGGC
Flt1 NM_010228.3
Forward GTTGAAAGAGGGGGCCACAGCC
Reverse CCTTGCTTCGTGCAGGCTCCC
sFlt1 NM_021704.3
Forward CCTATGCGTGCAGAGCCAGGAAC
Reverse TTGCCGCAGTGCTCACCTCTAAC
aAmpliﬁes all splice variants as products of same length
bAmpliﬁes two splice variants as numbered as products of same length
cMultiple products of diﬀerent length
dNo product
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Table 2.4: Primers for RTPCR (continued). Underlined pairs of bases indicate the posi-
tion of exon–exon boundaries crossed by one of the primer pairs.
Gene Refseq Direction Sequence
Epod NM_007942.2
Forward GATGGGGGTGCCCGAACGTC
Reverse GTCGCAGATGAGGCGTGGGG
Epo (2)d NM_007942.2
Forward CGGGTACTGGGAGCTCAGAAGGAAT
Reverse CCCCGGAGGAAGTTGGCGTAGA
Nos2 NM_010927.3
Forward TGGAGGCCTTGTGTCAGCCCT
Reverse GACAGCAGGAAGGCAGCGGG
Nos3 NM_008713.4
Forward CCCTTGCTCCAGCCCCGGTA
Reverse AGAGGGCCCAGCCCATCCTG
Slc2a1 NM_011400.3
Forward CGAGCTGTTCAGCCAGGGGC
Reverse GGCCGCACAGTTGCTCCACA
Ldha NM_001136069.2
Forward GTGCTGCTCTGCGTGCTGGA
Reverse GCAAGCTCATCCGCCAAGTCCTTC
Ccl2 NM_011333.3
Forward GCCAGCTCTCTCTTCCTCCACCA
Reverse GGGCGTTAACTGCATCTGGCTGA
Csf1a NM_001113529.1
Forward AGCAGGTGGTGGACAGTGCCT
Reverse CCCCAGAGGGTGTCTGCGCT
Cxcl12a NM_021704.3
Forward GCCCCTGCCGGTTCTTCGAG
Reverse AGCCGTGCAACAATCTGAAGGGC
Pedf1 NM_021704.3
Forward CTGAAGCCTGCTGGACGCTGG
Reverse TGCATCCCGGAACTGTGGTTGC
Pedf1 (2) NM_021704.3
Forward TCTCTGCCCTTTCTCTGGGAGCTG
Reverse GTGCTGTGGATGTCAGGGTTGGT
Pedf1 (3) NM_021704.3
Forward CCTCTCTGCCCTTTCTCTGGGAGC
Reverse AGGGGCAGTAACAGAGGCAAGGA
Thbs1 NM_021704.3
Forward CACACAGGCTCCGTGTTGGGC
Reverse CTCTGGAATGCGGTTGCTTCCACA
Timp3 NM_021704.3
Forward CAGTAAGATGCCCCACGTGCAGT
Reverse CCTTCATACACGCGCCCTGTCA
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and imaged using an InGenius gel documentation system (Syngene, Cambridge,
UK).
Analysis using RTPCR was performed with SYBR green PCR master mix (Ap-
plied Biosystems), and the appropriate primers and template using ABI PRISM 7000
and 7300 sequence detection systems (Applied Biosystems) on 96 well optical reac-
tion plates (Applied Biosystems). The protocol used an initialisation at 50 C (2min)
and then 95 C (10min). This was followed by a 40× cycle of extension and denatur-
ation at of 95 C (15 s) and annealing at 60 C (60 s), i.e. extension occurs in the denat-
uration step temperature ramp. 2 ng cDNA was used per reaction in a total reaction
volume of 25 µL containing 400 nM of both forward and reverse primers. Follow-
ing data acquisition, the CT values were exported for analysis from the acquisition
software, following the setting of a suitable threshold value for all samples.
2.8.6 Data analysis
Computation of CT values:
S Sample.
C Calibrator.
NRQsamp Normalised relative quantity for a comparison between sample and cal-
ibrator sample.
NRQgene Normalised relative quantity for a comparison between gene and calib-
rator gene.
DNRQsamp Error in NRQsamp.
DNRQgene Error in NRQgene.
CT,T Cycle threshold for target gene.
CT,R Cycle threshold for reference gene.
ET Eﬃciency of primer for target gene.
ET,C Eﬃciency of primer for target calibrator gene.
ET,S Eﬃciency of primer for target sample gene.
ER Eﬃciency of primer for reference gene.
DCT Normalised cycle threshold for target gene, relative to reference gene.
DCT,T Change in CT,T between Normalised cycle threshold for target gene, relative
to target calibrator gene.
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DCT,R Change in CT,T between Normalised cycle threshold for reference gene, relat-
ive to reference calibrator gene.
Relative quantiﬁcation of real-time RTPCR data is commonly analysed using the
2 DDCT method (Livak and Schmittgen, 2001), shown in Equation 2.1. The expression
of a target gene, relative to a reference gene, is comparedwith a target calibrator gene,
again relative to the same reference gene. This allows comparison of the expression
of the target gene between diﬀerent tissues, relative to a calibrator tissue, or between
diﬀerent timepoint, relative to a calibrator timepoint, for example.
NRQsamp = 2 DDCT = 2 [DCT(S) DCT(C)] =
2DCT(S)
2DCT(C)
=
2CT,T(C)/2CT,T(S)
2CT,R(C)/2CT,R(S)
(2.1)
where
DCT(X) = CT,T(X)  CT,R(X) (2.2)
However, this method makes the assumption that all primers amplify their targets
with 100% eﬃciency (E = 1; 1 + E = 2). This is not the case for all the primers
used in this work, and so a modiﬁed version derived by Pfaﬄ was used which takes
primer eﬃciency into account (Pfaﬄ, 2001), shown in Equation 2.3.
NRQsamp =
(1+ ET)CT,T(C)/(1+ ET)CT,T(S)
(1+ ER)CT,R(C)/(1+ ER)CT,R(S)
=
(1+ ET)DCT,T(C S)
(1+ ER)DCT,R(C S)
(2.3)
Standard error propagation methods were used to calculate the total error in the
above calculation, shown in Equation 2.4, derived from (Muller, Janovjak et al., 2002).
DNRQsamp(xi . . . xn) =
s
n
å
i=1
(ln(Exi  CT(xi))2) (2.4)
DNRQsamp =
q
(ln(ET)  CT,T(S))2 + (ln(ET)  CT,T(C))2
+ (ln(ER)  CT,R(S))2 + (ln(ER)  CT,R(C))2 (2.5)
It is also possible to study the expression of a target gene, relative to a reference
gene, within the same sample. Again, both are normalised relative to a reference
gene. This allows comparison of the changes in expression of the target gene between
diﬀerent tissues and/or timepoints, but normalised to the expression of a particular
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calibrator gene in each sample. This is accomplished by a simple modiﬁcation of
Equation 2.3 to give Equation 2.6.
NRQgene =
(1+ ET,C)CT,T(C)/(1+ ET,S)CT,T(S)
(1+ ER)CT,R(C)/(1+ ER)CT,R(S)
=
(1+ ET,C)CT,T(C)/(1+ ET,S)CT,T(S)
(1+ ER)CT,R(C S)
(2.6)
Error propagation is identical to Equation 2.3, using Equation 2.4.
2.9 Microﬂuidic networks
An overview of the key steps in patterning a collagen gelwith amicroﬂuidic network
are shown in Figure 2.6.
2.9.1 PEN slide preparation
Poly(ethylene 2,6-napthalate) (PEN) was used in the form of 12, 25 and 50µm thick
biaxially oriented sheets (Goodfellow, Cambridge, UK).
PEN coated slides were produced as follows. Glass slides were cleaned as de-
scribed in Section 2.3.1. The slides were then rendered non-wettable by treatingwith
DMDCS for 10min, as described in Section 2.3.2. PENﬁlm cut to the appropriate size
were aﬃxed to the slides by ﬂoating on the meniscus of water and drawing onto the
slide. The PEN was secured to the slide at two opposing edges using nail varnish,
and then dried at 40 °C overnight. The remaining two edges were subsequently se-
cured with nail varnish.
2.9.2 UV laser cutting of PEN sheets
AllUV laser cutting utilised a PALMMicrobeam systemwith ZeissAxiovert 200 base
(Carl Zeiss) containing a pulsed nitrogen UV laser. The controllable parameters of
the system are UV laser energy, UV laser focus oﬀset (relative to the camera focus)
and stagemovement speed. All three parameters require careful adjustment in order
to optimally cut PEN ﬁlm.
The manufacturer recommends the use of a 40× objective for the cutting of the
standard 1.5 µm thick PEN ﬁlm. However, this is unsuited to cutting thick materi-
als, requiring a 5× objective for cutting 25 and 50µm thick ﬁlm. 1.5 µm thick PEN
ﬁlm used slides with the PEN ﬁlm oriented on top of the slide, with the microscope
objective located underneath; this is the conﬁguration used for laser-capture micro-
dissection. Thicker ﬁlm (12, 25 and 50µm) required the ﬁlm to be oriented under-
neath the slide, in order to prevent the high laser power and dwell time from burning
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PEN film on glass 
substrate
PDMS mould 
Pattern cut using 
pulsed UV laser
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and curing with 
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with liquid gelatin 
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Figure 2.6: Method for making microﬂuidic collagen gels. PEN ﬁlm attached to a glass
slide is cut to form a positive relief representation of the microﬂuidic network using
a pulsed UV laser. After attachment to pre-cured PDMS substrate and blocking with
Pluronic F-127 to prevent adhesion, uncured PDMS poured on top and set forms a neg-
ative relief representation of the network. When placed upon a glass substrate and
blocked with Pluronic F-127 to permit wetting of the channels, liquid gelatin may be
perfused through the network at high temperature and gelled at low temperature. Fol-
lowing removal of the mould, the gelatin network, which has the same physical shape
as the original PEN network, may be overlaid with monomeric collagen. After gelation
of the collagenmatrix the temperature may be raised, and the liquiﬁed gelatin perfused
from the matrix to leave a collagen matrix with open microchannels.
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the PEN ﬁlm and ejecting glass chips from the slide surface. This orientation also
permitted more precise cutting and lower laser power to be used than in the upward
orientation. Due to the PEN ﬁlm being oriented underneath the glass slide, any part
of the PEN ﬁlm which was cut around entirely had the potential to fall down onto
the objective, it no longer being attached to the slide or any other part of the ﬁlm.
This did have the potential to cause problems with the beam focus, it being directly
in the light path. This problem was mitigated by placing a 120mm fan attached to a
12V power supply to pass a stream of air under the stage to direct any falling debris
away from the objective.
The UV laser focus was adjustable separately from the primary focus, permitting
independent adjustment of the camera focus and the relative oﬀset for PEN cutting.
This permitted simultaneous adjustment of both the sample focus and the laser fo-
cus, a requirement for accurately observing and controlling cutting. Additionally,
the laser power was also adjustable as a percentage of its total (ﬁxed) power output,
via a neutral density ﬁlter with a circular gradient rotated by a stepper motor, per-
mitting ﬁne control of the cutting in addition to the stage speed. Due to localised
melting and cooling as the material passes through the laser beam, this must be set
suﬃciently wide for a gap to be retained due to ﬂow as the material cools. If set up
correctly, the result is a narrow, deep cut.
While the provided PALM R software allowed one to manually draw lines,
circles and polygons for calibrating the cutting parameters and performing micro-
dissection, this was insuﬃciently precise and too labour intensive for creating mi-
croﬂuidic networks. The microﬂuidic network designs were drawn at a 1:1 scale
using the I vector graphics editor (Inkscape Project, 2011). The PALM sys-
tem is only capable of drawing straight lines, and so curves represented as Bézier
curves in the drawing were interpolated to series of straight lines with µm resolu-
tion. The drawing was then exported as PS (Adobe Systems Incorporated,
1999), a format which consists of drawing commands which are amenable to con-
version into the import/export format used by the PALM R software (Carl Zeiss
MicroImagingGmbH, 2007). Conversionwas performed using the GNUR statistical
package (R Development Core Team, 2006) following a simple search and replace to
transform the PS into a valid R program which would output the the pat-
tern in the PALM R import/export format. This conversion required a series of
matrix transforms to translate and transform the physical coordinates used in the
drawing to the origin, scale and orientation used by the stepper motors of the PALM
Microbeam stage, which had a scale of 12.8 steps/µm and an inverted y axis. The
separate transforms can be logically represented as a single aﬃne matrix transform,
which performs translation, scaling and rotation in a single step. The conversion pro-
cess only required performing once for each unique pattern. Once completed, the
conversion to the PALM R format permitted the patterns to be loaded into the
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PALM R software and aligned on the PEN ﬁlm using the CCD camera for guid-
ance, and reused multiple times to create several copies of a pattern. Once correctly
conﬁgured, the system could run unattended for several hours.
2.9.3 Perfusion and imaging jig
Technical drawings for the creation of metalwork for perfused 3-D cultures and ima-
ging are shown in Figure 2.7. Parts A–C and E–F were machined from aluminium,
and part D from perspex. Part H was cut from acetate sheet (standard overhead pro-
jector sheet of 100 µm thickness) with the design laser printed onto it. CAD/CAM
for parts A–F was contracted to Aztech Precision Engineering, using CAD drawings
drafted by myself. 90 40 3.5mm glass plates were made from ﬂat, toughened
window glass, obtained from a local glazing supplier.
2.9.4 Silicone elastomer moulding
Room temperature vulcanising silicone elastomer (RTV)was used in compositions of
diﬀerent shore hardness, including RTV3040A (base) and RTV3040B (curing agent),
andRTV3436 (base) andRTV3428B or 3436Bred (curing agents), all supplied by Bent-
ley Chemicals Ltd., Kidderminster, UK. Base and curing agent were mixed in a 10:1
ratio. Due to the high viscosity, bubbles introduced during mixing were not remov-
able under vacuum, and were removed by spinning at 1400 g for 5min.
The silicone elastomer PDMS, also knownas Sylgard 184, was obtained fromDow
Corning, Midland, MI, USA. It is also composed of a base and curing agent, used in
a 10:1 ratio. The two components were mixed in a dish using a plastic spatula and
degassed in a 50mL plastic centrifuge tube (Corning) with a female Luer-Lok ﬁtting
bonded to the screw cap to permit secure connection to a vacuum line. Compared
with RTV elastomer, the low viscosity of PDMS permitted handling and moulding
without the introduction of bubbles.
Non-patterned PDMS blocks were moulded using 90 40 3.5mm glass plates
and thick shims as shown in Figure 2.7(E). The shim was placed on a glass plate and
PDMS poured in , contained by the edges of the shim, and then sealed in by placing
a second glass plate on top, using excess PDMS to avoid the introduction of bubbles
into the sealed volume. This assembly was then held under compression between a
threaded base plate, either Figure 2.7(A) or (B) and an unthreaded top plate (C), (E)
or (F) using usingmachine screws. This both prevented leakage and ensured that the
moulded PDMS would have precise dimensions, with exact and uniform thickness.
Patterned PDMS blocks were moulded by placing the PEN network on either a
glass or non-patterned PDMS backing surface and then pouring PDMS over the top,
contained again by a shim and second glass plate, which was then placed under
compression as for non-patterned PDMSmoulding. Precise network alignment was
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A
B
Figure 2.7: Microﬂuidics jig parts. (A) Multiple sample imaging frame. (B) Single
sample imaging frame. Both these parts have a 0.1mm rebate to accommodate a slide-
sized glass coverslip on the top face, with the bottom face machined to permit the use
of a Zeiss 40× water-dipping objective.
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C
D
Figure 2.7: Microﬂuidics jig parts (continued). (C) Slide holding frame, with 1mm
rebate to accommodate a standard slide, used for aligning moulds and parts such as
the perfusion manifold. (D) Perfusion manifold with ﬁve parallel sets of ports.
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E
F
Figure 2.7: Microﬂuidics jig parts (continued). (E) Large and (F) small shims, used for
retaining and holding PDMS during and after moulding.
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G
Figure 2.7: Microﬂuidics jig parts (continued). (G) Acetate shim with tab for
PDMS–PDMS separation (100µm thickness).
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achieved by aligning the slide using the slide guides shown in Figure 2.7(C) with the
perfusion manifold (D) to ensure the manifold would align with the microchannel
endpoints when assembled for perfusion. In order to allow removal of the PEN from
the moulded PDMS after curing, the PEN and glass or PDMS backing were blocked
with Pluronic F-127 1% (w/v) for 1 hour, followed by washing three times with dis-
tilled water and drying, which allowed easy separation of the PEN from the PDMS.
When moulding PDMS on PDMS, an acetate shim with a tab (Figure 2.7(G)) was
used to allow separation, as well as to provide an additional 100 µm PDMS depth for
compressive sealing of the microchannels to glass substrate when under perfusion.
Chapter 3
Vascularisation of lymph node
anlagen in vivo
3.1 Introduction
3.1.1 Timecourse of LN development
During the process of LN organogenesis, the developing organ acquires a functional
vasculature. When development commences, as LTi and LTo cells accumulate at
the site in response to chemoattractive cues, little or no blood vasculature is ini-
tially present, and there is little evidence of a requirement for blood vasculature
to be present at the site in order for LN development to progress, vascularisation
being thought to occur later on during development (Coles et al., 2010). The fully
developed LN contains an elaborate blood vascular network which is critical for its
function . Without a vascular network, lymphocytes would not be able to enter the
LN via the HEVs, and the metabolic demands of the LN could not be met by diﬀu-
sion alone. At some point during LN development, a functional blood vasculature
develops. The timecourse and nature of this process are not well characterised, and
nor are the driving forces and mechanisms behind the process.
An overview of the timeline of development of the diﬀerent LNs is detailed in
Mebius (2003), showing that the cervical LN begins development at E11.5, the axil-
lary and brachial after E12.5, and the inguinal after E15.5. In Section 1.3.3, the major
steps undertaken during the development were described. The process is initiated
at E11.5, when LTi cells ﬁrst appear at sites of LN development and accumulate over
subsequent days (Coles et al., 2006). However, the development of the lymph sac
is initiated somewhat earlier, as described in the review by Blum and Pabst (2006):
lymphatic competence is ﬁrst detected at E9.5 by the expression of LYVE1 on cells
in the cardinal veins, leading to lymphatic bias on E10.5 seen by expression of the
lymphatic marker and transcription factor Prox1. This is followed bymigration away
from the vein by E11.5 and assembly of the lymph sac by E12.5. In a recent review
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(van de Pavert and Mebius, 2010), LN development is described starting at E12.5
with the initial inﬂux of LTis in response to CXCL13, followed by their activation
and maturation by E13.5, leading to stromal activation and LTo formation, but this
does not consider the lymph sac. By E13.5, some structure is detectable, the inguinal
LN being shown as a bud of cells (described as “endothelial”) surrounded bymesen-
chyme, which subsequently reorganises as the outer layer invades the inner by E17.5
(Bénézech, White et al., 2010). Some similarities are observed in the brachial node,
such as being surrounded by LYVE1+ cells, but the axillary and brachial anlagen
are generally heterogeneous, even at E14.5, containing both LTis and LTos (Vonden-
hoﬀ, Greuter et al., 2009a), possibly due to the axillary, brachial and cervical nodes
being in a more advanced stage of development compared to the inguinal node as
a result of developing earlier. The E14.5 brachial node was shown by Vondenhoﬀ
et al. (2009a) to be extensively vascularised, showing MECA32+ vessels in the centre
of the anlagen, and LYVE1+ vessels surrounding it, both expressing VEGFR2. This
observation does not ﬁt in with the existing concept of vascularisation occuring later
during development. T cells are able to enter the lymph node from P2, when HEVs
begin to express peripheral node addressin (PNAd) (Hoorweg and Cupedo, 2008),
at which time the vasculature is unquestionably functional.
In the adult, the LN vasculature is believed to be regulated by the stroma, which
Chyou, Ekland et al. (2008) demonstrated to produce VEGF in response to LT sig-
nalling via LTβR. However, this work did not distinguish between FRC, FDC and
MRC stromal subsets, so it is not entirely clear which are responsible. MRCs in the
adult are thought to be analogous to LTo in the embryo, due to expressing many of
the same chemokines, receptors and adhesion molecules (Katakai et al., 2008).
3.1.2 Models of LN vascularisation
An outstanding question is the nature of the relationship between lymph sac de-
velopment and stromal activation. Mebius (2003) presented a model for LN devel-
opment depicting the stroma developing adjacent to the lymph sac, subsequently
ﬂattening the sac into a double-layered subcapsular sinus which surrounds it, ex-
cept for at one side, which would presumably become the hilus. In this scenario, the
blood vasculature would be predicted to invade from this point, which is where it
will enter and exit in the developed node, and then ramify throughout. If vessels
already existed inside at this point, then they would require connection to the ex-
ternal vasculature, if this was not already the case. However, this model does not
ﬁt with the observations of Vondenhoﬀ et al. (2009a), which shows an almost con-
tinuous layer of LYVE1+ cells surrounding vessels and stromal cells inside the sac of
the E14.5 brachial node. Interestingly, MECA32+ cells are seen to exit the sac at its
major discontinuity, which may be the site of the future hilus. If this is genuine, and
not a sectioning artefact, this would imply that the anlagen is vascularised from the
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start, but raises questions as to how this structure develops. It could be hypothesised
that the lymphatic endothelium may migrate to surround a bud of mesenchyme, or
that the mesenchyme may migrate into the sac, or even that the mesenchyme may
condense adjacent to the sac, pulling the sac around it as a result of physical forces
acting upon it. It is also important to note that this observation in the brachial node
is entirely the opposite of that made in the inguinal node by Bénézech et al. (2010)
which shows that the lymphatic endothelium to be a solid bud of cells, encircled by
stroma.
3.1.3 Factors aﬀecting angiogenesis
Several of the major factors inﬂuencing angiogenesis were discussed previously in
Section 1.2.4. The currently accepted dogma is that angiogenesis arises as a result of
the combined eﬀect of pro- and anti-angiogenic factors, the balance of which aﬀects
whether a vascular tube will outgrow, regress or remain static (Davis et al., 2002;
Zhang andMa, 2007). Obtaining a clearer picture of which pro- and anti-angiogenic
factors are being produced in the LNanlagemayprovide some insight into themech-
anisms driving angiogenesis in this speciﬁc context. Hypoxia plays a critical role in
both vascular homeostasis, and vascular development during embryogenesis, and
hence may also be a contributing factor (Adelman, Maltepe et al., 1999; Iyer, Kotch
et al., 1998).
3.1.4 Hypoxia
Hypoxia is the reduction of oxygen tension within a tissue below that of normoxia,
usually considered to be 2–9% (v/v) (Simon andKeith, 2008) or 40–60mmHg (Kaluz,
Kaluzová et al., 2008). The transcription factor HIF-1α is constitutively transcribed
and translated, but under normoxia is continually degraded in an oxygen-dependent
manner (Kaluz et al., 2008). Under hypoxia, HIF-1α is no longer degraded, per-
mitting the formation of a HIF-1α21β1 complex which initiates the transcription
of genes containing HREs (Kaluz et al., 2008). Hypoxia-responsive genes have a
wide range of eﬀects, including changes to cellular metabolism, survival, increasing
angiogenesis and recruiting macrophages (Fong, 2009; Fraisl, Mazzone et al., 2009;
Kaluz et al., 2008; Murdoch, Muthana et al., 2005; Shweiki, Neeman et al., 1995). One
of the principal angiogenic responses is the upregulation of VEGF (Shweiki et al.,
1995), butmany other factors are also upregulated includingVEGFRs, angiopoietins,
erythropoietin, placental growth factor and insulin-like growth factors, and MMP9
(Fong, 2009). Chemoattractive and chemotactic factors are also inducedwhich attract
macrophages, including CCL2, M-CSF and CXCL12 (Murdoch et al., 2005). Macro-
phages are themselves sensitive to hypoxia, resulting in their transcription of mul-
tiple hypoxia-responsive genes, including VEGF (Murdoch and Lewis, 2005). Hyp-
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oxia can also increase collagen synthesis and additionally, lysyl hydroxylases re-
sponsible for hydroxylation and cross-linking of collagen are upregulated by hyp-
oxia (Myllyharju and Schipani, 2010).
Hypoxiamay play an important role in vascularisation during development, hyp-
oxic responses driving VEGF production having been previously shown to be re-
quired for the proliferation anddevelopment of hæmatopoietic precursors (Adelman
et al., 1999). Embryos are hypoxic and require HIF-1α expression to develop beyond
E11 (Adelman et al., 1999; Iyer et al., 1998), HIF-1α being involved in embryo pattern-
ing as a result of controlling the diﬀerentiation of condensing mesenchyme, at least
in the case of chondrogenesis (Provot, Zinyk et al., 2007) and bone formation (Dun-
woodie, 2009). In these examples, condensing tissues became hypoxic and began to
upregulate HIF-1α. Hypoxia may therefore also play an equivalent role in the case
in the LN, which also develop by the condensation of mesenchymal progenitors.
Various approaches exist tomeasure hypoxiawithin tissues (Evans,Mattock et al.,
2011), though many are invasive. Reduced oxygen tension in tissue results in an
altered redox environment, detectable non-invasively using pimonidazole hydro-
chloride (hypoxyprobe-1, Hypoxyprobe, Inc), a small 2-nitroimidazole compound
which forms stable adducts in hypoxic cells and tissues (Raleigh, Calkins-Adams
et al., 1998; Varia, Calkins-Adams et al., 1998). These adducts are detectable with
a rabbit polyclonal antibody, hence allowing visualisation using standard immun-
ohistochemical techniques. This may be a suitable method for determining if the
developing LN anlagen are hypoxic both in absolute terms, and relative to their sur-
roundings.
3.1.5 Aims
1. To determine the timescale and nature of lymphoid organ vascularisation dur-
ing development through immunoﬂuorescence imaging, in particular in its re-
lation to the changing organisation the of LN stroma.
2. To determine how changes in the organisation of cellular and extracellularmat-
rix components of the developing LN anlagen relate to the process of LN vas-
cularisation and development.
3. To determine if localised hypoxia is related to lymphoid organ vascularisation
in the developing embryo using the hypoxia sensing probe pimonidazole.
4. To determine the balance of major pro- and anti-angiogenic factors in the de-
veloping lymphoid organs throughout the timecourse of their development,
and in the fully developed state in the adult, and to correlate their inﬂuences
upon observed vascularisation during development.
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5. To compare the expression of pro- and anti-angiogenic factors in the embryo
with those in the adult, and to identify diﬀerences between the FRC and MRC
stromal compartments which may play a role in LN patterning.
3.2 Results
3.2.1 Lymphoid organvisualisationusingwholemountmicroscopy
In order to observe developing lymphoid organs in the three-dimensional context
of the embryo as a whole, wholemount confocal microscopy was used to visualise
development. Stage E15.5 of development was used as a starting point for testing
the various antibodies to be used for immunohistochemical staining, which would
then be extended to other timepoints during development. E15.5 hCD2-GFP em-
bryoswere ﬁxed, vibratome sectioned and stained as described in Section 2.6.2, using
the antibodies and reagents described in Tables 2.2 and 2.3. Samples were stained
with GFP-Alexa Fluor (AF)594 or AF647 to show LTi cells (and additionally lymph-
ocytes in the case of the thymus). Samples were additionally stained with α-SMA-
Cy3, endomucin-AF647, or the basement membrane proteins collagen IV, laminin
or ﬁbronectin (all rabbit polyclonals) with goat anti-rabbit AF594 or AF647 second-
ary. In order to improve staining quality, staining and wash times were extended
from overnight and several hours, respectively, to several days to ensure antibody
penetration into, and removal from, thick sections. The results are shown in Fig-
ure 3.1. Panels (A) and (B) show GFP+ cells, presumably LTis, in relation to vascu-
lature. Note the diﬀuse nature of LTis—they not yet associated intimately. However,
the high level of autoﬂuorescence in the tissue resulted in a great deal of ambiguity
when selecting genuine LTis, as illustrated by rotating the sample in (B), where it is
diﬃcult to diﬀerentiate between GFP+ cells and autoﬂuorescence, there being con-
tinuous variation in ﬂuorescence intensity between cells which appear to be GFP+
in (A) and the remainder of the cells within the ﬁeld of view as shown in (B). Panels
(L) and (M) illustrate the major diﬀerences between staining controls, which vary
widely in autoﬂuorescence depending upon their location within the embryo.
The remaining images are of the thymus, which was readily identiﬁable within
the thoracic cavity without GFP staining. Despite this, the large concentration of
lymphocyteswithin the organ didmake identiﬁcation possible by ﬂuorescence, since
the amount of ﬂuorescence resulting was above the background autoﬂuorescence.
Panels (C–K) all illustrate vascular structures in the thymus. Endomucin staining
clearly shows a complex vascular network throughout the entire organ, appearing to
extend around the entire capsule, ramifying throughout the cortex in a series of loops
and extending into the medulla where the structure appears to be more branched.
There appears to be a partial disconnect between the vasculature of the cortex and
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Figure 3.1: Wholemount microscopy of developing lymphoid organs. Vibratome-
sectioned slices of E15.5mouse embryoswere stained for GFP (LTis in A and B, LTis and
thymocytes in C–K), α-SMA, endomucin and several basementmembrane proteins. (A)
Putative LN anlagen, showing LTi in close proximity to α-SMA+ vessels. However, the
LTi staining is ambiguous when viewed from the side (B). Endomucin staining shows
a complex vascular network in the thymus (C), and when viewed as a series of 30µm
sections at the edge (D) and middle (E), shows vascularisation throughout, and an ap-
parent diﬀerence between cortical and medullary regions. A representative xz section
(F) also shows extensive vascularisation. Collagen IV at the edge (G) and middle (H)
shows staining only in the cortex, the same being seen in xz (I). This is not, however,
the case for laminin (J) and ﬁbronectin (K), which show a staining pattern similar to
endomucin, including in xz projection. The staining controls for A–F (L and M) show
that staining is speciﬁc, but that autoﬂuorescence varies greatly between tissues; (N) is
the control for G–K. Scales are 22.5 µm (A, B), 45 µm (C, D, G, H, L, M and main view
of J and K), 44 µm (F, N, and side view of J and L) and 38µm (I).
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medulla. Basement membrane staining highlights an interesting contrast between
laminin and ﬁbronectin and collagen IV. Laminin and ﬁbronectin both show staining
throughout the tissue as for endomucin, delineating structures with repeated hier-
archical branching, particularly in the case of ﬁbronectin. In contrast, collagen IV
stains the capsule and extends into the cortex, but does not extend into the medulla,
despite major vessels being visible due to autoﬂuorescence.
A number of diﬀerent directly-conjugated rat anti-mouse monoclonal antibodies
against CD31 and CD144 were additionally used to label the vasculature, listed in
Table 2.2. However, these all failed to demonstrate any speciﬁc staining (not shown).
3.2.2 Live imaging of lymphoid organs
In order to visualise the structure of the LN anlagen without the need for ﬁxation
and staining, anlagen (axillary, brachial, cervical and inguinal) and thymi were dis-
sected from E15.5 hCD2-GFP embryos and embedded within a collagen I gel in a
glass-bottomed dish, and were overlaid with IMDM. The gel was for support and
to prevent movement of the tissues during imaging. Using MP microscopy, second
harmonic generation was used to visualise the collagen I matrix around the anlagen,
the anlagen itself being visualised using the GFP ﬂuorescence of the LTi cells within
as well as SHG highlighting collagen I structures around the anlagen (Figure 3.2).
Few LTis are visible in the axillary node, possibly a result of the main population
not having been dissected or was not within the working distance of the objective.
Intense collagen I SHG around the edge of this sample is most likely to be the edge of
the skin taken alongwith the node, or alternatively the edge of the tissue has acted as
seed points for the supporting matrix during gelation. In comparison, the brachial
nodes contain densely-clustered LTis, in the case of panel (C), being surrounded by
a band of collagen I which may indicate the boundary of the lymph sac. In the lower
left of the anlage, the collagen is present in at least two parallel bands, which may
delimit the forming subcapsular sinus and/or lymph sac. This extends to the upper
left, which may be the site of an aﬀerent lymphatic vessel entering the sac. It is
notable that in all cases the LTis themselves are present in a void space apparently
absent of collagen I SHG, whether or not they are bounded by a visible collagen I
layer. In comparison, the thymus shows little supporting matrix inside the organ,
which is densely populated with GFP+ lymphocytes. However, a dense collagen I
matrix is present around the organ, presumably being the capsule.
3.2.3 Lymphoid organ visualisation using frozen sections
While live imaging, unlike wholemount microscopy, readily permitted visualisation
of the LTis within the anlagen, it did not permit simultaneous study of other features
such as their relation to other cell types, the extracellular matrix (other than colla-
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Figure 3.2: Live imaging of developing lymphoid organs. GFP-expressing LTi cells are
shown in green, and collagen type I SHG in white. LN anlagen and thymi dissected
from E15.5 embryos were embedded in a rail tail collagen support matrix and imaged
using a Zeiss LSM 510 NLO MP microscope. The tissues imaged were (A) axillary, (B)
brachial, (C) brachial LNs, showing collagen immediately around the LTis (yellow ar-
rowheads), with the LTis in a less dense void space. The double arrowheads indicate
parallel collagen bands which may be the subcapsular sinus, and which also extends
away from the anlage. (D,E) Cervical LNs!s. (F) Thymus, showing dense collagen sur-
round. The collagen support is visible as larger, brighter ﬁbres surrounding the tissue,
particularly noticeable in (A) and (D). Collagen ﬁbres surrounding the edge of the dis-
sected tissue are visible in (A,B,D), and may be the edge of the skin in the section. (C,E)
have only weak collagen SHG in comparison. Scale bars are 100 µm.
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Figure 3.3: Frozen section imaging of developing lymphoid organs. All hCD2-GFP sec-
tions of LN anlagen are stained with DAPI (blue) and GFP (green). Stains in red are
collagen IV (A–C), collagen I (D), laminin (E), endomucin (F), MECA-32 (G), LYVE-1
(H), VCAM (I). (J) and (K) are staining controls. Arrowheads indicate vascular struc-
tures (yellow), LTis (green) and LTos (white). Collagen IV and I show the presence of an
anastomosing vascular bed surrounding the LTi-containing anlagen, existing as two in-
terconnected layers (paired arrowheads). This structure is partially LYVE-1+. VCAM-1
staining illustrates close association between a small cluster of GFP+ LTis and VCAM+
LTos. Endomucin did not show positive staining of vessels, while MECA-32 stained a
vessel running along the edge of the anlagen. Scale bars are 50 µm.
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gen I), and the general structure of the surrounding tissue. Frozen sections were
therefore used as an alternative to wholemount.
As for live imaging, LN anlagen (axillary, brachial, cervical and inguinal) and
thymi were dissected from E15.5 embryos. The dissected tissues were processed and
cut into 7 µm thick sections as described in Section 2.6.1. All samples were stained
using DAPI and anti-GFP to show all cell nuclei and LTis, respectively. Samples were
then individually stained for extracellular matrix and basement membrane proteins
(collagens I and IV, and laminin), vascular markers (endomucin, MECA-32, LYVE-1)
and the LTo marker VCAM-1. Channel subtraction was used to correct for crosstalk
between channels post acquisition. The results are shown in Figure 3.3. Note that, as
for wholemount, CD31 and CD144 monoclonal antibodies were additionally used,
but again failed to show any speciﬁc staining (not shown).
Collagen I and IV showed very similar staining patterns, staining a bright band
surrounding the LTi cells, which is presumably the lymph sac. Interestingly, this
appeared to surround the anlagen in two layers, which appeared to be interconnec-
ted by small vessels bridging the gap between the layers (seen in panels (B) and (C),
which are serial sections of the same anlage. Collagen I was present in a single in-
ner layer, with some evidence of an incomplete outer layer. LYVE-1 staining gave
the impression of there being an incomplete LEC layer surrounding the develop-
ing node, but was less deﬁned than the basement membrane staining which may
imply that it is of mixed BEC/LEC composition. Sections stained for laminin un-
fortunately did not include any anlagen; the sample shown here is most likely to be
a section between the anlagen and the skin surface. Migrating LTis are present in
the spaces between dense cell clusters bordered with laminin, from which the LTis
appear to be excluded. Neither endomucin nor MECA-32 stained any ECs within
the anlagen, endomucin being restricted to two regions around the periphery, and
MECA-32 staining a long vessel running alongside a streak of LTis, but no staining
being apparent within the LTi cluster.
3.2.4 Hypoxia in developing LN anlagen by pimonidazole imaging
If the hypothesis that vascularisation of developing LN anlagen is a result of loc-
alised hypoxia is correct, the hypoxic environment should be detectable using pi-
monidazole. Pregnant female hCD2-GFP mice bearing embryos from E14.5–E17.5
were injected intraperitoneally with 200 mL 9mg/mL pimonidazole hydrochloride
in PBS or 200 mL vehicle (PBS only). The mice were killed after 120mins and the em-
bryos and adult liver and spleen taken for analysis. The embryos were sorted into
GFP positive and negative groups and all embryos and tissues were ﬁxed overnight
in 4% paraformaldehyde. Embryos and tissues were embedded in 4% agarose and
vibratome sectioned prior to wholemount staining with 1:25 2627 rabbit antisera
(Hypoxyprobe, Inc) and 1:500 AF594 goat anti-rabbit secondary (Figure 3.4).
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A  Adult liver
B  Adult liver
C  Adult spleen
E  E13.5 liver
D  E13.5 brain
G  E15.5 liver
F  E13.5 liver
H  Control
Figure 3.4: Detection of hypoxia with pimonidazole. Pregnant hCD2-GFP female mice
were injected intraperitoneallywith pimonidazole, andGFPpositive embryos and adult
liver and spleenwere taken after 120mins, then stainedwith 2627 rabbit antisera follow-
ing PFA ﬁxation and vibratome sectioning. For each sample, the 3-D rendering shown
on the left contains a horizontal line indicating the position of the xz projection shown
to the right. In all tissues and at all timepoints, staining was most intense at the sec-
tioned surface of the tissue, and additionally at any other exposed surface such as vessel
lumens and tissue boundaries (folds and edges). Secondary only controls showed no
staining. Scale bar is 250 µm.
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Localised hypoxia was not observed in any of the adult or embryo samples, the
same staining pattern seen in all samples. All samples show intense staining along
sectioned surfaces, with no staining in the sample interior. The exceptions to this
are interior areas connected to the surface, such as resulting from tissue infolding,
and where vessels running through the tissue reach the edge. The surface staining
shown in Figure 3.4 was not due to the secondary antibody not being washed out,
since the secondary-only control showed no staining, it appearing entirely black due
to the intensity of the anti-pimonidazole staining being orders of magnitude more
intense than intrinsic autoﬂuorescence.
3.2.5 Gene expression in lymphoid organs by RTPCR
As an alternative to studying hypoxia using imaging of redox potentials, it should
be possible to demonstrate hypoxia through the quantiﬁcation of hypoxia-driven
transcription products, i.e. through analysis of the expression of hypoxia-responsive
genes. Genes were chosen whose expression is increased or decreased under hyp-
oxia, having a direct functional activity such as enzymes, transporters, receptors and
soluble factors rather than indirect eﬀects, such as matrix components, Thbs1 being
the exception. These included geneswith speciﬁc eﬀects uponmetabolism andmeta-
bolite transport (Ldha and Slc2a1; Greijer, van der Groep et al. (2005); Iyer et al. (1998);
Semenza, Jiang et al. (1996)), angiogenesis and erythropoiesis (Flt1, Kdr, Vegfa and
Epo; Elvert, Kappel et al. (2003); Forsythe, Jiang et al. (1996); Gerber, Condorelli et al.
(1997);Madan andCurtin (1993)), vascular function (eNos and iNos; Coulet, Nadaud
et al. (2003); Palmer, Semenza et al. (1998)) and macrophage-speciﬁc chemotaxis and
proliferation (Ccl2 and Cxcl12; (Bosco, Puppo et al., 2004; Ceradini, Kulkarni et al.,
2004)). As positive controls the constitutively transcribedHif1a and Arnt genes were
used to demonstrate the presence of functional hypoxia response machinery in the
tissues of interest in addition to Gapdh and Hprt as internal controls. Csf1 was ad-
ditionally used as a pro-angiogenic hypoxia-independent marker with eﬀects upon
VEGF production in macrophages (Curry, Eubank et al., 2008). Genes with anti-
angiogenic eﬀects (Thbs1, sFlt1, Pedf1 and Timp3; Dawson (1999); Good et al. (1990);
Kappas et al. (2008); Saunders, Bohnsack et al. (2006)) were selected to allow compar-
ison of the balance between pro- and anti-angiogenic mRNA levels.
Standard rules for real-time primer design were followed, as detailed in Section
2.8.4. In the case of genes with several splice variants, the primer was designed to
amplify all variants. Total RNA from was obtained from an E14.5 hCD2-GFP whole
embryo lysate in order to test the designed primers and determine their eﬃciency
and speciﬁcity. The primers were tested using gradient PCR as described in Section
2.8.5. The results are shown in Figure 3.5. As a result of the initial test, the Epo,
Vegfa and Pedf primers needed redesigning. Separate primer pairs were required to
amplify the splice variants individually because the placement of the splice points in
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the Vegfa transcripts precludes the use of a single primer pair for all splice variants,
given the requirement for one of the real-time primers to cross an exon–exon bound-
ary to prevent simultaneous ampliﬁcation of genomic DNA, and length restrictions
again due to the location of exon boundaries. The results for the modiﬁed primers
are also shown in Figure 3.5.
Using cDNA derived from the thymus of hCD2-GFP at E17.5, as described in
Sections 2.8.2 and 2.8.3, all primers (with the exception of Epo) were tested using
conventional PCR as described in Section 2.8.5. The results are shown in Figure 3.6.
While this is not quantitative, several observations may be made. Firstly, the pro-
angiogenic growth factor VEGF-A is transcribed, and this includes a minimum of
three of its splice variants, and potentially up to six given that the splice variants
were detected in pairs. The VEGF receptors Kdr (VEGFR2) and Flt1 (VEGFR1) were
additionally expressed. Interestingly, the soluble decoy receptor sFlt1 (sVEGFR1)
was additionally present, as was the anti-angiogenic factor Pedf1 (PEDF). Molecules
having a potential anti-angiogenic role, such as thrombospondin (Thbs1) and tissue
inhibitor of metalloproteinase 3 (Timp3) were also present. GLUT1 (Slc2a1) and lact-
ate dehydrogenase (Ldha) are involved with glucose transport and glycolytic meta-
bolism, respectively, as well as being upregulated during hypoxia, and were both
highly expressed. Ccl2, Csf1 and Cxcl12 are also upregulated during hypoxia and
were seen to be expressed. However, Cxcl12 and Ccl2 are also found in normally
functioning LN stroma, hence may not be truly be representative of hypoxia in the
context of a lymphoid organ (Katakai et al., 2004).
The above experiments demonstrated that the primers were speciﬁc, resulting in
only a single product of a size suitable for quantitative real-time PCR. LN anlagen
(axillary, brachial, cervical, inguinal), thymi, fœtal liver and skin from directly above
the brachial node were dissected from embryos for all days from E14.5–E17.5. RNA
was extracted as described in Section 2.8.2, and cDNA synthesised as described in
2.8.3. Due to the small size of the dissected anlagen, LN samples were pooled for
each timepoint in order to provide a suﬃcient quantity cDNA for analysis. The small
amount of material reduced the number of genes which could be studied, which
were reduced to soluble pro-angiogenic factors (Vegfa splice variants), a soluble anti-
angiogenic factor (Pedf1) and a matrix-bound anti-angiogenic factor (Thbs1) plus an
endogenous control (Hprt).
The PCR reactions were run on ABI PRISM systems as described in Section 2.8.5,
and analysis was performed as described in Section 2.8.6, using Hprt as the endo-
genous control and the E17.5 timepoint as the calibrator (Figure 3.7). The last devel-
opmental timepoint was used rather than the ﬁrst due to E14.5 being a less reliable
timepoint as a result of the diﬀuse nature of the anlagen causing extraneous mater-
ial to be included at this timepoint. This analysis was entirely standard, computing
NRQsamp as described in Equation 2.3, but due to being normalised by timepoint,
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only permits comparison of individual genes between timepoints. It does not, how-
ever, permit comparison between genes at a single timepoint. This is due to using rel-
ative rather than absolute quantiﬁcation. However, this is possible with some caveats
by rearranging Pfaﬄ’s equation to compute NRQgene (Equation 2.6). Because this is
comparing two unrelated genes without any knowledge of the absolute quantities,
this means that the computed ratio is meaningless. However, the change in the ratio
does have meaning, even if the absolute values are not known. The same dataset has
therefore been normalised in this manner using an anti-angiogenic gene (PEDF) and
a pro-angiogenic gene (VEGF splice variants 2+5), shown in Figure 3.8, to illustrate
the changes in pro-angiogenic factors relative to an anti-angiogenic factor, and vice
versa.
When describing the changes in expression for Figure 3.7, below, only changes
greater than twofold were treated as signiﬁcant. E16.5 had lower values for all genes
in the LN, and higher values for the skin which will not be considered when de-
scribing general trends due to being inconsistent with the other timepoints. The LN
samples show more variation than for other tissues, perhaps due to the presence
of undeﬁned amounts of extraneous material, as opposed to the liver and thymus
which were discrete and self-contained tissues. The skin also contained some vari-
ation over time, possibly due to the use of a rotor-stator homogeniser rather than a
pestle as for the other samples, due to the ﬁbrous nature of the tissue, which may
have resulted in inconsistent RNA extraction.
In the LN, PEDF expression remained constant duringdevelopment, but dropped
over tenfold in the adult. Thrombospondin, however declined throughout develop-
ment but was over tenfold higher in the adult. All VEGF variants were similar from
E14.5 to 17.5, with a possible drop in between. Vegfa1+4 was similar in the adult,
while 2+5 is higher and 3+6 lower. In the thymus, PEDF declined during develop-
ment, andwas expressed at a similar level in the adult. Thrombospondin declined at
a slower rate, but was expressed over tenfold higher in the adult. All VEGF variants
show an uneven decline during development, with the same trends in the adult as
observed for the LN. In the liver, PEDF expression increased approximately expo-
nentially over time during development, and was higher still in the adult. Throm-
bospondin also increased linearly during development, but was dramatically lower
in the adult. VEGF expression increased during development (E14.5 being an anom-
aly). However, in the adult Vefga1+4 was much higher, 2+5 similar and 3+6 much
lower than their levels as E17.5. In the skin, PEDF expression declined during de-
velopment, being expressed at an intermediate level in the adult. Thrombospondin
was relatively steady, and if the large decline at E17.5 was real, was subsequently
upregulated back to its initial level in the adult. VEGF variants followed the same
inconsistent pattern, declining overall during development, with Vegfa1+4 and 2+5
being expressed at a higher level in the adult, and 3+6 at a lower level.
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The Vegfa 1+4, 2+5 and 3+6 primers created products of 107, 121 and 124 base
pairs, respectively. In very general terms, Figure 3.8 showed that Vegfa1+4 was ex-
pressed more than 2+5, which was expressed more than 3+6. That is, VEGF188 >
VEGF164 > VEGF120, assuming translation is equivalent to transcription and that the
diﬀerences in product lengths do not signiﬁcantly aﬀect interpretation. In the LN
thrombospondin, Vegfa1+4 and 2+5 increased in the adult relative to PEDF, while
in relative terms Vegfa3+6 changed little. A similar pattern was seen in the thymus,
though Vegfa1+4 changed little relative to PEDF. Thrombospondin changed little
relative to PEDF in the liver during development, but dropped dramatically in the
adult. Vegfa levels were relatively constant during development but dropped in the
adult, presumably as a result of the increase in PEDF expression in the liver in the
adult. In the skin, thrombospondin dropped relative to PEDF during development,
but increased back to the level at E15.5 in the adult. Vegfa1+4 slowly rose during de-
velopment and was higher in the adult relative to PEDF, but 2+5 and 3+6 dropped
slightly during development, 2+5 being higher in the adult and 3+6 being lower.
When considering the changes relative to Vegfa2+5 instead (Figure 3.8), opposite
trends are observed between pro- and anti-angiogenic factors when compared with
normalisation using PEDF. However, this does highlight changes in the ratios of
VEGF isoforms, relative to VEGF164. Vegfa1+4 is always higher than 2+5, and 3+6
lower. In the adult Vegfa3+6 is generally much lower in the adult than at all devel-
opmental stages, it being generally unchanging relative to 2+5 during development.
3.2.6 Gene expression in the fœtal human lymph node
Microarray analysis of mouse LN anlagen was not possible due to their small size
(insuﬃcient material could be obtained). FRC andMRC stromal subsets were sorted
from human fœtal lymph nodes, ages 16–24weeks post-conception, of unknown sex.
The stromal cells were characterised as CD31 CD45 gp38+ and TRANCEwas used
to diﬀerentiate between TRANCE  FRCs and TRANCE+ MRCs. While both express
ICAM and VCAM, MRCs additionally express MAdCAM. Following sorting, RNA
was extracted using an RNA-XS kit (Machery Nagel, Düren, Germany). RNA con-
centration and quality were determined using a Bioanalyzer (Agilent, Wokingham,
UK). cDNAwas synthesised from the RNA using reverse transcription with random
hexamer primers, with equal amounts of RNA for each sample, using the Ovation
PicoWTA system (Nugen, Bemmel, The Netherlands). For both samples, 5 ng cDNA
was hybridised to Aﬀymetrix GeneChip Human Genome U133 Plus 2.0 arrays (Af-
fymetrix, High Wycombe, UK), and normalised using R B/MAS. Note
that this work was done by the Cupedo lab at Erasmus University, who performed
all the above steps from cell sorting to the microarrays, and who kindly shared the
resulting normalised Aﬀymetrix data.
Expression values less than 35 were set to 0 (MRC) or 1 (FRC) to eliminate insig-
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Figure 3.5: Gradient PCR testing of primers. All primers ampliﬁed a single product
at all temperatures with the following exceptions: Epo and Pedf1 (no product at any
temperature), Vegfa (two products), Nos2 (multiple products), Nos3 (varied with tem-
perature, but worked during a subsequent test) and Ldha (no product at 57 C). Epo
and Pedf primers were subsequently redesigned, all of which worked except Epo. Ve-
gfa primers were redesigned to amplify speciﬁc pairs of splice variants. The Leng8
product is present but only at very low quantity. C denotes a control without template
cDNA annealed at 57.5 C; numbers are annealing temperatures.
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Figure 3.6: Gene expression in E17.5 thymus. With the exception of Nos2, which amp-
liﬁed multiple products, all genes were found to be expressed. These include genes for
housekeeping (Hprt, B2m, Eef2, Leng8), hypoxia-driven transcription (Hif1a, Arnt), an-
giogenesis, including pro-angiogenic factors and receptors (Vegfa splice variants, Flt1,
Kdr) and anti-angiogenic factors (sFlt1, Pedf1, Thbs1, Timp3), vascular function (Nos3)
and hypoxia response (Slc2a1, Ldha, Ccl2, Csf1, Cxcl12).
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Figure 3.7: Gene expression between timepoints E14.5–E17.5 during development, and
the adult. The mRNA levels of the transcripts of Vegfa (three sets of splice variants),
Pedf1, Thbs1 and Hprt were analysed using cDNA from the LN (pooled), thymus
(pooled), liver and skin at each timepoint. mRNA levels were normalised to the en-
dogenous control Hprt, and E17.5 was used as the calibrator sample. Error bars are ±
the standard error of the mean.
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Figure 3.7: Gene expression between timepoints E14.5–E17.5 during development, and
the adult (contd). The mRNA levels of the transcripts of Vegfa (three sets of splice vari-
ants), Pedf1, Thbs1 andHprt were analysed using cDNA from the LN (pooled), thymus
(pooled), liver and skin at each timepoint. mRNA levels were normalised to the endo-
genous control Hprt, and E17.5 was used as the calibrator sample. Error bars are ± the
standard error of the mean.
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Figure 3.8: Gene expression between the genes Pedf1, Thbs1 and Vegfa splice variants
during development. The mRNA levels of the transcripts of Vegfa (three sets of splice
variants), Pedf1, Thbs1 and Hprt were analysed using cDNA from the LN (pooled),
thymus (pooled), liver and skin at each timepoint. mRNA levels were normalised to
the reference gene Hprt, and Pedf1 was used as the calibrator sample. Error bars are ±
the standard error of the mean.
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Figure 3.8: Gene expression between the genes Pedf1, Thbs1 and Vegfa splice variants
during development (contd). The mRNA levels of the transcripts of Vegfa (three sets
of splice variants), Pedf1, Thbs1 and Hprt were analysed using cDNA from the LN
(pooled), thymus (pooled), liver and skin at each timepoint. mRNA levels were nor-
malised to the reference gene Hprt, and Pedf1 was used as the calibrator sample. Error
bars are ± the standard error of the mean.
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Figure 3.8: Gene expression between the genes Pedf1, Thbs1 and Vegfa splice variants
during development (contd). The mRNA levels of the transcripts of Vegfa (three sets
of splice variants), Pedf1, Thbs1 and Hprt were analysed using cDNA from the LN
(pooled), thymus (pooled), liver and skin at each timepoint. mRNA levels were nor-
malised to the reference gene Hprt, and Vegfa2+5 was used as the calibrator sample.
Error bars are ± the standard error of the mean.
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Figure 3.8: Gene expression between the genes Pedf1, Thbs1 and Vegfa splice variants
during development (contd). The mRNA levels of the transcripts of Vegfa (three sets
of splice variants), Pedf1, Thbs1 and Hprt were analysed using cDNA from the LN
(pooled), thymus (pooled), liver and skin at each timepoint. mRNA levels were nor-
malised to the reference gene Hprt, and Vegfa2+5 was used as the calibrator sample.
Error bars are ± the standard error of the mean.
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niﬁcant probes and to avoid divide by zero errors when computing the MRC/FRC
ratio. However, this does introduce some bias into the ratio when this only aﬀects
a single probe. The normalised data was analysed to look at the diﬀerences in ab-
solute and relative terms between the two sets, and also to permit comparison with
the RTPCR data from embryonic and adult mouse lymphoid anlagen and organs.
Genes were selected from the total probeset in three major categories: genes in-
volved in hypoxia, LN development and angiogenesis. The hypoxia-related genes
were identical to those selected in Section 3.2.5, with the addition of Angpt1 and
2, of which Angpt2 is hypoxia-inducible (Oh, Takagi et al., 1999; Yamakawa, Liu
et al., 2003), Epas1, a HIF-like hypoxia-sensitive transcription factor found in ECs
(Tian, McKnight et al., 1997) and Ldhb, which unlike Lhda is not HIF-regulated (Kay,
Zhu et al., 2007). The LN development-related genes were chosen based upon those
described as being key molecules upregulated during LN organogenesis as a con-
sequence of LTi–LTo interactions in Section 1.3.3 andwere reviewed by van de Pavert
and Mebius (2010). The angiogenesis-related genes include those described in Sec-
tion 1.2.4 plus Pdgfc (in lieu of a positive signal being observed for Pdgfb) and Timp3
(Gilbertson, Duﬀ et al., 2001; Saunders et al., 2006; Wan, Chai et al., 2011). Diﬀerences
in absolute and relative expression levels for genes in each of these categories are
shown in Figure 3.9. When describing the diﬀerences, below, only changes greater
than twofold were considered to be signiﬁcantly diﬀerent, and for genes where one
probe was signiﬁcantly diﬀerent from the other replicate probes, this probe was dis-
counted. Note that some key genes are missing entirely; in most cases this was due
to there being no probe on the microarray, or in some cases having no detectable
level of expression for both MRCs and FRCs, e.g. Kdr. However, the probes present
with detectable signal were suﬃcient to gain a general overview of possible active
signalling pathways and cellular interactions within the LN.
Hypoxia-related genes Hypoxia inducible factor-1 α and β (Hif1a and Arnt) were
both expressed at similar levels in MRCs and FRCs , but the level of expressed pro-
tein is not possible to determine based upon the mRNA level. The genes Ccl2, Csf1,
Epas1, Flt1, Ldha and Ldhb were also expressed at similar levels in both samples.
Angiopoietin 1 was around twice as high in FRCs, and angiopoietin 2 around ten
times as high. Cxcl12 was around tenfold higher in MRCs. FRCs had about three
times more expression of the glucose transporter GLUT1 (Slc2a1), but slightly lower
levels of lactate dehydrogenase (Lhda and Ldhb).
LN development-related genes Both cell types expressed Ccl19, Ccl21, and Cxcl13
andTRANCE (Tnfsf11). However, all were upregulated inMRCs, particularlyCxcl13
and TRANCE. TRANCER (Tnfrsf11a) was present on the chip, but expression was
not detected; its paralogue Tnfrsf11b is shown here, and was only seen in MRCs;
this is thought to be a soluble decoy receptor. IL-7 and LTβRwere only expressed by
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MRCs, with LTβ being expressed by both, but upregulated in FRCs. The adhesion
molecules ICAM and VCAM were expressed by both, but upregulated in MRCs,
while MAdCAMwas only expressed by MRCs.
Angiogenesis-related genes The genes VEGFR1, PDGF-C, placental growth factor
(PlGF), thrombospondin, and VEGF-B were present in both MRCs and FRCs at sim-
ilar levels. PEDF (Serpinf1), VEGF-A and VEGF-C were present in both, but were
all upregulated in the MRCs, VEGF-C in particular. The absolute level of VEGF-A
was much higher than VEGF-B or VEGF-C. Tissue inhibitor of metalloproteinases 3
(TIMP3) was expressed much more in FRCs than MRCs.
3.3 Discussion
3.3.1 Wholemount microscopy
Wholemount microscopy permitted detailed visualisation of the vascular networks
within the developing thymus, both by the staining of the vascular endotheliumwith
endomucin, and the basement membrane with collagen IV, laminin and ﬁbronectin
(Figure 3.1). This demonstrated that while staining and imaging of the LN anla-
gen did not yield usable results, this was not due to deﬁciencies in the wholemount
staining protocol. In practice, it was not possible to identify LN anlagen in em-
bryo sections stained using wholemount protocols, not because the GFP staining
was deﬁcient, but because the overnight PFA ﬁxation resulted in such intense back-
ground autoﬂuorescence that it was not possible to distinguish between GFP ﬂuor-
escence and autoﬂuorescence. The failure of all the CD31 and CD144 antibodies to
stain any speciﬁc structures may have been a result of their inability to penetrate the
vibratome-sectioned tissue, or perhaps a consequence of ﬁxation and/or the epi-
topes being mainly restricted to cell–cell junctions (Halama et al., 2001; Sandoval,
Malik et al., 2001) where the junctional complexes are inaccessible to the antibodies.
Foster, Sheridan et al. (2008) noted that endomucin only stained endothelial cells
from E15.5 in the thymus as a result of endomucin only being expressed by mature
endothelial cells. It is therefore possible that endomucin would not stain endothe-
lium in the LNanlagen at E15.5, the LNs developing later than the thymus, and being
less well formed at this stage, the thymus being partly developed at E13.5, at which
point LN development has only just begun (van de Pavert and Mebius, 2010).
Changes were made to the wholemount protocol in order to improve staining,
including extending the staining and wash steps from overnight to several days, but
did not appear to result in more speciﬁc or brighter staining compared with the high
autoﬂuorescence.
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Figure 3.9: Microarray analysis of human LNmRNA levels. The FRC andMRC stromal
subsets were sorted from human fœtal lymph nodes, ages 16–24weeks post-conception,
of unknown sex, and analysed using human Aﬀymetrix gene chips. The ratio of the
levels between the FRC and MRC subsets (top) was calculated from the mean of the
levels for each probe on both chips (bottom). Error bars are ± the standard error of the
mean, shown for genes where more than one probe is present on the array and where
each probe had a signal above the threshold for one or both of the samples.
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Figure 3.9: Microarray analysis of human LNmRNA levels (contd). The FRC andMRC
stromal subsets were sorted from human fœtal lymph nodes, ages 16–24 weeks post-
conception, of unknown sex, and analysed using human Aﬀymetrix gene chips. The
ratio of the levels between the FRC and MRC subsets (top) was calculated from the
mean of the levels for each probe on both chips (bottom). Error bars are ± the standard
error of the mean, shown for genes where more than one probe is present on the array
and where each probe had a signal above the threshold for one or both of the samples.
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Figure 3.9: Microarray analysis of human LNmRNA levels (contd). The FRC andMRC
stromal subsets were sorted from human fœtal lymph nodes, ages 16–24 weeks post-
conception, of unknown sex, and analysed using human Aﬀymetrix gene chips. The
ratio of the levels between the FRC and MRC subsets (top) was calculated from the
mean of the levels for each probe on both chips (bottom). Error bars are ± the standard
error of the mean, shown for genes where more than one probe is present on the array
and where each probe had a signal above the threshold for one or both of the samples.
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In the E15.5 thymus, ﬁbronectin was observed to be laid down throughout the
whole vascular network, unlike collagen IV, which was restricted to the outer cor-
tex. Laminin was also seen to have a similar distribution to ﬁbronectin. This pattern
may reﬂect two diﬀerent processes occuring during vascularisation of the thymus.
Firstly, basement membrane components are laid down in a speciﬁc order, start-
ing with ﬁbronectin, collagen I/III ﬁbres requiring the pre-existence of a ﬁbronectin
matrix (Velling, Risteli et al., 2002), which may also apply to collagen IV polymerisa-
tion. The process may also be recapitulated during wound repair and revascularisa-
tion, where ﬁbronectin is laid down ﬁrst as a component of the provisional matrix
in granulation tissue, which is subsequently supplemented by collagen and laminin
(Schultz and Wysocki, 2009). This process is also observed in the development of
the vascular basement membrane (Sephel et al., 1996). The second process is that of
smooth muscle coverage as the vasculature matures and recruits VSMCs, which res-
ults in an increase in matrix biosynthesis (Stratman et al., 2009a). In this paper, it was
shown that several matrix components, including collagen IV and nidogen, were not
produced unless ECs were cocultured with pericytes, while ﬁbronectin, laminin and
perlecan production was upregulated in the presence of pericytes. It was addition-
ally demonstrated that collagen IV, unlike laminin, did not assemble into a network
unless ﬁbronectinwas already present, as noted for collagen I, above. Together, these
observations imply that the collagen IV staining observed in the thymus is a result
of the ECs in the cortex having VSMC coverage, while the medullary ECs and inner
cortical ECs do not, laying down ﬁbronectin and laminin only, and from this it is
logical to deduce that VSMCs migrate inward along the vascular network from the
edge, assuming that they are not derived directly from the local mesenchyme.
While this process may be unique to the thymus, the process of vascularisation
and ordered basement membrane production may be common to other organs, per-
haps also including the lymph node. The thymus does contain a somewhat unique
vasculature, capillaries being double-walled and having two basal laminæ (Kato,
1997), and may hence develop in a diﬀerent manner to other systems. However,
pericyte coverage is common to all capillaries, and as discussed in a recent pericyte
review by Armulik et al. (2011), it is becoming clear that while pericytes do not have
a common lineage, they originate from deﬁned points such as the neural crest and
mesothelium in the embryo and spread along the vasculature, hence it is probable
that all of the pericytes within a single lymph node would all have a common origin,
though the dynamics of migration and cell division during this process still require
investigation.
Further work would be required to correlate collagen IV distribution with VSMC
coverage, for example by additionally stainingwith a pericytemarker such asα-SMA,
NG2, PDGFRβ or desmin (Armulik et al., 2011).
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3.3.2 Development of LNs
Due to the problems imaging LN anlagen in wholemount preparations, direct visu-
alisation using SHGand immunohistochemistrywere used as an alternative (Figures
3.2 and 3.3). It is unclear if ECs are present in the centre of the anlagen as a result
of the endomucin staining showing no staining within the cluster of LTis (Mebius
et al., 1997); however, some endomucin staining was visible above and below the
cluster, perhaps within a few ECs comprising the surrounding lymph sac. Rather
than no ECs being present, this may be a lack of endomucin staining at this point in
LN development (Foster et al., 2008). MECA-32 staining did highlight a band of cells
running alongside an LTi cluster (from the shape, this is likely to be a streak from the
cervical node), but no staining was seen within the cluster. As observed in previous
work, LTis and LTos were seen interacting at low frequency, LTos being identiﬁed by
their VCAM expression and most being in direct contact with adjacent LTis, and as
yet unactivated stroma being visible by DAPI staining (Vondenhoﬀ et al., 2009a).
The most interesting observations concern the placement of vascular basement
membrane relative to the LTi clusters. While the anlagen in Figure 3.2 appear rather
diﬀerent, this may be an artefact of the limited optical sectioning possible due to
the tissue thickness—features may depend on the location in the tissue, so diﬀerent
nodes may be more similar than apparent. Live SHG imaging showed tight clusters
of LTis, in some cases bordered on three sides by a collagen I band, indicating that
the LTis were clustering in a morphologically distinct “pocket”, which was open at
one end. This bears great similarity to the collagen I staining in Figure 3.3(D), which
again showed a cluster of LTis surrounded by collagen I, which was open at one end.
In both cases, a partial second layer of collagen I stainingwas observed. In the frozen
section, LTiswere also seen outside the pocket, towards the bottomof the ﬁgure. This
might be an extension of the anlagen, whichmight not ﬁt into thewhole ﬁeld of view,
or itmay indicate that the LTisweremigrating into the pocket through this route. The
LTis must arise from the circulation due to their hæmatopoietic origin (Mebius et al.,
1997), but whether they arise from the vessels surrounding the anlagen, or migrate
after extravasation from distant major vessels is not known. Laminin staining of the
skin, showing scattered LTis restricted in their movement by the basal lamina gives
the impression of wandering cells; scattered LTis were also observed in or under the
skin of hCD2-GFP embryos during dissection, implying that their distribution is not
speciﬁcally restricted to the anlagen, but they are physically bounded by the basal
lamina (Gao, DeRouen et al., 2008).
Collagen IV staining correlated closely with the distribution of collagen I, im-
plying that they demarcate the same structures. As for collagen I, LTi clusters are
surrounded by a double layer of anastomosing vessels, the nature of which is clearly
seen in serial sections showing vessels bridging the gap between the layers. Though
a double-layered sac is predicted in the model described by Mebius (2003), in this
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model this is a precursor to the subcapsular sinus, and does not contain any ves-
sels spanning the gap. In contrast, in these images non-EC cells stained with DAPI
are clearly seen ﬁlling the gap, though some empty spaces are present. In the data
presented by Bénézech et al. (2010), a double layer of collagen I is seen in the E15.5
inguinal LN, but the inner mass is additionally heavily stained with collagen at both
this timepoint and E17.5, whereas the inner LTi cluster is completely absent of col-
lagen I staining in Figure 3.3, leading one to conclude that there is little similarity.
Vondenhoﬀ et al. (2009a) did not speciﬁcally examine basement membrane expres-
sion in the brachial node, but did stain with LYVE1 and VEGFR2 which should have
stained the same cells; indeed, at E14.5 [Figure 1(F)] a three sided pocket of LECs is
seen, and on the right-hand side a potential second cell layer is visible at the edge of
the ﬁeld of view, though this is less clear at E16.5.
Part of the discrepancy with the data of Bénézech et al. (2010) may lie in their use
of Gp38 and CCL21 to identify lymphatic endothelium, neither of which are speciﬁc
to LECs (Katakai et al., 2004, 2008; Roozendaal and Mebius, 2011). However, the
assumption that such cells are LECs may not be incorrect, especially given that they
are PDGFRα .
While lymph sac structure appears to bear similarities with the work of Vond-
enhoﬀ et al. (2009a), the data is diﬀerent with respect to the vascularisation of the
anlagen. In Figure 3.3(A–C), very little collagen IV is seen on cells within the anla-
gen, and certainly not in any pattern resembling a vessel as seen for the lymph sac,
whereas Vondenhoﬀ et al. (2009a) observed the presence ofMECA32+VEGFR2+ and
VEGFR2+ vessels at E14.5, and additionally VEGFR1+VEGFR2+ vessels at E16.5. It
is a possibility that the ECs express collagen I and IV after their initial migration (as
discussed above and in Stratman et al. (2009a)), which would have resulted in only
older, established vessels being stained.
The double-layered structure appears to be at least partially LYVE1+, perhaps in-
dicating that the lymph sac is not entirely committed to an LEC lineage at this point
(Cupedo, Vondenhoﬀ et al., 2004). While being less clearly deﬁned than collagen I
and IV, it appears to be approximately similar, also having a partially double-layered
structure. Structurally and functionally, it is unclear what the double-layered struc-
ture is, and what it will develop into from these images alone. There are two hypo-
theses worth considering. The ﬁrst hypothesis is that due to the second layer being
only a sparsely-distributed collection of cells, it may be a remnant of the cells migrat-
ing from the nearby vessel, the source of the cells comprising the lymph sac (Harvey
and Oliver, 2004; Oliver, 2004). These might subsequently regress and disappear.
The second hypothesis is that this double layer is a precursor to the subcapsular
sinus. At least in the rat, the subcapsular sinus contains tissue pillars extending
across the sinus, and appearing to have continuity with the cortical reticular net-
work (Ohtani and Ohtani, 2008), which leads one to question how such a complex
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structure might develop given that it would not be likely that cells could bridge the
gap once lymphatic ﬂow has commenced. It may be the case that the stromal cells
interspersed amongst the anastomosing vessels will subsequently play a role in the
formation of such structures. Like the inner and outer surfaces of the sinus, which
are composed of lymphatic endothelium (Liersch and Detmar, 2007; Sixt et al., 2005),
the pillars themselves may be lined with an outer endothelial layer, perhaps with
an inner VSMC or stromal layer continuous with the FRC network; the collagen IV-
stained “bridge” structures between the two layers may be the forerunner of such
structures, and may play both a structural role in keeping the sinus open, and po-
tentially a functional role in the loading of the conduit system with low molecular
weight soluble factors (Sixt et al., 2005).
It has recently been shown that mice lacking lymphatics still have LNs (Vonden-
hoﬀ et al., 2009b). Conditional Prox1 mutant embryos defective in lymph sac form-
ation were still shown to exhibit LTi clustering, but had impaired vascular develop-
ment, in particular in the surrounding lymph sac and in the absence of major ves-
sels inside (compared with Vondenhoﬀ et al. (2009a)), with the loss of Gp38+ and/or
VEGFR2+ vessels. This may imply that the vessels inside the sac originated from the
sac, and that loss of Prox1 prevented sac formation and consequently their forma-
tion. However, their loss might also be a direct or indirect consequence of the altered
phenotype.
3.3.3 Hypoxia
Pimonidazole imaging of hypoxia (Figure 3.4), if valid, showed that the embryos
were so hypoxic that it appeared that the antibody used to stain bound probe ap-
peared to be limiting. If the primary had not washed out properly, staining would
also be seen in the interior. In consequence, the staining is likely entirely artefac-
tual, due to unbound probe not being washed out, forming adducts prior to ﬁxation,
thereby showing all the tissues to be entirely hypoxic. Alternatively, the entire em-
bryo may be hypoxic. In this situation, the antisera is likely to be limiting and will
hence only penetrate a small distance into the tissue before it is almost all completely
bound, which would result in the staining pattern observed, where staining is seen
on all exposed external and internal surfaces including those exposed by sectioning,
those of tissue boundaries, and vessels and ducts penetrating the tissue.
Speciﬁc staining of embryos has been achieved by others in themouse (Lee, Jeong
et al., 2001) and also the quail (Nanka, Valásek et al., 2006). The main experimental
diﬀerence is that Lee et al. (2001) injected the probe intravenously rather than in-
traperitoneally; the same length of time was left between injection and collection of
the embryos, which should be suﬃcient time for unbound probe to be excreted. The
embryos were kept on ice for several hours during transport and while sorting the
GFP+ embryos, therefore it may be possible that an increase in hypoxia in the tissues
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of the embryos during this period may have caused any unbound probe remaining
to irreversibly bind. Given that pimonidazole has been shown tomark hypoxic areas
speciﬁcally in both adult and embryonic tissues (Lee et al., 2001; Raleigh et al., 1998),
it is likely that the staining observed here is a result of a technical deﬁciency in the
experimental protocol.
3.3.4 Gene expression
While these data measure mRNA levels, this does not necessarily imply that these
equate to functional eﬀect, which would need to account for translation of protein
product, sequestration, diﬀusion, lifetime, etc.
Changes in the balance of pro- and anti-angiogenic factors in the LNwere incon-
sistent between timepoints, most likely due to undeﬁned nature of the samples being
pooled given that they contained surrounding mesenchyme in addition to the LTis,
LTos and other cell types in the anlagen. Other tissues such as the liver, which were
homogeneous in comparison, showed much more consistency over time.
Notable changes in the LN include a drop of over an order of magnitude in PEDF
expression, which is coupled with a a reciprocal rise in thrombospondin expression.
This may be related to diﬀerences in regulation during development and mainten-
ance in the adult. PEDF, being a direct-acting inhibitor may be required in the em-
bryo to act with immediate eﬀect, whereas thrombospondin being a matrix com-
ponent which must undergo proteolysis to exert its eﬀects, and may hence act over
longer timescales and play a role in the homeostasis of existing vessels. PEDF also
acts upon new sprouts rather than older vessels, hence plays a role in the suppres-
sion of new sprouting angiogenesis (Ek et al., 2006). A similar pattern is seen in all
tissues for thrombospondin with the exception of the liver, and PEDF was only seen
to rise appreciably in the liver. Thrombospondin expression was noted to decline in
the adult by Morwood and Nicholson (2006); Sun et al. (2009), however for the tis-
sues investigated, this only appeared to apply to the liver, where PEDF appears to
continue to play an important role, unlike the other tissues. Unlike the LN, the skin
is completely vascularised early in development, the lymphatics developing after the
blood vasculature and being complete by E15.5 (Srinivasan et al., 2007), and hence
the changes may be reduced or eﬀectively absent in consequence.
While an internal TaqMan probe would permit all splice variants to be quanti-
ﬁed collectively, using a probe for a sequence common to all splice variants, here the
relative levels of Vegfa splice variants were compared using SYBR green with three
sets of primers to amplify three sets of two splice variants. In very general terms,
Vegfa1+4 (VEGF188) remains steady or increases in all cases, while 2+5 (VEGF164)
remains steady or increases and 3+6 (VEGF120) decreases. Comparison relative to
Pedf1 shows 1+4 to be produced at the highest level, followed by 2+5, with 3+6 be-
ing over two orders of magnitude less in the adult, the diﬀerence becoming greater
106 CHAPTER 3. VASCULARISATION OF LYMPH NODE ANLAGEN IN VIVO
over time. This change may reﬂect the need for a smaller non-heparin binding iso-
form during vascularisation (VEGF120), due to its lack of matrix interaction and its
ability to diﬀuse further. During vascular maintenance in the adult, larger heparin-
binding isoformswhich act in amuchmore localisedmannermay be preferred, eg to
promote the survival of existing vessels. The diﬀerent isoforms have been shown to
have diﬀerential eﬀects upon EC proliferation and vessel branching (Park et al., 1993;
Ruhrberg, Gerhardt et al., 2002), and in the case of bone growth plates, have been
shown to have diﬀerent spatio-temporal distributions, indicating that diﬀerent iso-
forms play diﬀerent roles during the process of development (Evans and Oberbauer,
2008). TheVEGF-A isoforms also vary in their ability to bind theVEGFR co-receptors
neuropilins 1 and 2, which are associatedwith BECs and LECs, respectively (Holmes
and Zachary, 2005; Lohela et al., 2009), thus changes in their composition may reﬂect
changes in angiogenesis and lymphangiogenesis.
Figure 3.6 demonstrates non-quantitatively that pro- and anti-angiogenic factors
are produced simultaneously, in this case in the thymus. However, this is the net
expression within the tissue, and this (and all of the RTPCR data) do not localise ex-
pression, therefore it is not possible to determine whether pro- and anti-angiogenic
factors are expressed evenly thoughout the tissue, or are localised to speciﬁc struc-
tures. This could be determinedusing immunohistochemistry (to localise the protein
product), though growth factors may be present at too low a concentration to allow
detection.
3.3.5 Diﬀerences between MRCs and FRCs
One approach to localise gene expression is to sort the LN into diﬀerent subsets,
which was done to separate MRCs and FRCs in the human, prior to analysis using a
microarray. Note that the microarray data would require conﬁrmation using RTPCR
due to the reduced sensitivity of microarrays and the likelihood of bad probes which
would result in false negatives. In consequence, only tentative conclusions may be
drawn from these data. The small size of mouse LNs made cell sorting impractical,
but would be a possibility if a suﬃcient quantity of material could be pooled.
The MRC and FRC stromal subsets may play rather diﬀerent roles due to their
spatial distribution within the LN. The MRCs are restricted to the subcapsular si-
nus, while the FRCs are present within the cortex and paracortex, in close associ-
ation with the capillary and HEV networks running through. Using the microarray
data presented in Figure 3.9, the signalling interactions which may occur between
and within the layers are shown in Figure 3.10, and the relative levels of the genes
involved are summarised in Table 3.1. In order to reduce the complexity, the path-
ways have been split into two separate diagrams.
While some changes in hypoxia-responsive genes such as GLUT1 were observed,
no consistent pattern was seen, and hence it is not possible to conclude that one
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subset is more hypoxic than the other.
Organisation and maintenance
The ﬁrst pathway diagram in Figure 3.10 details the signalling molecules previously
described as being involved in stromal induction in Section 1.3.3. MRCs retain many
of the characteristics of LTos, while these are downregulated or absent in the FRCs.
Of particular note is the absence of LTβR and IL-7 expression in the FRCs, and the up-
regulation of LT in the FRCs, whichmay imply that only theMRC layer is sensitive to
LT. Both subsets were seen to produce LT however, with FRCs producing the most,
perhaps suggesting that FRCs may maintain the peripheral MRCs through LT sig-
nalling, in addition to resident lymphocytes. FRCswere shown by Chyou et al. (2008)
to be the main source of VEGF-A used to maintain the LN vasculature, and that this
was a LT–LTβR-dependent process, but did not distinguish MRCs. LTβR signalling
was also shown by (Katakai et al., 2004) to be responsible for inducing formation of
the FRC/conduit network, but LTβRwas not speciﬁcally localised to the FRCs. LTβR
distribution has been studied in lymphoid tissue including the thymus and spleen,
but this study did not include LNs (Murphy, Walter et al., 1998). White et al. (2007)
showed that LTβR was mostly restricted to the ICAM VCAM  non-hæmatopoietic
population, but did not distinguish between FRCs and MRCs. However, the lack of
LTβR on FRCs may however be an artefact from the microarray, and would require
conﬁrmation using RTPCR.
The lack of IL-7 in the FRCs may imply that the MRCs are the sole source of
IL-7 within the node (though as mentioned previously, the microarray data require
RTPCR validation). IL-7 is required for T cell survival (Vivien et al., 2001) and its
levels are believed to be responsible for regulating the size of the peripheral T cell
pool. Additionally, LTis in the embryo require IL-7 for survival, as do adult LTis,
which are implicated in LNmaintenance and reconstruction followingdamage (Hou,
Mustafa et al., 2010). An IL-7-ECFP reporter mouse was developed to study the cel-
lular localisation of IL-7 production (Mazzucchelli, Warming et al., 2009). However,
while this demonstrated IL-7 expression in the thymus and spleen, the reporter failed
to work in LNs. FRCs were shown by Link et al. (2007) to be a source of IL-7, CCL19
and CCL21, however this work did not distinguish between MRCs and FRCs, there-
fore it remains a possibility that IL-7 production is restricted to the MRC subset, and
that the size of the T cell pool is proportional to the size of the MRC population.
Katakai et al. (2008) described the newly discovered MRC subset as “organiser-
like”, referring to their sharing of many markers with LTos and implying that MRCs
were the adult equivalent. These ﬁndings are reﬂected in the microarray, MRCs ex-
pressing CXCL13, TRANCE, ICAM, VCAM and MAdCAM at higher levels than the
FRCs. Katakai et al. (2008) also showed IL-7 to be produced upon stimulation with
LT or anti-LTβR antibody; here it was observed that MRCs produced IL-7, but FRCs
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Table 3.1: Genes involved in vascular maintenance and lymph node
development. The level of mRNA shown for the MRC and FRC
stromal subsets is based upon the levels shown in Figure 3.9, and
indicates an approximate absent (blank), low (+), intermediate (++)
or high (+++) level of abundance.
Category Gene MRC FRC
V 
Promoter PDGF C ++ ++
PlGF ++ ++
VEGF A ++ ++
VEGF B + +
VEGF C ++ +
Inhibitor PEDF +++ ++
Thrombospondin 1 +++ +++
Stabiliser Angiopoietin 1 + ++
Angiopoietin 2 + +++
L  
Signalling CCL 19 +++ ++
CCL 21 +++ ++
CXCL 12 +++ ++
CXCL 13 +++ +
TRANCE +++ +
LT + ++
LTβR +
IL 7 +
Adhesion ICAM +++ ++
VCAM +++ +++
MAdCAM ++
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Figure 3.10: Models of LN organisation and angiogenesis. The spatial distribution of
mRNA levels between the MRC layer and FRC zone is illustrated, with genes shown in
a reduced size if they are less abundant in one compartment relative to another, and are
highlighted in red if they are presumed to be active. Possible signalling interactions are
indicated with arrows.
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produced no IL-7 at all. Link et al. (2007) noted IL-7 production by FRCs, but being
prior to the discovery of MRCs is likely to have included both subsets in their ana-
lysis. Given the requirement of both LTis and T cells for IL-7 to survive (Schmutz,
Bosco et al., 2009; Vivien et al., 2001), it is possible that MRCs are the principal regu-
lators of the pool size if it is the sole source of IL-7 in peripheral lymphoid organs.
It is likely that IL-7, TRANCE and VEGF-C expression are a result of LT signalling
(Vondenhoﬀ et al., 2009a).
Vascular homeostasis
The second pathway diagram in Figure 3.10 details potential interactions between
pro- and anti-angiogenic factors in both MRC and FRC areas. The most obvious dif-
ference in the angiogenic environment between the two subsets is the upregulation of
VEGF-C expression byMRCs. If validated by RTPCR, and given that MRCs underlie
the LEC-lined subcapsular sinus, this may indicate that MRCs play a role in lymph-
angiogenesis and the maintenance of the lymphatic endothelium (Vondenhoﬀ et al.,
2009a). VEGF-B, involved in vascular maintenance (Zhang, Tang et al., 2009), is sim-
ilar in both, while the upregulation of both PEDF and VEGF-A in the MRCs, again
following RTPCR validation, may imply a need for suppression of neovessel growth
underneath the subcapsular sinus, potentially to maintain separation between the
sinus and blood vasculature. PEDF was recently shown to diﬀerentially regulate an-
giogenesis and lymphangiogenesis in the context of a prostate tumourmodel, where
angiogenesis was suppressed, but lymphangiogenesis increased Halin, Rudolfsson
et al. (2010); it is possible that in the LN, PEDF suppresses angiogenesis selectively,
while promoting lymphangiogenesis and/or lymphatic maintenance with VEGF-C
acting in a synergistic role. VEGF-A from inﬂamed tissues has been shown to in-
duce angiogenesis in draining lymph nodes (Halin, Tobler et al., 2007); it is therefore
possible that some of the anti-angiogenic factors such as PEDF, TIMP3 and the an-
giopoietins exist to dampen responses to external factors.
The FRC zone has increased angiopoietin activity, which is normally associated
with vascular stabilisation rather than angiogenesis. This raises questions regarding
the nature of the association of the FRC network with the vasculature, and whether
the FRCs are the origin of the pericytes covering and regulating the HEV network,
or if they act in a pericyte-like manner in addition to the pericytes, being apparently
continuous with them (Ma et al., 2007).
Thbs1 was expressed at equal levels in both MRCs and FRCs. However, this ac-
counts only for transcription, not translation or turnover. Turnover may aﬀect se-
questration of other components and matrix binding partners (Iruela-Arispe, 2008),
hence the microarray data is not informative if the downstream eﬀects are not ob-
servable as a change in gene expression.
While the exact eﬀects upon the vasculature arising from the diﬀerences in gene
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expression between the MRCs and FRCs are far from clear, there are diﬀerences
between the two. Questions arising from these diﬀerences include determination
of the roles the two subsets play in the normal functioning of the LN versus main-
tenance and repair following an inﬂammatory response.
3.4 Conclusions
Following observation LN anlagen using various diﬀerent imaging strategies, the
method of LN vascularisation is still unclear, with evidence in the literature appear-
ing contradictory. Some evidence points to vascularisation at the earliest stages of
development, while in other cases the anlagen appear avascular until much later.
The developmental origin of the vessels is also unclear, the lymph sac and vessels in
the mesenchyme both being possibilities.
The overall impression of the diﬀerences between FRCs and MRCs, based upon
themicroarray data is thatMRCs aremost likely to be involved inmaintenance of the
lymphatic endothelium of the subcapsular sinus, and upregulate a number of genes
with anti-angiogenic potential, though some pro-angiogenic genes were also seen to
be upregulated. FRCs also express genes promoting vascular stability, though given
their diﬀerences it is clear that there are signiﬁcant diﬀerences between theMRC and
FRC compartments.
The RTPCR data highlighted changes in the balance of pro- and anti-angiogenic
factors during development and in the adult. In order to determine how these factors
aﬀect endothelial cells in the vicinity of the anlagen, a functional in vitro angiogenesis
assaywas developed in the following chapter to allow the angiogenic environment of
the anlagen to be measured, and to also allow dissection of the signalling pathways
involved.
3.5 Future work
While hCD2-GFP embryos are suﬃcient for studying development once LTi inﬁlt-
ration commences, study of the earliest stages will still require identiﬁcation of the
site using some other means, perhaps using LYVE1-GFP or some other marker to
identify the early establishment of the anlagen prior to LTi recruitment.
3.5.1 Wholemount imaging of LN anlagen
Given the problems identiﬁed with wholemount preparations, it is clear that the
autoﬂuorescence resulting from long ﬁxation times must be reduced in order for
immunohistochemical staining to achieve a signal greater than the background. The
112 CHAPTER 3. VASCULARISATION OF LYMPH NODE ANLAGEN IN VIVO
obvious solution is to dissect the anlagen and ﬁx the smaller pieces of tissue for a
reduced amount of time prior to staining.
All of the recent papers investigating LN anlagen such as Vondenhoﬀ et al. (2009a)
and Bénézech et al. (2010) utilised frozen section staining. While this is a useful tech-
nique, important information about the true 3-D structure of the tissue is lost, res-
ulting in ambiguity given that apparent features may simply be artefacts of the sec-
tioning angle and/or slice used. Imaging the entire structure would eliminate such
problems. For example, the complete structure of all collagen IV basement mem-
branes could be visualised, together with all VEGFR1+/VEGFR2+/MECA32+ cells
to fully realise the spatial arrangement of ECs and basement membranes with re-
spect to the lymph sac and LTis, and to also observe their orientation and placement
relative to stromal induction.
Autoﬂuorescence could additionally be eliminated or reduced with the use of
spectral unmixing during imaging. Additionally, ﬂuorophores in the far red could
be used such as AF647, which would reduce the interference of autoﬂuorescence
given that autoﬂuorescence declines with increased excitation wavelength.
3.5.2 Serial frozen sections
In addition to wholemount, it would also be useful to image the developing anlagen
using serial frozen sections, which would allow for the use of antibodies which will
not work with wholemount preparations, eg due to lack of penetration into thick
sections or inaccessibility such as within junctional complexes, as well as techniques
which will not work with wholemount such as the use of diﬀerent antibodies of
the same isotype labelled with ﬂuorescent Fab fragments of diﬀerent colour, such as
Zenon kits (Invitrogen), again due to lack of penetration.
Using both wholemount and frozen sections, it should be possible to image the
diﬀerent LN anlagen throughout all timepoints during development to gain a de-
tailed understanding of how the vascular network develops within and without the
anlagen, and its origins within or external to the lymph sac and/or surrounding
mesenchyme.
3.5.3 RTPCR to validate microarray
The microarray data highlighted some interesting and potentially signiﬁcant diﬀer-
ences between the MRC and FRC stromal subsets, most notably the diﬀerences in
IL-7, LT and LTβR, TRANCE and TRANCER expression. These require validation
with RTPCR in order to conﬁrm that the observations are real.
Chapter 4
Development of a model system to
study angiogenesis in vitro
4.1 Introduction
4.1.1 Models of angiogenesis and vasculogenesis
Angiogenesis is the result of changes in the gene expression, proliferation, migration
and organisation of endothelial cells in response to various cues (Adams andAlitalo,
2007). Many diﬀerentmodels have been established in order to study various aspects
of this process. In vivo animal models include the chick chorioallantoic membrane
(embryo yolk sac), which is both accessible and easy to visualise (leNoble et al., 2004).
Other models include implantation of in vitro constructs, e.g. subcutaneous implant-
ation of ECs in collagen, ﬁbronectin orMatrigel gels intomice (Auerbach, Lewis et al.,
2003; Koike, Fukumura et al., 2004; Schechner, Nath et al., 2000). In vitro models in-
clude basic tube formation on Matrigel, beads in ﬁbrin gels to stimulate sprouting
and anastomosis, and mouse aortic ring vessel outgrowth (Nakatsu, Sainson et al.,
2003). Other models include the vascularisation of embryoid bodies formed from
embryonic stem cells (Vailhé et al., 2001). Parameters measured in existing assays in-
clude disruption of the vascular basement membrane, EC migration, proliferation,
and tube formation. However only tube formation (i.e. outgrowth and vessel as-
sembly) is a direct measurement of angiogenesis (Auerbach et al., 2003).
Human umbilical vein ECs (HUVECs) are the most commonly used primary EC
line, though other lines are also used, for example bovine aortic endothelial cells
(BAECs) (Korﬀ and Augustin, 1999). Primary cells can only be passaged a limited
number of times before growth is arrested, and while several attempts have been to
derive immortalised cell lines, in most cases it is clear that these lines have altered
gene expression which puts their physiological relevance in doubt (van Beijnum,
van der Linden et al., 2008; Rhim, Tsai et al., 1998). HUVECs in culture have been
found to exist in two main states, proliferative at low density and organised into tu-
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bular structures at high densities (Maciag, Kadish et al., 1982). Maciag et al. (1982)
found that tube formation was driven by omission of proliferative factors from the
culture medium (endothelial cell growth factor; bovine hypothalamus extract) and
the ﬁbronectin matrix. However, these in vitro observations may not truly reﬂect the
in vivo behaviour, where proliferation is not the norm. In vivo, cells in an established
network exist as phalanx cells, with sprouting angiogenesis occuring from this net-
work as a result of the phalanx cells transforming into leading tip cells and following
stalk cells (Augustin et al., 2009). Growth factors such asVEGF andbFGF are respons-
ible for the induction of angiogenesis (Pepper, Ferrara et al., 1992), with factors such
as angiopoietin being responsible for stabilising of an established network, and are
also implicated in arterial–venous diﬀerentiation (Augustin et al., 2009).
4.1.2 Requirements of an in vitromodel
An in vitromodel of angiogenesis should reﬂect the in vivo process to the maximum
practicable extent, whilst allowing precise and accurate quantiﬁcation and analysis
of the process via extraction of meaningful features from the model, e.g. via micro-
scopic imaging and analysis. A “complete” vascular model should include all of the
major features of a vascular bed. The vascular bed is composed of an interconnec-
ted network of capillary vessels composed of vascular endothelial tubes, which are
covered with a layer of pericytes (Bergers and Song, 2005). These two cell layers are
separated by a basement membrane providing both structural stability and a barrier
to endothelial cell migration (Armulik, Abramsson et al., 2005; Sato and Rifkin, 1989).
Vessels also experience ﬂuid ﬂow, perfused through the vascular network, provid-
ing hydrodynamic shear stress and pressure, which may also cause changes in en-
dothelial behaviour (Jones et al., 2006; Nguyen, Eichmann et al., 2006; Price, Wong
et al., 2010). Vascular networks do not exist in isolation, being incorporated into a
tissue throughout which they ramify and being specialised to satisfy the functional
needs of that tissue, e.g. the blood-brain barrier (Bergers and Song, 2005) andHEVs in
LNs (Willard-Mack, 2006). A vascularmodel should ideally contain both endothelial
cells and pericytes, andmust exist in thewider context of a speciﬁc tissue. Themodel
will thus contain endothelial, pericyte and tissue-like components. The model must
possess the potential for remodelling via sprouting and intussusceptive angiogen-
esis in response to cues from the local environment (i.e. in the tissue-like component
and/or itself).
If a network is required from the start of an experiment, thiswould require de novo
formation of a network, i.e. vasculogenesis to drive formation of a primary capillary
plexus (Davis et al., 2007). However, depending upon the process being studied,
initial network formation may be foregone in favour of simpler methods, such as
a starting point of a conﬂuent monolayer or other forms of multicellular aggregate
such as spheroids, or even a single cell suspensionwhichwill form a network, extend
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tubes, or undergo some other quantiﬁable change. Examples include number of tip
cells, sprout length, number of branchpoints, and area occupied by vessels (Wang,
Nakayama et al., 2010).
Given the important role of VSMCs and pericytes in stabilising, supporting and
regulating the endothelial layer of vessels, having smoothmuscle coverage would be
an important component of a realistic vascular model. The behaviour of endothelial
cells in the model, for example in response to exogenous or endogenous growth
factors, may diﬀer dramatically with the presence or absence of smooth muscle, and
so may not accurately reﬂect in vivo behaviour in their absence. However, during
development, sprouting vessels do not initially possess smooth muscle coverage,
VSMCs being recruited and retained due to PDGF-B signalling from ECs, and so
this may be an unnecessary complication depending upon the context (Hellström,
Kalén et al., 1999; Lindblom, Gerhardt et al., 2003).
As discussed above, the in vitro model must include a component to model the
tissue through which the capillary bed inﬁltrates. This may be adapted to model
various diﬀerent scenarios, for example inclusion of tissue-speciﬁc cell types, addi-
tion of medium- or matrix-borne growth factors, inhibitors or blocking antibodies,
control of physical and chemical properties and/or combination of the vascular com-
ponentwith ex vivo tissue explants, tumours, spheroids, engineered tissue constructs
or other implantable material.
Tissue-speciﬁc cell types may be used to model the speciﬁc features and beha-
viours of particular tissues, for example via the addition of stromal cells, solid or
metastatic tumour cells, to study their inﬂuence upon vascular structure and func-
tion. Growth factors, inhibitors or blocking antibodies would allow the investigation
of responses to speciﬁc factors in a tissue-free context, to remove the multiplicity of
eﬀects additional cell types would add, and to also permit the dissection of the sig-
nalling pathways involved. Controllable physical and chemical properties include
mechanical stress and deformation, oxygen tension, pH, etc., which vary between
diﬀerent tissues (Assoian and Klein, 2008; Nanka et al., 2006). The use of ex vivo tis-
sue explants would permit the eﬀects of the tissue upon remodelling and outgrowth
of the vascular component to be studied. Depending upon the processes one wishes
to study in vitro, a simpler model may incorporate one or more of the above features.
Spheroidmodels have previously been used as amodel for angiogenic outgrowth
in collagen gels. Thomas Korﬀ developed an in vitro model, using methylcellulose
spheroids which could be embedded within a collagen gel and used to study the
eﬀects of soluble factors and forces (Korﬀ and Augustin, 1998, 1999). A detailed
protocol for producing spheroids in bulk was subsequently published (Laib et al.,
2009), and assay plates containing collagen gels seededwith HUVEC spheroids have
recently become commercially available (3D-Angiogenesis Assay, PromoCell).
Fluid ﬂow and the resulting pressure and shear stress are obviously integral fa-
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cets of the normal functioning vascular system, and have been shown to have some
inﬂuence upon certain aspects of the diﬀerentiation, organisation and morphology
of endothelial cells in particular and vascular networks as a whole (Jones et al., 2006;
Nguyen et al., 2006; Price et al., 2010). The arterial side of the circulation is addi-
tionally subjected to high pressure pulsatile ﬂow compared with the low pressure
smoother ﬂow experienced on the venous side and a pressure diﬀerential exists
across the capillary beds connecting the two. Depending upon which parts of the
vascular system one wishes to model, incorporating ﬂuid ﬂow, hydrodynamic pres-
sure, pulsatile ﬂow (and potentially even a low pressure ﬂuid drain to mimic lymph-
atics) may be desirable. However, accurate modelling of ﬂuid ﬂow may not always
be required. In development, until the major arterial and venous circuits complete,
ﬂow is absent, and consequently any pressure diﬀerential. Additionally, adventi-
tious endothelial sprouts initially lack lumens or are blind-ended, so therefore lack
ﬂow entirely even after the initiation of circulation (Gerhardt et al., 2003).
The purpose of themodel is to observe and quantify changes in the vascular com-
ponent in response to various treatments. Thus, it is paramount that it be possible to
visualise themodel, and extract from it parameterswhich accurately quantify certain
aspects of the vascular component, thereby permitting meaningful comparisons to
be made between treatments. In order to observe and record changes in the model,
such as growth, regression and remodelling of the network, it should be possible
to use microscopy to image, ideally in real time to allow the study of the kinetics
and dynamic changes within a single sample, resulting in less variation and hence
more statistically robust results, rather than comparing diﬀerent samples at multiple
timepoints. The ability to ﬂuorescently label the cells used in the model would per-
mit real time imaging, using epiﬂuorescence, confocal and MP microscopy, as well
as allowing easy separation from other cells using ﬂow cytometry.
In this thesis, HUVECs have been chosen as a model endothelial cell. HUVECs
are used in vascular modelling and angiogenesis research in a wide variety of mod-
els. While a variety of diﬀerent endothelial cell types are available, HUVECs are
widely used and can be cultured in large quantities (Bishop et al., 1999; Korﬀ andAu-
gustin, 1998; Maciag, Hoover et al., 1981; Nakatsu et al., 2003). Utilising a commonly
used cell type also permits comparisons to be drawn with the many published ﬁnd-
ings using the same cell type. Two smooth muscle cell lines were also used, the ﬁrst
being a primary culture of mouse aortic vascular smooth muscle and the second
being the multipotent mouse mesenchymal line, C3H/10T½. The C3H/10T½ line
(Reznikoﬀ, Brankow et al., 1973) is widely used as a model pericyte cell line; though
they are not formally characterised as such, they can be diﬀerentiated into smooth
muscle and are used in a wide variety of models. C3H/10T½ were shown to be of
multipotent cells mesodermal origin, capable of diﬀerentiation into diﬀerent mes-
enchymal lineages, including chondrocytes and smooth muscle (Pinney and Emer-
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son, 1989). C3H/10T½ were additionally shown to be recruited to ECs via PDGF
and TGF-β signalling, as well as by direct cell–cell contact, and diﬀerentiated into
smooth muscle (Hirschi, Rohovsky et al., 1998). A deﬁning marker for pericytes
(and othermural cells) during development is theNG2 proteoglycan (Ozerdem et al.,
2001), therefore any smooth muscle cell line used to model pericytes should be ex-
pected to express this unique diﬀerentiation marker. Note that NG2 is also found
on neural cells, but is restricted to mural cells in the vasculature and is hence spe-
ciﬁc for pericytes and mural cells compared with other types of smooth muscle (i.e.
is α-SMA+NG2+). The primary line was hypothesised to be a better choice, being
derived directly from vascular smooth muscle.
4.1.3 Extracellular matrix
The extracellular matrix is composed of a number of proteins which link together
to provide a “scaﬀold”, to give a tissue mechanical support, and also play a role in
deﬁning its shape and structure. The ECM structure deﬁnes tissue boundaries, se-
questers and present growth factors to cells, and allows cells to sense mechanical
forces (Rozario and DeSimone, 2010). Within this loose meshwork, cells are able to
ﬁrmly anchor themselves in position, or to exert directional force upon the ﬁbrils of
the network to allow locomotion and migration through the tissue (Friedl, Zänker
et al., 1998; Martins and Kolega, 2006). The cells, in turn, are also capable of sens-
ing forces exerted upon the matrix such as tensile and compressive forces, and are
hence capable of transducing signals at a distance from themselves, which serve to
act as cues to inﬂuence their behaviour (Korﬀ and Augustin, 1999). The matrix also
permits free diﬀusion of small and large molecules through its pores, though the
tortuous paths through the dense ﬁbrillar network can impede the passage of mo-
lecules of increasing size, creating steeper concentration gradients than would exist
in the absence of the matrix (Ramanujan, Pluen et al., 2002). Additionally, many sol-
uble factors contain matrix-binding domains which allow them to be sequestered
directly by the matrix, allowing for the creation of very steep, localised concentra-
tion gradients, and also allows for controlled release into solution from the matrix
under certain circumstances (Park et al., 1993; Sottile, 2004). The extracellular mat-
rix is a dynamic structure, being continually remodelled by cells synthesising and
degrading the matrix surrounding them (Rozario and DeSimone, 2010).
In the context of the vasculature, there are two diﬀerent types of ECM to con-
sider. The ﬁrst is the basement membrane, separating the endothelium from its sur-
rounding smooth muscle or pericyte layer. Individual “phalanx” endothelial cells
experience a polar environment, with their basal surface in intimate contact with
the basement and apical surface exposed to the lumen (Davis and Senger, 2005). The
basement not only provides a degree of structural stability, but also provides pro-
survival signalling cues via integrin signalling and sequestration of growth factors
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as discussed above. While phalanx cells are known to be a quiescent, non-migratory,
cell type, the basement membrane plays a role in suppressing migration both by
maintaining the diﬀerentiated state, and additionally by presenting a physical bar-
rier tomigration (Davis and Senger, 2005). Were the basementmembrane to be phys-
ically disrupted or enzymatically degraded, loss of signalling from the matrix and
removal of physical limitations upon migration may promote either cell death or
permit switching to an invasive, migratory state which may result in migration into
the surrounding tissue, i.e. angiogenesis.
The second type of ECM to consider is the composition of the matrix in the tissue
being vascularised, i.e. outside the blood vessel. This may vary depending upon the
tissue in question, but it may also serve to impede, or promote, angiogenesis depend-
ing upon whether a migratory endothelial cell can pass through it, and whether or
not it contains pro- or anti-angiogenic factors.
The ECM may therefore be considered as a scaﬀold providing a physical frame-
work to which cells may adhere, and within which they may migrate. Contact with
thematrix provides a variety of signalling cueswhichmay inﬂuence cellular function
and behaviour, including eﬀects upon cell cycle control, metabolic activity, motility
and migration, and diﬀerentiation status. These eﬀects may arise as a result of dir-
ect interaction between matrix components and cellular receptors, but may also be
inﬂuenced by modulating factors such as the sequestration of growth factors, cy-
tokines, chemokines, enzymes, and chemotactic factors which may enhance or at-
tenuate other signalling pathways, or may have entirely orthogonal eﬀects. Themat-
rix alters the diﬀusion rates, lifetime and signalling eﬀectiveness of soluble and se-
questered factors. Sequestration in particular may enhance certain signal–receptor
interactions by presenting growth factors conjugated to the matrix which can en-
hance signalling compared with the same factor in soluble form, and retard others
for example by regulating their bioavailability (Wijelath, 2002).
Many diﬀerent materials, of both biological and non-biological origin, have been
used to create three-dimensional culture systems for both in vitro and in vivo use.
When considering the most appropriate matrix to use for modelling, the primary
concern is that it permits the biological process being studied to occur, and does not
result in any adverse eﬀects. Tissue engineering research has led to the creation
of a wide variety of hydrogels for research and therapeutic purposes. These are
typically polymers which are either polymerised with the cells in place, or seeded
with cells following polymerisation. Example artiﬁcial matrices include cross-linked
polyethylene glycol (PEG) and polylactic co-glycolic acid (PLGA) which have been
shown to support vessel formation when seeded with ECs and implanted subcu-
taneously (Ford, Bertram et al., 2006), and biodegradable polyurethane (Hofmann,
Ritz et al., 2008).
Many non-biological artiﬁcial matrices suﬀer from not permitting cell attach-
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ment or remodelling due to lacking the appropriate peptide sequences. Artiﬁcial
hydrogels not composed of peptides are often not intrinsically degradable by cells,
given that MMPs can not cleave them, and they do not contain peptide motifs for
cell attachment or degradation to permit remodelling. Consequently, many artiﬁ-
cial matrices are functionalised using peptide sequences to allow cell attachment via
integrin binding using the RGD peptidemotif, and to permit matrix cleavage and re-
modelling with the addition of MMP-sensitive sequences to the hydrogel backbone
(Seliktar, Zisch et al., 2004). While such features may be added to allow an artiﬁcial
polymer tomimic naturalmatrix, there aremany other features of biologicalmatrices
which would still be absent, such as the ability to sequester growth factors. Addi-
tionally, the necessary covalent modiﬁcations to produce such specialised polymers
require signiﬁcant chemical engineering expertise.
Example biological matrices include collagen andMatrigel, both being capable of
supporting tube formation . There is strong evidence that the matrix has profound
eﬀects uponECphenotype, with cells grownonbasementmembrane collagens IV/V
formingmore tube-like structures than those grownon the interstitial collagens I/III,
which tend to proliferatemore and forma conﬂuentmonolayer (Madri andWilliams,
1983).
Of the biological matrices suitable for studying angiogenesis, ﬁbrin, collagen and
Matrigel stand out as the most viable candidates, all having been used for many
years and being capable of supporting tube formation (Montesano, Mouron et al.,
1985; Olander et al., 1985). Matrigel would appear to be preferable, given that it con-
tains mainly basement membrane proteins. However, diﬀerences do exist between
collagen and Matrigel, indicating that diﬀerent mechanisms may be involved in the
formation of capillary- and lumen-like structures depending upon the matrix, with
collagen being a more realistic model (Montañez, Casaroli-Marano et al., 2002). This
is most likely due to collagen I being a better model of the extracellularmatrix within
a tissue, which would not normally contain basement membrane proteins. Fibrin is
normally associated with blood clotting and granulation tissue, i.e. wound repair,
comparedwith collagenwhich is found in normal ECM (Schultz andWysocki, 2009).
Collagenwould therefore appear to be a bettermodel for developing and adult tissue
than ﬁbrin, and collagen has been used extensively in previous in vitromodels of an-
giogenesis (Bayless andDavis, 2004; Korﬀ andAugustin, 1998;Montesano et al., 1985;
Saunders et al., 2005; Schultz and Wysocki, 2009; Stratman et al., 2009b). In addition
to accurately modelling biological processes, the matrix must also meet the phys-
ical requirements, i.e.modelling physical forces including compression, tension and
hydrodynamic pressure, in addition to possessing suﬃcient physical robustness.
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4.1.4 Microﬂuidics
In order to create an artiﬁcial perfused vascular system, it is necessary to create some
form of tubular structure within the biological scaﬀold being used, which should
be amenable to perfusion with liquid analogous to the perfusion of tissue microva-
sulature with blood. While a wide variety of techniques and processes have been
used, the core concept is that ofmoulding or fashioning a vessel-like structurewithin
the scaﬀold material. The process of forming microscale channels for ﬂuid ﬂow has
spawned the relatively new ﬁeld of microﬂuidics (Duﬀy, McDonald et al., 1998; Mc-
Donald and Whitesides, 2002). While initially pioneered by chemical engineers us-
ing solid and semi-solid materials such as elastomers (Kim, Xia et al., 1996, 1995),
microﬂuidic networks are now created in cell-seeded biological scaﬀolds such as
agarose, alginate and collagen, permitting the modelling of a variety of biological
processes with precisely-controlled ﬂuidic ﬂow (Cabodi, Choi et al., 2005; Golden
and Tien, 2007; Ling, Rubin et al., 2007). The available techniques may be separated
into two main categories: those involving embedding and removal of a sacriﬁcial
element, leaving open channels behind in the scaﬀold, and direct moulding of the
scaﬀold using a mould.
Pattern generation using photolithography
Whilemanymethods exist to create patterns formould formation, photolithography
is the most commonly-used technique, and may be used as a basis for both embed-
ded sacriﬁcial elements and direct moulding. George Whitesides’ group in Cam-
bridge, Massachusetts developed the technique of “soft” lithography used for mi-
cromoulding using conventional photolithographic techniques to create PDMS elast-
omermoulds (Kim et al., 1995). The process is detailed below, and has been reviewed
by McDonald, Duﬀy et al. (2000).
SU-8 is a negative i-line (365 nm) epoxy photoresist widely used in microﬂuidics
because it may be used to create structures up to 2mm in depth with a high aspect
ratio, and for microﬂuidics up to 50 µm depth is common (Golden and Tien, 2007;
Jackman, Duﬀy et al., 1998). It is additionally both biocompatible and stable to attack
bymost solvents. When a silicon wafer spin-coated with SU-8 photoresist is exposed
to 365 nmUV light, areas of the resist not covered by the photomask are cross-linked.
The cross-linked areas remain solid and attached to the wafer when washed with
solvent, whereas unexposed non-cross-linked areas are removed, exposing the bare
wafer. The negative of the pattern on the photomaskwill be therefore be reproduced
in the photoresist as a structure in relief (McDonald et al., 2000).
“Soft” lithography is so named due to the use of PDMS to create a mould in in-
verse relief to the SU-8 “master”. PDMS is one of a class of elastomers known as RTV
elastomers, which consist of two parts, a base and catalyst (cross-linker). Both RTV
components are liquids, typically mixed in a 10:1 ratio, which form an elastomeric
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solid following curing. Cured PDMS is an optically clear and colourless solid, which
makes it useful for use as a microﬂuidic material and for imaging (McDonald et al.,
2000). When moulded against pattered SU-8, PDMS is capable of reproducing fea-
tures at the micron scale (Christensen, Chang-Yen et al., 2005; Kurpinski, Chu et al.,
2006). Following curing, the PDMSmay be peeled away from themaster, whichmay
be reused several times.
Following the creation of a PDMSmould, it may be used directly as amicroﬂuidic
device, given that it may be directly bonded to glass (Bhattacharya, Datta et al., 2005;
Cha, Kim et al., 2006). Or it may in turn be used to pattern other materials, which
will result in thatmaterial having the same features as those originally present on the
SU-8 master (Xia, McClelland et al., 1997). PDMS is relatively inert, chemically, and
biocompatible, making it safe to use directly in model biological systems (Khetani
and Bhatia, 2006).
Patterning with removable elements
Patterning with removable elements involves the creation of a gel containing ele-
ments which may be later removed. These may be simple linear arrangements, such
as needles, wire or ﬁbres which may be withdrawn from the gel following gelation.
Examples include collagen gels created containing nylon ﬁbres (Takei, Sakai et al.,
2006), or with a needle (Chrobak, Potter et al., 2006), which may be removed to create
a linear vessel lumen suitable for EC seeding and perfusion. However, more complex
structures may be created, for example by twisting a wire or ﬁbre to create nonlinear
paths such as bends and loops (Takei, Sakai et al., 2007). Branching and joining of
paths may also be created using multiple ﬁbres, for example as shown by Neumann,
Nicholson et al. (2003), however it should be noted that this is creatingmultiple linear
channels, rather than channels with branching. This paper is notable due to using
the nylon ﬁbres to create sleeves of VSMC suspended in media, rather than using a
matrix directly (though it would be possible to subsequently embed within a matrix
and ﬂow in ECs to form a functional vessel).
Unfortunately, these strategies all create channels which are generally of a larger
scale than may be achieved through SU-8 photolithography and PDMS moulding,
and the networks are of limited size and complexity. A PDMSmouldmay be of arbit-
rary size, limited only by the size of the silicon wafer, and the channels may contain
as many branchpoints as desired, as well as variations in channel width which are
diﬃcult, if not impossible, to achieve with removable elements with any degree of
accuracy or reproducibility. However, such systems are useful, and simple variation
in parameters such as channelwidth in one direction along a linear path are possible,
enabling the study of the eﬀects of physical factors such as variation in pressure and
shear stress on EC in collagen gels (Price et al., 2010).
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Patterning with sacriﬁcial elements
The use of PDMS to pattern sacriﬁcial elements was pioneered by Joe Tien’s group in
Boston, Massachusetts (Nelson and Tien, 2006; Tang, Golden et al., 2004) extending
previouswork using simple polymers byGeorgeWhitesides’ group (Jeon, Choi et al.,
1999; Kim et al., 1995). Microscale cavities may be created using patterned Matrigel
surrounded by collagen, using dispase to digest theMatrigel leaving open cavities or
channels (Tang et al., 2004). Alternatively, the PDMS mould may be used to pattern
a meshwork of gelatin, the gelatin being ﬂowed through the PDMS in a liquid state.
Once the gelatin has been set, it may subsequently be removed from the PDMS and
then embedded within a collagen gel. Channels are created in the gel by by raising
the temperature to liquefy the gelatin, which can then ﬂow out of the gel to leave
open channels in the gel interior. The process is outlined in the last ﬁve steps of
Figure 2.7, based upon the work in Tang, Golden et al. (2003) and Golden and Tien
(2007).
Non-linear vessels have also been created using sacriﬁcial alginate ﬁbres seeded
with ECs placed inside collagen gels containing alginase (Takei et al., 2007), but mod-
elling larger scale vessels, rather than capillary networks or single-cell sprouting an-
giogenesis.
Patterning using direct moulding
Direct moulding is rather simpler than indirect methods using sacriﬁcial elements;
the gel to be patterned is simply poured onto the PDMS master and set into a solid
which may then be subsequently removed and perfused. Examples include mould-
ing and perfusion of agarose (Ling et al., 2007), alginate (Cabodi et al., 2005; Choi,
Cabodi et al., 2007) and collagen (Cross, Zheng et al., 2010). However, the gel must
be of suﬃcient strength tomaintain its structure and integrity during handlingwhile
demoulding and subsequently perfusing.
4.1.5 Development of a microﬂuidic vascular model
Microﬂuidics have been used previously in various models and, as discussed in Sec-
tion 4.1.4, vary from being crude and simple (but less technically demanding) to
having micron-scale precision (but requiring a great deal of technical expertise and
expensive photolithography equipment not usually found outside microelectronics
fabrication). It would be greatly desirable to achieve the scale and precision of pho-
tolithography utilising equipment found in a biological research setting, given that
access to photolithography equipment is diﬃcult as well as prohibitively expensive.
Being able to rapidly prototype diﬀerent designs would also give ﬂexibility which
photolithography does not oﬀer, and permit rapid, iterative prototyping and reﬁne-
ment of the model. This would require the creation of a template which could be
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used as an analogue of the pattern etched into SU-8 photoresist tomould PDMS. Fol-
lowing the creation of a PDMS mould, subsequent experimental steps could utilise
the same procedures used by existing work with PDMS microﬂuidics, as described
above.
4.1.6 Aims
1. To develop a 3-D endothelial culture model capable of forming a vascular net-
work, andwhichwill remodel and/or outgrowunder the appropriate angiogenic
stimuli.
2. To incorporate microﬂuidic ﬂow into the model to reproduce ﬂow and shear
forces experienced by ECs in vivo.
3. To incorporate VSMCs into the model as an EC-stabilising and -modulating
perivascular component.
4. To derive GFP-expressing endothelial and VSMC cell lines to allow real-time
imaging in 3-D.
5. To develop methods for accurate quantiﬁcation of network remodelling and
angiogenesis.
6. To demonstrate that the model is responsive to growth factors and that the
responses may be accurately quantiﬁed.
4.2 Results
4.2.1 PDMS microﬂuidic networks
PEN template creation
PEN slides were prepared as described in Section 2.9.1, and cut as described in Sec-
tion 2.9.2. Fine tuning of the stage movement speed, laser focus and laser power
resulted in successful cutting of 25 and 50µm thick PEN ﬁlm. In practice, only a nar-
row range of laser power settings were suitable, with there being a hard lower cutoﬀ
below which no cutting will occur, and an upper limit above which the sample is
damaged. Using all three adjustments, the system was set up to cut the ﬁnest line
possible.
An example PENnetwork cutwith the PALMsystem is shown in Figure 4.1(A–C),
showing the process from the initial scale drawing, conversion to points, and ﬁnally
the cut PEN template. The PALM R software showing the PEN surface during
cutting is shown in (D). Note the current cutting point indicated by the red triangle.
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Figure 4.1: PEN-PDMS moulding. Networks for perfusion were designed as editable
vector graphics (A) prior to conversion to a series of points for laser cutting (B); solid
lines are laser cuts, while the dashed line is the bounding box of the coordinate system.
The PEN template after cutting with this pattern is shown in (C). All three images are
use the same (µm) scale shown in (B). The PEN with overlaid template during cutting
is shown in (D). SEM analysis of 25 µm PEN is shown (D,E) showing striations in sur-
face and ridges along cut edges, but with consistent 50 µm width. Using PEN cut with
the pattern in (G), which uses the same scale and coordinate system as (B), elastomer
moulds were made placing the PEN template on glass and overlaying with RTV (H)
or on PDMS and overlaying with PDMS (I). When placed on glass, liquid elastomer
can run under the PEN, sealing it within the cured elastomer, resulting in tearing of
the mould during removal shown as large tabs (arrows) or multiple small tears (arrow-
heads indicate tears on one line) on the bottom four channels. When placed on PDMS
and blocked with Pluronic F-127, underrun is eliminated and the cured elastomer can
be cleanly separated, showing only minor imperfections such as very tiny tabs (arrows)
and minute debris (arrowheads).
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Figure 4.2: PDMS mould perfusion. An example of PEN in PDMS during moulding
is shown in (A), with the template used shown inset. The tab of the acetate shim used
to separate the PDMS layers is indicated with an arrow. The channels are shown in in-
verse relief (B) following removal of the PDMS backing and PEN template. Arrowheads
indicate the perfusion endpoints. A branched network pattern (C) was converted to a
series of lines (D); as before, the scale is in µm and the bounding box of the coordinate
system is shown by a dashed line, with the lines to cut shown as solid lines. Following
PEN cutting andPDMS-PDMSmoulding as shown in Figure 4.1(F), holes cored through
the PDMS (arrows) connect the perfusion apparatus to the perfusion endpoints in the
network (arrowheads), allowing entry and exit of liquid via the perfusion manifold on
the back side of the PDMS. The PDMS mould was compressed against coverslip glass
and perfused (E) with lissamine-rhodamine doped gelatin; scale bar is 1mm.
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SEM analysis of cut material (E,F) showed vertical striations along the cut edges,
presumably a result of the UV laser pulses; their frequency appears to correlate with
the laser pulse frequency. While these introduced a small element of roughness into
the sample, these are tiny (µm) in comparison to the material cross-section (50 
50µm2), and should be insigniﬁcant.
PDMS moulding
RTV and PDMS were mixed and cured as described in Section 2.9.4 using the per-
fusion jig parts shown in Section 2.9.3. An example network moulded using both
glass and PDMS backing is shown in Figure 4.1(H–J). The template pattern is shown
in (H), with (I) showing the result of moulding using PEN on glass backing with
RTV polymer, and (J) showing PEN on PDMS backing with PDMS polymer. Using
glass backing resulted in polymer running underneath the PEN template, resulting
in damage to the moulded elastomer during PEN template removal following cur-
ing. This is seen by the presence of several tabs, as well as a multitude of small
tears along the length of several of the microchannels. Conversely, PEN on PDMS
backing completely eliminates the polymer underrun issue, showing only minute
imperfections in the microchannels, due to either alignment issues during cutting,
or physical handling of the PEN network with insect pins and ﬁne forceps. An ex-
ample of a PDMS network during and after moulding is shown in Figure 4.2(A) and
(B).
PDMS network perfusion
Plasma sterilisation of PDMS permitted direct bonding to glass substrate under the
following conditions: 0.75–1.0 keV, 16-60mA, and 700–1000mTorr as also described
in Bhattacharya et al. (2005). However, this resulted in onlyweak bonding andwould
require further optimisation in order to achieve a strong seal capable ofwithstanding
ﬂuid pressure in the absence of additional compressive sealing. Note that due to
PDMS being hydrophobic, plasma treatment or use of a block copolymer such as
Pluronic F-127 is required in order to obtain ﬁlling of microﬂuidic channels with
aqueous solutions and prevent adsorption of material (Golden and Tien, 2007; Tien
and Chen, 2002).
To permit perfusion, the channel endpoints were connected to the manifold by
punching holes all the way through the PDMS block, using a blunt 23 gauge needle
to core out a hole, a common practice for microﬂuidic interconnects (Christensen
et al., 2005). The PDMS block containing the microﬂuidic network and held with its
shim was placed on top of a coverslip glass located within the slide guides of Figure
2.7(A) or (B). The top plate (C) was used to secure the perfusion manifold (D) on top
of this, and screws passing through the unthreaded top plate to threaded base plate
were used to apply uniform compression to seal the PDMS to the coverslip glass.
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Excessive compression resulted in the coverslip glass cracking; too little in leakage
due to having a weak seal. Blunt 23 gauge needles passing through the perfusion
manifold and into the previously punched holes in the PDMS block were used as a
source and sink for perfusion.
Lissamine-rhodamine (Gurr, BDH) was used to dope gelatin to allow visualisa-
tion using brightﬁeld or epiﬂuorescence microscopy. Perfusion was carried out at
37 °C to ensure that the gelatin was in a molten state. Untreated PDMS is hydro-
phobic, so the channels were ﬁrst blocked with Pluronic F-127 1% (w/v) for 20min,
injected into the network using a 10mL syringe connected to one of the needles, fol-
lowed by injectingwater towash, and thenmolten doped gelatin. Perfusionwas per-
formed at a rate of 50µL/s, using negative pressure to retain the PDMS–coverslip
seal. It was found that positive pressure alone would tend to push the perfused
ﬂuid out of the microchannels and between the PDMS and coverslip glass, breaking
the seal. The perfused network was subsequently imaged using a stereo microscope
with a colour CCD camera. The process is illustrated in Figure 4.2(C–E), showing
initial network design in vector and line form, followed by an image of the network
perfused with doped gelatin, showing complete ﬁlling of the channels without air
bubbles. In particular, note the uniform channel width at all points in the network,
conﬁrming the accuracy of the initial PEN template cutting.
4.2.2 HUVECs form complex networks when cultured in 3-D
HUVECs were seeded in 3-D collagen gels with or without the addition of factors
known to induce endothelial tube formation. Monomeric rat tail collagen was neut-
ralised with 0.8M NaHCO3, seeded with HUVECs at a density of 5 106 cells/mL,
then gelled at 37 °C for 60min in a glass-bottomed dish (Iwaki), having approx-
imate dimensions of 1mm thickness, 14mm diameter. Control gels were covered
with 4mL ECGM and treatment gels were covered with 4mL tube forming medium
(ECGM supplemented with 40 ng/mL hVEGF165, 40 ng/mL bFGF, 50 ng/mL PMA
and 50µg/mL sodium ascorbate).
Following incubation at 37 °C with 5% CO2 for 48 hours, an interconnected net-
work of tubes was visible in the treatment gels using brightﬁeld microscopy, while
control gels showed no such structures (Figure 4.3, top). Treated gels were also seen
to have contracted compared with control gels. In order to more accurately visualise
and quantify the formation of tubes, the gels were ﬁxed in 4% PFA for 10min then
stainedwithmouse anti-humanCD31 clone 10G9with a goat anti-mouse-AF594 sec-
ondary, phalloidin-Atto647 and YO-PRO-1 (Figure 4.3, middle). Phalloidin labelled
F-actin, while YO-PRO-1 labelled DNA.
Analysis of HUVECs grown on glass in two dimensions (2-D) showed that, com-
pared with the control gel, tube forming conditions induced alignment of the cyto-
skeleton between cells, and upregulation of CD31 expression. However, induction
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Figure 4.3: HUVEC tube formation with growth factors. HUVECs on glass in 2-D or in
a collagen in 3-D were treated using using normal medium (control) or tube-forming
medium (treatment). Brightﬁeld imaging showed the presence of a capillary plexus-
like structure, and greater matrix contraction and disruption in the treated gel. Cell
nuclei are blue, CD31 is red and phalloidin (actin) is green. Growth of control cells
in 2-D appears disorganised, and also in 3-D, as a disorganised 2-D monolayer on the
surface of glass or collagen, the gel interior being devoid of cells. Treated cells have
a common orientation and morphology in 2-D, with apparent upregulation of CD31,
and in 3-D formed branched, interconnected cord-like structures running through the
interior of the gel, similar to a capillary plexus in vivo. xyz projections of representative
parts of the gels are shown below. Yellow arrowheads show the gel and glass surfaces,
again showing an empty 2D gel interior (left side), and complex structures in the 3D
gel interior are shown, with an open tube indicated with white arrows. 2D scale bar is
50 µm, 3D scale is 22.5 µm, xyz scale is 30 µm (2D) and 40µm (3D).
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of tube formation was not observed, cells having formed a conﬂuent, aligned mono-
layer. HUVECs placed in collagen gels in the absence of the inducing conditions
failed to form tubes; the gels were completely devoid of cells internally, though a
2-D monolayer was observed on all sides of the gel. Bright spots in the gel may be
apoptotic blebs or fragments of dead cells. In contrast, the culture of HUVECs in 3-D
collagen gels in the presence of inducing conditions lead to the formation of a dense
3-D network of branched, interconnected cord-like structures in the gel interior, and
these gels also possessed a 2D monolayer on the gel surface. However, when ob-
serving the gel via xy and xz projections (Figure 4.3, bottom), it was not entirely
clear if the tubular structures were infoldings of the collagen gel surface, or tubes in
the interior. Some structures are clearly tubes, surrounded by collagen on all sides,
whereas others are connected to the external surface. Tubes in 3-D had external dia-
meters of 13–17 µm, while in 2-D cross-sections of larger ﬂattened structures (arrows
in ﬁgure) had diameters of 12–40 µm.
4.2.3 Scaling up HUVEC-seeded collagen gels
Workwith HUVEC-seeded collagen gels had so far used glass-bottomed dishes with
thin gels ( 1mm thick) of large diameter (14mm). In order to scale up the quantity
of gels, which could then be used for several diﬀerent treatments, with replicates,
gels of 3mm diameter, 3mm thickness were created using the collagen culture plate
shown in Figure 2.1(D).
HUVECs were seeded in collagen gels of varying concentration (0.75, 1.50, 2.25,
3.00, 3.75, 4.50, 5.25, and 6.00mg/mL)with 5 106HUVECs/mL for each concentra-
tion. These concentrations range span the practical concentration limits for collagen
gels, from low density with little robustness to high density and almost solid. 30 µL
aliquots (in triplicate for each concentration) were gelled in the support at 15 °C for
60min. After the collagen was gelled, the gels were overlaid with 15mL ECGM con-
taining the same tube forming factors used in Section 4.2.2. The media was replaced
every two days and the gels ﬁxed with 4% PFA following 14days of culture, ob-
serving tube formation daily by phase contrast microscopy. Some gels began visibly
contracting after 2 days, with all contracted after 6 days. Lower density gels resulted
in smaller gels following contraction.
Gels were stained overnight with CD31-AF488 at 1:200, 1:500 and 1:1000 dilu-
tions, with control gels stained using block only, then imaged using a confocal mi-
croscope, shown in Figure 4.4(A,B). Only the 1:200 dilution is shown here; higher di-
lutions stained the same features, with 1:500 providing adequate staining, but 1:1000
losing some detail and requiring increased laser power to visualise adequately us-
ing confocal microscopy. As seen previously, a highly organised network composed
of HUVECs formed following treatment with tube-forming factors. Imaging using
second harmonics to visualise the collagen matrix showed that the network was in-
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Figure 4.4: Thicker HUVEC gels. HUVECs seeded into 3mm deep, 3mm diameter col-
lagen gels under tube-forming conditions form a highly organised network, seen with
CD31 staining shown in green (A,B) and white (D,G–I); (C) is the staining control. The
collagen extracellular matrix is clearly visible after condensation (A,B) with second har-
monic generation showing collagen ﬁbrils in white (A) and absent (B) with the HUVEC
network ramifying through. After imaging an entire gel as a z-stack, a complex 3-D net-
work is seen branching through the entire gel (D), shown converted to a single volume
(E) ormultiple volumes (F) for analysis using lowandhigh intensity thresholds, respect-
ively. When the gel interiors are examined by cropping half the z-stack (G), it is seen
that the tubes surround an apparently necrotic central core, marked sections shown in
cross-section in (H) showing necrosis in the centre and (I) showing no necrosis near the
edge. Scales are 22.6 µm (A,B), 46.3 µm (C) and 90.3 µm (C–H).
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Figure 4.5: HUVEC tube formation by TEM. HUVECs seeded in a collagenmatrix were
grown in the absence (A, B) and presence (C-E) of tube-forming conditions. Collagen
ﬁbrils formed the majority of control gels without growth factors (A), with a very low
frequency of single cells (B). Gels containing growth factors resulted in the formation of
tube-like structures containing open lumens, surrounded by collagen extracellular mat-
rix; a representative example is shown in (C), withmagniﬁed views of cell–cell junctions
shown in (D) and (E). (C) is a putative vessel composed of three separate endothelial
cells, the adherens junctions of which are marked with arrowheads. The lumenal ends
of one of these junctions is marked by a small cytoplasmic protrusion (M), which may
be a marginal fold. (D) is a magniﬁcation of the top adherens junction in (C), in close
proximity to rough endoplasmic reticulum (R). (E) is a high magniﬁcation of the left
adherens junction in (C); the adherens junction (A) is seen as two electron-dense bands
markedwith arrows. The diﬀerence in composition of lumenal contents and extracellu-
lar matrix are shown in (E). Major marked features include ECM (E), vessel lumen (L),
and nucleus (N).
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timately associated with the matrix, it being surrounded by a very dense collagen
meshwork at all points, the matrix having been condensed to this point during cul-
ture from the initial low density, loose composition. However, the tubes in the net-
work stained uniformly across their cross-section; lumenswere not visible using con-
focal microscopy.
Due to the dense collagen preventing imaging at depth using MP microscopy,
the gels were subsequently dehydrated and cleared, then re-imaged using the same
microscope with a 10× air objective and single-photon confocal microscopy. Figure
4.4(D) shows a representative sample, containing a large network under the surface
of the gel extending into the gel interior. Analysis was complicated by the presence
of a conﬂuent 2D monolayer on the gel surface; these cell-cell junctions show bright
CD31 staining, seen as thin lines in the image. Measurement of the external tube
diameterswithin the network showed the tubes to be 25 µmat their narrowest points,
extending up to 50 µm at junctions. V was used to segment the network to
diﬀerent extents using diﬀerent intensity thresholds, shown in Figures 4.4(E) and (F).
Setting a higher threshold prevented selection of the 2D layer and other features not
of interest, but this was too crude a method for truly quantitative analysis. V
is capable of skeletonising a volume to a one voxel thick line, whichwould be usable as
a basis for quantifying branch point and distance between branches, but the program
does not make this information available to the user. V was therefore not
capable of performing the sophisticated analysis required. Further study of HUVEC
network formation showed frequent occurrence of what appeared to be a central
core devoid of endothelial tubes, but containing small punctate CD31 stained bodies,
shown in Figure 4.4(G–I), which are possibly apoptotic blebs or cellular fragments
resulting from necrosis.
4.2.4 HUVEC networks contain open lumens
The experiment described in Section 4.2.2 was repeated, creating 3mm diameter,
3mm thick gels using the collagen culture plate shown in Figure 2.1(D). Collagen
was neutralised with 0.8M NaHCO3 and seeded with HUVECs at a density of 5
106 cells/mL, transferred in 20 µL aliquots into the wells, then gelled at 15 °C for
120min. After the collagenwas gelled, control gels were overlaidwith 100 µL ECGM
and treatment gels were covered with 100 µL tube forming medium (ECGM sup-
plemented with 40 ng/mL hVEGF165, 40 ng/mL bFGF, 50 ng/mL PMA, 50µg/mL
sodium ascorbate), and 1% (v/v) penicillin/streptomycin.
Following culture for 48 hours, gels were visibly condensed, particularly under
tube forming conditions. Samples were ﬁxed and processed for TEM as described
in Section 2.6.8. TEM of HUVEC networks was performed using thin sections of
gels with and without the addition of growth factors (Figure 4.5). In all gels, the ﬁb-
rils comprising the collagen extracellular matrix were clearly visible, shown in high
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contrast in (A). No tube formation was seen in control gels (B), where cells are only
seen as single rounded cells containing numerousmicron-scale bodies, with no evid-
ence of multicellular structure or lumen formation. The growth factor-treated gels
showed the development of vessel-like structures, composed of several endothelial
cells surrounding a central lumen (C). Control cells had a diameter of 8–10 µm, while
treated cells were mainly 2.5-3.5 µm wide, 5 µm maximum and were approximately
15, 20, and 25µm long each with a rounded rounded to ﬂattened appearance. The
lumen diameter was 13–16 µm, with the external vessel diameter being 20–25 µm.
Collagen matrix surrounded the structures, and is distinctly diﬀerent in composi-
tion that of the central lumen (F), which appears to be a void space free of matrix
material, containing membranous debris. Examination of cell–cell junctions showed
evidence of adherens junction formation (D,E). Additionally, cytoplasm at the ends
of two of the junctions extends into the lumen; these processesmay bemarginal folds
(Young and Heath, 2000). In (D), numerous vesicles are outlined between the lumen
and nucleus.
4.2.5 Mouse aortic smooth muscle expresses NG2
Utilising the temperature-sensitive VSMC line, it was initially determined that the
primary culture derived frommouse aorta expressed vascular smooth muscle mark-
ers.
VSMCwere blockedwith 1%goat serum inPBSprior to stainingwith 1:400 rabbit
anti-mouse NG2, 1:400 rabbit anti-mouse LYVE-1 (isotype) or no antibody, and then
washed and stained with 1:500 goat anti-rabbit AF488. The cells were then run on
a CyAn ADP ﬂow cytometer (Dako Cytomation), with the results shown in Figure
4.6. Compared with the isotype control, over 90% of the cells are NG2+. However,
a smaller population (under 10%) is NG2 .
The NG2+ cells were sorted on a MoFlo cell sorter (Dako Cytomation) set to
purify in single-cell mode in order to remove all of the NG2  cells; doublet discrim-
ination was used as a matter of routine (data not shown). However, the NG2  cells
were not removed from the culture. It appears that these cells are not a contamin-
ating population—they diﬀerentiate from the NG2+ population and are morpho-
logically distinct in culture; the sorted population gained an increasing number of
these morphologically distinct cells over time, demonstrating that their origin must
be from the NG2+ population; they are not a separate, contaminating population.
4.2.6 Co-culture of HUVEC and mouse aortic smooth muscle
Monomeric rat tail collagen was neutralised with 0.8M NaHCO3 and seeded with
cells as follows: (A) collagen gel containing no cells overlaid with media contain-
ing 3 106HUVECs/mL, (B) collagen gel containing 3 106VSMCs/mL overlaid
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Figure 4.6: VSMC expression of NG2. Primary vascular smooth muscle derived from
mouse aorta was stained with anti-NG2 antibody and compared with an isotype con-
trol. Cells were selected by gating on the population of cells in forward- and side-scatter
(A) and doublets removed using the singlet population in forward-scatter and pulse-
width (B). The gated populations for each treatment are shown in (C). The positive pop-
ulationswere selected using a 99%one-tailed conﬁdence interval on the isotype control,
shown as a dashed line.
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Figure 4.7: HUVEC-VSMC coculture, following ﬁve days of culture. CD31 (red) marks
HUVECs, while NG2 (green) marks VSMCs. Collagen gels were created containing: no
cells, overlaid with HUVECs (overlay), HUVECs only (gel) and VSMCs, overlaid with
HUVECs (gel VSMC coculture). Empty gels overlaid with HUVECs contained only few
cells, which did not form organised structures; cells are mostly conﬁned to the surface
(A–C). Gels containing HUVECs were again sparsely-populated; the examples shown
here show instances of cells inside the gel, which have not formed organised structures
(D–E). (A) and (D) are shown in cross-section in (C) and (F), respectively. Gels contain-
ing VSMCs overlaid with HUVECs were mostly contained little structure (G). How-
ever, discrete areas showed evidence of cord- or tube-formation and self-organisation
at low frequency (H–J); H and I are shown in cross-section in (K) and (L), respectively.
HUVECs have formed the tube-like structure seen crossing from the bottom-left to the
top-right, while VSMCs are seen in close association with it (I). VSMCs are also seen
in intimate contact with the presumptive tubes in (H) and (J), shown clearly wrapping
around the tube in (K,L). (M) is the staining control. Scales are 22.5 µm (A,B,D,G–J)
20 µm (C), 29.0 µm (E), 30.0 µm (F), 50 µm (K), 29.0 µm (L) and 46.0 µm (M).
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with media containing 3  106HUVECs/mL and (C) collagen gel containing 3 
106HUVECs/mL and overlaid with media containing no cells. The seeding densit-
ies arewith respect to the volume of the collagen gel (100 µL). Collagenwas diluted in
1:1 ECGM:VSMC medium (HUVEC-seeded gels) or VSMC medium (VSMC-seeded
gels). After setting in glass-bottomed dishes at 37 °C for 30min, the gels were over-
laid with a 1:1 mixture of HUVEC:VSMC media, containing cells as described.
Following incubation at 37 °C with 5% CO2 for 5 days, the gels were ﬁxed in 4%
PFA for 10min and stained with mouse anti-human CD31 with a goat anti-mouse-
AF594 secondary, rabbit anti-mouse NG2 with a goat anti-rabbit-AF488 secondary,
and phalloidin-Atto647 (not shown). Spontaneous formation of tube-like structures
in HUVECs was only observed in treatment B, shown in Figure 4.7 (G–L), the only
treatment in which both HUVECs and VSMCs could interact with each other. While
formation of tube-like structures was seen, this occurred only at low frequency, and
formation of larger-scale networks as seen with growth factor treatments was not
observed.
HUVECs overlaid on an empty collagen gel grew in 2D on the surface of the gel.
This is shown by the characteristic cuboid morphology seen in Figure 4.7(B) with
CD31 staining localised to the cell borders. There were no cells located within the
gel. Green staining is autoﬂuorescence; there are no NG2+ cells in (A–F). When
embedded into the gel, HUVECs were not found within the gel in great numbers;
Figure 4.7(D) shows some aggregation of cells, but possessing little structure. Note
that looking at xz or yz projections shows these to be invaginations of the collagen
surface; these cells are not actually inside the gel. The same is true of the cells in
(E). The green autoﬂuorescence in all samples appeared to be cell nuclei on cells
adherent to the collagen surface, between the collagen and the coverslip; in the co-
culture sample, the larger and brighter green objects are smooth muscle. In cocul-
ture samples (H–J), tube-like structures composed of endothelial cells were seen to
run through the gel interior, with 2-D projections (K,L) demonstrating their intim-
ate association with VSMCs, which directly contact and encircle the tubular struc-
tures with high frequency, while not providing complete coverage. However, only
a minority of HUVECs formed tube-like structures, with the majority (G) remaining
disorganised.
4.2.7 Diﬀerentiation of smooth muscle from C3H/10T½
Similarly to VSMC, it was determined that C3H/10T½ cells express the pericyte
marker NG2. Unlike VSMC, which were fully diﬀerentiated into smooth muscle,
C3H/10T½ are multipotent. TGF-β1 was therefore used to induce diﬀerentiation
into smooth muscle. C3H/10T½ were seeded on 6 well plates (Nunc) and glass-
bottomed dishes (Iwaki) and covered in medium containing 0, 1.5, 3.0 or 6.0 ng/mL
TGF-β1 from a 50µg/mL stock. Following three days of culture, the cells on glass-
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bottomed dishes were 4% PFA ﬁxed for 20min, and the cells on plates recovered and
stained for ﬂow analysis.
C3H/10T½were blockedwith 0.3%BSA in PBS prior to stainingwith 1:300 rabbit
anti-mouse NG2, 1:300 rabbit anti-mouse LYVE-1 (isotype) or no antibody, and then
washed and stained with 1:500 goat anti-rabbit AF488 and 1:5000 DAPI (5mg/mL
stock). The cells were then run on a CyAn ADP ﬂow cytometer (Dako Cytomation),
with the results shown in Figure 4.8. Compared with the isotype control, the entire
population of C3H/10T½ is NG2+ irrespective of the TGF-β1 concentration used.
The median NG2 expression is slightly higher for the untreated sample than for the
three treated samples.
Cells on glass-bottomed dishes were blocked with 3% goat serum and stained
with 1:300 α-SMA-Cy3 or 1:300NG2with 1:500 goat anti-rabbit AF594 followedwith
1:1000 YO-PRO-1 (one hour per step, excluding washes). The results are shown in
Figure 4.9. C3H/10T½ cells express the pericyte marker NG2 whether or not stimu-
lated to diﬀerentiate with TGF-β1. Likewise, α-SMA is expressed whether or not the
cells are treatedwith TGF-β1. However, while the intensity ofNG2 andα-SMA stain-
ing did not change appreciably between control and treated samples, the cell mor-
phology and actin cytoskeleton organisation changed dramatically upon treatment
(Figure 4.9). Untreated cells possessed a ﬁbroblastic morphology and random ori-
entation, while treated cells adopt an elongated morphology with both the cells and
actin cytoskeleton aligned in a uniform orientation, consistent with smooth muscle
organisation.
4.2.8 Co-culture of HUVEC and C3H/10T½
Cells were co-cultured as follows:
(A) 5 106HUVECs/mL with 1 106C3H/10T½/mL (5:1),
(B) 5 106HUVECs/mL with 5 105C3H/10T½/mL (10:1),
(C) 5 106HUVECs/mL with 2.5 105C3H/10T½/mL (20:1),
(D) 5 106HUVECs/mL only, and
(E) 5 105C3H/10T½/mL only.
Each treatmentwas repeated in triplicate. C3H/10T½werediﬀerentiated to a smooth
muscle fate using 3 ng/mL human recombinant TGF-β1 for 24 hours prior to use.
Gels of 3mm diameter, 3mm thickness were created using the collagen culture plate
shown in Figure 2.1(A). Collagen was neutralised with 0.8M NaHCO3 and seeded
with cells at the above concentrations, transferred in 30 µL aliquots into the wells,
then gelled at 15 °C for 60min. After the collagen was gelled, the gels were overlaid
with 15mL ECGM.
Following 20 days of culture, monitoring progress of tube formation and changes
in cell organisation via phase contrast microscopy, the gels were ﬁxed in 4% PFA
for 75min, then washed twice in PBS and stored at 4 °C. The gels were transferred
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Figure 4.8: C3H/10T½ expression of NG2. C3H/10T½ cells were treated with in-
creasing concentrations of TGF-β1. Cells were selected by gating on the population of
cells in forward- and side-scatter (A), doublets removed using the singlet population in
forward-scatter and pulse-width (B), and live cells selected using the nuclear stainDAPI
(C). The NG2 expression of the gated populations for each treatment are shown in (D).
The positive populations were selected using a 99% one-tailed conﬁdence interval on
the isotype control, shown as a dashed line. All C3H/10T½ treatments express similar
levels of NG2, irrespective of the concentration of TGF-β1 used.
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Figure 4.9: Diﬀerentiation of smooth muscle from C3H/10T½ cells. For each treat-
ment and diﬀerentiation marker, the staining controls and stained samples are shown
in the top and bottom images, respectively. The staining intensity of the smooth muscle
markers NG2 (A,B) and α-SMA (C,D) did not change signiﬁcantly between control and
TGF-β1-treated cells. However the morphology of the cells changes dramatically when
treated with TGF-β1. Treated cells change from being randomly organised (A,C) to hav-
ing an elongated morphology and uniform orientation with a highly organised cyto-
skeleton (B,D). Scale bars are 100 µm.
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to a 96 well plate (Nunc) prior to staining using the protocol detailed in Section
2.6.3. HUVEC-only gels were stained with 1:500 CD31-AF488 (mouse), while all
the other gels were stained with 1:500 CD31-AF488 (mouse), 1:500 NG2 (rabbit),
then stained with 1:500 goat anti-rabbit-AF647 and 1:1000 α-SMA-Cy3. One set of
gels was stained with secondary antibodies only (1:500 goat anti-rabbit-AF647). The
stained gels were dehydrated and cleared prior to imaging, as described in Section
2.6.2.
The results are shown in Figure 4.10. Only the gels from treatments C and E,
plus staining controls, survived intact for imaging; the other gels were lost during
staining or during dehydration and clearing. The dimensions of the images may be
slightly smaller than expected due to a degree of gel shrinkage during dehydration.
The control image (A) showed residual autoﬂuorescence and non-speciﬁc staining
in the co-culture gel when stained with secondary antibodies only. In the stained
co-culture gel (B), branched tube-like structures were seen in the gel interior, which
appeared to be similar to those seen in Figure 4.3, but as in this ﬁgure, it is not clear
if these were vessels or mere aggregations of cells. These structures appeared to
have smooth-muscle-like coverage with C3H/10T½, whichwere seen to encircle and
follow the tube-like structures ramifying through the gel. C3H/10T½ only gels (C)
showed the formation of a rather diﬀerent, stromal-like, networkwhichwas not seen
in the co-culture gels. It also showed that the TGF-β1-diﬀerentiation may result in a
heterogeneous population of smoothmuscle cells, as seen by the variation in α-SMA
andNG2 expression. While all of the cells were NG2+, a small proportion were seen
to have relatively higher levels of α-SMA.
4.2.9 Fluorescent labelling ofHUVECs andC3H/10T½ for real-time
imaging
Amaxa and Neon transfection
HUVECs at passage 6 (P6) were transfected with the plasmid pMAX-GFP using the
Neon transfection system (Invitrogen). Using 1 105 cells per transfection. The cells
were washed in PBS, spun down, and resuspended in 95 µL transfection buﬀer and
5µL plasmid (1 µg/µL). The cellswere transfected using the settings shown in Figure
4.11. Transfected cells were immediately transferred to a 24 well plate (Nunc) con-
taining antibiotic-free ECGM. The transfection eﬃciency and cell death as a result
of transfection were assessed by ﬂow cytometry, shown in Figure 4.11. This showed
the optimal protocol (1400V, 30ms pulse width) resulted in about 60% of the cells
being both live and expressing GFP. In general, it appeared that a higher voltage and
short pulse width were optimal. When keeping the pulse width constant, a higher
voltage gave a higher transfection eﬃciency, though at the expense of slightly more
cell death.
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Figure 4.10: HUVEC-C3H/10T½ collagen spheroid coculture, following 20 days of
culture. Cocultures were stained with anti-CD31 directly conjugated to AF488 (red),
α-SMA-Cy3 (green) and NG2 with AF647 secondary (blue). Staining controls contain-
ing HUVECs and C3H/10T½ were stained with secondary antibodies only, showing
autoﬂuorescence intrinsic to the sample. HUVECs andC3H/10T½ coculture (20:1 ratio)
showed formation of endothelial tubeswhich are seen in several cases to be encircled by,
or in immediate contact with, smooth muscle, shown as a projection and 2D slices (top
andmiddle, respectively). The bottom image shows a separate gelwheremostHUVECs
have not formed tubes, are are rounded, but individual cells are encircled by or in con-
tact with C3H/10T½ and are not rounded. In control gels containing C3H/10T½ cells
only, highly directional organised networks are created on the gel surface (bottom of
images) and organised networks are also present in the gel interior (top and centre of
images). Not all C3H/10T½ cells are physiologically similar; some express high levels
of α-SMA and NG2 (cyan) while others express mainly NG2 (blue). Scale bars are (A)
45 µm and 80µm, (B) 22.6 µm, 32 µm and 90µm and (C) 22.6 µm (top and middle) and
52µm (bottom).
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Figure 4.11: HUVEC transfection with Neon system. HUVECs transfected with GFP
were analysed by ﬂow cytometry using a range of diﬀerent parameters. Cells were
selected using an FS/SS plot (A) and doublets removed using FS/pulse width (B). Cells
were assessed (C) for GFP expression and DAPI uptake (live/dead). Parameters are
voltage (V) and pulse duration (ms), applied in a single pulse. Summary statistics are
shown in (D), detailing transfection eﬃciency by means of the percentage transfected,
percentage live and the percentage both transfected and live.
4.2. RESULTS 143
To
ta
lL
iv
e
(%
)
0
20
40
60
80
10
0
0V
/ 0
ms
/ 1
p (
Co
ntr
ol)
10
50
V
/ 2
0m
s /
3p
10
50
V
/ 3
0m
s /
2p
11
00
V
/ 4
0m
s /
1p
11
50
V
/ 2
0m
s /
3p
11
50
V
/ 3
0m
s /
2p
12
00
V
/ 4
0m
s /
1p
13
00
V
/ 2
0m
s /
2p
14
00
V
/ 2
0m
s /
2p
Tr
an
sf
ec
te
d,
Li
ve
(%
)
0
20
40
60
80
10
0
0V
/ 0
ms
/ 1
p (
Co
ntr
ol)
10
50
V
/ 2
0m
s /
3p
10
50
V
/ 3
0m
s /
2p
11
00
V
/ 4
0m
s /
1p
11
50
V
/ 2
0m
s /
3p
11
50
V
/ 3
0m
s /
2p
12
00
V
/ 4
0m
s /
1p
13
00
V
/ 2
0m
s /
2p
14
00
V
/ 2
0m
s /
2p
To
ta
lT
ra
ns
fe
ct
ed
(%
)
0
20
40
60
80
10
0
0V
/ 0
ms
/ 1
p (
Co
ntr
ol)
10
50
V
/ 2
0m
s /
3p
10
50
V
/ 3
0m
s /
2p
11
00
V
/ 4
0m
s /
1p
11
50
V
/ 2
0m
s /
3p
11
50
V
/ 3
0m
s /
2p
12
00
V
/ 4
0m
s /
1p
13
00
V
/ 2
0m
s /
2p
14
00
V
/ 2
0m
s /
2p
FS
S
S
1
10
100
1000
10000
0 20000 40000 60000
FS
P
ul
se
W
id
th
0
100
200
300
400
500
0 20000 40000 60000
A B
C
D
GFP
D
A
P
I
1
10
100
1000
10000
0V / 0ms / 1p (Control)
1 10 100 1000 10000
1050V / 20ms / 3p 1050V / 30ms / 2p
1100V / 40ms / 1p 1150V / 20p / 3p
1
10
100
1000
10000
1150V / 30ms / 2p
1
10
100
1000
10000
1 10 100 1000 10000
1200V / 40ms / 1p 1300V / 20ms / 2p
1 10 100 1000 10000
1400V / 20ms / 2p
Figure 4.12: C3H/10T½ transfection with Neon system. C3H/10T½ transfected with
GFP were analysed by ﬂow cytometry using a range of diﬀerent parameters. Cells
were selected using an FS/SS plot (A) and doublets removed using FS/pulse width (B).
Cells were assessed (C) for GFP expression and DAPI uptake (live/dead). Parameters
are voltage (V), pulse duration (ms) and number of pulses (p). Summary statistics are
shown in (D), detailing transfection eﬃciency by means of the percentage transfected,
percentage live and the percentage both transfected and live.
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C3H/10T½ cells were also transfected using theNeon system (Figure 4.12), show-
ing much less cell death and higher transfection eﬃciency compared with HUVECs,
having over 80% live and transfected when using 1300V, 20ms pulse width and two
pulses. Unlike HUVECs, which are far more limited in their potential for long-term
culture, it was possible to transfect with cyan, citrine, tomato and dsRed ﬂuorescent
proteins inserted into a pCMV6-neo plasmid, using G418 to select for stable integ-
ration. HUVECs, in contrast, can not realistically be taken through suﬃcient pas-
sages to achieve stable integration and then subsequently be used for experiments.
Without selecting for integration, ﬂuorescence rapidly declines, due to dilution of
plasmid during division, as well as loss or silencing.
In addition to the Neon system, the Amaxa system (Lonza) was used to trans-
fect both HUVECs and C3H/10T½ with ﬂuorescent proteins, using speciﬁc kits for
HUVECs and smooth muscle, but was not as eﬃcient as the Neon system, while
being considerably more eﬃcient than Lipofectamine (Invitrogen). Overall, Neon
transfection appeared to cause far less damage to the cells and also achieved the
highest transfection eﬃciencies.
Adenovirus transduction
HUVECs at P6 were transduced with GFP-adenovirus at an multiplicity of infec-
tion (MOI) of 0, 1, 10, 100 and 500. Flow analysis, shown in Figure 4.13(C), showed
that an MOI of 1 resulted in 62% expressing GFP at a low level, while an MOI of
10 resulted in 97% expressing GFP, and an MOI of 100 99.8%. An MOI of 500 res-
ulted in the death of all cells. GFP intensity increased by approximately one order
of magnitude as the MOI increased by an order of magnitude, showing a roughly
linear relationship between viral transduction and the resulting GFP ﬂuorescence.
HUVECswere subsequently transfected at P6with anMOI of 100, and expression
of GFP determined 24 hours later, and subsequently every 48 hours after passage at
P7 and P8, shown in Figure 4.13(D). This showed high initial transduction eﬃciency,
with GFP expression peaking at P8, though there is a shift in GFP ﬂuorescence re-
lative to the untransduced control which may have resulted in an artiﬁcially high
percentage for this passage; it may, in fact be less than P7 when taking the peaks
into account. By P9, GFP ﬂuorescence is almost entirely absent, with most cells only
having a very low level of GFP expression.
CFSE labelling
HUVECs were labelled with CFSE using M199 medium as the labelling buﬀer as
described in Section 2.1.5. The cells were spun down and resuspended in neutral-
ised collagen as described in Section 4.2.4 and were set in the matrix support slide
with integral well shown in Figure 2.1(C). The gels were overlaid with tube forming
medium, again as described in Section 4.2.4. Initial timelapse imaging to a depth of
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Figure 4.13: HUVEC transduction with adenovirus. HUVECs transduced to express
adenovirus with GFP-adenovirus were assessed each passage (every 48 hours) post-
transduction to assess the level of GFP expression. Cells were selected using FS/SS
(A) and doublets removed using FS/pulse width (B). The eﬀects of changing the MOI
are shown in (C) with higher MOI resulting in higher GFP expression; at higher MOI,
the GFP expression is so bright it exceeds the dynamic range of the instrument, and
is clipped at 10000. The expression of GFP over time post-transduction with an MOI
of 100, in comparison with an untransduced control of the same passage, is shown in
(D). Expression 24 h post-transduction at P7 is high, but peaks at P8. However, by P9
expression levels dropped dramatically.
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250 µm on a multiphoton microscope showed no evidence of either cell movement
or tube formation. However, when repeated in triplicate using the matrix support
in Figure 2.1(D) with both unlabelled and labelled HUVECs and with normal and
tube forming medium (i.e. four combinations), after two days the unlabelled cells
had contracted their collagen matrix, in particular under tube forming conditions,
while the CFSE-labelled cells had not. The CFSE-labelled cells are shown in Figure
4.14, while the unlabelled cells were used for TEM, shown previously in Figure 4.5.
As seen previously, the control gels showed HUVECs only as single cells, with no
outgrowth or tube formation. Tube forming medium did not induce much tube out-
growth, with the majority of the cells in the gel existing as single cells, some visibly
apoptotic. However, a very small number of cells in the gel did exhibit some evid-
ence of tube outgrowth.
4.2.10 Spheroid models are an alternative to seeded collagen gels
Collagen spheroids were created by seeding 1 104 cells in 1 µL collagen drops on
the surface of Petri dishes, gelling at 4 °C for 1 hour and then overlaying with me-
dium. Small spheroids formed following two days of culture contracting the gel
to a very small volume, shown in Figure 4.15(A). However, the spheroids are much
larger than their methylcellulose counterparts (see below), their shape is less consist-
ent, and they can stick to each other upon contact. Each spheroid also used a very
large quantity of cells, making it diﬃcult to scale up to large numbers. A quantity
of 1 106 cells can produce just 100 collagen spheroids at 1 104 cells/spheroid, or
1333 methylcellulose spheroids at 750 cells/spheroid.
HUVEC methylcellulose spheroids were made using 2.4% (w/v) methylcellu-
lose, as described in Section 2.5, using unsupplemented ECGM as the basal me-
dium. A commonly used method for making spheroids with methylcellulose is to
use round-bottomed non-adherent (non-plasma treated polyethylene) 96well plates,
but when this method was used with HUVECs, the cells stuck to the sides of the
round bottomed place, and did not aggregate into spheroids. Any aggregation ob-
served was both inconsistent and nonuniform, having multiple aggregates per well,
withmost cells remaining stuck to the sides of thewell. Hanging drop culturewas at-
tempted using the described method, which leads to spheroids forming with a high
degree of consistency and uniformity. Example spheroidsmade using 1000HUVECs
in 25 µL 0.3% (w/v) methylcellulose-ECGM drops are shown in Figure 4.15(B) fol-
lowing 24 hours of culture.
Both types of spheroid were subsequently embedded in collagen gels with the
addition of diﬀerent growth factors in order to determine their ability to grow out
into the gel in response to the factors. Outgrowth from collagen spheroids was far
poorer than for methylcellulose spheroids (data not shown). The larger quantity and
smaller size ofmethylcellulose spheroidsmeant thatmoremight be added to a single
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Figure 4.14: HUVEC labelling with CFSE. CFSE-labelled HUVECs were seeded in a
collagen gels and overlaid with normal or tube forming media. (A) In normal growth
medium, HUVECs showed no evidence of tube formation after 48 hours. The majority
of cells under tube forming conditions also showed no evidence of tube formation (B),
with some cells appearing fragmented and apoptotic, however a minority of cells did
exhibit some evidence of tube formation (C). Scales are 45 µm (A, B) and 22.5 µm (C).
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Figure 4.15: Methylcellulose and collagen spheroids. (A) HUVEC collagen spheroids
(10000 cells/spheroid). The size and shape of collagen spheroids is variable, and they
exhibit a tendency to adhere to each other (far right). (B)HUVECmethylcellulose spher-
oids (1000 cells/spheroid). All spheroids are seen to have a uniformly spherical ap-
pearance despite the presence of single cells on their surface. Collagen spheroids are
approximately 3× the diameter of methylcellulose spheroids. Scale bars are 100 µm.
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Figure 4.16: Spheroid outgrowth in response to diﬀerent growth factors. Spheroids
were grown in ECGM (A), shown cropped for analysis removing well edges and spher-
oids touching the edge, and having background correction (B) and then following
thresholding and exclusion of small particles (C). Spheroids were also grown in ECGM
supplemented with bFGF (D), VEGF (E), bFGF and VEGF (F) or under tube forming
conditions (G). Outgrowth of tubes into the collagen extracellular matrix is observed in
all cases, including the control (A), but under tube forming conditions (G), growth and
cell proliferation appear to be greatly increased comparedwith all other treatments. The
amount of outgrowth is shown graphically in (H), calculating the total area covered by
each spheroid from total area measurements and spheroid counts. Per-spheroid meas-
urements were not possible due to the spheroids touching, hence this plot does not
include error bars. Scale bars are 1mm.
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gel, resulting in a greater number of observations and hence allowing more reliable
statistics and robust conclusions to be drawn from the data.
4.2.11 HUVEC spheroids are responsive to growth factors
HUVEC methylcellulose spheroids (750 cells/spheroid) were suspended in 1mm
thick, 6mmdiameter collagen gels using support rings as shown in Figure 2.1(B), and
treated with diﬀerent growth factors. Control gels were covered with 4mL ECGM
and treated gels were coveredwith 40 ng/mL hVEGF165, 40 ng/mL bFGF, 40 ng/mL
hVEGF165, 40 ng/mL bFGF and 4mL tube forming medium. The gels were stained
withmouse anti-humanCD31with a goat anti-mouse-AF594 secondary and imaged
as sets of between 35–45 tileswhichwere later stitched together to form single images
as described in Section 2.6.6. The assembled images are shown in Figure 4.16.
While spheroid outgrowth increased moderately compared with the control on
the addition of bFGF, VEGF, or both, it dramatically increased when using the tube
forming conditions used in previous experiments. In some of the treatments, the
spheroids had grown so large that they were touching and visually inseparable,
making per-spheroid measurements as detailed in Figure 2.3 impossible. Instead,
the outgrowth was quantiﬁed by masking out all parts of the image except the col-
lagen gel (excluding the well edge and metal ring). The spheroids in the gel were
then quantiﬁed by subtracting the background using rolling ball background sub-
traction with a radius of 200 pixels, followed by thresholding to select the stained
spheroids and outgrowths, and measurement of the total stained area. This allowed
calculation of the mean area per spheroid; larger spheroids with more angiogenic
outgrowth should have an increased mean area. However, this method had the dis-
advantage of selecting background staining in the gel in some samples; while some
of this could be masked out, this was not feasible for all samples. This method pre-
cluded determining the error in the calculated area per spheroid, due to measuring
the total area covered by all spheroids, rather than for each spheroid individually.
4.3 Discussion
4.3.1 Microﬂuidic networks in collagen gels
The PALM Microbeam laser capture microdissection system (Carl Zeiss) contains a
pulsed nitrogen UV laser, used to cut biological sample sections placed upon glass
slides coated with 1.5 µm PEN ﬁlm. The UV laser is capable of cutting the PEN
ﬁlm, which is sensitive to 405 nm laser light, and this also results in cutting of the
overlying sample. While 1.5 µm is too thin for practical microﬂuidics, it was hypo-
thesised that if the system was capable of cutting thicker ﬁlm, this would be able
to substitute for photolithography by allowing the direct cutting of a template, and
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hence be usable for PDMSmoulding. The primary variable to control cuttingwas the
stage speed, faster speeds implying less energy absorption by the PEN per unit dis-
tance, but also less cutting accuracy due to greater distance between pulses. Cutting
therefore required a ﬁne balance between travelling suﬃciently slowly to accurately
deﬁne features, but not so slowly that too much energy was put into the sample at a
single point, resulting in excessive melting (and, at the extreme, burning). This was
controlled through ﬁne-tuning of the laser power.
In order to create PEN templates of deﬁned dimensions, custom software was
written to transform scale drawings into the speciﬁc format required by the PALM
R software controlling the system. Using the PALM Microbeam system, PEN
ﬁlm was cut into precisely-deﬁned network templates with µm tolerance, which
compares favourably with photolithography at large 50 µm thicknesses (Duﬀy et al.,
1998), though photolithography is capable of accuracy to tens of nanometres when
used for very thin ﬁlms, e.g. in semiconductor masking applications, as well as in
thin ﬁlm micromoulding (Kim et al., 1996). The channel roughness is a function
of the resolution of the photomask, and while this is not particularly apparent for
straight edges and right angles in line with the pixel grid, it results in the introduc-
tion of roughness when curves and lines at other angles are used (Duﬀy et al., 1998;
McDonald et al., 2000), e.g. a photomask printed at a resolution of 5000 pixels/inch
will only achieve a resolution of 5 µm when used at a 1:1 scale and illuminated with
parallel light (lens-free). This is a typical scenario when using thick photoresist lay-
ers, since using lenses would bend the light from a parallel path, resulting in features
without uniformly vertical edges, moving away radially from the centre of focus. In
comparison, laser cutting results in smooth undulations under 1 µm in depth as a res-
ult of the laser beam pulses overlapping to a large extent. The resolution is limited
by the stage steppers, which have a movement of 78.125 nm/step and the laser pulse
frequency, which is ﬁxed at 30Hz. In practice, the pulse frequency is limiting; resol-
ution could be improved using a laser with higher frequency, but less power output
which would result in the same total energy input into the sample, but resulting in
ﬁner control and smoother surface features. The fabrication of network templates in
this fashion is a completely novel application, both of the PALMMicrobeam system
and for the production of microﬂuidic networks. In comparison with existing work
using direct laser etching of silicon to create microchannels, for example, cutting of
PEN results in smoother, more consistent feature reproduction which will translate
to less turbulent, more laminar ﬂow in moulded microﬂuidic channels (Kam, 2008).
Using the PEN template, networks in PDMS elastomer were successfully pro-
duced, and the functionality and integrity of the network was demonstrated by per-
fusion with gelatin. This highlighted the precise control of the channel dimensions,
with the channel width being uniform within µm tolerance, and the height being
determined by the thickness of the PEN ﬁlm.
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The overall aimwas to use this technique to producemicroﬂuidic collagen gels as
outlined in Figure 2.6. Using this approach, the step of producing a deﬁned gelatin
network on glass substrate was reached. The following steps, overlaying the gelatin
network with neutralised collagen, gelling the collagen, and then perfusing the net-
work at raised temperature to remove the molten gelatin would have resulted in the
production of a collagen gel containing a microﬂuidic network moulded within it.
However, this was not possible using our current methods for creating collagen gels,
a 3mg/mL concentration resulting in a gel which was not suﬃciently solid to retain
such ﬁne features or survive the forces imposed upon it during perfusion. Addi-
tionally, the observed behaviour of HUVEC-mediated gel contraction would result
in rapid destruction of the moulded features, and a loss of sealing with the glass
substrate.
Potential solutions to these problems include the use of highermass fraction colla-
gen gels. The Stroock group at Cornell University have recently successfully created
perfusedmicroﬂuidic collagen gels at concentrations of 10mg/mL and above (Cross
et al., 2010); while gels at concentrations as low as 3mg/mLwere patterned, they rap-
idly deformed under perfusion. Our observations are that collagen at concentrations
of 6mg/mL and above, even at acidic pH in monomeric form, is eﬀectively a solid
which does not readily ﬂow, making handling problematic. It can not be pipetted,
even with 1000 µL pipette tips with the tips cut oﬀ, and it would not be possible to
evenly mix cells or spheroids within it following gelation due to the high viscosity.
Additionally, dense gels are also likely to present a barrier to cell migration, which
would require degradation and remodelling of thematrix to allowmovement; MMPs
which cleave collagen I (collagenases) are not typically associated with angiogenesis
and may even be anti-angiogenic, unlike gelatinases (Bergers, Brekken et al., 2000;
Saunders et al., 2005; Vu, Shipley et al., 1998). In contrast, collagen at 3mg/mL is
handled straightforwardly, cells and spheroids may be rapidly and evenly dispersed
within the solution, and cells may freely migrate through the resulting matrix. Ob-
servations in the Coles lab using real-time MP imaging of the HT1080 ﬁbrosarcoma
line and OP9 bone stromal line in 3mg/mL collagen gels (not shown) were able to
freely migrate within the gel; higher concentrations have not yet been tested.
The “ideal” gel is of lowmass fraction, with a pore size suﬃciently large to permit
migration and remodelling, permits direct incorporation of cells or cell aggregates
during gelling, and is suﬃciently strong to resist the forces exerted upon it during
perfusion and tube formation. Potential solutions to improve the mechanical and
structural properties of collagen could include composite gels composed of multiple
matrix components, containing both collagen and other components which could
resist contraction and provide additional structural integrity, or to increase the rigid-
ity of the collagen ﬁbrils by cross-linking. Various diﬀerent cross-linking strategies
are reported in the literature, varying from chemical cross-linking to enzymatic treat-
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ment. Aldehydes such as formaldehyde and paraformaldehyde are widely used
cross-linkers, but are incompatible with the direct incorporation of cells into mono-
meric collagen due to their toxicity. Other chemistries are also possible, such as us-
ing N-hydroxysuccinimide/ethyl(dimethylaminopropyl) carbodiimide to cross-link
chondroitin sulphate and heparin to collagen I (Pieper, Hafmans et al., 2000), but
again the chemistry is rather toxic and incompatible with direct cell seeding. Mo-
lecules used in the tanning industry may be a source of useful biocompatible mo-
lecules suitable for this purpose, such as procyanidin, a plant-derived polyphenol
and collagen cross-linker (He, Mu et al., 2011), though their biocompatibility and any
eﬀects upon cellular physiology would require assessing. Enzymes such as lysyl ox-
idase are responsible for the establishment of inter-ﬁbril cross-links in vivo (Mäki,
Sormunen et al., 2005), therefore mixing of recombinant lysyl oxidase with the pre-
polymer could potentially result in enzymatic cross-linking through the formation
of reactive aldehyde groups, resulting in a stronger gel without any change in dens-
ity. Non-chemical approaches include the use of UV cross-linking, but again is in-
compatible with direct cell seeding. The strength of collagen may also be increased
through ﬂow casting, resulting in axial orientation of ﬁbrils, whichmay be built up in
layers to produce, for example, biaxially oriented laminar sheets with great strength
(Tanaka, Baba et al., 2011), but is again incompatible with cell seeding during man-
ufacture, and the processing also results in very dense collagen which may present
an eﬀective barrier to migration and remodelling.
While PEN cutting oﬀers an alternative to photolithography, the approach also
has its drawbacks. Networks are cut out, and hence detached from, both thematerial
from which they are derived, and the substrate to which the material was attached.
In consequence, the network may only consist of a single piece; if multiple pieces are
cut from the same material, their relative spatial orientation will be lost following
cutting, for example separate networks or channels oriented alongside each other.
This limits the complexity of the systems which may be created using this approach.
In contrast, with photolithography the photoresist remains attached to the silicon
substrate, permitting the creation of precisely aligned discrete networks which are
in close spatial proximity, but not in intimate contact. In order to mitigate issues
with alignment tolerance when coring perfusion ports through the PDMS, large en-
dpoints were created to allow for variability in needle placement, as shown in Figure
4.2(A) and (C). Photolithography permitsmuch tighter alignment due to the fact that
alignment marks and points for holes may be directly incorporated into the photo-
mask and hence the SU-8 master and moulded PDMS.
Cracking of the coverslip glass under pressure was also an issue. In order to
permit the use of live confocal and multiphoton imaging during perfusion, № 1½
slide-sized coverslip glass was used. However, this only permits visualisation of
a tiny part of a much larger network. If these requirements were relaxed, low NA
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objectives (e.g. 2× or 5×) or even a stereo microscope could be used to visualise the
entire network at once, and thicker glass could be used in consequence since spher-
ical aberration due to the glass thickness would not cause problems due to the low
NA of the objective, which could be speciﬁcally corrected for the glass thickness.
4.3.2 Formation of vascular networks using exogenous factors
The vascular model should be capable of forming a complex vascular network in a
3-D environment. In order to determine if HUVECs were capable of being cultured
in three dimensions in a collagen gel, and if they were capable of forming a net-
work of tubes in the gel, HUVECs were seeded directly in the gel. The eﬀects of the
treatments in 2-D and 3-D environments are rather diﬀerent, with control cells ap-
pearing to prefer a 2-D environment, on either glass or collagen surfaces. Cells were
not found in the interior of the control gel, presumably either having migrated out
after initial seeding, or died following apoptosis or anoikis, which could account for
the presence of brightly-staining blobs within the gel as a consequence of blebbing
and fragmenting. It is likely that in the absence of cell–cell contact, unstimulated
HUVECs lack the survival signals needed to exist in a 3-D context (Bird et al., 1999).
HUVECs have been previously shown not to survive in 3D gels, even when supple-
mented with VEGF (Ilan, Mahooti et al., 1998). Additionally ECs have very diﬀerent
morphology and migration strategies in 2-D versus 3-D (Martins and Kolega, 2006).
Existingwork andpublishedprotocols have focussed on 3-D invasion of collagen gels
starting from a 2-Dmonolayer of ECs seeded onto the empty gel (Bayless, Kwak et al.,
2009; Davis et al., 2000a; Yang et al., 1999). These models require ECs to actively re-
spond to stimulation via growth factors and invade the gel, rather than immediately
transitioning from 2-D culture to direct seeding in the matrix. In Davis’ reviews of
themechanisms of ECmorphogenesis and lumen formation (Davis et al., 2002, 2007),
and in Tatin, Varon et al. (2006), protein kinase C (PKC) signalling via Rac1 andCdc42
in order to control migration, tube assembly, cell–cell adhesion and survival were
shown to be of critical importance. Following stimulation to invade in 3-D, phalanx
ECs are required to undergo changes in cell-cell junctions (disassembly), cytoskeletal
organisation changes to permit migration, including loss of polarity, and MMP ex-
pression to degrade the local ECM. In the absence of signalling to provide survival
signals, for example via PKB or ERK as a result of VEGFR2 signalling and/or PMA-
induced activation of PKC, it is very likely that cell deathwould occur in consequence
(Ilan et al., 1998).
This initial experimental work demonstrated that HUVECs may be used as a
model endothelial cell. They may be induced to form a network of tubes in 3-D
collagen gels by treatment with exogenous factors, as shown in Figure 4.3. However,
the true extent of tube formation was not clear due to the possibility of the “tubes”
being infoldings of the collagen gel surface. The gel was seen to contract from its
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initial 14mm diameter to less than three times this size. The reduction in surface
area may have resulted in extensive infolding of the surface during contraction, in
addition to contraction of the gel as a whole as individual ﬁbrils are pulled closer to-
gether through the action of ECs. In consequence, apparent tubes and even branched
structuresmay not have formed as a result of vasculogenesis or angiogenesis, and the
cells may exist in the same 2D environment on the infolded gel surface as their coun-
terparts on the exterior faces. This notwithstanding, tubes are clearly visible in the
gel interior, and the tube forming conditions have resulted in clear morphological
changes. However, it would be greatly desirable to separate the wanted changes
(tube assembly and angiogenesis) from the unwanted side eﬀects of microfolding of
the collagen gel surface as a result of the gel contraction. One solution to this would
be to use smaller, thicker gels with a lower surface area to volume ratio in order to
increase the distance between the interior and gel surface, so that the unwanted sur-
face changes may be ignored or eliminated entirely. Subsequent experiments in this
chapter therefore used 3mm diameter, 3mm thick gels as shown in Figure 4.4, and
these showed clear evidence of tube formation in the gel interior (albeit with the un-
wanted side-eﬀect of necrosis in the gel centre), while eliminating surface infolding,
since the entire surface is clearly visible showing 2-D cell–cell junctions. Later work
used 6mmdiameter, 1mmgels to additionally avoid necrosis and to provide a larger
imageable area.
The 3mm diameter, 3mm deep collagen gels used for the majority of the exper-
imental work allow for very large images to be taken of the gel, with a very deep z
depth. Less dense collagen gels resulted in smaller gels. This ismost likely not due to
an increased amount of contraction within the gel, but rather that the cells contract
the collagen until it reaches a density which limits further contraction; due to the
presence a lower amount of collagen in less dense gels, this would result in a smaller
ﬁnal volume after contraction. This size of gel was not optimal due to the observed
void space in the core of the growth-factor-treated gels, though thiswas not observed
for coculture gels. While the speciﬁc nature of this phenomenon was not investig-
ated, a probable cause would be necrosis and/or apoptosis of the cells in the gel core
as a result of nutrient or oxygen starvation, or of waste product buildup. This is a
phenomenon previously observed in both tissue, tumours and 3D culture models,
due to the diﬀusion of oxygen and nutrients becoming limiting, of the concentration
of waste products reaching toxic levels; the passive diﬀusion rate can not meet the
metabolic demand of the cells, or remove waste suﬃciently rapidly (Shweiki et al.,
1995). Cells nearer the edge of the gel are closer to the source of oxygen or nutrients
or the waste sink, and so are correspondingly more likely to survive. One beneﬁt of
having microﬂuidic circulation in 3D collagen cultures is that oxygen and nutrients
are actively perfused, and waste removed, in a similar manner to a real circulatory
system. Recent work by Demol, Lambrechts et al. (2011) has attempted to quantify
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some of these factors making both direct observations under controlled conditions,
and mathematical modelling. Interestingly, the primary cause of hypoxia in their
model is not the metabolic demand of cells within the gel, but as a result of cells
on the gel surface inhibiting diﬀusion into the gel, resulting in extreme hypoxia in
the gel centre. The HUVEC gels were observed to possess a conﬂuent 2-D surface
monolayer, hence the same process may be occuring in these gels.
HUVECs were shown to form tubes in a 3-D collagen gel when treated with
factors to induce tube formation. However, it was not possible to determine if the
tubes were vessels containing patent (open) lumens, or merely cell aggregates, from
the confocalmicroscopydata. It is not clearwhy theCD31 staining appears across the
entire vessel cross-section when it should be mainly restricted to the plasma mem-
brane at cell–cell junctions, but may be due to the membranous debris ﬁlling the
lumen, shown in Figure 4.5. In order to determine if the tubes were genuine ves-
sels, transmission electron microscopy was used to visualise the tube morphology,
repeating the tube formation experiment, but using 3mm diameter, 3mm thick col-
lagen gels to ensure the presence of tubes in the interior, rather than simple surface
infolding. TEManalysis (Figure 4.5) demonstrated that tubeswere indeed formed by
treatment under tube-forming conditions, and that they contained several key fea-
tures of capillaries: apical–basal polarisation with the basal surface in contact with
the matrix, the apical face exposed to the open lumen, and lateral faces in contact
with neighbouring cells via adherens junctions (Adams and Alitalo, 2007; Dejana,
Tournier-Lasserve et al., 2009). The TEM images bear close similarities to previously
published work, including Bishop et al. (1999); Davis et al. (2002), showing adher-
ens junctions, and the presence of Wiebel-Palade bodies is potentially shown in Fig-
ure 4.5(D), ﬁlling the cytoplasm between the nucleus and lumen (Berriman, Li et al.,
2009). Additionally, at higher magniﬁcations (not shown), the classic banding pat-
tern of the collagen ﬁbril structure was clearly visible (Bozec, van der Heijden et al.,
2007; Williams, Gelman et al., 1978), demonstrating that the matrix was composed of
correctly assembled collagen ﬁbrils. The use of gels of reduced size could eliminate
the problems identiﬁed here, but the ﬁnal size after gel contraction could be under
0.5mm in diameter and height, andwould present additional technical challenges to
mould a seeded gel due to issues with the gel viscosity and small gel volumes, and
also during subsequent manual handling during immunohistochemical processing.
The observation that HUVECs are foundmainly in a 2-D environment on the sur-
face of the collagen gel when only overlaid with normal growth media, and in the
absence of other cell types reﬂects the normal state of “phalanx” endothelial cells
lining blood vessels. These cells experience a 2-D environment, given that they lie
upon a 2-D basement membrane, which although rolled up as a cylindrical structure
is eﬀectively two dimensional from the perspective of an individual endothelial cell.
In addition to the basement membrane which underlies the cell, the upper surface is
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exposed to the lumenal contents of the vessel whilst to either side each endothelial
cell makes intimate contactwith its neighbours through adherens junctions. Phalanx
cells are highly polarised, non-migratory and have very low rates of proliferation,
being specialised to fulﬁlling their function. In order for cells to migrate into a 3-D
environment, they must lose their specialised, polarised structure, decrease their at-
tachment to their neighbours and adopt amore ﬁbroblastic phenotypewith a growth
cone, in order to enable their migration through the basement membrane and into
the surrounding tissue. In an artiﬁcial gel, the interface between cell and collagen
provides an equivalent role to the vascular basement membrane and the volume of
the gel a tissue analogue, providing a substrate for integrin engagement and adher-
ence as well as a volume through which migration is possible. In order to transition
from a 2-D to 3-D context, migrate and form new structures inside the gel, growth
factors appear to be a major requirement, either provided exogenously or in a parac-
rine manner through neighbouring cells, as demonstrated.
In experiments using exogenous growth factors, four separate components were
used: bFGF, VEGF, PMA and ascorbate. Ascorbate is not required for angiogenesis,
but it is a requirement for collagen biosynthesis (Green and Goldberg, 1965). bFGF,
VEGF and PMA all have broadly similar eﬀects, due to activating many of the same
signalling pathways. While the signalling pathways have many diﬀerent eﬀects, the
major molecular players are as follows:
Both VEGFR and FGFR are activated by dimerisation upon binding of VEGF
and bFGF, respectively. Both receptors activate phospholipase Cγ (PLCγ), catalys-
ing the breakdown of phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylgly-
cerol (DAG), resulting in PKC activation, and into inositol trisphosphate (IP3), which
triggers release of calcium from intracellular stores causing, amongst other eﬀects,
release of von Willebrand factor fromWiebel-Palade bodies and further PKC activa-
tion (Carew, Paleolog et al., 1992; Gliki, Wheeler-Jones et al., 2002; Yoshiji, Kuriyama
et al., 1999). Both additionally activate phosphatidylinositol 3-kinase (PI3K), result-
ing in the formation of phosphatidylinositol 3,4,5-trisphosphate (PIP3), activating
PKB and RhoA, though they may both activate diﬀerent PI3K isoforms and hence
have diﬀerent eﬀects (Gliki et al., 2002; Graupera, Guillermet-Guibert et al., 2008; van
NieuwAmerongen, Koolwijk et al., 2003; Zeng, Zhao et al., 2002). Both pathways ad-
ditionally activate a Ras,Raf,MEK,ERK1/2 signalling cascade, resulting in transcrip-
tional changes, and activate p38 MAPK which aﬀects actin remodelling and migra-
tion (Cuadrado and Nebreda, 2010; Yoshiji et al., 1999). p38 additionally induces ap-
optosis, though this is inhibited by ERK signalling (Eguchi, Suzuki et al., 2007). The
eﬀect of PKB is to promote cell survival by inhibition of caspase and mitochondrial
apoptotic machinery, as well as regulating proliferation via nitric oxide and regu-
lating vascular permeability (Ilan et al., 1998; Spyridopoulos, 2002). RhoA activated
by VEGF is required for migration and cellular organisation during angiogenesis
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(Hoang, Whelan et al., 2004; Spyridopoulos, 2002). In some respects, VEGFR1 acts
antagonistically to VEGFR2, signalling via nitric oxide, inhibiting proliferation and
promoting network formation (Bussolati et al., 2001).
In summary, bFGF, VEGF and PMA induce a wide range of changes upon gene
expression, diﬀerentiation, survival, proliferation and tube formation. Similar mod-
els of vasculogenesis have been investigated by Davis and Camarillo (1996), Ilan et al.
(1998) and Taylor, Motamed et al. (2006). From these, it may be concluded that in the
absence of such stimulation, apoptosis is induced in HUVECs, which explains the
absence of cells in the control gels. Cell–cell contact is also a critical requirement for
HUVECs, CD31 contacts preventing apoptosis, not inducing migration, spreading
or tube formation (Bird et al., 1999). Thus untreated cells may exist as a conﬂuent
monolayer on the cell surface, but when seeded as a single cell suspension within
the gel are unable to survive. Upon appropriate stimulation, cells are able to sur-
vive, migrate and form tubes in a 3-D context (Davis et al., 2000a). PMA, being a
DAG analogue and PKC agonist, strongly activates the PKC pathway, and also the
PI3K pathway (Ilan et al., 1998). PMA upregulates VEGFR1/2 making ECs respons-
ive to VEGF, drives angiogenesis, and additionally allows VEGF to act as a survival
factor after PMA withdrawal (Ilan et al., 1998; Montesano and Orci, 1987).
These experiments demonstrated that the HUVECs were behaving as previously
observed in the literature. However, the resulting networks posed a challenge for ac-
curate quantiﬁcation, andmore importantlywould be diﬃcult to use for the observa-
tion of remodelling, especially after strong stimulation with PMA and other factors,
which could make the system rather less responsive to subtle external changes such
as in the inﬂuence of soluble growth factors and inhibitors. For these reasons, it
was decided to induce network formation using coculture with pericytes, which
should be both of greater physiological relevance and eliminate the need for exo-
genous factors.
4.3.3 Formation of vascular networks using VSMC coculture
Following the ﬁndings that HUVECs could be induced to form a primitive vascular
network in a collagen gel, a more realistic and complete model was created through
the introduction of smooth muscle or pericytes to cover the endothelial tubes. The
initial experiments used a temperature-sensitive VSMC derived from aortic smooth
muscle (Foo et al., 2006; Jat et al., 1991). In order to determine that the primary culture
was vascular smooth muscle, the expression of the vascular smooth muscle marker
NG2 was determined using ﬂow cytometry (Figure 4.6). While 90% of the popula-
tion was shown to be positive for this marker, the primary culture of aortic smooth
muscle was shown to contain a contaminating population of morphologically dis-
tinct non-NG2-expressing cells. Because these were not removed via the sorting of
a pure NG2-positive population, it was assumed that this population was derived
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from the NG2-positive population, as cells lost their smooth muscle diﬀerentiation
over time in culture. Observation of the cells showed an increasing proportion of
these cells with increasing passage number, lending credence to this hypothesis.
Endothelial cells can not be seeded sparsely in 2-D or 3-D without the loss of
cell–cell contact, resulting in apoptosis (Dejana et al., 2009; Yang et al., 1999). Apop-
tosis is prevented by homotypic cell–cell interactions mediated through CD31 inter-
actions (Bird et al., 1999). The problem becomes more pronounced in 3-D, because
the distances between cells is greatly increased with the addition of the third di-
mension unless the cells are seeded at very high densities, which introduce addi-
tional complications, such as the necrosis observed above. As an example, seeding
at 5–10 103 cells/cm2 in 2-D would require seeding at 354–1000 103 cells/cm3 in
3-D to achieve equivalent spacing anddensity, a 70–100-fold increase. In practice, op-
timal tube formationwas seenwhen seeding at even higher levels (5 106 cells/cm3).
It was hypothesised that unlike the previous experiments withHUVECs and growth
factors, where the growth factor signalling can counteract apoptotic cues, HUVECs
co-cultured with smooth muscle would not establish organised structures rapidly
enough to prevent apoptosis, and that seeding HUVECs on the gel surface would
be a potential solution to this problem. HUVECs were therefore seeded on top of
the gel to form a conﬂuent monolayer capable of invading the gel in response to an-
giogenic and/or migratory stimuli from the seeded VSMCs, an approach used in
previous work (Bayless et al., 2009; Darland and D’Amore, 2001; Davis et al., 2000a).
This should reduce the amount of cell death in the gel, at the expense of requiring
directed migration into the gel from a 2-D environment. Endothelial cells may also
undergo apoptosis when cell–matrix contact is lost, or when their geometric con-
formation with respect to the matrix is inappropriate (Dike, Chen et al., 1999). Po-
larised phalanx cells conditioned to exist attached the surface of the matrix may be
equally ill-equipped to survive when surrounded by matrix—a condition normally
experienced by tip and stalk cells which have been signalled tomigrate through, and
have adopted a morphology suited to the task.
VSMCs induced tube formation in HUVECs at very low frequency, but did not
give rise to the complete networks seen with growth factors (or C3H/10T½ cocul-
ture, below). The controls in Figure 4.7(A–F) showed that in the absence of VSMCs,
HUVECs plated on the gel surface do not invade the gel, and that HUVECs seeded
inside the gel do not form any organised structures; the only structures observed
proved on close inspection to be 2-D adherent cells associated with invaginations of
the collagen gel surface, rather than being truly in the gel interior. Figure 4.7(G–L)
demonstrated that HUVECs form tubes and organised structures when co-cultured
with VSMCs. When viewed as xz and yz projections, the majority of the structures
are shown to arise from invasion from the gel surface, indicating that the presence
of VSMCs inside the gel was suﬃcient to signal and induce the HUVECs to migrate
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into the gel, and form organised tubular structures with VSMC coverage. In Figure
4.7(G), no organised structures are visible, and the HUVECs are mostly separated
spatially from the VSMCs; in contrast the organised structures in (H-J) show a higher
frequency of VSMCs, many of which are in close proximity to, or in intimate contact
with, the HUVECs as shown in xz and yz projection.
There are a few possibilities why tube formation was only observed at low fre-
quency. This may be due to not seeding the HUVECs directly in the gel as done in
other experiments; overlaying HUVECs on the gel surface may not allow suﬃcient
cell numbers to migrate into the gel to form a network, or there may be insuﬃcient
VSMCs to produce a strong enough signal to induce their inmigration. Stratman
et al. (2009a, 2010) subsequently utilised EC–pericyte cocultures in their work, but
have focussed upon direct seeding of both pericytes and ECs directly into a collagen
matrix. This resulted in the formation of beautiful vascular networks with pericyte
coverage and basement membrane assembly, thus invalidating our hypothesis that
ECs would not be able to survive immediately after seeding. Alternatively, the cells
may not be of the correct type to eﬃciently induce tube formation in HUVECs; they
may not be producing the required factors to set up the paracrine signalling circuit
to induce the process, i.e. be correctly responsive to EC-derived PDGF-B, required
for recruitment to ECs (Hellström et al., 1999). This may be because they are derived
from the wrong tissue (smooth muscle from aorta, rather than pericytes), or they
may have lost the ability to fully function as VSMCs whilst in culture. Stratman util-
ised pericytes derived from bovine retina and human brain, which may have greater
competence in responding to PDGF.
Co-culture of endothelial cells and pericytes derived from bone marrow results
in the formation of capillary networks, albeit in 2-D only (Pelletier, Regnard et al.,
2000). In this model, tube formation was related to the production of endogenous
VEGF and NO; the presence of pericytes reduced the eﬀect of VEGF neutralisation,
which would reduce the number of tubes formed. Tube formation was also related
to αvβ5 integrin binding of the matrix, demonstrating the importance of matrix con-
tact. This model allowed the eﬀect of diﬀerent cytokines and growth factors to be
quantiﬁed by comparing the basal number of tubes formed under control condi-
tions with the addition of cytokines and growth factors. Interestingly the rate de-
creased slightly with bFGF or TGF-β1, while PDGF-BB and VEGF resulted in a large
increase. Neutralising bFGF and TGF-β1 resulted in a return to the basal rate, while
neutralisation of VEGF resulted in a dramatic decline from the basal rate, indicating
the importance of endogenous VEGF in driving tube formation. The hæmatopoi-
etic cytokines SCF, GM-CSF, EPO and G-CSF all raised the rates of tube formation
above the basal rate in order of increasing eﬀectiveness, with EPO being equival-
ent to PDGF-BB. These experiments demonstrate that endothelial cells and pericytes
alone are suﬃcient to develop a vascular network, however the fact that the pericytes
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were a contaminating population not removed during endothelial cell puriﬁcation
does not preclude other contaminating cell types from also being present, which
may also inﬂuence endothelial behaviour and morphology. Other EC–VSMC mod-
els which might prove useful as a basis for modelling and quantifying angiogenesis
include the ﬁbroblast spheroid–EC cocultures of Kunz-Schughart, Schroeder et al.
(2006), which result in the formation of branched vessels on the spheroid surface;
diﬀerentiation of the ﬁbroblasts into VSMC may also have occurred.
The model investigated here could be further improved, ﬁrstly by testing if direct
seeding of ECs results in the production of a functional network. Stimulation of the
ECs with PMA prior to seeding, and supplementing of the medium overlaying the
gel with bFGF and/or VEGF may additionally overcome any apoptosis as a result
of the transition to 3-D culture. However, the primary smooth muscle line had ad-
ditional complications, given that it required seeding at very high densities and had
a very slow growth rate, so obtaining suﬃcient quantities of cells for experimental
workwas diﬃcult given that it could also only be used for a low number of passages.
In consequence, alternative cell lines were investigated.
4.3.4 Formation of vascular networks using C3H/10T½ coculture
Due to the low frequency of tube formation and cell migration with VSMCs, the
C3H/10T½, clone 8 cell line was also investigated. The cell line C3H/10T½was used
as a replacement for the primary smooth muscle line, given that the entire popula-
tion expressed NG2, and that it could be rapidly diﬀerentiated into smooth muscle
with human recombinant TGF-β1, as shownby Figures 4.8 and 4.9. This line lacks the
complications of the primary culture, being rapidly growing so that obtaining suﬃ-
cient quantities of cells was not a problem. The literature describes C3H/10T½ as a
multipotent mouse mesenchymal line, though its exact origin is unclear due to the
method of isolation (Pinney and Emerson, 1989; Taylor and Jones, 1979), which may
be diﬀerentiated toward a smoothmuscle or pericyte lineage (Darland andD’Amore,
2001; Hirschi, Rohovsky et al., 1999). C3H/10T½ clone 8 appears to express NG2
without deliberately inducing diﬀerentiation, so it is likely partially diﬀerentiated
toward a smoothmuscle or pericyte fate, but not yet committed. Diﬀerentiationwith
TGF-β1 may therefore complete the process and induce complete diﬀerentiation and
commitment (Darland and D’Amore, 2001).
The network formed by coculture of HUVEC and C3H/10T½ was similar in ap-
pearance to HUVEC only treated with growth factors, but with additional VSMC
coverage of the network. The network formed with no exogenous growth factors,
the process being entirely due to presence of VSMCs, but did take signiﬁcant time
to develop in comparison to Stratman et al. (2009a) (16 days instead of 5). VSMCs
probably triggered formation of EC network due to the creation of a positive feed-
back paracrine signalling loop between HUVECs (secreting PDGF and TGF-β1) and
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VSMCs (secreting VEGF) (Darland, Massingham et al., 2003; Hellström et al., 1999;
Hirschi et al., 1998, 1999; Sato and Rifkin, 1989).
Interestingly, C3H/10T½VSMC alone seeded in collagen form a stromal-like net-
work. This network is very diﬀerent from the endothelial network, being composed
of interconnected long, elongated single cells, giving it a much more “spindly” ap-
pearance, similar to the stromal reticular networks seen in the lymph node (Katakai
et al., 2004; Ma et al., 2007). This stromal network is not formed when in presence
of HUVECs. The implication of this observation is that the default behaviour of the
C3H/10T½ in 3-D is to form a stromal-like network. In the presence of endothelial
cells, this process is disrupted, the stroma (C3H/10T½) being induced to play a dif-
ferent role: that of pericytes. ECs therefore appear to prevent formation of a stromal
network, through the attraction of the smooth muscle cells to themselves and direc-
tion to a pericyte fate, and/or the stabilisation of the smooth muscle coverage once
established.
It has been shown that TGF-β1 is required for tube forming in endothelial–VSMC
coculture using C3H/10T½ (Darland and D’Amore, 2001). Blocking TGF-β1 lead to
a reduction in the length, area and circumference of cords, in a 3D coculture of en-
dothelial cells and C3H/10T½ in Matrigel. While these results have the appropriate
controls, the use of Matrigel led to cord formation at both a very rapid rate and in
unusual conﬁgurations. While TGF-β1 clearly has an eﬀect upon the EC organisa-
tion, its physiological relevance must be questioned. Montañez et al. (2002) clearly
demonstrate that capillary-like network formation in collagen is very diﬀerent from
the “cord” formation observed inMatrigel, and that the tubes formed in collagen re-
produce the lumen formation observed in vivo better than the Matrigel model. Our
observations (not shown) have shown “cord formation” on Matrigel with a variety
of non-endothelial cell types, implying that the process being studied is more likely
to be merely aggregation of cells. The polygonal patterns observed in or onMatrigel
are indicative of exclusion of cells from the matrix, adopting the most energetically
stable organisation, which could be explained by the phase separation of immiscible
colloids, in a manner analogous to the exclusion of phospholipids from the aqueous
phase resulting in the self-organised formation of micelle, hexagonal and lamellar
structures, and also in liquid crystals (Goodby, Görtz et al., 2007; Kinoshita, Tsukada
et al., 2005; Lauzeral, Metens et al., 1993; Milhaud, 2004).
4.3.5 Transfection and ﬂuorescent labelling
Various diﬀerent transfection strategies to establish ﬂuorescent HUVEC and VSMC
lines were employed, including Neon, Amaxa, Lipofectamine, adenoviral and len-
tiviral transfection and transduction systems. All techniques with the exception of
lentiviral transduction (not shown) worked successfully. However, due to the in-
ability of HUVECs to be passaged past P6–P7, selection of stably transformed cells
4.3. DISCUSSION 163
was not an option. Adenoviral transduction was most successful in terms of eﬃ-
ciency, copy number and cell death, but expression was too short-lived to be useful
in longer-running cultures. Lentiviral transduction appears to be the best choice,
having been successfully used to transduce both HUVECs and pericytes by others
(Saunders et al., 2006; Stratman et al., 2010). Without having suitable ﬂuorescent cell
lines, live MP imaging was not a possibility.
CFSE labelling ofHUVECswas demonstrated to alter the response ofHUVECs to
tube-forming media compared with unlabelled controls. Clearly, the CFSE labelling
resulted in deleterious eﬀects upon the cells. This could potentially be mitigated by
further culture of the cells followed by sorting to select cells which are actively prolif-
erating, using decreasing CFSE ﬂuorescence to determine which cells have divided
after labelling.
4.3.6 Spheroid models
HUVEC spheroids are a rather diﬀerent solution to the issues identiﬁedwith seeding
single cells or inducing invasion of the gel (Korﬀ and Augustin, 1998, 1999). Spher-
oids embedded into a collagen gel possess a number advantages over earlier meth-
ods. Each spheroid being composed of hundreds of cells, the cells are always in the
presence of many neighbours, thus avoiding problems caused by sparse seeding and
lack of neighbour contact. The cells at the edge of the spheroid contact the extracel-
lular matrix, and can thus be partially exposed to a 2-D environment, in a polarised
context (collagen basement), albeit with no lumen initially due to cells ﬁlling the
space. Outgrowth of cells from the spheroid surface into the matrix mimics the ad-
ventitious nature of invasive sprouting angiogenesis, with tip cells leading and stalk
cells following. Tube growth leads outwards radially from the spheroid. The reduc-
tion in complexity, in comparison with with whole-gel seeding, allows more robust
analysis since each outgrowthmay be measured and quantiﬁed separately, and each
separate spheroid may be measured separately and treated as a biological replicate.
Spheroids are distributed randomly in the gel, and their distance to embedded tissue
or beads may be measured to observe and quantify spatial relationships.
Experiments to date have shown that HUVECmethylcellulose spheroids may be
created in bulk and embedded in collagen gels, allowing quantiﬁcation of the eﬀects
of pro- and anti-angiogenic factors present in their local environment, discussed in
further detail below.
Neither the vascular network nor spheroid models contain ﬂuid ﬂow or pres-
sure diﬀerentials. Our primary interest is in modelling mechanisms involved in or-
gan and tissue vascularisation during development. While circulation is established
when organs are vascularised, invasion of the tissues is most likely due to invasive
sprouting angiogenesis. Given that this mechanism does not involve ﬂow due to
the invading tip cells and following stalk cells either being blind-ended or lacking a
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lumen, this should not prove to be a major limitation.
4.3.7 Quantiﬁcation of angiogenesis
Quantitative analysis of the acquired 3-D images remains an unresolved technical
limitation. While software packages such as V (Improvision/Perkin-Elmer)
allow sophisticated visualisation of 3-D confocal images, analysis of such images
to allow extraction of meaningful quantitative data remains a signiﬁcant challenge.
V can be used to select features in the 3-D space as volumes comprised of
voxels. From these volumes, several statistics may be derived, including dimen-
sional limits (bounds along x, y and z axes), size measurements (surface area and
volume), pixel intensity statistics (minimum, maximum, mean, standard deviation
etc) and shape descriptors (centroid). A vascular network is a complex, branched, in-
terconnected structure, and unfortunately the measurements one may extract from
the identiﬁed volumes are not informative. The size, surface area and volume do
not provide information about the network structure. Such parameters would include
statistics concerning the total network length and volume, number of branch points,
mean distance between branch points etc., which would allow comparison of diﬀer-
ent networks and assessment of the network size, complexity and degree of intercon-
nectivity. Unfortunately, V is not capable of computing such values, making
it diﬃcult to make practical use of the limited information which may be obtained.
In order to gain statisticallymeaningful data fromeither the vasculogenesismodel
or spheroidmodel, it is necessary to be able to analyse and extract useful quantitative
data from the captured images. Existing approaches have mostly focussed upon the
analysis of 2-D networks, though some of thesemay be adapted for use in 3-D. Using
the chick chorioallantoic membrane model, Doukas, Maglogiannis et al. (2006) used
skeletonisation to reduce the network to single pixel lines, from which the vessel
length and branchpoints could be determined. This type of approach is suitable for
repeatedly-branched networks, which may be imaged in suﬃcient detail to show all
vessels. However, the approach falls short where thresholding tends to remove the
ﬁnest detail, turning the capillary bed into a tree of discontinuous endpoints rather
than it being a continuous web as it is in reality. Later work using similar 2-D mod-
els additionally permitted quantiﬁcation of vessel area in addition to length (Egaña,
Condurache et al., 2009; Machens, Grzybowski et al., 2006), and to classify vessels in
a hierarchy depending upon their size and branching (Vickerman, Keith et al., 2009).
The approach of using iterative erosion to skeletonise images to determine branch-
points and linear segments between branches is illustrated nicely by Heinzer, Kuhn
et al. (2008), though in this case this is a 2-D approximation of the process in 3-D,
which decomposes a complex network into a graph consisting of edges and vertices.
This representation allows comprehensive description of all networks of any degree
of connectedness, i.e. any tubular structure from hierarchical branching to a capil-
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lary plexus. This type of hierarchical ordering is termed Strahler ordering (Fenton and
Zweifach, 1981). The same process should work in 3-D using confocal orMP images,
providing the resolution and quality are suﬃcient to segment the vessel structure.
While software such as V can skeletonise 3-D volumes, it is not currently pos-
sible to retrieve the skeletons for further analysis or manipulation. Algorithms also
exist based upon approaches other than skeletonisation, such as (Lee, Beighley et al.,
2007), which is based upon tracking vessels and branches from seed points in the
3-D volume, and has been used to map the vasculature of an entire organ; while this
work used micro-CT imaging of the heart, the approach should also be usable with
confocal data and artiﬁcial vascular networks.
The spheroid outgrowth model is somewhat diﬀerent, radial outgrowths hav-
ing a limited degree of branching, little interconnectedness and hence no large-scale
structure. The above algorithms are based upon highly-branched tree and network
structures, and hence a diﬀerent approach is required in this case. For spheroid ana-
lysis, approaches for quantifying outgrowth in the rat aortic ring explant model may
bemore applicable, such as that taken by Blacher, Devy et al. (2001). Here, phase con-
trast microscopy was used to image the entire explant, and a series of contours were
drawn around the explant at increasing distance from its edge, making the measure-
ments independent of the explant shape. The number ofmicrovessels present at each
contour may then be determined. However, this approach does not take branching
into account, and comparing treatments is complicated by the fact that the result is
a frequency distribution. Korﬀ, Kimmina et al. (2001) take a simpler and potentially
more robust approach, determining the “cumulative sprout length” per spheroid,
but this again does not take branching or sprout radii into account.
Two diﬀerent approaches for analysing spheroid outgrowth are described in Sec-
tion 2.7, and an example of the analysis and quantiﬁcation of images of methylcellu-
lose spheroids is illustrated graphically in Figures 2.3 and 2.4. It was not possible to
use any of the abovemethods for analysing the spheroid outgrowth from Figure 4.16
due to the spheroids being spaced too closely, resulting in the sprouts being insep-
arable and hence not possible to measure accurately individually. Experiments in
Chapter 5 using this model used less spheroids per unit area in order to reduce this
problem and permit measurement of individual sprouts. The approach taken here
was to calculate the total area occupied per spheroid, which does show diﬀerences
between the diﬀerent treatments, in particular the tube forming conditions result in
a much more outgrowth than the control or other treatments. However, because the
measurements are per-well rather than per-spheroid it was not possible to determine
the error associatedwith thesemeasurements. Using edge detectionwas not a viable
approach, because the samples with large outgrowths had smaller diﬀerences in in-
tensity change, equivalent to background changes in other samples. Using rolling
ball background subtraction with a radius of 200 pixels eﬀectively removed most of
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the unwanted background staining in the gel, and this then allowed thresholding
to more accurately segment the image, combined with removal of small objects to
remove noise.
This crude measurement methodology permitted the quantiﬁcation of the out-
growth in Figure 4.16, demonstrating that outgrowth was upregulated compared
with the control when treated with bFGF, VEGF or both combined, and increased
ﬁve-fold when tube-forming conditions were used, demonstrating the potency of
PMA treatment in inducing angiogenic outgrowth. bFGF and VEGF act synergist-
ically (Pepper et al., 1992); each alone increased the length of tubes formed with in-
creasing concentration, but when used in combination, dramatically increased the
tube length. However, synergy between VEGF and bFGF signalling was not ob-
served, possibly due to the error inherent in this analysis.
4.4 Conclusions
In this chapter, several of the required components of a “complete” in vitro vascular
model have been experimented with in isolation. Two diﬀerent models have been
demonstrated: a vasculogenic model where ECs have self-assembled into a vascu-
lar plexus, with or without pericyte coverage, and an angiogenic model where ECs
in a spheroid aggregate sprout into the surrounding matrix. While a very simple
model, spheroid outgrowth is easier to quantify in terms of measurement paramet-
ers, accuracy and robustness than an entire interconnected network due to the fact
that each separate spheroid is an individual biological replicate and that visualisa-
tion is simple and relatively unambiguous. In contrast, the vasculogenesis model
was highly variable in terms of reproducibility and consistency, with analysis being
complex, and its ability to extend and remodel being untested at present. Micro-
ﬂuidics and live imaging are yet to be incorporated into these models, though both
were tested in isolation.
4.5 Future work
Live imaging of networks via confocal or multiphoton microscopy requires ﬂuores-
cent cells. Transient transfection has been achieved using several diﬀerent technolo-
gies, but in all cases is too transient for practical use with either the vasculogenesis
or spheroid model due to the number of days the model requires for both set up and
culture before the network or sprouting has occurred to a suﬃcient extent. The use of
lentivirus to derive stable expression of ﬂuorescent proteins is a potential solution,
and has been shown to work with HUVECs previously, for example in Saunders
et al. (2006). Other alternatives include label-free imaging using ﬂuorescence life-
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time imaging (FLIM), or even phase contrast provided that the gels are suﬃciently
thin to allow visualisation of ﬁne detail.
A future alternative to both photolithography and PEN ﬁlm for the creating of
PDMS moulds is direct fabrication using 3-D printing technology. While such tech-
nologies are currently limited by resolution at the scale of the PEN networks cre-
ated above, some eﬀorts have been made to manufacture 3-D objects using 3-D pho-
topolymerisation and 2 photon photoinitiator absorption to drive the polymerisa-
tion reaction, permitting an object to be created or patterned using multiphoton
microscope-driven excitation or stereolithography (Arcaute, Mann et al., 2006; En-
gelhardt, Hoch et al., 2011; Lee, Moon et al., 2008). Biomaterials mimicking colla-
gen have also been created which could also take advantage of this technology (e.g.
Lee, Lee et al. (2006a)), which could potentially allow direct polymerisation of a cell-
seeded matrix with a functional microﬂuidic network within it, obviating the need
for PDMS moulding entirely.
The current limiting factor is in the physical properties of the extracellular mat-
rix, where the current choices are either using a biologically relevant but weak mat-
rix such as collagen, or strong matrix based upon artiﬁcial polymers which is not
biocompatible. The challenge is to ﬁnd a biocompatible matrix which permits the
biological processes of interest to take place whilst also having desirable physical
characteristics. There is much ongoing work in the biomaterials ﬁeld to produce
vascularised constructs for surgical purposes, which may be equally adaptable for
this use, or used as a basis for further research in this area. A diﬀerent approach
to micromoulding would be the use of scaﬀold material which may be selectively
photopolymerised, or better, ablated, by MP laser excitation may permit direct cre-
ation ofmicroﬂuidics in cell-laden hydrogels, providing that such direct control over
microscope hardware is possible and that photopolymerisation and/or ablation is
compatible with direct cell seeding.
Attempts to cocultureHUVECswithVSMCswere not as successful as previously-
published work. This might be due to the culture conditions or the smooth muscle
types used, so further investigation of the coculture system might provide new in-
sights into factors involved in the formation and stabilisation of a vascular network.
Spheroids containing both cell types formed, but did not result in stable associations,
with the C3H/10T½ migrating freely through the gel (not shown). Further work
to integrate smooth muscle with the spheroid outgrowth model would allow more
complex situations to be modelled, since EC–VSMC interactions result in the pro-
duction of basement membrane proteins, such as laminin, ﬁbronectin, collagen IV,
perlecan, nidogen, etc., which will stabilise and modulate cellular interactions and
behaviour, being a more complete, and hence physiologically relevant, model. This
would allow, for example, study of angiogenesis as a consequence of disruption of
the smooth muscle layer.
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This work did not explicitly investigate the proliferation and viability of cells in
the culture models used. The issue with necrosis in larger gels, and potential apop-
tosis in control gels or under conditions where the necessary survival cues are not
present, indicates a need to investigate the extent to which it occurs and its causes
in order to use a model without these additional factors complicating observations.
This would allow the observation of apoptosis as part of vascular regression and
homeostasis without additional unwanted eﬀects complicating interpretation.
In order to further understand the signalling and developmental processes at
work in the spheroid model, it would be useful to examine the spheroid structure
in more detail. Cells at the outer surface in contact with the matrix may show apical-
basal polarity, while those in the centre surrounded entirely by cells may not, and
may even have a tendency towards apoptosis if in an unsuitable environment (Korﬀ
and Augustin, 1998). This should be possible to investigate using TEM to examine
cellular ultrastructure and immunoﬂuorescence to localise junctional and basement-
associated proteins, as well as to assess cell viability and proliferation within the
spheroid.
Spheroid gels may also be a useful means for investigating the eﬀects of growth
factors, inhibitors and matrix properties used in combination with microﬂuidics.
Shamloo andHeilshorn (2010) have used endothelial-coated dextran beads to invest-
igate matrix stiﬀness and growth factor gradients in a microﬂuidic device. However,
spheroids may provide a more realistic model, in particular beads may result in an
incorrect polarisation of the EC layer, and were signiﬁcantly larger, though they are
readily be produced in greater quantity than spheroids, which requiremanual pipet-
ting. Similar microﬂuidic designs, for example Jeong, Kwon et al. (2011), have also
been used tomodel EC responses to growth factor gradients. The beneﬁt of this type
of device is precise control over growth factor or inhibitor concentration through
the creation of a deﬁned concentration gradient between the source and sink, which
would allow much greater control over eﬀective concentrations than in static 3-D
cultures where diﬀusion is passive, though both are potentially aﬀected by matrix
interaction in addition. Such a system may be used to model the combination of
bulk ﬂow of interstitial ﬂuid between capillaries and lymphatics (source and sink)
combined with the eﬀects of factors arising from cells and tissues within the gel, the
diﬀusion and interactions of which will be modulated by the bulk ﬂow.
Chapter 5
Role of vascularisation in lymph node
development
5.1 Introduction
5.1.1 Cellular interactions and signalling during LN development
As discussed in Section 1.3.3, secondary lymphoid organs develop as a result of the
interaction between lymphoid tissue inducer and organiser cells. Brieﬂy, following
initial attraction of LTis as a result of LTo expression of chemokines such as CXCL13
and CCL21, LTis activate the LTβR-bearing LTos by LT expression, leading to upreg-
ulation of cytokines, adhesion molecules and TRANCE with positive feedback as a
result of increased LTi recruitment causing further increase in LTo activation (van de
Pavert and Mebius, 2010; van de Pavert et al., 2009; Vondenhoﬀ et al., 2009a). LTis
express both TRANCE and TRANCER, leading to activation of LTis as they come
into intimate contact, leading to further LT upregulation and local clustering and
retention of LTis (Vondenhoﬀ et al., 2009a). The cellular interactions and signalling
processes involved are now fairly well established, though the means by which the
initial sites for LNdevelopment are speciﬁed are still not fully understood. The above
interactions are required to establish a functional stromal environment in the LN,
which is subsequently followed by compartmentalisation into T and B cell zones
(Bajénoﬀ et al., 2006). However, the LN is also deﬁned by its unique association of
blood and lymphatic vasculature, which develop to some extent independently, and
whose development is initiated prior to LTi inﬁltration (Bénézech et al., 2010). The
means by which the developing anlagen is subsequently vascularised are also not
well understood, and the spheroid model developed by Korﬀ and Augustin (1998)
and in Chapter 4 could potentially be used to elucidate the mechanisms which drive
this process.
Existing work shows LNs to be vascularised at later stages of development, for
example after E17.5 when HEVs begin to express PNAd, subsequently permitting
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lymphocytes to inﬁltrate the anlagen (Mebius, 2003; Randall, Carragher et al., 2008).
The process of lymphocyte entry into the anlagen ismost likely to be dependent upon
a functional vascular network, and particularly aHEV network to permit eﬃcient ex-
travasation and inmigration (Willard-Mack, 2006). In the adult LN, lymphatic and
HEV maintenance is dependent upon LTβR (Liao and Ruddle, 2006), and this may
also apply to the developing anlagen, which is surrounded by a lymph sac and con-
tains vessels expressing LTβR (Vondenhoﬀ et al., 2009a). Initially the HEVs express
MAdCAM, and only later express PNAd (Mebius, Streeter et al., 1996), restricting
initial lymphocyte migration to LTi and γδ T cells, and only later permitting entry
of naïve T and B cells, which act as a source of LT signalling in place of LTis (Ran-
dall et al., 2008). Changes in LT signalling may drive maturation and expansion of
the nacent blood vasculature in the anlagen. An alternative route for lymphocytes
would be to migrate through the surrounding tissue after extravasation elsewhere,
perhaps in a similar manner to the initial LTis, though the lymph sac may present a
physical barrier to migration; this is however unlikely to play a major role following
the establishment of a functional HEV network.
While blood vessels are clearly present at later stages, this does not preclude their
presence at earlier stages, with blood vasculature being visible in at least the bra-
chial node at E14.5 (Vondenhoﬀ et al., 2009a), containing both VEGFR2+MECA32+
and VEGFR1+VEGFR2+MECA32 /low vessels, which could represent venous and
arterial supply, respectively. Other nodes such as the inguinal node could not be
identiﬁed by Vondenhoﬀ et al. (2009a), but this was not a problem using hCD2-GFP
embryos, where the inguinal anlagen was clearly visible, albeit slightly smaller and
having more diﬀuse LTi distribution than the axillary and brachial nodes. However,
the embryonic origin of these vessels is not known, and the cells could have arisen
from the surrounding lymph sac, which is known to contain cells of both blood and
lymphatic character (Cupedo et al., 2004), or inﬁltrated from external vessels through
angiogenesis or migration of single cells. Despite this ﬁnding, most current models
of lymph node development consider vascularisation to be a late stage development,
prior to lymphocyte ingress, as discussed in a recent review by Coles et al. (2010). At
other sites, such as the lymph sac adjacent to the cardinal vein, vessels are entirely
absent at E14.5, as shown by Hirashima, Sano et al. (2008). This discrepancy may
be explained by the majority of vascular development being extensive elaboration at
later stages of a small network present at early stages, which may have been missed
by other workers. This may have been due to the diﬃcultly of obtaining anlagen
at early stages; in particular due to identiﬁcation of anlagen prior to LTi inﬁltration,
early stage development has not been studied in the same detail as later stages. Prior
to the advent of suitable transgenic mouse models such as the hCD2-GFP mouse
enabling identiﬁcation and isolation of the anlagen, study via serial sectioning was
haphazard at best and may have resulted in miss-identiﬁcation or lack of identiﬁc-
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ation of important features of LN development. Endothelial and basement mem-
brane marker expression change during development, for example the expression of
endomucin only at later stages in comparison with CD31 (Foster et al., 2008) which
may lead to the mistaken assumption that vascular endothelium is not present when
immunoﬂuorescence, for example, fails to show endothelial staining. This may in-
deed have been an issue with the wholemount and frozen section imaging of LN
anlagen in the Chapter 3.
Here, the assumption ismade that the anlagen is initially avascular (bar the lymph
sac), though the true state of vascularisation during early anlagen formation (prior
to E14.5, and possibly later) is not well established. Given that this assumption is
correct, it must therefore become vascularised at some point during development,
and it was hypothesised that this is as a result of ingrowth of existing vasculature
via angiogenesis in response to the production of pro-angiogenic signalling from
the anlagen, possibly as a result of hypoxia and metabolic demands as the tissue
condenses (Nanka et al., 2006). Alternatively, this could be due to the inﬁltration of
single endothelial cells followed by de novo assembly of the vascular bed (i.e. vas-
culogenesis), later followed by connection to the external vasculature, i.e. similar to
lymph sac formation from local veins. This would presumably also depend upon the
production of pro-angiogenic and/or chemoattractant molecules from the anlagen,
such as VEGF and bFGF. It might additionally be hypothesised that the anlagen will
also produce anti-angiogenic molecules to precisely regulate the point at which vas-
cularisation occurs, which may lead to a switch between anti- and pro-angiogenic
states, and potentially a switch back from pro- to anti-angiogenic (or at least a neut-
ral state to maintain the vasculature) once vascularisation is complete, to prevent
hypervascularisation.
5.1.2 Study of vascularisation mechanisms using an in vitromodel
If the evidence of a vascular supply (arterial and venous vessels) at the centre of the
anlagen at E14.5 is correct, this primitive network must expand and elaborate dra-
matically during subsequent days to give rise to the complex HEV-containing vascu-
lar network found in the mature organ. The spheroid model may be able to provide
some insight into the processes driving these changes. In Chapter 4, it was demon-
strated that the spheroid model was responsive to growth factors, seen as increased
sprouting into the surrounding gel. More growthwas seenwhen the spheroids were
exposed to more potent combinations of factors. This model may be equally useful
for studying LN development and vascularisation. If LN anlagen were carefully dis-
sected from hCD2-GFPmice, and embedded into a gel containing endothelial spher-
oids, it should be possible to determine whether the rate of outgrowth of the spher-
oids is greater or less than a control gel containing spheroids only. Additionally,
due to the placement of spheroids in the gel, it should also be additionally possible
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to study spatial relationships as a consequence of soluble growth factors or inhibitors
diﬀusing through the gel, as well as physical forces (Korﬀ and Augustin, 1999). A
schematic illustration of how the model would allow the study of spatial eﬀects is
shown in Figure 5.1. Using this model, it should therefore be possible to determine
if the combination of all factors produced by the anlagen result in a net pro- or anti-
angiogenic environment, and with the addition of inhibitors and exogenous growth
factors it may be possible to use this model to dissect the signalling pathways via
blockade and rescue of speciﬁc signalling steps.
5.1.3 Aims
1. To determine if the spheroid outgrowth model may be used to quantify the
spatial distribution of growth factors and/or inhibitors.
2. To determine if developing lymphoid organs promote or retard angiogenesis
using the spheroid outgrowth model.
3. To determine if during the timecourse of development there are changes in any
observed eﬀects.
4. To determine the generalmechanisms bywhich any observed eﬀects take place.
5.2 Results
5.2.1 Lymphoid explants suppress spheroid angiogenesis
LN anlagen (axillary, brachial, cervical and inguinal) and thymi were dissected from
E15.5 hCD2-GFP mouse embryos and transferred into PBS on ice. HUVEC methyl-
cellulose spheroids made as described in Section 2.5 were recovered, spun down
and resuspended in neutralised collagen solution as described in Section 2.4.1. The
spheroid–collagen suspension was then pipetted into three glass-bottomed dishes
(Iwaki) containing ethanol-sterilised nylon rings of deﬁned volume (6mm diameter,
1mm deep), on ice. To prevent leakage of the spheroid-collagen suspension, and to
prevent the nylon rings from ﬂoating in the culture medium given their low dens-
ity, the rings were sealed to the cover glass using vacuum grease (Dow Corning).
Selected LN anlagen and thymi were transferred into the collagen gels and gently
mixed in. No tissue was transferred into the control gel, which contained HUVEC
spheroids only. Following gelling of the collagen at 15 °C for 1 hour, each gel was
overlaid with ECGM and incubated at 37 °C for 48 hours. The gels were ﬁxed in 4%
PFA for 1 hour, washed three times in PBS, and then stained for CD31 and GFP to al-
low visualisation of the HUVECs and hCD2-GFP+ cells (LTi cells in the LN anlagen
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A Pro-angiogenic
B Anti-angiogenic
Explant distance
Figure 5.1: Predicted behaviour of the spheroid model. If a tissue explant produces
predominantly pro-angiogenic soluble factors (A), these would be expected to increase
angiogenesis locally, with the eﬀect decreasing with distance as the concentration falls.
If the explant is producing mainly anti-angiogenic soluble factors (B), the opposite ef-
fect would be predicted, with angiogenesis being suppressed in close proximity to the
explant, the eﬀect again decreasing with distance.
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and LTis and lymphocytes in the thymus). Mouse anti-human CD31 clone 10G9 was
used with goat anti-mouse AF594 secondary and GFP-AF488.
The gels were suﬃciently large (3-4mm approximate ﬁnal minimum diameter
following gel contraction) that it was not possible to image using a single ﬁeld of
view. The GFP (green) and CD31 (red) channels were imaged separately, compris-
ing between 8–14 overlapping monochrome images per channel, which were later
recombined as described in Section 2.6.6. The assembled images are shown in Fig-
ure 5.2, with image analysis data (described below) overlaid over each image. The
edges of the LN and thymus explants were determined using thresholding to distin-
guish between local background and hCD2-GFP ﬂuorescence.
There is a certain amount of variation in the amount of outgrowth between the
spheroids in the control sample, with all but a few spheroids having multiple out-
growths of at least 100–200 µm. A similar observation may be made for the sample
containing the thymus explant, however spheroids in close proximity to the explants
appear to have reduced outgrowth in comparison to their counterparts at further dis-
tances. A directional eﬀect was also seen; in several cases outgrowths were only seen
on the side of the spheroid distant to the explant, while on the near side there was
little or no outgrowth (examples: spheroids 16, 19, 20, 27 and 29). These spheroids
appeared at an intermediate distance from the explant, while those nearer (e.g. 17,
23, 31, 34) showed suppression on all sides, and those at further distance (e.g. 4, 6, 30,
40) showed long outgrowths on all sides. A similar eﬀect was seen in the LN explant
gel, however due to the greater number of smaller LN explants in place, the max-
imum distance a spheroid may be found from an explant was reduced, and the close
packing of spheroids in the gel made accurate analysis of all spheroids impossible,
analysis of touching spheroids being omitted. However, it was again possible to
make the general observation that spheroids in close proximity to an explant (e.g.
18, 28, 32, 36, 41, 42, 46) outgrew less than at greater distance (e.g. 3–7). Diﬀerential
outgrowth at intermediate distances was not as clearly visible in this gel, but might
be present (e.g. 14, 22, 25).
5.2.2 Determination of optimal image analysis strategy
Image analysis was performed using the strategies described in Figure 2.3 (panels
C–F). The total number of sprout tips, initial minimum and ﬁnal maximum radii,
perimeter length, area and total outgrowth length weremeasured using ImageJ (Ab-
ràmoﬀ, Magalhães et al., 2004; Rasband, 1997-2011). Figures 5.3, 5.4 and 5.5 show the
results of this analysis following export of themeasured data and visualisation using
the R statistical package (R Development Core Team, 2006). The primary measure-
ment parameters in Figure 5.3 showed close correlation with each other with high
R2 values using linear regression. In order to determine which parameters most
closely represent angiogenic outgrowth, an unbiased pairwise comparison without
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a priori expectations was performed between each parameter correlation in order to
rank the measurement parameters. This was performed for the control and thymus
only, the LN sample having limited utility owing to the limited range of several of
the parameters, which might have introduced bias. The process and results are de-
tailed in Table 5.1. The ranks for each parameter were summed in order to compute a
summed rank for each. Both control and thymus samples show similar results, with
perimeter length and total sprout length being most highly correlated, i.e. measur-
ing very similar features. In contrast, sprouts and surface area do not correlate as
well overall, and do not correlate well with each other, i.e. are not measuring sim-
ilar features. Outer radius is the poorest measure of outgrowth, showing limited
correlation overall.
5.2.3 Quantiﬁcation of angiogenesis suppression
In order to determine if distance from LN or thymus explant aﬀected the amount
of spheroid outgrowth, the number of sprouts and total sprout length were plotted
against the distance from each spheroid to the explant. Additionally, the derived
parameters radius ratio (outer/inner radius) and area ratio (perimeter/area) were
also plotted (Figure 5.4). In all cases, a signiﬁcant amount of variability complic-
ated interpretation, reduced by grouping the measurements into 250 µm bands with
distance from the explant in order to reduce the eﬀects of noise, eﬀectively the same
strategy as employed by Blacher et al. (2001) to quantify aortic ring outgrowth. Apos-
itive relationship was seen for both the LN and thymus samples, the general trend
being a reduction in spheroid outgrowth closer to the explant, i.e. local suppression
of angiogenesis. The correlation was generally stronger for all measurement para-
meters for the LN sample, despite the thymus sample having an extended distribu-
tion over distance. R2 values were generally low due to there being a large amount
of intrinsic variation which could not be accounted for by the ﬁtted line; while the
LN relationship appeared to be approximately linear, this was not the case for the
thymus, perhaps due to outgrowth reaching a plateau after a certain distance. The
best correlation was seen with the total sprout length parameter, followed by the ra-
dius ratio parameter derived from the outer radius, which was unexpected due to
the inner radius term servingmainly to introduce noise. The radius ratio was shown
to correlate poorly with the other parameters in the previous section. The area ra-
tio was extremely noisy and the thymus value was very poor; while the perimeter
length appeared to be a good measure of outgrowth, combining it with the surface
area introduced a large amount of noise. In contrast, the number of sprouts and total
sprout length which were used underived showed a much higher R2 values for the
LN, which appeared to reﬂect the dataset more closely—the higher values seen for
the derived parameters may be artefactual.
In order to determine if proximity of spheroids to each other, rather than the
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Control
LN anlagen
Thymus
Detail of analysis
Figure 5.2: E15.5 lymphoid tissue explants suppress HUVEC spheroid tube outgrowth.
HUVECswere stained using anti-CD31withAlexa Fluor 594 (white) and explants using
anti-GFP-Alexa Fluor 488 (green). Measurements are overlaid in cyan (inner and outer
radius) and orange (perimeter/area and sprout length), with the borders of the GFP+
explants outlined in green. Magniﬁed views showing analysis of the control sample in
greater detail are shown on the bottom right. The analysis is identical to that described
in Figure 2.3. The control gel contained spheroids only, while the LN and thymus gels
contained LNs and thymi from E15.5 hCD2-GFP embryos.
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Figure 5.3: Correlations between E15.5 primary measurement parameters. The asso-
ciation between the measured parameters sprouts perimeter length area, and total sprout
length are shown in all possible pairwise combinations. The coeﬃcient of determina-
tion (R2) for each sample shows the proportion of the variation accounted for by simple
(least squares) linear regression.
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Table 5.1: Determination of optimal image analysis strategy for E15.5 explants.
Strategies were ranked in ascending order from highest to lowest correlation, using
pairwise comparisons with the strategy listed under “rank” being common to the com-
parisons. The strategies are ordered by the sum of all their ranks, with perimeter length
and total sprout length having the highest relative correlations overall. The rank sum
is also shown excluding the outer radius, due to this measurement introducing a large
amount of noise which could bias the other rankings. The lymph node sample was
omitted here due to the limited range of explant distances biasing the measurements.
Rank
Total
Perimeter sprout Outer Rank Rank
Strategy length length Sprouts Area radius suma sumb
C
Perimeter length - 1 2 1 1 5 4
Total sprout length 1 - 1 2 2 6 4
Sprouts 3 2 - 3 4 12 8
Area 2 3 3 - 3 11 8
Outer radius 4 4 4 4 - 16 -
T
Perimeter length - 1 2 1 1 5 4
Total sprout length 1 - 1 2 2 6 4
Sprouts 2 2 - 4 4 12 7
Area 3 3 3 - 3 12 9
Outer radius 4 4 4 3 - 15 -
aOf all strategies
b Excluding outer radius
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Figure 5.4: Relationship between E15.5 spheroid outgrowth and distance to tissue ex-
plant. The primary measurement parameters sprouts and total sprout length and derived
parameters perimeter:area ratio and outer:inner radius ratio have been plotted against dis-
tance from the explant (shown as eﬀectively inﬁnite for the control). Themeasurements
were grouped into 250 µm explant distance bands, with the mean and standard error of
the mean calculated for the explant distance and measured parameter for each group.
The coeﬃcient of determination (R2) for each sample shows the proportion of the vari-
ation accounted for by simple (least squares) linear regression. All parameters show
suppression of angiogenesis in close proximity to the explant with the exception of the
the thymus for perimeter:area ratiowhich shows a weak correlation only.
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Figure 5.5: Relationship between E15.5 spheroid outgrowth and distance to neighbour-
ing spheroids. The primary measurement parameters sprouts and total sprout length
and derived parameters perimeter:area ratio and outer:inner radius ratio have been plotted
against distance to nearest neighbouring spheroid. The measurements were grouped
into 250 µm neighbour distance bands, with the mean and standard error of the mean
calculated for the neighbour distance and measured parameter for each group. The
coeﬃcient of determination (R2) for each sample shows the proportion of the variation
accounted for by simple (least squares) linear regression. The control sample, which is
not subject to the additional eﬀects of tissue explants, shows a weak positive correlation
for all parameters except total sprout lengthwhich shows a stronger correlation, possibly
due to the inﬂuence of outliers.
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LN anlagen or thymus explants, caused the observed diﬀerences in spheroid out-
growth, neighbour distance (distance from spheroid to nearest neighbour) was plot-
ted against the same measurement parameters used above (Figure 5.5). The com-
ments above regarding measurement parameters apply equally here. These data
exhibited too much variability to show any robust trend, but there was a possible
relationship between neighbour distance and total number of sprouts or total sprout
length for the LN and thymus samples (not shown). In the LN and thymus samples,
spheroids were more closely spaced nearer the explants, which would result in cor-
relation between neighbour distance and the measured parameters when the eﬀect
was really due to the explant. For this reason, the control sample was the only
useful sample to observe, the other samples being omitted from the plots, and this
showed some correlation for several measurement parameters, but for sprouts and
total sprout length it was biased by two very large measurements.
Due to noise in the measured outlines, the perimeter:area ratio for a spheroid
without any outgrowthsmay actually be similar to a spheroidwith large outgrowths,
due to the roughness of the outline leading to a disproportionate increase in the
perimeter length compared with the surface area. Adding several erosion or dila-
tion steps to the analysis protocol may reduce the contribution of high-frequency
noise and 2-D outgrowth under the collagen gel in the images, both of which in-
troduce additional unwanted variation. Additionally, single large measurements
exerted a disproportionate eﬀect upon the mean of some points in the distribution
plots. Spheroids of incorrect initial size were excluded, it being necessary to exclude
small fragments of spheroids and joined spheroids which were too large, and not
meaningful to include in the analysis.
5.2.4 Collagen matrix does not aﬀect angiogenesis suppression
In order to determine if reduced tube outgrowth in proximity to tissue explants was
due to a lack of collagen formation, perhaps due to dilution of the collagen with
PBS or due to secretion of MMPs or MMP inhibitors by the explant, selected spher-
oids were imaged using MP microscopy to visualise the collagen ﬁbres (Figure 5.6).
Spheroids were imaged both near to the explants, where angiogenesis was seen to be
suppressed, and at a distance of several millimetres where it was not. Collagen ﬁbres
were seen in all cases in intimate association with the spheroids. Spheroids adjacent
to the explants were almost perfectly spherical with little evidence of outgrowth; a
small number of round single cells were seen close to the spheroids, but were not
in contact with them. In contrast, the control sample, and explant samples distant
from the explant, contained spheroids with a large number of sprouts extending
radially away from the spheroid surface, some showing evidence of branching. A
larger number of rounded single cells were also in evidence at further distance than
seen for the adjacent spheroids.
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Figure 5.6: Eﬀect of collagen matrix upon tube outgrowth. Using SHG, collagen ﬁbres
(white) were imaged in addition to hCD2-GFP (green) and CD31 (red). In treatments
containing E15.5 tissue explants, spheroids were imaged both adjacent to and at a dis-
tance (> 1mm) from the explants. In all cases, collagen ﬁbres are seen in intimate
contact with both the spheroid and its outgrowing tubes, and additionally surround-
ing the explant. Collagen ﬁbres are slightly denser where in intimate contact the the
spheroid and any tube outgrowth, but are otherwise continuous with some variation
in local density, possibly a result of gel contraction by nearby spheroids. The second
harmonics have been removed in the bottom panels to permit an unobscured view of
the spheroid and explant structures. Tube outgrowth in spheroids distant to the LN
or thymus explant is comparable to the control sample containing no explant. Tube
outgrowth in spheroids adjacent to explants is almost entirely absent, spheroids hav-
ing an almost perfectly spherical shape. GFP+ cells appear to have migrated out of the
explanted tissues some way into the collagen gel. Scale is 45 µm.
5.2. RESULTS 183
In addition to the collagen structure, these images showed that for both the LN
and thymus samples, GFP+ cells were present in the matrix up to at least 300 µm
from the tissue explant. It is not clear if these have migrated out into the gel from
the explant, or were dispersed in the gel when mixing the tissue into the collagen
solution prior to gelling.
5.2.5 High throughput screening of explant–spheroid interactions
Following the initial experiments using the HUVEC spheroid model with E15.5 tis-
sue explants, the protocol was scaled up to allow larger scale experiments using
multi-well plates. Axillary, brachial, cervical and inguinal LNs and thymiwere taken
from E14.5–E17.5 mice. Additionally, the skin above the brachial node was taken as
a control for vascularised tissue. A spheroid-seeded 3mg/mL neutralised collagen
solution was introduced into 6mm diameter, 1mm thick steel rings in the wells of a
24-well plate, chilled to 4 °C on ice. Tissue explants were gently mixed into the colla-
gen solution using ﬁne forceps, and the collagen was then set at 37 °C for 10mins be-
fore overlaying with ECGM. The gels were cultured for 24 hours prior to ﬁxing with
4% PFA for 1 hour and then washed with PBS before staining with GFP-AF488 and
CD31 with an AF594 secondary, as for the previous experiment, followed by 1:5000
DAPI (5mg/mL stock). Half of the tissue samples were ﬁxed with PFA for 60mins
prior to addition to the collagen; these samples were controls to demonstrate that
any eﬀects were due to soluble factors being actively produced by the explant, since
in ﬁxed samples soluble factors should be ﬁxed to the matrix and the cells should be
killed and hence unable to actively produce more.
Images of gels in 24-well plateswere obtained through high thoughput plate ima-
ging using an ImageXpress epiﬂuorescence system (Molecular Devices), which was
used to acquire z-stacks of tiled epiﬂuorescence images, which were subsequently
assembled into colour z-stacks using ImageJ as described in Section 2.6.6. Repres-
entative wells for E14.5 explants are shown in Figure 5.7, and for E17.5 explants in
Figure 5.8. Note that these images aremaximum intensity projections of the z-stacks,
and contain out of focus information due to each spheroid being in focus only in a
speciﬁc subset of the planes; during analysis, each spheroid outgrowth was meas-
ured individually in the correct focal plane (or planes, for sprouts growing at angles
passing through multiple focal planes).
The same trends observed previouslywith the E15.5 explants were also seenwith
the E14.5 and E17.5 explants: spheroid outgrowth was reduced or eliminated en-
tirely in close proximity to the explants, while appearing normal at further distance.
When PFAﬁxed explantswere used, the outgrowth in close proximity to the explants
appeared to be normal, equivalent to outgrowth at further distance. Additionally,
skin explants did not appear to suppress angiogenesis either, showing equivalent
outgrowth to the control sample, the same also applying to unﬁxed explants at fur-
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Figure 5.7: E14.5 explants suppress angiogenesis. Cervical node, thymus and skin from
an E14.5 embryo were embedded in a collagen gel seeded with HUVEC spheroids. In-
hibition of tube outgrowth from the spheroids is clearly visible in close proximity to the
cervical LN explant, whilst the eﬀect is not observed at distant sites. When the cervical
node is PFA ﬁxed prior to embedding in the gel, no inhibition of outgrowth is seen at
any distance from the explant. The same trend was observed when repeating using the
thymus in place of LNs. Using skin from above the brachial node, angiogenesis does
not appear to be suppressed. The spheroid only control shows the basal outgrowth rate
of sprouts from the spheroids. Spheroids have been annotated with numbers to allow
identiﬁcation during analysis. Images are representative views of 6mmdiameter wells;
scale bar is 1mm.
5.2. RESULTS 185
1
2
3
4
5
6
7
8
9
10
11 121314
15
16
18
19
20
21
17
22 23 24 25
26
27
28
29 30
3141
32 33
34
35
36
37
Cervical Cervical + PFA
Thymus Thymus + PFA
Skin Control
11
20 21
22
23
24
25
2627 28
29
30
31
39
40
41
4342
44
32
33
3435
36
38 45
46
1 2
3 45 6
7
8 9
10
11
13
19
20
21
22
23
24 2526
27
28 29
30 31 39
40
41 43
4232
33
34
35 36
37
38
1
2 3
4
5
6
78 9
10 11 12
13
14 15
16
19
20
21 22
23
24
27
28
29
30
31 3233
34
37
50 51
48
49
2
3
4 5
6 78
9
101112
15 16 17
22 23 24
25 26 27
39
40
41
42
32
33 34 3536 37
38
50
51
53
47
48 49
57
54
55
56
58
59
60
6
7
89 10
11 12
13
15
16
18 19
20 2117
2223
24
25 26 27
28
29
30
39 40
41
43
42
44
33
34
35
36
37 38
45
46
Figure 5.8: E17.5 explants suppress angiogenesis. Cervical node, thymus and skin from
an E17.5 embryo were embedded in a collagen gel seeded with HUVEC spheroids. In-
hibition of tube outgrowth from the spheroids is clearly visible in close proximity to the
cervical LN explant, whilst the eﬀect is not observed at distant sites. When the cervical
node is PFA ﬁxed prior to embedding in the gel, no inhibition of outgrowth is seen at
any distance from the explant. The same trend was observed when repeating using the
thymus in place of LNs. Using skin from above the brachial node, angiogenesis does
not appear to be suppressed. The spheroid only control shows the basal outgrowth rate
of sprouts from the spheroids. Spheroids have been annotated with numbers to allow
identiﬁcation during analysis. Images are representative views of 6mmdiameter wells;
scale bar is 1mm.
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ther distance from the explants. The images were analysed using ImageJ using cus-
tom macros to analyse the images as detailed in Section 2.7.2 and Figure 2.4. Auto-
mated analysiswas unfortunately incompatiblewith epiﬂuorescence z-stacks, neces-
sitating manual analysis as detailed in Section 2.7.1 and Figure 2.3. Using manual
analysis, the total sprout outgrowth lengthwasmeasured for both E14.5 andE17.5, in
addition to the number of sprouts andmaximum spheroid outgrowth length (Feret’s
diameter) for E14.5 only, using ImageJ to perform the measurements. The results are
shown in Figures 5.10 and 5.11.
Correlation plots, as for the previous experiment, show relatedness between the
diﬀerent measurement parameters; ordering by rank is shown in Table 5.2. Over-
all, total sprout length was the most highly-correlated, followed, by maximum out-
growth length and then number of sprouts. Plots of spheroid outgrowth against
distance from explant showed that the cervical LN and thymus resulted in a positive
relationship due to the local suppression of outgrowthwith a relatively high R2 value
(when taking into account the variation within the sample). Fixed cervical LN and
thymus, and unﬁxed skin explants, resulted in a ﬂat line with an R2 value tending
towards zero, i.e. showing no relationship between explant distance and spheroid
outgrowth. The only exception is that the PFA-ﬁxed cervical LN showed a positive
relationship when considering total sprout outgrowth which appeared to be a result
of two potential outliers close to the explant.
5.3 Discussion
5.3.1 Experimental details
The initial experiment using E15.5 explantswas complicated by several factorswhich
later experiments attempted to correct. In some of the gels, there were too many tis-
sue explants and/or too many spheroids, which altered the spatial distribution of
spheroids with respect to the explants. As shown in Figure 5.2, an increased num-
ber of explants increased the probability of a spheroid being in close proximity to
an explant, while reducing the maximum distance, e.g. the LN sample contained
no spheroids further away than  700µm, while the thymus sample extended past
1500 µm.
Having multiple small explants also complicated ﬁnding the boundary of the ex-
plants during image analysis, particularly in the E15.5 LN sample where the edges
were determined using thresholding on the GFP ﬂuorescence, the large number of
explants making determination of the local background diﬃcult. Additionally, hav-
ing too many spheroids complicated quantiﬁcation of outgrowth since it was not
possible to measure outgrowth for spheroids which touched, as seen for the LN
sample, in particular in Figure 5.2 where the measurements are biased heavily in
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Figure 5.9: Correlations between E14.5 primary measurement parameters. The associ-
ation between the measured parameters total outgrowth,maximum outgrowth and sprouts
are shown in all possible pairwise combinations. The coeﬃcient of determination (R2)
for each sample shows the proportion of the variation accounted for by simple (least
squares) linear regression.
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Table 5.2: Determination of optimal image analysis strategy for E14.5
and E17.5 explants. Strategies for E14.5 measurements were ranked
in ascending order from highest to lowest correlation, using pairwise
comparisons with the strategy listed under “rank” being common to
the comparisons. The strategies are ordered by the sum of all their
ranks, with total sprout length having the highest relative correlations
overall.
Rank
Maximum Total
outgrowth sprout Rank
Strategy length length Sprouts sum
C
Maximum outgrowth length - 1 1 2
Total sprout length 1 - 2 3
Sprouts 2 2 - 4
C LN
Maximum outgrowth length - 2 2 4
Total sprout length 1 - 1 2
Sprouts 2 1 - 3
T
Maximum outgrowth length - 1 2 3
Total sprout length 1 - 1 2
Sprouts 2 2 - 4
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Figure 5.10: Analysis of spatial eﬀects for E14.5 explants. The relationship between dis-
tance of spheroids from the explants and the measured parameters total outgrowth,max-
imum outgrowth and sprouts are shown. The measurements were grouped into 250 µm
explant distance bands, with themean and standard error of themean calculated for the
explant distance andmeasured parameter for each group. The coeﬃcient of determina-
tion (R2) for each sample shows the proportion of the variation accounted for by simple
(least squares) linear regression. In all three cases, a positive linear relationship is seen
for both the cervical LN and thymus, which is absent or less apparent with ﬁxed tissue,
and is also absent in the skin sample.
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Figure 5.11: Analysis of spatial eﬀects for E17.5 explants. The relationship between
distance of spheroids from the explants and total outgrowth is shown. Themeasurements
were grouped into 250 µm explant distance bands, with the mean and standard error of
themean calculated for the explant distance and total sprout outgrowth. The coeﬃcient
of determination (R2) for each sample shows the proportion of the variation accounted
for by simple (least squares) linear regression. A positive relationship is seen for both
the cervical LN and thymus, though this relationship is not completely linear. Fixation
of the cervical LN results in an increased amount of outgrowth, comparable to the skin
sample. The skin sample showed less suppression of angiogenesis, however it and the
thymus appeared to have a peak amount of outgrowth at 800–1000 µm, with less nearer
to the explant and thewell edge. Fixation of the thymus raised the amount of outgrowth
within 500 µm from the explant to levels comparable to the skin sample.
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Figure 5.12: Edge and neighbour eﬀects. Using the E17.5 control sample, spheroid out-
growthwas plotted against edge distance (distance from spheroid to support ring edge)
and neighbour distance (distance from spheroid to nearest neighbour). The measure-
ments were grouped into 250 µm distance bands, with the mean and standard error of
the mean calculated for the edge and neighbour distance and total sprout outgrowth.
The coeﬃcient of determination (R2) for each sample shows the proportion of the vari-
ation accounted for by simple (least squares) linear regression. This showed a general
decrease in outgrowth moving away from the ring edge toward the centre of the well.
Plotting spheroid outgrowth against distance to nearest neighbour showsno clear trend.
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favour of short distances. Later experiments attempted to rectify these problems by
limiting the number of explants to one or two per gel, and by reducing the spheroid
density. However, this change reduced the probability of spheroids being present in
close proximity to the explant. This is illustrated graphically in Figure 5.13. Ideally,
the number of spheroids should be evenly distributed over distance, but the radial
arrangement precludes this. Increasing the number of explants reduces the range of
distances, hence increasing the probability of ﬁnding a spheroid at shorter distance,
but at the expense of not collecting information for further distances. These issues
could be mitigated by alteration of the gel dimensions, discussed below.
Clustering of spheroidswas also reduced bymore eﬃcient resuspension of spher-
oids in neutralised collagen solution, which was intended to result in a more even
distribution of spheroids within and between treatments. Initially 48 hours, the out-
growth time prior to ﬁxation was reduced to 24 hours in order to reduce total out-
growth, to prevent outgrowths from neighbouring spheroids touching, and to in-
crease the robustness of quantiﬁcation.
5.3.2 Secreted factor gradients
When considering the process of vascularisation of a developing organ, the initial
working hypothesis was that initially avascular developing LN anlagen require vas-
cularisation, and hence they would secrete factors which would collectively form
a net pro-angiogenic environment, e.g. driven by hypoxia or some other mechan-
ism. When taken and placed in close proximity to HUVEC spheroids embedded in
a collagen gel, the spheroids would therefore respond to these factors. Due to the
random placement of spheroids within the gel, gradient eﬀects due to the diﬀusion
of factors from the spheroid would result in spheroids nearest to the explant being
exposed to a higher concentration of soluble factors than those at greater distance.
In consequence, it was expected that tube outgrowth would be greatest at closest
proximity to the anlagen, and least at a distance where diﬀusion of pro-angiogenic
soluble factors (such as VEGF) from the anlagen would be limited. As the vascu-
lar bed becomes established, this might lead to a change in the balance of pro- and
anti-angiogenic factors to switch to an anti-angiogenic or neutral state, which would
result in a change in the spatial pattern of spheroid outgrowth.
The experimental data, however, show that in fact the opposite appears to be
true. At E15.5, the LN explants collectively show an approximately linear relation-
ship between outgrowth and distance from the explant, with spheroids closer to
the explant having less sprout outgrowth, or total number of sprouts, than those at
greater distance. A similar pattern was seen at E14.5 and E17.5. At both E14.5 and
E17.5, PFA ﬁxation resulted in outgrowth near to the explant to increase to levels
similar to the control or unﬁxed tissue at further distance from the explant. The
thymus showed a similar pattern, albeit with the relationship not appearing as lin-
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Figure 5.13: Spheroid distribution. Given a 6mm diameter ring with a 1mm diameter
explant placed in the centre, the top plot illustrates that as the distance from the explant
increases, the gel area increases linearly. The measurements have been split into into
250 µm radial bands for convenience, and to mimic the pooling of experimental meas-
urements. If the gel was seeded with 50 spheroids, assuming even distribution within
the gel, the bottom plot illustrates the number of spheroids which would be expected to
be present within each band. Bands further away from the explant contain more spher-
oids, again as a linear function of distance. Note that this is a probability distribution;
spheroids are discrete objects and hence only whole numbers are present in reality.
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ear. In general the suppressive eﬀect of the E15.5 thymus was less than the LNs,
showing greater outgrowth overall with less suppression; only at distances under
250 µm is the suppression comparable to the LN suppression. The same trend was
also seen at E14.5 and E17.5, but at E17.5 outgrowth increases with increasing dis-
tance before declining to a steady level. Skin did not appear to signiﬁcantly aﬀect
outgrowth, being approximately similar to the control sample at E14.5; at E17.5 it
was not linear, having a mean value similar to the control, but a peak in outgrowth
at around 1000 µm from the explant. This was possibly a result of large explants
aﬀecting gel tension, discussed in more detail below. The most probable interpreta-
tion of these data is that soluble factors being actively produced by the LN or thymus
explants exerted a net anti-angiogenic eﬀect. The general trendwhichmay be drawn
from the data is that LN explants at all timepoints exhibited greater spheroid out-
growth with increasing distance from the explant, with a similar trend being shown
for thymus explants but exerting a less potent eﬀect. PFA ﬁxation of the tissue re-
stored angiogenic outgrowth in part or in full, indicating that this is likely to be an
active process of secreted factor production. Failure to restore all outgrowth at very
close distancesmay be a result of steric eﬀects at close proximity to the explant (phys-
ical constraints upon tube outgrowth) or due to inhibition upon direct contact with
the explant (e.g. upon contact with ﬁxed or sequestered inhibitory factors). It may
alternatively be a result of incomplete ﬁxation of the tissue, resulting in continued
production of inhibitory factors, but at a lower level than in unﬁxed tissue. At all
timepoints the thymus samples, and also the skin sample at E17.5, showed a peak
in angiogenic outgrowth at around 1000µm, and this eﬀect was reduced but not
entirely eliminated by ﬁxation. This eﬀect was not seen for the LN samples at any
timepoint.
In Figures 5.4, 5.5, 5.10, 5.11 and 5.12, linear regression was used to analyse the
relationship between distance and the amount of angiogenic outgrowth quantiﬁed.
This makes the assumption that the relationship is of a linear nature, which may not
be the case. Diﬀusion and the establishment of a concentration gradient within the
gel is aﬀected by several factors, including the gel concentration (pore size, degree
of cross-linking), aﬃnity of the solute for the matrix, and the solute concentration
and half life (if applicable). These eﬀects have been explored in a recent review by
Lieleg and Ribbeck (2011), considering these and other eﬀects upon diﬀusive ﬁlter-
ing mechanisms in extracellular matrix. Complex mathematical models of diﬀusion
in biological matrices exist, such as that developed by Kapellos, Alexiou et al. (2007).
However, the most appropriate models in this context are direct experimental meas-
urements such as those of Ramanujan et al. (2002), which demonstrated that colla-
gen increasingly hinders diﬀusion with increasing concentration, most likely to due
an increase in the “eﬀective tortuosity”, that is the eﬀective path a molecule must
travel to get from a starting point to its destination compared with the straight line
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path it could travel in the absence of such hindrance. The diﬀusion coeﬃcient was
also determined experimentally to decrease with increasing hydrodynamic radius
(or Stokes radius; eﬀectively the particle size or mass for the purpose of this discus-
sion). The gel composition and solute–matrix interactions such as sequestration and
adsorption should be constants however, which would aﬀect the slope of the gradi-
ent as a result of altering the rate of diﬀusion, but would not alter the shape of the
slope. The collagen gel is mostly acellular and so degradation of soluble factors by
cellular processes is unlikely to be a major factor, though breakdown by non-cellular
activity, e.g. if it is broken down spontaneously or degraded by chemical reaction
with the media or matrix, may aﬀect the gradient.
For the LN samples, the response appeared to be approximately linear. However,
responses to growth factors are typically non-linear. Using VEGF as an example
(Akeson, Herman et al., 2010), cells are responsive to the factor only within a narrow
range, with receptor phosphorylation having sigmoidal relationship with respect to
the log dose of VEGF. A linear response may be a result of the spheroids being
exposed only to a narrow range of concentrations, i.e. being only apparently linear, or
alternatively if both the dose and response are non-linear, the combined eﬀect could
result in a linear relationship.
Making the assumption that the explant secretes factors at a ﬁxed rate, the closest
analogue in the literature is the study of diﬀusion from microﬂuidic networks into
hydrogels. In these systems, a solute is introduced into the network at a ﬁxed rate
and concentration. For example, Choi et al. (2007) illustrated this using calcein-AM
diﬀusion into a chondrocyte-seeded alginate scaﬀold, showing exponential decay
over distance from the source. Because calcein is actively metabolised by the cells,
this system reaches a steady state with a stable concentration gradient. This is also
shown in the same paper with ﬂuorescein isothiocyanate (FITC)-BSA, showing the
same exponential decay gradient, but without reaching a steady state. The spher-
oid model does not have cells seeded uniformly throughout the gel, given that they
are present in the spheroids at discrete points, which may result in a mixture of free
diﬀusion and turnover in cell-free and spheroid parts of the gel, respectively. The
diﬀusion of FITC-dextran within a collagen gel was investigated by Kothapalli, van
Veen et al. (2011), observing changes in the concentration gradient over time. This
was again an exponential decay curve, which approached steady state over time.
This system was not subject to ﬂow after initial loading, so represents passive diﬀu-
sion only between source and sink reservoirs. Additionally, FITC dextran does not
bind to the collagen matrix, unlike many of the growth factors and inhibitors which
modulate angiogenesis, which may result in the formation of much steeper gradi-
ents in the spheroidmodel. VEGF binding to heparin is one such example (Ruhrberg
et al., 2002), but many other factors can bind to matrix components including bFGF
and TGF-β1, reviewed by Schultz andWysocki (2009). The complex combinations of
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diﬀering concentrations of multiple factors, resulting as a consequence of the inter-
action between sequestered non-sequestered factors, as well as those with diﬀering
diﬀusion rates, half-lives and concentrations, may be responsible for the patterning
of the vasculature, resulting in precise control of decisions regarding cellular fate,
including proliferation, migration and branching.
The spheroid model is an eﬀectively closed systemwith respect to solute diﬀusion.
There is no sink other than the culture medium above the gel, which implies that
in the absence of degradation of soluble factors, a steady state will not be reached.
Thus the gradient set up by factor secretion from the explant will continue to expand
in size over time, with consequent reduction in the steepness of the gradient, as il-
lustrated by Kothapalli et al. (2011). The highest concentration (at the edge of the
explant) will also be variable depending upon the size of the explant, assuming that
this is related to the cellularity of the explanted material. If produced by a subset of
cells within the explant, the proportion of which may change during development
and/or between tissue types, the cellularity alone is also an unreliable indicator of
the quantity of soluble factors arising from the explant. Due to imaging using epi-
ﬂuorescence, the size of the explants could not be determined by the visible surface
area nor integrated DAPI ﬂuorescence; the tissue size in the z dimension was inde-
terminate due to its height exceeding the microscope’s working z range, and with
out of focus ﬂuorescence preventing accurate measurement, precluded drawing any
conclusions regarding explant size and its eﬀect upon spheroid outgrowth based
upon the experimental data presented here.
In consequence, one would expect any factors arising from the explant to follow
an exponential decay curve, though the extent of the gradient and how it changes
during the 24 hour culture period are unknown. Given that multiple factors may
be secreted, each of which may have a diﬀerent gradient in the gel, a consequence of
diﬀusing independently, having potentially diﬀerent initial concentrations, diﬀusion
rates due to size, shape and charge diﬀerences aswell as diﬀerences inmatrix aﬃnity
and half-life, the interaction between the various pro- and anti-angiogenic factors
may be very complex. The spheroid model measured the response to the combined
eﬀects of all these factors at discrete points in the gel.
An alternative hypothesis to growth factor gradients being the cause of inhibition
is that the eﬀect is due to direct inhibition as a result of cells migrating out of the ex-
plant and into the gel, as seen in Figure 5.6. These migratory cells might themselves
be secreting anti-angiogenic factors. While this may be a contributing factor to the
observed eﬀects, it is unlikely that this may invalidate the hypothesis that soluble
factors arising from the explant are the primary cause. In the E15.5 samples, cells
were seen to migrate at least 300 µm into the gel, however the inhibitory eﬀects were
observed up to at least 500 µm from the explant. In the E14.5 and E17.5, very little
migration was seen for the cervical LNs (a small number migrated < 200µm from
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the E14.5 explant), and no migration from the thymus or skin samples was observed
using GFP and DAPI ﬂuorescence to identify individual cells. This may be an arte-
fact of single cells liberated during dissection being mixed into the unpolymerised
collagen gel, and their signiﬁcance is unclear.
5.3.3 Candidate factors
The ECGMmedium used to overlay the gels contained 1 ng/mL bFGF in addition to
2% FBS and 0.4% endothelial cell growth supplement / hypothalamus (ECGS/H),
prepared from bovine hypothalamus containing growth factors including bFGF and
VEGF (Ferrara and Henzel, 1989; Maciag, Cerundolo et al., 1979), further supple-
mentedwith an additional 10% FBS. The growthmedium therefore contains at least
1 ng/mL bFGF in addition to an undeﬁned concentration of VEGF as well as other
factors.
Inhibition could be the result of two primary mechanisms: inhibition of pro-
angiogenic signalling (i.e. loss of positive signal), or direct inhibition (i.e. gain of neg-
ative signal). The former could be the result of growth factor sequestration, break-
down, or blockade or competition with the receptor. The latter could be an inhibitor
signalling directly and independently via a separate receptor. Both of these mech-
anisms are known to operate in vivo (Ho et al., 2009; Jiménez et al., 2000; Luque et al.,
2003). Loss of soluble pro-angiogenic factors can be ruled out as amajor contributing
factor; being present in the growth medium they are eﬀectively constant, with any
additional quantities secreted by the explant possibly having a local pro-angiogenic
eﬀect (which was not observed). The eﬀect of these factors is seen as the basal rate
of outgrowth observed in control samples, and in treatment samples separated from
the explants by large distance. The number of soluble angiogenesis inhibitors found
in vivo is limited, restricting the pool of candidates to just a few molecules, some of
which have been reviewed by Nyberg et al. (2005). Both PEDF and thrombospondin
are potential candidates, given their conﬁrmed presence as shown in Section 3.2.5
(Figure 3.7).
Soluble VEGFR1 and ADAMTS1 Both the soluble alternative splice variant of
VEGFR1 and ADAMTS1 are capable of sequestering VEGF, preventing VEGF-A
from signalling via VEGFR2 and therefore reduce EC proliferation and sprouting
(He, 1999; Luque et al., 2003). However, for this form of inhibition to operate eﬀect-
ively, at least a 1:1 stoichiometry of inhibitor:VEGF would be required at sites close
to the explant, and this would require the inhibitor to diﬀuse to the site. Neverthe-
less, this could still account for the gradient eﬀect seen. However, sequestering of
VEGF alone should not be suﬃcient to completely suppress angiogenesis, given the
additional presence of bFGF in the media. Section 4.2.11 (Figure 4.16) showed that
HUVECs responded to bFGF with increased outgrowth, and so it would be reason-
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able to expect some level of outgrowth, even if reduced from the basal rate, to exist
in the absence of all VEGF signalling given that this has previously been demon-
strated by Pepper et al. (1992). However, as for the experiments described here and
in Section 2.1.1, Pepper supplemented the medium with FBS, so a small possibility
exists that if all of any VEGF present in the FBS was sequestered, this could have an
negative eﬀect which would not be encompassed by either of these experiments. As
shown by Hood, Frausto et al. (2003), both VEGF and bFGF are required to prevent
apoptosis due to diﬀerential activation of Ras and ERK pathways, preventing both
cell-extrinsic and intrinsic apoptosis pathways. It is possible that if all VEGF were to
be removed from the immediate environment that the cell-extrinsic pathway would
no longer be inhibited.
PEDF PEDF is the single most likely candidate for the angiogenesis suppression
observed, it being one of the only direct biological inhibitors of angiogenesis acting
independently of pro-angiogenic growth factor signalling.
PEDF has recently been shown to bind collagen and other matrix proteins, us-
ing the same collagen binding site as heparan sulphate proteoglycans, as well as
binding heparin itself (Sekiya et al., 2011). This property could be used to investig-
ate the involvement of PEDF with the addition of heparin sulphate to the collagen
solution, which should cause a concomitant reduction in the radius of sprouting in-
hibition through the creation of a steeper concentration gradient as more PEDF is
sequestered in closer proximity to the explant. However, this change could equally
apply to other heparin sulphate-binding proteins, andwould need requiremore spe-
ciﬁc experiments to deﬁnitively identify PEDF as the factor responsible.
PEDF has been shown to be a potent inhibitor of angiogenesis in the eye, with a
PEDF /  transgenicmousemodel showing extensive hypervascularisation (Huang,
Wang et al., 2008), and recently its receptorwas discovered (Subramanian et al., 2010).
Unfortunately, most work to date has been restricted to the vascularisation of the
eye, and yet as the PEDF expression data in Chapter 3 clearly showed (Figures 3.8
and 3.8), it is also expressed in developing LN anlagen at all timepoints during de-
velopment, as well as other tissues such as the thymus, liver and skin. While the
expression pattern of PEDF and and pigment epithelium-derived factor receptor
(PEDFR) in the whole organism have yet to be studied, it would make logical sense
for PEDFR to be present upon all endothelial cell types, potentially with diﬀerent
levels of receptor or intracellular signalling between BEC and LEC. It is certainly
present on HUVECs, given the presence of cytosolic phospholipase A2-α signalling,
downstreamof PEDFR (Ho et al., 2009). In section 3.2.6 (Figure 3.9), PEDFwas shown
to be upregulated in the MRCs relative to the FRCs in the human fœtal lymph node.
As discussed in Chapter 3, its role in lymphatic development has yet to be determ-
ined through imaging or genomic methods, and functional assays such as the spher-
oid model may be useful for demonstrating the ability of anlagen to produce PEDF
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and suppress angiogenesis. Use of the assaywith LEC spheroidswould also provide
functional evidence of the diﬀerential eﬀects of PEDF (if any) between blood and
lymphatic endothelium. In a tumour environment, PEDF decreased blood vessel
growth both in the tumour and surrounding tissue, but increased lymphangiogen-
esis in the surrounding tissue was also observed (Halin et al., 2010). This would
suggest that PEDF diﬀerentially regulates angiogenesis and lymphangiogenesis, in
the absence of compensatory mechanisms and other compounding factors. The use
of the assay with anlagen from the PEDF /  mouse would also allow the contribu-
tion of PEDF to angiogenesis suppression to be compared with wild type anlagen,
provided that LN anlagen development is not overtly abnormal.
Thrombospondin Thrombospondin is produced in large quantities by platelets,
which play a signiﬁcant role in controlling pathological angiogenesis, particularly in
cancer (Zaslavsky et al., 2010). It is a possibility that platelet-derived thrombospondin
played some role in the observed suppression of angiogenesis, yet this is unlikely.
When harvesting the LN anlagen, great care was taken not to include adjacent ves-
sels; only the smallest of vessels could have been present in the samples, and the
tissues were washed in a large volume of IMDM or PBS prior to embedding in the
gel, which should have removed the vast majority of platelets capable of exiting the
tissue. Additionally, no suppression of angiogenesis was noted in the skin samples,
which were completely vascularised and contained blood; if any platelet-derived
thrombospondin were to inhibit angiogenesis, it would have been expected to have
arisen in this sample.
Thrombospondin has been shown to act in several ways, including antagonist-
ically to VEGF signalling via Akt, reducing EC survival (Sun et al., 2009). Its other
suppressive function, the inhibition of MMP activation, is unlikely to have a signi-
ﬁcant eﬀect in collagen I gels, ECs being able to freely migrate without the need for
matrix degradation. Whether MMP inactivation plays a role could be further invest-
igated using MMP inhibitors to observe if inhibitors further suppress angiogenesis.
Plasminogen, MMPs and TIMPs As mentioned for thrombospondin, MMP activ-
ity (or inhibition) is unlikely to have a direct eﬀect on outgrowth. Experiments were
performed using GM6001 (ilomastat) and BB2516 (marimastat) to determine if MMP
activity was a requirement for spheroid outgrowth but due to technical problems
with the collagen matrix did not produce usable results. Given the ﬁndings of Davis
et al. (2000b) that MMP activation results in tube regression, it is possible that MMP
activity could result in regression (or no initial outgrowth in this case). However,
when analysing the spheroid outgrowth using MP SHG imaging to visualise indi-
vidual collagen ﬁbrils in the matrix, there was no evidence of matrix degradation, at
least at the resolution of the microscope used. It is a possibility that MMP activity
resulted in the formation of anti-angiogenic matrix fragments which this analysis
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would not be able to detect. In an experiment to visualise GFP-expressing HUVEC
spheroids in a collagen matrix (not shown), outgrowths were clearly visible rami-
fying through the matrix with what appeared to be a basement membrane (or at
least, remodelled matrix) surrounding the tube; any tube regression would have left
behind clearly visible tunnels in the matrix, which were not observed in this case.
Given the absence of blood in the explants, plasminogen (an MMP activator) was
unlikely to the present, and hence neither would its anti-angiogenic products plas-
min or angiostatin (Davis et al., 2000b).
Collagen-derived inhibitors The collagen IV-derived inhibitors arresten, canstatin
and tumstatin and collagen XVIII-derived inhibitor endostatin are thought to act via
integrin attachment, and arise through MMP-mediated degradation (Mundel and
Kalluri, 2007), hence the observations regarding MMPs, above, apply equally here.
Given the lack of collagen IV basement membrane surrounding the spheroids and
new outgrowths, at least initially, such inhibitors are unlikely to originate locally,
and would most likely result from degradation of basement membrane within the
explant.
5.3.4 Explant eﬀects
The fact that outgrowth is suppressed in close proximity to the spheroid suggests
that this is a result of a soluble factor (or factors) arising from the tissue explant.
However, this might also be due to other factors, for example localised depletion of
oxygen and/or nutrients from the media due to the metabolic demands of the ex-
plant. Given that the collagen gel was of high porosity and should allow oxygen
and metabolites to diﬀuse freely, this should not have been a contributing factor, es-
pecially given the fact that in the case of E17.5 LN suppression of outgrowth was
observed at distances of at least 1mm away from the explant, at which distance
explant-mediated depletion should have little eﬀect. Whether this is a contributing
factor could be assessed by using e.g. pimonidazole or FLIM (Mik, Johannes et al.,
2008) to compare oxygen tension and metabolite concentration between spheroids.
However, unlike in the previous chapter, these gels were not completely covered by
a 2-D layer of HUVECs, 2-D coverage being both sparse and restricted to the lower
surface of the gel when present. In consequence, diﬀusion restriction as a result of
surface cell coverage could not have played a major role in these experiments.
At E14.5, the LN anlagen, at least in the neck and upper thorax (cervical, axil-
lary and brachial) are at least partly vascularised (Mebius, 2003; Vondenhoﬀ et al.,
2009a). Once vascularisation has begun, it may be hypothesised that in order to pre-
vent further, hyper-vascularisation, the cells of the anlagen and/or the inﬁltrating
vessels secrete anti-angiogenic factors. Subsequent repetition of the experiment at
E14.5 and E17.5 showed similar eﬀects at these timepoints in both thymus and cer-
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vical LNs. Collectively, these do not show any obvious trend—it is possible that
the LN vasculature is continuing to develop, or being restricted from developing,
throughout this period. However, when observing the thymus and skin samples,
there is an interesting diﬀerence. Both of these samples have one important feature
in common: they both contain a complete vascular network, as shown in Figure 3.1
and observed during dissection where the skin microvasculature is clearly visible,
and an established vasculature may result in a rather diﬀerent angiogenic environ-
ment. Both tissues showamarked increase in angiogenic outgrowth around 1000 µm
from the explant, and the reasons for this are not clear. More established vascular
systems will be less responsive to pro-angiogenic factors as a result of their stabil-
isation by smooth muscle and through basement membrane biosynthesis and MMP
inhibition (Saunders et al., 2006; Stratman et al., 2009a; Xian, Håkansson et al., 2006),
and consequently may not require as much active suppression of angiogenesis by
soluble factors; this is indicated by the falling levels of Pedf and rising levels of Thbs
mRNA in the skin sample in Figure 3.7.
Pro-angiogenic factors tend to have a lowermolecularweight, while anti-angiogenic
factors have a higher molecular weight; PEDF is 50 kDa, while thrombospondin
is 190 kDa, bFGF is 18-19 kDa and VEGF-A165 is 46 kDa (Gautschi, Fràter-Schröder
et al., 1986; Holmes andZachary, 2005; Zhang andMa, 2007). Assuming equalmatrix
aﬃnity and shape characteristics, it could be hypothesised that the pro-angiogenic
VEGF-A165 and bFGF would be expected to diﬀuse faster, causing separation of the
pro- and anti-angiogenic factors within the gel, which could hence be responsible
for the band of pro-angiogenic activity observed at intermediate distance. At E17.5,
where this eﬀect is most pronounced, the amount of angiogenesis at this point is sig-
niﬁcantly higher than the control, indicating that this is a positive eﬀect rather than
a lack of negative regulation (unlike the other cases, where outgrowth is reduced re-
lative to the control). Outgrowth nearer to the the explant is the same as the control
in the case of the skin sample at E17.5; this may be due to a mostly equal balance of
pro- and anti-angiogenic factors since both would be present. While this is also seen
for the thymus sample, suppression at close distances was observed, which could
be a result of incomplete smooth muscle coverage at this timepoint, as seen by the
lack of collagen IV staining in Figure 3.1 and in Foster et al. (2008). Consequently,
anti-angiogenic signalling may not have been downregulated, indicating that it is
producing more anti-angiogenic factors than the skin sample. The correlation of the
distance between the samples indicates that the same factor, or factors, are being
produced by both samples, but in varying quantity.
Given that the overall environment in the developing LN is anti-angiogenic, this
does not preclude angiogenesis in regions where pro-angiogenic factors are con-
centrated, overcoming the inhibitory eﬀects. Combined with the precise control of
sprouting with Dll4/Notch inhibition (Hellström, Phng et al., 2007), this may result
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in sprouting whilst the spheroid model is only responsive to the net eﬀects.
The data resulting from image analysis show ﬁrstly that the diﬀerent measured
parameters (perimeter, area, radius andnumber of sprouts) correlatewith each other,
some to a greater extent than others, indicating that they are quantifying similar
changes. This means that these diﬀerent parameters are each quantifying diﬀerent
aspects of the same process: spheroid outgrowth as a result of sprouting angiogen-
esis. It was found that perimeter length and total sprout length correlated to the
greatest extent, while the number of sprouts and area correlated less well, and outer
radius rather poorly. These observations may be explained in terms of the error
they introduce, the error being the diﬀerence between the quantiﬁed amount of an-
giogenic outgrowth and the “real” amount. Without an external calibrating meas-
ure, the most obvious means of determining the most reliable measure is to perform
pairwise comparisons between the diﬀerent measurement parameters.
The outer radius measurement is biased due to a single large outgrowth be-
ing treated equivalently to multiple outgrowths of similar length, despite the lat-
ter having experienced more outgrowth in total. In a similar vein, the total number
of sprouts does not take outgrowth into account, treating spheroids with the same
number of sprouts, but vastly diﬀerent sprout lengths, as equal, when they aremani-
festly diﬀerent. Area being an unreliablemeasure is perhaps less obvious, and is due
to the area increase being disproportionately small compared with the amount of
outgrowth. Due to the initial large area of the spheroid and the small diameter of any
outgrowths, outgrowth resulted in only amodest increase in surface area, whichmay
be statistically insigniﬁcant relative to the sample variation in initial spheroid surface
area. In comparison, perimeter length and total sprout length both increase linearly
with outgrowth and are both independent of factors such as the number of sprouts
and individual sprout lengths, making them much less susceptible to bias. This is
reﬂected in their almost equivalent ranking in Table 5.1. Future analyses dropped
parameters which performed poorly (outer radius, area) or which were excessively
time consuming to measure (perimeter length).
Lastly, there appeared to be a strong positive correlation between tube outgrowth
and increasing distance fromLNor thymus explants, showing that despite the rather
large amount of variance in the data, there is an apparent relationship. The fact that
perimeter length and area (not shown), as opposed to the derived area ratio, were
more robust measurements may reﬂect ampliﬁcation of error as a result of measure-
ment inaccuracies, or the ratio may simply not represent outgrowth as well as either
parameter alone. Curiously, the same does not apply to the derived radius ratio,
despite the known poor suitability of the outer radius measurement, which is ad-
ditionally compounded by the noise introduced by the inner radius, largely similar
for all spheroids, but reduced for spheroids which are ovoid rather than spherical
(Figure 2.3(D)).
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The analysed images were tiled epiﬂuorescence images taken in a single plane of
focus and then stitched together. Because the spheroids may be present at diﬀerent
z depths within the gel, and tubes outgrow in all directions in three dimensions,
getting accurate data from 2D images is challenging. Drawing an outline is diﬃcult
due to the outgrowing tubes going out of focus; indeed it is possible to discount
tubes which have no visible connection to the spheroid, but which pass through the
plane of focus at a distance. It is also diﬃcult to separate spheroids in close proximity,
whose outgrowths cross in diﬀerent z planes, but appear to be joined. As a result,
imaging entire gels using tiled confocal z-stacks has been undertaken, but this is
currently impractical to both acquire and analyse.
5.3.5 Image analysis strategies
Data have now been acquired using the spheroid model for explanted anlagen from
E14.5–E17.5. To gain useful information from this data, the analysis protocols require
improving to remove the unwanted variance mentioned above.
When considering the distance between the explant and a spheroid, there are two
obvious measurements which may be made: from the edge (or centre) of the inner
spheroidmass to either the edge of the explant (determined usingDAPI ﬂuorescence
or autoﬂuorescence) or to the anlagen itself (determined using hCD2-GFP ﬂuores-
cence). Given that the speciﬁc cellular source (or sources) of the soluble factors are
unknown, and may be produced by the LTis, LTo or any other cell type present, the
explant edgewas used. This additionally allowed comparisons to bemadewith non-
lymphoid explants such as skin, which do not contain any LTis.
Diﬀerent types of outgrowth were observed during analysis, from thick multi-
cellular outgrowths, to thin single cell adventitious sprouts and ﬁlopodia extending
from the leading edge of the growth cone of tip cells. When quantifying spheroid
size, all outgrowths of all sizes were included. However, this could potentially lead
to underestimates of size for spheroids where ﬁne ﬁlopodia, for example, are not vis-
ible due to the CD31 ﬂuorescence being too faint or out of focus. The cells in some
outgrowths also appeared to be rounded, connected to the spheroid and/or their
neighbours only by ﬁne slender threads of cytoplasm. Without further analysis, it
was not possible to determine if these were apoptotic, dividing, or undergoing some
other process relating to angiogenesis.
5.3.6 2-D outgrowth
Several experiments showed evidence of both 2-D and 3-D outgrowth; this was par-
ticularly apparent in the E17.5 images shown in Figure 5.8, where angiogenic sprout-
ing is clearly distinguishable from a less intense region surrounding each spheroid.
This complicated the image analysis by requiring careful examination of the diﬀer-
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ent z-planes in order to distinguish the two, and may have introduced some of the
noise seen in the measurements, where such determination was ambiguous. The
outgrowth was predominantly on the bottom surface of the collagen gel, in contact
with the glass or plastic well bottom. Presumably, this was a result of the spheroids
settling to the bottom of the collagen matrix during gelation, which took place over
an hour at 15 °C in the case of the E15.5 experiment. In an attempt to reduce this
eﬀect, the gelling time was decreased to 10mins at 37 °C. Unfortunately, this did not
result in great improvement, and in fact some experiments (not shown) could not be
analysed as a result of outgrowth being predominantly in 2-D, with 3-D outgrowth
being absent entirely, or being indistinguishable from 2-D outgrowth. In Korﬀ and
Augustin (1999), 0.25% (w/v) carboxymethylcellulosewas present in the neutralised
collagen solution, used to prevent spheroid sedimentation prior to gelling. This, or
an equivalent which increases the solution density without interfering with collagen
gelation or spheroid outgrowth, could be used to reduce or eliminate this undesir-
able complication.
5.3.7 Neighbour eﬀects
There appeared to be a small but positive relationship between tube outgrowth and
increasing neighbour distance, i.e. spheroids are themselves inhibiting the tube out-
growth of their neighbours, at least to some extent. Figure 5.5 showed an increase in
outgrowth as the neighbour distance increased, whichmay imply that the spheroids
themselvesmay inhibit their neighbours’ outgrowth. However, the opposite appears
to be the case at E17.5 (Figure 5.12, bottom plot). Only the control sample was used,
to avoid the complication of the additional eﬀects of the explants. However, given
the errors involved and the fact that the group of measurements at 450 µm contains
large outliers, it is unclear if this is a signiﬁcant relationship at E15.5. At E17.5, neigh-
bouring spheroids do not appear to have any signiﬁcant inﬂuence upon spheroid
outgrowth, but if truly present, the eﬀect would appear to be negative rather than
positive, i.e. angiogenesis increases with reduced neighbour distance.
The main diﬀerence between the initial E15.5 experiment and later experiments
was the use of untreated nylon washers for the former, and PEI-coated steel rings for
the latter, used to contain the collagen matrix. The diﬀerences may therefore be due
to tensional forces within the collagen matrix. The collagen did not strongly bind
to the collagen washers, and was observed to contract in the E15.5 control sample
during culture, along with the gels containing explants. Conversely, the gels in
PEI coated rings were bonded to the inner surface of the rings, and hence HUVEC-
mediated collagen contraction would result in an increase in tension within the gel
rather than radial contraction of the gel, which is physically constrained, as illus-
trated in Figure 5.14(A). Collagen contraction is likely to be mediated via integrin
α2β1, which has been previously shown to be responsible for collagen contraction
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with other cell types (Riikonen, Koivisto et al., 1995), and is known to be expressed
by HUVECs and required for matrix invasion (Bayless, 2003).
In the case of collagen contraction being constrained, it is likely that local con-
traction of collagen by spheroids results in global changes in gel tension, at least
in the radial (horizontal) plane. Contraction in the transverse (vertical) plane is
not constrained, except at the edge where it is bonded to the ring. The eﬀects of
altering the constraints of contraction are shown in Figure 5.14. The eﬀects of in-
dividual spheroids upon their neighbours was investigated by Korﬀ and Augustin
(1999), and shown to be a result of tension in the matrix resulting in directional out-
growth (and eventual anastomosing) of outgrowths between the two spheroids. This
pattern was observed between spheroids in these experiments, but at such low fre-
quency it was considered to be coincidental. While this appears to be a genuine
phenomenon, it also appears to be dependent upon the type of gel support used,
presumably as a consequence of the diﬀerence in the orientation and intensity of
tensile forces within the gel. In the case of the E15.5 control, the apparent increase in
outgrowth as neighbour distance increases is in direct contrast to the observations
of Korﬀ and Augustin (1999), who observed that directional sprouting occurs most
at close separation (< 200µm).
5.3.8 Edge eﬀects
The contribution of edge eﬀects to spheroid outgrowth in the E17.5 control sample
are shown in Figure 5.12 (top plot). With the exception of a few outliers, there is
a clear relationship between the amount of outgrowth and the distance to the well
edge, with spheroids closest to the edge exhibiting more outgrowth than their coun-
terparts at the well centre.
Given the assumption that all conditions within the well are constant, except
for the placement of the spheroids within the well, and that neighbour eﬀects were
shown to be insigniﬁcant, it ismost likely that the observed biological eﬀect is a result
of physical forces within the gel. If the collagen gel is bonded only to the inner edge
of the support ring, and each spheroid dispersed evenly within the gel exerts the
same contractile forces in all directions upon the matrix surrounding it, the matrix
will appear as in the idealised, exaggerated illustration shown in 5.14(A). The resist-
ance to radial contraction as a result of the bonding to the inner edge of the ring will
establish tension in this dimension, shown as lines within the gel. The spheroids will
also exert force in the transverse dimension, shown here resulting in a concave shape
as a result of diﬀerential contraction of the gel. In the centre of the gel, contraction
is opposed only by the intrinsic resistance within the gel itself, whereas at the edge
it is additionally opposed by the incompliant support ring, resulting in increased
tension at the edge. Figure 5.14(E–F) additionally illustrate how matrix compliancy
may aﬀect tensional forces as a result of diﬀerences in edge distance around an indi-
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Figure 5.14: Eﬀects of tensile forces within the matrix. (A–C) depict the distribution
of lateral forces within a cross-section through the centre of the gel. (A) A collagen gel
set in a PEI-coated glutaraldehyde-functionalised steel ring is shown in cross-section.
Due to the attachment of collagen to the inner wall of the ring, if the gel is subject to
uniform contractile force the forces exerted upon the gel vary with the radial position,
shown here as in an idealised form assuming omnidirectional application of force by
each cell or spheroid throughout the gel. The edges of the gel are attached to the rigid
wall, providing an opposing force to contractile force. The centre of the gel contains no
attachments, and so will tend to bow inwards due to local contractile forces. If the gel
is anchored to the well bottom (B) or additionally the top (C), the distribution of lateral
force would be altered, and the intensity would also be reduced as a consequence of
the attachment, with a consequent increase in the role of vertical tensile forces. (D)
A large explant such as an E17.5 thymus may be relatively incompliant and hence act
to redistribute tensile forces within the gel, resulting in increased tension overall as a
product of a shorter distance between edges. (E–F) depict the distribution of radial
forces within the gel. (E) A spheroid placed in the centre of the gel will exert equal
force in all directions. (F) A spheroid placed oﬀ-centre will exert force in each direction
as a function of the edge distance as a result of diﬀerential gel compliancy.
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vidual spheroid. These eﬀects may therefore act to establish an overall radial tension
gradient from well edge to centre.
The spheroid model has previously been used to study how tensional forces in
extracellular matrix inﬂuence sprouting by Korﬀ and Augustin (1999). Here, ten-
sion was imposed externally by pulling the collagen gel in one dimension using pins
pushed into the gel. This resulted in directional sprouting in line with the tensile
force. In contrast, in the ring model the tensional force arises internally due to the
intrinsic eﬀects of the HUVEC contraction of collagen. While Korﬀ and Augustin
(1999) examined the local eﬀects of directed sprout growth between spheroids, the
eﬀect was only found to occur up to 700 µm, while Figure 5.12 shows this is present
up to at least 2mmwhen considering edge eﬀects. This diﬀerence may be due to the
fact that while Korﬀ and Augustin (1999) used gels set in wells (as opposed to free-
ﬂoating), these were not physically bonded to their container as in the case of the
metal rings. This may limit the amount of tension in the gel because contraction is
not opposed as strongly. It is thought that cells are capable of transducing mechan-
ical forces into nuclear transcriptional changes (Wang, Tytell et al., 2009), and in the
case of smooth muscle experimental evidence suggests a role for RhoA (Peyton, Kim
et al., 2008). Given the role of RhoA in endothelial migration and angiogenesis, this
may imply that RhoA in EC is responsible for increased angiogenesis in response to
increased matrix tension (van Nieuw Amerongen et al., 2003).
Potential improvements to the model to reduce edge eﬀects are illustrated in Fig-
ure 5.15. The theme common to the diﬀerent supports is to minimise the distance
between edges to ensure that the minimum andmaximum distances any spheroid is
placed relative to an edge is strictly controlled. In its simplest form (A), this could be
accomplished by placing the spheroids into a closed channel with a box or circular
cross-section; such devices are commercially available, and allow live imaging of the
gel (e.g. µ-slides from Ibidi, München, Germany). However, it would be necessary
to use multiple channels to use such a model with tissue explants, shown in radial
orientation in (B). Note that both strategies would result in an even distribution of
spheroids over distance, eliminating the distribution bias discussed previously (Fig-
ure 5.13). Using a micropatterned surface substrate (e.g. of PDMS), either as a closed
channel network or open at the top (C), would permit a cell- or spheroid-seeded col-
lagen solution to be gelledwithin the channels andprovide a larger total volume than
single channels, and hence more replicates. This could be further improved with
the use of micropegs or posts (D) which would oppose gel contraction and provide
relatively uniform tensile forces within the gel. Such systems have been used pre-
viously for measuring forces imposed upon substrata by cells including epithelial
cells (du Roure, Saez et al., 2005) and ﬁbroblasts (Li, Xie et al., 2007). While these
are at a small scale (< 5µm), pillars of larger dimensions and reduced compliancy
are capable of opposing the contraction of a gel, for example as produced by Zheng,
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Henderson et al. (2011).
5.3.9 Other eﬀects
An additional eﬀect of diﬀerential matrix tension is the known inﬂuence of matrix
stiﬀness upon the cell cycle, reviewed by Assoian and Klein (2008). This may result
in diﬀerential rates of cell proliferation, for example if the gel is stiﬀer at the edge
due to increased tensile forces this may result in greater cell proliferation, which
may additionally aﬀect outgrowth rates. This could be assessed by staining with a
cell cycle marker such as Ki67 or incorporation of thymidine analogue such as BrdU
or EdU (Chehrehasa, Meedeniya et al., 2009).
Given that increasing collagen concentration negatively aﬀects the diﬀusion of
solutes (Ramanujan et al., 2002), and that EC in the spheroid were seen to visibly
condense the matrix surrounding them, as shown in Figure 5.6, it may be the case
in vivo that tissue condensation, perhaps driven in whole or in part by vascularisa-
tion, may be limited by negative feedback as a consequence of increasing diﬀusion
limitations. Vascularisation may also arise due to positive feedback as EC invasion
increases matrix tension, driving further invasion and tension increase, until limited
by some other factor. As shown above and by Korﬀ and Augustin (1999), vascular-
isation is partly driven by tensional forces in addition to the eﬀects of growth factors.
How these observations should inﬂuence our current understanding of in vivo vas-
cularisation is limited by our lack of knowledge of the tensional forces within the
developing embryo. In the adult, tension has been shown to play an important role
in the revascularisation of granulation tissue (Kilarski et al., 2009), and it may be
equally important during development. In the case of the LN, which is surrounded
by the lymph sac, tension may be reduced around the edges of what will become the
subcapsular sinus and cortex, which may explain why the medulla and paracortex
are highly vascularised while the edge of the cortex is not. While diﬀerential expres-
sion of pro- and anti-angiogenic factors undoubtedly play a role in the maintenance
of this architecture, as discussed in Chapter 3, tensional forces may also play a role.
As illustrated by Ohtani and Ohtani (2008), the reticular network of the developed
node appears to run mainly radially through the cortex and continue through the
subcapsular sinus to the ﬁbrous cortex. This may be indicative of the node being
subject to tensile forces in this direction, presumably to cope with expansion under
both hydrostatic pressure and lymphocyte inﬂux. Speculatively, this may explain
how the looping of the HEVs is established within the stroma, by extension outward
radially along a tensile force gradient from the hilus to cortex, then looping around
as forces decrease (and inhibitory factors increase) as the subcapsular sinus is ap-
proached.
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Figure 5.15: Minimising edge eﬀects upon spheroid outgrowth. (A) The gel may be
set in channels, to ensure that all parts of the gel are within a small distance of a ri-
gid surface. Black areas are an incompliant substrate, while white areas are channels.
(B) These may be arranged radially to allow study of diﬀusion eﬀects e.g. arising from
explants placed at a central point. (C) An optimal arrangement of microchannels for
spheroid-seeded gels. (D) Micropegs protruding from the seeding surface provide a
large contact area, and should not interfere appreciably with cell migration or diﬀusion
of soluble factors.
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5.4 Conclusions
This is, to the best of my knowledge, the ﬁrst use of the Korﬀ spheroid model as a
means of assaying the presence of solute gradients and spatial patterns within an
extracellular matrix. Using the spheroid model, diﬀerential angiogenic outgrowth
was demonstrated in the presence of live explants of developing lymphoid tissue,
reduced outgrowth being observedwith increasing spatial proximity to the explants.
The nature of the soluble anti-angiogenic molecule and its cellular source within the
explant remain to be elucidated. This is also the ﬁrst use of the spheroid model to
demonstrate the response of endothelial cells to self-imposed intrinsic long distance
tensile force gradients within a collagen gel.
5.5 Future Work
5.5.1 Spheroid model
Using the spheroid model as a means of creating embeddable biosensors to mon-
itor pro- and anti- angiogenic signalling has many other uses in addition to devel-
opmental biology. They might, for example, be embedded into gels alongside solid
tumours (either cultured cell aggregates or biopsies) in order to assay theirmetabolic
state andmetastatic potential. In this case the eﬀects of pharmacological compounds
could be screened for their eﬀects upon tumour vascularisation and cell migration.
The model may also be used to model aspects of LN development entirely in vitro.
Recent work in the lab has shown that various cell lines of mesenchymal origin may
be diﬀerentiated into FRC-like stroma through treatment with anti-lymphotoxin re-
ceptor antibody (in place of LTi signalling through LT). Thus it may be possible to
combine diﬀerentiated LTos with vascular and lymphatic endothelium and model
their interactions.
The role of cell proliferation and apoptosis in the spheroid model remains to be
investigated. As demonstrated by Korﬀ and Augustin (1998), cells in the centre of
the spheroid are prone to apoptosis, and this is modulated by the presence of growth
factors or blocking antibodies. This tendency might also prove useful as a sens-
ing mechanism for VEGF and bFGF in the immediate environment of the spheroid.
Single EC were also observed in close proximity to the spheroids, particularly those
at a distance away from unﬁxed explants as shown in Figure 5.6. As observed by
Korﬀ and Augustin (1999), these cells undergo apoptosis following loss of contact
with their neighbours, but this would be desirable to conﬁrm independently, and to
additionally observe if EC apoptosis (or lack of proliferation) of surface or sprouting
EC is responsible for limiting sprouting or sprout outgrowth.
The principal deﬁciency with the spheroid model is excessive noise. In addition
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to the issues regarding spheroid sedimentation and gel geometry, addressed above,
the spheroid model could be further improved with a few simple modiﬁcations. For
example, decreasing the spheroid size to permit more to be seeded within a single
gel, would result in greater statistical signiﬁcance to measurements. An additional
improvementwould be to incorporate smoothmuscle coverage, whichwouldmodu-
late the response of HUVECs to pro-angiogenic factors (Korﬀ et al., 2001). HUVEC–
C3H/10T½ spheroid cocultures were attempted (not shown), but C3H/10T½ mi-
grated freely throughout the gel rather than forming stable interactions with the
HUVECs. The use of a more appropriate pericyte line might result in formation
of more physiologically-relevant structures (Stratman et al., 2010).
5.5.2 Image analysis
Several strategies for imaging the spheroids have been tested, including phase con-
trast, epiﬂuorescence, confocal z-stacks, tiled confocal z-stacks and high-throughput
imaging using an ImageXpress system to image complete parts of, or entire, gels.
Due to the fact that the spheroids outgrow in three dimensions within the gel, phase
contrast images are hard to interpret and are not suitable for automated image ana-
lysis. Epiﬂuorescence images allow visualisation of most of the features within a
single spheroid, but due to the fact that spheroids are found within diﬀering planes
of focus within a gel, are not suited to imaging multiple spheroids in a single ﬁeld
of view. Confocal imaging of the entire volume should solve this problem, at the
expense of greatly increased acquisition time and image size. Such data has been ac-
quired, but is prohibitively expensive to acquire in terms of acquisition time and data
storage, and additionally currently available software is incapable of sophisticated
analysis and quantiﬁcation in 3D.
High-throughput acquisition using the ImageXpress system avoids some of these
problems, at the expense of reduced resolution, which in this case is perfectly accept-
able for quantiﬁcation purposes. However, the analysis requires further reﬁnement
to eliminate 2D outgrowth from the spheroids and to eliminate outliers which skew
the data. Were epiﬂuorescence imaging to be used again, deconvolution of the image
stacks may remove suﬃcient out of focus information to permit reliable automated
analysis of 3-D structures.
5.5.3 Signalling pathways
The cellular source of the soluble factors is currently unknown. Where suﬃcient
cellular material may be obtained, such as in the case of the thymus, this could be in-
vestigated by sorting the cells into diﬀerent major subsets (for example hCD2-GFP+
thymocytes and hCD2-GFP  thymic stroma) and seeding these into a spheroid gel
either as a single cell suspension or in spheroid form as an anlagen analogue. Re-
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peated iteratively, this approach could be used to identify the speciﬁc cellular source
(or sources) of pro- and anti-angiogenic factors in the developing anlagen. Given
their small size, this would be rather more diﬃcult for LN anlagen, but would also
be possible given suﬃcient cellular material pooled from multiple embryos, or the
use of a bigger animal model with larger LNs.
The identity of the soluble factors is also yet to be elucidated. These could poten-
tially be identiﬁed using the spheroid model in combination with blocking agents
against candidate factors. In order to investigate its speciﬁc role, PEDF is available in
recombinant form, and PEDF blocking antibodies are also available. It should there-
fore be possible to use anti-PEDF to block PEDF activity in spheroid gels containing
explants. Additionally, gels with PEDF, PEDF plus anti-PEDF and anti-PEDF alone
could be used to demonstrate the eﬀectiveness of the PEDF blockade, and show that
anti-PEDF does not aﬀect angiogenesis by itself. Anti-VEGF could be used to ad-
ditionally assess the role of VEGF, and a number of small molecule tyrosine kinase
inhibitors such as SU5416 (semaxinib) and SU11248 (sunitinib malate) are available,
which inhibit the intracellular kinase activity of all the VEGFRs. MMP inhibitors
such as GM6001 (ilomastat) and BB2516 (marimastat) could also be used to investig-
ate the role of MMP activity in this model.
5.5.4 Tensile forces
Imaging the structure of the collagen gel either by SHG or direct labelling would
allow the direction of forces within the gel to be determined by the local collagen
ﬁbril alignment. Clearly, to further investigate the phenomenon of gel tension, it is
necessary to measure tensile forces within the gel. Several workers have attempted
to measure the tensile force of gel contraction with various strategies, for example
John, Quinlan et al. (2010) used the displacement of cantilevers attached to the gel
edge. However, such strategiesmeasure only the bulk properties of the gel, rather than
being able to sense the direction andmagnitude of force at discrete points in a gel, as
would be experienced by a cell. An alternative would be make use of stress-sensing
mechanisms used in vivo, for example the deformation of ﬁbronectin. Under tension,
ﬁbronectin deforms to expose cryptic binding sites which could be used map stress
forces within a gel (Klotzsch, Smith et al., 2009). As demonstrated by this paper, a
Förster resonance energy transfer (FRET) pair placed either side of the cryptic site
may be used as an in vitro strain probe. An alternative would be to use an antibody
to label the exposed cryptic sites, providing they were accessible.
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Figure 5.16: Major factors inﬂuencing spheroid outgrowth. (A) Tissue explants, extra-
cellular matrix and culturemedium are sources of both pro- and anti-angiogenic factors
which collectively aﬀect angiogenic sprouting. (B) These factors may be present as spa-
tial gradients. Soluble factors arising from a tissue explant will establish a concentration
gradient decreasing exponentially with distance away from the explant, additionally
complicated by matrix interactions and sequestration. The data in this chapter indic-
ate that anti-angiogenic factors predominate. Matrix tension additionally aﬀects spher-
oid outgrowth, there being more outgrowth closer to the edge in a linear relationship.
Single explants were placed in the well centre, while two explants were oﬀset from the
centre, which complicates the eﬀect of matrix tension because spheroids at a given dis-
tance from the explant will have a distribution of distances to the well edge. Spheroids
in close proximity may also inﬂuence the outgrowth of their neighbours. Factors in
the culture medium are constant at all radial distances, bar any local depletion in close
proximity to the explant, being above the gel and free to diﬀuse within it.
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Chapter 6
Discussion
The aims behind the work presented in this thesis have been to investigate the pro-
cesses and mechanisms by which the LN is vascularised during development. The
aims were addressed using a combination of imaging, gene expression analysis and
in vitromodelling of the eﬀects of LN-derived soluble factors upon angiogenesis util-
ising a model developed for the purpose.
6.1 Summary of ﬁndings
6.1.1 In vivo observations
In Chapter 3, in vivo observations were made using both confocal microscopy to
study structural aspects of cellular organisation and quantitative RTPCR to study
gene expression within the developing LN anlagen. Imaging of wholemount pre-
parations of the thymus at E15.5 (Figure 3.1) demonstrated that the vascular base-
ment membrane is synthesised in stages, with laminin and ﬁbronectin being laid
down before collagen IV, which was observed to be present only in the cortex while
laminin and ﬁbronectin were also present in the medulla. This was additionally in-
terpreted to imply that smoothmuscle coverage of the nascent vascular network was
acquired from the outside moving inwards to the centre, which would be the case if
the source of the VSMCs was external to the thymus. Wholemount was however not
suitable for imaging the developing LN anlagen due to excessive autoﬂuorescence,
which masked immunoﬂuorescence and eﬀectively prevented identiﬁcation of the
anlagen. LN anlagen imaged using live MP imaging (Figure 3.2) showed that the
site of LTi clustering was structurally diﬀerent from the surrounding tissue, being a
pocket having less dense collagen I matrix than the surrounding mesenchyme, and
being bounded by a dense collagen I band, identiﬁed by SHG reﬂectance, and being a
double band around part of the pocket. Confocal imaging of frozen sections (Figure
3.3) showed a similar collagen I pattern, which appeared to stain the same structures
as collagen IV, and additionally were at least in part positive for LYVE-1, indicating a
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composition of LECs in part or in full. These structures, surrounding the clustering
LTis, were assumed to be the lymph sac based upon comparisons with LN develop-
ment data in the literature, appearing roughly hemispherical in shape enclosing the
majority of the LTis (Vondenhoﬀ et al., 2009a). The anlagen also contained VCAM+
stromal organisers in intimate associationwith LTis (Cupedo et al., 2004). Staining for
endothelial cells using the markers endomucin and MECA-32 showed little staining
within the lymph sac, though some positive staining was observed around the sac,
indicating a lack of vascularisation within the anlagen. Small spots of collagen IV
staining were observed within the LTi clusters, however these were not suﬃciently
large to indicate the presence of blood vessels, unlike for the lymph sac.
RTPCR analysis of pro- and anti-angiogenic factors (Figures 3.7 and 3.8) illus-
trated a complex pattern of changes in diﬀerent tissues during development, with
PEDF, thrombospondin and the diﬀerent VEGF-A isoforms all varying. However,
due to relative quantiﬁcation being used and the relationship between expression
level and angiogenic activity being unknown, these data alone were insuﬃcient to
determine whether the anlagen were predominantly pro- or anti-angiogenic at any
timepoint during development, and hence how these changes related to the process
of LN vascularisation could not be determined. In consequence, a functional in vitro
assay was developed in order that the net eﬀect of all secreted factors could be as-
sayed.
Additionally, gene expression in the MRC and FRC subsets of human fœtal LNs
wasmeasured usingmicroarray analysis (Figure 3.9). These data highlighted a num-
ber of signiﬁcant diﬀerences between the MRC and FRC populations which may
have functional signiﬁcance regarding their role in vascular maintenance and LN
function. Chemokine, interleukin and adhesion molecule upregulation in the MRCs
demonstrated their phenotypic similarity with LTos (Katakai et al., 2008). Addition-
ally, diﬀerences in factors promoting, inhibiting and regulating angiogenesis illus-
trated that the angiogenic environments of the two subsets were rather diﬀerent,
which may reﬂect their diﬀerent functional roles.
6.1.2 In vitro vascular modelling
In order to develop a “complete” vascularmodel, containing endothelial cells, smooth
muscle coverage of the endothelium and ﬂuid ﬂow, models of both vasculogenesis
and angiogenesis were implemented. The technology to develop perfused micro-
ﬂuidic networks inside gels was successfully developed and demonstrated to work
(Figures 4.1 and 4.2), but limitations in the strength of collagen type I gels prevented
their use in experiments.
Modelling vasculogenesis required the use of a cocktail of growth factors and
PMA to stimulate tube formation and permit EC survival within a collagen gel, res-
ulting in formation of a complex interconnected network which was demonstrated
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to contain tubes with patent lumens and other features of capillaries including ad-
herens junctions (Figures 4.3, 4.4 and 4.5). However, thicker gels were observed
to contain apparently necrotic central cores (Figure 4.4), a factor of their size and
the high seeding densities required. Introduction of smooth muscle coverage us-
ing aortic VSMCs resulted in induction of tube formation at low frequency (Figure
4.7), which was increased through utilisation of TGF-β1-diﬀerentiated C3H/10T½
cells (Figure 4.10), but which took signiﬁcant time to develop a fully interconnected
network. Vasculogenesis models with and without smooth muscle coverage both
formed interconnected networks, but had the disadvantage of the network struc-
ture being diﬃcult to analyse using existing image analysis strategies, and additional
complications arose when considering how to subsequently measure changes in the
network in response to diﬀerent treatments. The images shown in Chapter 4 were
ﬁxed rather than live; due to the lack of stably-transfected GFP-expressing ECs, ima-
ging and quantifying the remodelling of a single network over time was not feasible.
Angiogenesis was modelled utilising an existing model developed by Thomas
Korﬀ andHelmut Augustin, based around the concept of seeding EC spheroids (Fig-
ure 4.15) into a collagen gel, resulting in sprouting angiogenesis from the spheroid
surface into the gel, as demonstrated in Figure 4.16 (Korﬀ andAugustin, 1998). Quan-
tiﬁcation of the outgrowth allowed the response of the spheroids to diﬀerent treat-
ments to bemeasured, whichwas demonstrated using diﬀerent growth factors. This
model was subsequently adapted to permit the measure of spatial eﬀects within a
gel.
6.1.3 In vitro observations
Using LN anlagen and thymi dissected from E14.5–E17.5 embryos, explanted into
collagen gels seededwith collagen spheroids, outgrowth of the spheroids wasmeas-
ured and correlated with the distance of the spheroid from the explanted material
(Figures 5.2, 5.4, 5.6, 5.8, 5.7, 5.10 and 5.11). In all cases, angiogenesis was suppressed
in close proximity to the explant, an eﬀect which declined with distance indicating
that the eﬀect was due to a soluble factor emanating from the explant. Upon PFA
ﬁxation (Figures 5.8, 5.7, 5.10 and 5.11), outgrowth was shown to occur at baseline
levels at all distances from the explant in most cases, interpreted to mean that the
factors originating from the explant were being actively produced by the cells within
the explant. An additional eﬀect observed in particular with larger explants at later
timepoints was a rise and fall in outgrowth moving away from the explant; due to
anti-angiogenic factors such as PEDF having a lower molecular weight than pro-
angiogenic factors such as VEGF, this was thought likely to be a result of separation
of the factors during their diﬀusion through the gel (Ramanujan et al., 2002), result-
ing in the formation of net pro- and anti-angiogenic radial bands.
The relationship between outgrowth and nearest-neighbour distancewas also in-
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vestigated (Figures 5.5 and 5.12), but no clear trends were visible; it was concluded
that spheroids did not appear to signiﬁcantly aﬀect each other’s outgrowth. How-
ever, when comparing outgrowth to edge distance (Figure 5.12) it was observed that
growth was proportional to distance from the edge, with growth being highest at
the edge. The most obvious variable which could be responsible for this eﬀect was
gel tension imposed by EC contraction of the gel as a result of contraction being con-
strained by the bonding of the gel edges to the support ring, which would result in
a gradient of high to low tension from edge to centre (Figure 5.14), tension having
been previously shown to aﬀect angiogenesis by Korﬀ and Augustin (1999).
6.2 A model of early LN vascularisation
The question of when and how the LN anlagen becomes vascularised remains out-
standing, with the early development of the inguinal and axillary/brachial nodes as
investigated by Bénézech et al. (2010) and Vondenhoﬀ et al. (2009a), respectively, be-
ing apparently contradictory in their observations regarding the organisation of the
endothelial and stromal layers, with the inguinal node shown to be composed of an
endothelial bud surrounded by stromawhile the opposite appeared to be the case for
the brachial node. These apparent diﬀerences may be a result of the diﬀerent timing
of their development, or it may be the case that there are diﬀerences in the initial de-
velopment of diﬀerent LNs, as is the case for bronchus-associated lymphoid tissue,
for example, which is induced by IL-17 and is LT-independent in its initial stages of
formation, yet still requires CCL19 and CXCL13 (Rangel-Moreno, Carragher et al.,
2011). However, the development of the inguinal node at later stages does not ap-
pear to reﬂect axillary or brachial node development at any of the stages studied.
The data shown in Figures 3.2 and 3.3 bear some structural similarities with the data
presented by Vondenhoﬀ et al. (2009a), both showing LTi and LTo cells surrounded
by a lymph sac, albeit using diﬀerent markers to identify the diﬀerent cell types. The
key diﬀerence is that in Figure 3.3 no vessels were seen to be present within the LTi
clusters, while Vondenhoﬀ et al. (2009a) convincingly showed that several diﬀerent
vessel types, identiﬁed using VEGFR1, VEGFR2 and MECA-32, were present inside
the E14.5 brachial node anlagen, some potentially also expressing LTβR as present
upon developedHEVs and lymphatic vessels within the LN (Liao and Ruddle, 2006).
If present, these may have been missed in Figure 3.3 due to a combination of the an-
tibodies used such as endomucin potentially not staining endothelial markers being
expressed at this developmental timepoint (Foster et al., 2008), and markers such as
MECA-32 may have by chance not stained sections containing a full cross-section
through the anlagen, and consequently these observations can not refute the ﬁnd-
ings of Vondenhoﬀ et al. (2009a).
Given the observations from the spheroid model that the environment is pre-
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dominantly anti-angiogenic, and the additional observation that physical forces such
as matrix tension also inﬂuence angiogenesis, Figure 6.1 presents a tentative model
which combines these eﬀects, taking into account the above observations regarding
early anlagen structure and also the observation that during development the cells
of the anlagen progressively condense (Coles et al., 2010). This model proposes that
the mesenchyme, during the process of condensation, will impose contractile forces
upon its surroundings. In the case of the adjacent lymph sac, this will be pulled
around the mesenchyme, which could result in the the formation of the “pocket”
containing the LTis observed in Figure 3.2. Contraction may also induce vascular-
isation, not by growth factors, given the net anti-angiogenic environment observed
experimentally, but by pulling vascular loops into the condensing mass. This pro-
cess of “looping angiogenesis” has been shown to be important in the revascular-
isation of granulation tissue by Kilarski et al. (2009), who demonstrated that a ﬁb-
rin/collagen matrix could pull vessels from an existing vascular bed, and that the
process was blocked by preventing gel contraction by mixing in glass ﬁbres. This
observation leads to the question of whether this plays a role in development, es-
pecially given the fact that repair processes appear to recapitulate developmental
processes (Schultz and Wysocki, 2009; Sephel et al., 1996).
Naturally, this model does not preclude the inﬂuence of pro- and anti-angiogenic
factors and the more common forms of sprouting and intussusceptive angiogen-
esis, which would be required for elaboration of the initial vascular supply into the
highly-branched structures seen in the developed node (Willard-Mack, 2006). How-
ever, biomechanical extrusion of vascular loops may play a role in the initial acquis-
ition of blood vasculature by the anlagen, which may explain how the E14.5 brachial
node observed by Vondenhoﬀ et al. (2009a) came to contain MECA-32+ vessels in
a predominantly anti-angiogenic environment prior to extensive stromal activation
by LTis. This process operates at a higher order of tissue organisation than sprout-
ing and intussusceptive angiogenesis, which act at the level of single cells and small
groups of cells respectively (sprouts and tissue pillars), whereas looping angiogen-
esis leads to the reorganisation of the route and positioning of entire groups of ves-
sels (Burri and Djonov, 2002; Kilarski et al., 2009). This process may therefore play a
wider role in general vascular organisation during development. The in vitro ﬁnd-
ings that the anlagen generate a net anti-angiogenic environment does not preclude
local pro-angiogenic environments where pro-angiogenic factors reach a threshold
concentration capable of negating the anti-angiogenic background, resulting in con-
trolled angiogenic outgrowth in speciﬁc locations (Chappell et al., 2009; Kappas et al.,
2008). Such highly-localised eﬀects would not have been detectable using RTPCR or
the in vitro spheroid model.
In addition to condensation of the mesenchyme, the lymph sac structure might
additionally arise due to matrix contraction by the lymphatic endothelium itself,
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1) Formation of lymphoid anlage
2) Initial condensation drives lymph sac remodelling and angiogenesis
3) Further condensation, collagen contraction,
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paracortical vascular
loops
Supcapsular
sinus
Lymphatic
endothelium
LTo/MRC
LTi
Collagen
ﬁbres
Blood
vessel
FRC
Lymph sac
Mesenchyme
Capillary within mesenchyme
Lymph sac pulled around
condensing mesenchyme
Capillary loop pulled into condensing mesenchyme
Figure 6.1: Model of condensation-driven LN vascularisation and organisation. The
mesenchyme adjacent to the lymph sac is initially avascular, with capillaries present in
themesenchyme at a distance. LTi- and LTo-mediated condensation of themesenchyme
pulls a capillary loop into the anlage as a result of the resulting contractile forces, i.e.
looping angiogenesis. The condensation also has the eﬀect of pulling the lymph sac
around the condensing structure. Further elaboration of this simple structure, includ-
ing further tissue condensation, contraction of collagen ﬁbres in the extracellular mat-
rix, and further development of organised cellular structures results in the formation
of the mature LN vasculature, including its HEVs in medullary and paracortical vascu-
lar loops, connected to the subcapsular sinus by the conduit system of reticular ﬁbres
ensheathed by FRCs.
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given the observation that ECs are capable of matrix contraction. If the cells adja-
cent to the stroma contract the matrix more strongly than those on the outer face,
this would result in eversion of the sac. In Figure 3.3 (panels A–D in particular),
the density of cells outside the lymph sac shown by DAPI staining is signiﬁcantly
lower than inside. This might result in diﬀerential contraction of the lymph sac, or
may arise in consequence of the contraction and/or condensation taking place. The
structuremay therefore arise due to stromal condensation, lymph sac-mediatedmat-
rix contraction, or a combination of the two.
6.3 Hypoxia, organogenesis and vascularisation
Hypoxia has been shown to be critically important during development, in particular
its induction of VEGF-A demonstrates the importance of hypoxia-driven angiogen-
esis in the maintenance of a stable oxygen supply to tissues, and in inducing tissue
vascularisation during development (Iyer et al., 1998). The presence of diﬀerential
hypoxia was demonstrated in the mouse embryo by Lee et al. (2001), for example in
the heart ventricle and head mesenchyme while Nanka et al. (2006) demonstrated
a direct link, albeit in the quail, between hypoxia, VEGF expression and the dens-
ity of the vascular beds. In this model, the condensing mesenchyme of the limb
buds became hypoxic; hypoxia resulting from mesenchymal condensation has also
been found to occur in the developing endochondral bones as a result of chondro-
cyte condensation, resulting in the induction of HIF-1α-mediated responses, shown
by Provot et al. (2007) and reviewed by Dunwoodie (2009). If condensation-induced
hypoxia also occurs in the LN anlagen, this may therefore be both responsible for
vascular remodelling as well as in mesenchymal diﬀerentiation.
Lymphocytes are unable to gain entry to the LN until P3, when the HEVs switch
from expressing MAdCAM to PNAd (Randall et al., 2008). In consequence, at this
timepoint T and B cells expressing LT are able to replace LTis and in greater num-
bers given the low frequency of LTis in peripheral blood (Mebius et al., 1997), which
may result in increased oxygen demand from the increased cellularity of the LN,
and hence an increase in hypoxia-induced angiogenesis. In addition, the reticular
networks are formed as a result of contact with lymphocytes, and thus the comple-
tion of stromal development can not commence until the arrival of lymphocytes in
the node (Katakai et al., 2004). This may imply that the LN vascularisation proceeds
in two stages: initial vascularisation during development, followed by remodelling
to adapt to the increased metabolic demands of a functional node and completion of
stromal organisation.
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6.4 Coordination of vascular and stromal organisation
The development of a functional node depends upon two major events to occur in
parallel: the formation of the lymph sac and the induction of the stroma. These
events are to some extent independent; the stroma has been shown in at least some
situations to be induced by CXCL13 signalling resulting from neuronal-derived RA
signalling (van de Pavert et al., 2009). Additionally, it has been shown by the same
group that lymph sacs are not strictly required for stromal patterning (Vondenhoﬀ
et al., 2009b), however the phenotype of the conditional Prox1 mutants used was
complex. Defects were noted in stromal diﬀerentiation, and the authors suggested
that this could be explained by the positioning of the LTis being aﬀected by the lack
of LECs. The model described in Figure 6.1 could potentially explain these changes:
as the lymph sac is pulled around the condensing mesenchyme, it may act as a phys-
ical barrier to cellular migration (due to the presence of a basement membrane and
high cell density) in addition to the adhesion molecules used to retain LTis after
stromal activation. This may result in the retention of the LTis within a conﬁned
area and a consequent increase in the duration and frequency of their interaction
with stromal cells. This physical boundary and LTi partitioning is particularly obvi-
ous in Figures 3.2(C) and 3.3(A–D). In consequence, the lack of lymph sac may result
in decreased eﬃciency of LTi–stromal interactions, leading to reduced stromal activ-
ation and hence reduced LTi retention, decreasing the positive feedback observed to
occur during normal development (Roozendaal and Mebius, 2011).
6.5 Future directions
The existing observations both in this thesis and by Vondenhoﬀ et al. (2009a) do not
include development prior to E14.5. However, at E14.5 LTis contained within the
enclosing lymph sac indicate that development began at an earlier timepoint given
the signiﬁcant amount of structure already present. It is therefore necessary to study
earlier timepoints through imaging, for example E12.5 and E13.5, in order to observe
the initial events of LN induction. This would provide further insight into the struc-
tural changes taking place prior to LTi inﬁltration. Of particular importance would
be to image the structures in 3-D using confocal or MP microscopy in order to fully
comprehend the organisation in three dimensions, since from the existing 2-D data
the “pocket” structure could be a fold rather than a pocket, which would have im-
plications regarding the constraints imposed upon the movement of cells within it.
Given the requirement for the vascular and stromal organisation to be coordin-
ated, it is possible that both these somewhat independent processes are coordinated
by an as-yet unidentiﬁed signal. The trigger for LEC speciﬁcation in the cardinal
veins is unknown. Given the link between neural-derived RA in induction of stromal
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CXCL13 expression, it is possible that neural-derived signals are also responsible for
triggering lymphatic development, perhaps in combination with some other signal
found at venous conﬂuences in order to create the conditions for inducing the spe-
ciﬁc patterning observed. Correlation of the timescale of innervation, angiogenesis
and lymphangiogenesis at the sites of LNdevelopmentmay provide further insights.
Given the discrepancies between the axillary/brachial and inguinal nodes in the
observations of Bénézech et al. (2010) and Vondenhoﬀ et al. (2009a), further study of
all the peripheral nodes at all timepoints is required in order to understand the diﬀer-
ences between the nodes, in particular, whether the diﬀerences are merely temporal,
or if the diﬀerent LNs have diﬀerent requirements for the initial stromal and/or vas-
cular speciﬁcation. Diﬀerences are already known for other lymphoid tissues, for ex-
ample the requirement in Peyer’s patch formation for LTin cells in addition to LTis,
and in bronchus-associated lymphoid tissue which is is LT- and LTi-independent,
induced by IL-17, and also in the formation of tertiary lymphoid structures during
inﬂammation (Coles et al., 2010; Gräbner, Lötzer et al., 2009; Muniz, Pacer et al., 2011;
Randall et al., 2008; Rangel-Moreno et al., 2011). It may therefore be the case that
peripheral secondary lymphoid organs are not completely identical in the cellular
and molecular requirements for their induction.
In vitromodellingmay be used to studywhether themodel proposed in Figure 6.1
is possible by creating models containing sorted LTis and LTos or stromal cells con-
tainedwithin collagen gels of diﬀering compliancy (concentration) andwith deﬁned
shape, in order to constrain cellular movements. Such a model could prove whether
constraining LTi movement aﬀects the activation of LTos, which could be assessed
by observing the upregulation of appropriate markers, for example adhesion mo-
lecules, using imaging or ﬂow cytometry.
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Deﬁnitions
2-D two-dimensional
3-D three-dimensional
ADAM a disintegrin and metallopeptidase domain
ADAMTS a disintegrin and metallopeptidase domain with thrombospondin
motifs
AF Alexa Fluor
APC antigen presenting cell
BABB benzyl alcohol benzyl benzoate
BAEC bovine aortic endothelial cell
bFGF basic ﬁbroblast growth factor
BEC blood endothelial cell
BSA bovine serum albumin
CAD computer aided design
CAM computer aided manufacturing
CCL CC chemokine ligand
CCR CC chemokine receptor
CD cluster of diﬀerentiation
CD144 See VE-cadherin
CD31 See PECAM-1
C3H/10T½ multipotent mesenchymal cell line, derived from the C3H mouse
CFSE carboxyﬂuorescein succinimidyl ester
CMTMR chloromethyl tetramethylrhodamine
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226 DEFINITIONS
CXCL CXC chemokine ligand
CXCR CXC chemokine receptor
DAG diacylglycerol
DAPI 4￿,6-diamidino-2-phenylindole
DC dendritic cell
DMDCS dimethyldichlorosilane
DMEM Dulbecco’s modiﬁed Eagle’s medium
DMSO dimethyl sulphoxide
DPBS Dulbecco’s phosphate buﬀered saline
EC endothelial cell
ECGS/H endothelial cell growth supplement / hypothalamus
ECM extracellular matrix
ECGM endothelial cell growth medium
ECGM MV2 endothelial cell growth medium (microvascular) 2
EDTA ethylenediaminetetraacetic acid
EF eFluor quantum dot ﬂuorophore
ERK extracellular-regulated kinase
FBS fœtal bovine serum
FDC follicular dendritic cell
FGF ﬁbroblast growth factor
FGFR ﬁbroblast growth factor receptor
FITC ﬂuorescein isothiocyanate
FLIM ﬂuorescence lifetime imaging
FRC ﬁbroblastic reticular cell
FRET Förster resonance energy transfer
FS forward scatter
GFP green ﬂuorescent protein
DEFINITIONS 227
Gp38 glycoprotein 38; podoplanin
hCD2-GFP human-CD2-GFP
HDLEC human dermal lymphatic endothelial cell
HEPES-BSS 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buﬀered saline
solution
HEV high endothelial venule
HIF-1α hypoxia inducible factor-1α
HRE hypoxic response element
HUVEC human umbilical vein endothelial cell
ICAM intercellular adhesion molecule
ID2 inhibitor of DNA binding 2
IDC interdigiating dendritic cell
IL interleukin
IP3 inositol trisphosphate
IMDM Iscove’s modiﬁed Dulbecco’s medium
LEC lymphatic endothelial cell
LN lymph node
LT lymphotoxin
LTβR lymphotoxin-β receptor
LTi lymphoid tissue inducer
LTo lymphoid tissue organiser
MAdCAM mucosal addressin cellular adhesion molecule
MAPK mitogen-activated protein kinase
MEK MAP kinase kinase
MOI multiplicity of infection
MØ macrophage
MP multiphoton
228 DEFINITIONS
MMP matrix metallopeptidase
MRC marginal reticular cell
MT-MMP membrane-type matrix metallopeptidase
NA numerical aperture
NDD non-descanned detector
NG2 neuron-glial 2
NO nitric oxide
OCT optimal cutting temperature embedding medium
PBS phosphate buﬀered saline
PCR polymerase chain reaction
PDGF platelet-derived growth factor
PDGFRβ platelet-derived growth factor receptor β
PDMS poly(dimethylsiloxane)
PECAM-1 platelet/endothelial cell adhesion molecule 1
PEDF pigment epithelium-derived factor
PEDFR pigment epithelium-derived factor receptor
PEG polyethylene glycol
PEI poly(ethylenimine)
PEN poly(ethylene 2,6-napthalate)
PFA paraformaldehyde
PI3K phosphatidylinositol 3-kinase
PIP2 phosphatidylinositol 4,5-bisphosphate
PIP3 phosphatidylinositol 3,4,5-trisphosphate
PLCγ phospholipase Cγ
PKB protein kinase B
PKC protein kinase C
PLGA polylactic co-glycolic acid
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PlGF placental growth factor
PMA phorbol 12-myristate 13-acetate
PNAd peripheral node addressin
PPAR-γ proliferator-activated receptor γ
RA retinoic acid
RALDH2 retinaldehyde dehydrogenase 2
RANK receptor activator of NF-κB
RANKL receptor activator of NF-κB ligand
RARE retinoic acid response element
RT room temperature
RTPCR quantitative real-time reverse transcriptase PCR
RTV room temperature vulcanising
RORγt retinoic acid receptor-related orphan receptor-γt
SEM scanning electron microscopy
SHG second harmonic generation
α-SMA α-smooth muscle actin
S1P sphingosine-1-phosphate
SS side scatter
TEM transmission electron microscopy
TGF-β1 transforming growth factor β1
TIMP tissue inhibitor of metalloproteinases
TNF tumour necrosis factor
TRANCE TNF-related activation-induced cytokine
TRANCER TNF-related activation-induced cytokine receptor
VCAM vascular cell adhesion molecule
VE-cadherin vascular endothelial cadherin
VEGF vascular endothelial growth factor
230 DEFINITIONS
VEGFR vascular endothelial growth factor receptor
VSMC vascular smooth muscle cell
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